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Urinary tract infections (UTIs) are the second most common infection seen by general
practitioners (GPs) in the elderly. UTIs in the elderly can lead to serious complications
with increased risk of mortality, yet there are no national or international dedicated
guidelines for antibiotic treatment in this patient group. The epidemiology of UTIs in the
United Kingdom (UK) for the elderly population and GPs’ antibiotics prescribing for this
condition have received little or no attention. This thesis describes GPs’ antibiotics
prescribing for UTIs in elderly patients in the UK by exploring the prevalence of UTIs in
elderly patients, auditing GPs’ antibiotics prescribing, explaining the variations in GPs’
views and perceptions and identifying the factors that may influence or affect GPs’
antibiotics prescribing using a mixed methods approach.
To achieve research aim, a comprehensive explanatory sequential mixed methods
approach was undertaken. The initial research was quantitative and took the form of a
retrospective, cross-sectional, drug utilisation study that included elderly patients’ data
retrieved from electronics medical records, namely, Disease Analyzer (IMS-DA), for the
period between 1 January 2010 and 31 December 2012. The subsequent research was
qualitative and took a phenomenographic approach with two analytical techniques:
phenomenographic analysis and thematic analysis, with data collected through semi-
structured interviews with 17 GPs.
The results from the quantitative study identified 77,290 UTI visits by 21,150 elderly
patients, of whom 77.42% (N = 16,375) received at least one antibiotic prescription per
visit over the study period. The mean age and sex adjusted UTI prevalence was found to
be 23.35 (95% CI 21.84-24.85) per 1,000 person-years for year 2010, 21.44 (95% CI
19.99-22.88) per 1,000 person-years for year 2011 and 17.88 (95% CI 16.56-19.19) per
1,000 person-years. The total number of issued antibiotics prescriptions for UTIs during
the study period was 37,815. Adherence results showed that 9,125 (24.1%) broad-
spectrum antibiotics prescriptions were issued for elderly patients, including
ciprofloxacin (N = 1,733; 4.6%), co-amoxiclav (N = 2,350; 6.2%) and cephalexin (N =
5,042; 13.3%). Additionally, 32.2% (N = 12,159) of antibiotics prescriptions were
prescribed for durations other than those recommended either for treatment or for
prophylaxis; this was seen in 10,605 (33%) female patients’ UTI antibiotics prescriptions
and 1,554 (27.5%) male patients’ UTI antibiotics prescriptions. The findings from the
qualitative study identified five distinct categories of description representing the ways in
which GPs perceive antibiotics prescribing in elderly patients with UTIs. These categories
are perceptions, knowledge, decision, practice and approach. Moreover, GPs’ knowledge
and perceptions about antibiotics were found to be shaped through seven external
horizons: undergraduate education, postgraduate training, personal experience,
interaction with peers, interaction and influence of patients’ expectations, the healthcare
system, and availability of guidelines and evidence. Additionally, the thematic analysis
revealed 29 factors that may influence GPs’ antibiotics prescribing for UTIs including:
GPs’ personal experience and familiarity with specific antibiotics, GPs’ education,
knowledge and training, complacency, GPs’ fear, responsibility of other healthcare
professionals, GPs’ awareness about antibiotic resistance threat, GPs’ awareness about
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microbial resistance results and information GPs’ awareness about local resistance
pattern, GPs’ antibiotic prescribing concerns, diagnosis and clinical decision making by
GPs’, GPs’ ethos and ethical values, patient’s age and gender, patient’s medical history
and clinical characteristics, patient’s social situation and living conditions, patient’s level
of understanding and knowledge, patient’s desire for a quick fix, patient’s autonomy,
visits and education by prescribing advisors, audit, monitoring and feedback of
prescribing, influence by secondary care doctor prescribing practice, implementation of
local policies, guidance and formulary, time, guidelines and evidence, antibiotics
shortage, incentives, media, cost, healthcare resources and constraints, pharmaceutical
companies, over-prescribing and society experience and expectation.
In conclusion, the findings from the mixed methods research confirmed that some GPs in
the UK are less likely to adhere to available good practice points for the management of
UTIs in elderly patients, that there are variations among GPs’ views and perceptions about
antibiotics and that GPs’ antibiotics prescribing practice is influenced by various factors
such as guidelines, complacency, clinical presentation, resistance, and audit and
feedback. The results highlight the need to optimise and rationalise GPs’ antibiotics
prescribing in the elderly by developing robust guidelines synthesised specifically for the
elderly population based on studies and evidence from literature designed for elderly
patients, to increase GPs’ awareness of and familiarity with guidelines, to increase their
uptake and involve GPs in the process of evidence synthesis because of their knowledge
of the context of general practice. There is also a need to implement a multifaceted
intensive approach with the aim of minimising variations in GPs’ views for AMR and
approaching elderly patients, modifying GPs’ antibiotics perceptions and determining
whether  they  will  change  their  practice,  correcting  some  GPs’  misperceptions  such  as
patients’ expectations of antibiotics and patients’ satisfaction through encouraging
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A response to a drug that is noxious and unintended and occurs at doses
normally used in man for the prophylaxis, diagnosis or therapy of disease
or for modification of physiological function (Cluff et al. 1972, p. 9).
Ageing
Chronological age, that is, time elapsed since birth; and any person aged
65 years or over is often referred to as ‘elderly’ (Orimo 2006, Shi et al.
2008, WHO 2010, Singh and Bajorek 2014).
Antibiotics Chemical substances which have the capacity to inhibit the growth andeven to destroy pathogenic organisms (Waksman 1952, p. 370).
Antimicrobial resistance
The is resistance of a microorganism to an antimicrobial drug that was
originally effective for treatment of infections caused by it (Ashiru-
Oredope et al. 2014, p. 6).
Antimicrobial stewardship
An organisational or healthcare-system-wide approach to promoting and
monitoring judicious use of antimicrobials to preserve their future
effectiveness (Cefai et al. 2015, p. 7).
Appropriate antibiotic use
CPSG
The use of antimicrobials in the most appropriate way for the treatment
or prevention of human infectious diseases, having regard to the
diagnosis (or presumed diagnosis), evidence of clinical effectiveness,
likely benefits, safety, cost (in comparison with alternative choices), and
propensity for the emergence of resistance. The most appropriate way
implies  that  the  choice,  route,  dose,  frequency  and  duration  of
administration have been rigorously determined (Clinical Prescribing
Subgroup 2001, p. 8).
Appropriate antibiotic use
WHO
The cost-effective use of antimicrobials which maximises their clinical
therapeutic effect, while minimising both drug-related toxicity and the
development of antimicrobial resistance (Stamm et al. 2001, p. 15).
Broad-spectrum antibiotics Antibiotics that target many pathogens (Genao and Buhr 2012, Murrayet al. 2013b).
Co-morbidity Combination of additional diseases beyond an index disorder(Marengoni et al. 2011, p. 430).
Confirmability Objectivity (neutrality) and the control of researcher bias (Lincoln andGuba 1985, Ritchie et al. 2014).
Credibility
A quality assessment of whether the data convincingly describe the
phenomenon under investigation (Lincoln and Guba 1985, Ritchie et al.
2014).
Days of therapy
Number of days that a patient receives a certain antibiotic, independently
of the quantity and used doses (Grau et al. 2013, Schechner et al. 2013,
WHO Collaborating Centre 2015).
Defined daily dose
The assumed average maintenance dose per day for a drug used for its
main indication in adults (Grau et al. 2013, Schechner et al. 2013, WHO
Collaborating Centre 2015).
Dependability A concept of consistency of the findings when the research replicated(Lincoln and Guba 1985, Ritchie et al. 2014).
Drug utilisation review
WHO
Studies or research related to marketing, distribution, prescription and
use of drugs in a society, with special emphasis on the resulting medical,
social, and economic consequences (Birkett et al. 2003, p. 8).
Drug utilisation review
North America
Research or studies related to the prescribing, dispensing and ingesting
of drugs (Brodie 1971, p. 1).
Epistemology The manner by which knowledge is constructed and the relationship ofthe knower to the known (Guba and Lincoln 1994, p. 108).
External horizon The way in which the phenomenon is delimited from and related to itscontext (Barnard et al. 1999, p. 216).
General practice
First level contact with people to improve health in a community. In a
system with a gatekeeper, all initial (non-emergency) consultations with
doctors, nurses or other health staff (Lakhani et al. 2007, p. 4).
General practitioners
Personal doctors, primarily responsible for the provision of
comprehensive and continuing generalist care to every individual
seeking medical care irrespective of age, sex and state of health (Lakhani





A term concerned with the extent to which research findings can be
relevant beyond the setting and context in which they were generated,
that is, outside the sample in which the research was conducted (Lincoln
and Guba 1985, Mays and Pope 2000).
Grey literature
Literature which is produced on all levels of government, academics,
business and industry in print and electronic formats, but which is not
controlled by commercial publisher (Farace and Frantzen 1998, p. iii).
Hawthorne effect
A phenomenon where a study subject’s behaviour and/or study
outcomes are altered as a result of the subject’s awareness of being under
observation (Mangione-Smith et al. 2002, p. 1604).
Human behaviour
The collective range of behaviours performed by humans, influenced by
a number of factors such as attitudes, culture, ethics, emotions, values,
rapport, authority, persuasion, coercion and/or genetics; while the way a
human being acts is determined more by their attitudes, genetics, core
faith and social norms (Ajzen 2005).
Internal horizon How component parts of the phenomenon are understood and are relatedto each other (Barnard et al. 1999, p. 216).
Length of therapy
Number of days that a patient receives an antibiotic irrespective of the
number of different drugs (Grau et al. 2013, Schechner et al. 2013, WHO
Collaborating Centre 2015).
Literature review The comprehensive study and interpretation of literature that relates to aparticular topic (Aveyard 2014, p. 1).
Macro-level factors Factors related to society, national or international context (Watt et al.2007, p. 29).
Meso-level factors Factors related to practice or CCG context (Watt et al. 2007, p. 29).
Methodological approach
Framework that brings together broad research assumptions into a
detailed plan, data collection method(s), analysis of data and
interpretation of research findings (Harwell 2011, Creswell 2014).
Micro-level factors Factors related to individual GP and patient interaction context (Watt etal. 2007, p. 29).
Mixed methods
Class of research where the researcher mixes or combines quantitative
and qualitative research techniques, methods, approaches, concepts or
language into a single study. Mixed methods research also is an attempt
to legitimate the use of multiple approaches in answering research
questions, rather than restricting or constraining researchers’ choices
(i.e., it rejects dogmatism).
It is an expansive and creative form of research, not a limiting form of
research. It is inclusive, pluralistic, and complementary, and it suggests
that researchers take an eclectic approach to method selection and the
thinking about and conduct of research (Johnson and Onwuegbuzie
2004, pp. 17-18).
Multi-morbidity The coexistence of multiple chronic diseases (Marengoni et al. 2011, p.430).
Narrow-spectrum
antibiotics
Antibiotics that target a limited range of pathogens (Genao and Buhr
2012, Murray et al. 2013b).
Ontology The nature of reality (Guba and Lincoln 1994, p. 108).
Outcome space
A graphical, hierarchical presentation of findings which consists of a
related set of a finite number of categories of description that collectively
expresses the variety of ways in which the phenomenon under study is
experienced by a group of individuals in a given context, that is, real
world (Åkerlind 2005).
Patterns of antibiotic use The extent and profiles of antibiotic use and the trends in antibiotic useover time (Birkett et al. 2003).
Perception
An individual’s or group’s unique way of viewing phenomena,
involving the processing of stimuli and incorporate memories and
experiences in the process of understanding. (McDonald 2012, p. 8).
Pharmacoepidemiology
The study of the use and effects/side-effects of drugs in large numbers
of people with the purpose of supporting the rational and cost-effective
use of drugs in the population thereby improving health outcomes






A qualitative analysis in which data is analysed and discussed from a
second-order perspective that described how the phenomenon was
viewed and understood by the participants rather than how it was
understood by the researcher (Marton and Booth 1997).
Phenomenography
A research method for mapping the qualitatively different ways in which
people experience, conceptualise, perceive, and understand various
aspects of, and various phenomena in, the world around them (Marton
1986, p. 31).
Polypharmacy
Quantitative: Concurrently taking two or more drugs for 240 days or
more; or administering at least two to nine drugs concurrently (Veehof
et al. 2000).
Qualitative: The prescription, administration or use of more drugs than
are clinically indicated in a given patient (Montamat and Cusack 1992).
Prescribed daily dose
The average dose prescribed according to a representative sample of
prescriptions (Grau et al. 2013, Schechner et  al. 2013,  WHO
Collaborating Centre 2015).
Prevalence Measures of all cases in the population who have the disease within aspecified time frame (Kier 2011, p. 12).
Prudent prescribing of
antibiotics
Prudent (or optimal) use meant both ‘less’, there still being leeway to
reduce unnecessary use, and ‘appropriate’ (not only the right antibiotic
but also the right dose, administered by the most appropriate route and
for the right length of time to effect a clinical cure, while minimising
side effects and the development of resistance) (Clinical Prescribing
Subgroup 2001, p. 8).
Qualitative research
A broad term used to describe a wide range of diverse research
approaches in respect to research aims, theoretical assumptions,
understanding of phenomenon under investigation, methodological
focus and the methods they apply (Flick et al. 2004).
Recruitment The process whereby the researcher identifies and invites (recruits)participants to join the study (Given 2008, p. 743).
Recruitment adequacy Sufficient, relevant data being generated through the participants(Bassett 2004).
Recruitment
appropriateness
Selecting participants with relevant experience and knowledge to inform
the research (Bassett 2004).
Thematic analysis
Independent qualitative and descriptive method that is mainly used to
identify, analyse and report patterns, that is, themes, within data in
nuanced and rich details (Braun and Clarke 2006, p. 79).
Transferability Whether the descriptions and interpretations in the study are useful inother contexts (Lincoln and Guba 1986, Guba and Lincoln 1992).
Triangulation
The process of combining different study groups, methods, temporal and
local settings, and different theoretical perspectives in dealing with a
phenomenon. As a strategy, triangulation aims to promote and improve
the quality of qualitative research, that is, reliability and validity (Flick
2009).
UTIs
The presence and multiplication of microorganism(s), in one or more
structures of the urinary tract, with associated tissue invasion (Cowling





This chapter consists of four sections that together represent a general overview of the
research topic. Of the sections, the first provides a brief overview of primary care and
general  practitioners  (GPs)  in  the  United  Kingdom  (UK);  the  second  outlines  the
behaviours and problems associated with GPs’ antibiotics prescribing, along with
antibiotics consumption in primary care; the third focuses on age-related changes and
infectious diseases as well as antibiotics use in the elderly; and the fourth gives general
information about urinary tract infections (UTIs) in the elderly.
1.2 UK Primary Care and the GP Workforce
Definitions and Responsibilities
In the UK, general practice surgeries (GP surgeries) are the first point of access to
healthcare (Kennedy et al. 2011). The Royal College of General Practitioners (RCGP)
defines general practice as:
‘First level contact with people taking action to improve health in a community.
In a system with a gatekeeper, all initial (non-emergency) consultations with
doctors, nurses or other health staff’ (Lakhani et al. 2007, p. 4);
whereas GPs are:
‘Personal doctors, primarily responsible for the provision of comprehensive and
continuing generalist care to every individual seeking medical care irrespective
of age, sex and state of health’ (Lakhani et al. 2007, p. 4).
One  of  a  UK  GP’s  core  duties  –  alongside  offering  patient  consultations,  referrals,
screening, immunisation, managing long-term conditions and promoting health – is safely
prescribing drugs to patients if needed (Lakhani et al. 2007).
In  the  UK,  any  person  wanting  to  become  a  GP1 must go through a five-year
undergraduate programme in medical school followed by a two-year foundation level
1The terms ‘GP’, ‘doctor’, ‘family medicine’ and ‘physician’ are different and have specific definitions.
However, they are often used interchangeably in the relevant literature. Thus, in this thesis they are used
interchangeably to refer to GPs.
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programme, then a three-year postgraduate course, with 18 months spent in hospitals
seeing a wide range of acute conditions at first hand and the other 18 months spent in one
or two general practices (Knowles and Bliss 2014). GPs as healthcare professionals
(HCPs) have a mindset centred on patients’ best care by considering patients as priorities
and providing excellent quality care (Papanikitas and Toon 2011). In general practice,
ethos and values are usually strong and GPs tend to have an open-ended relationship with
their patients, many of whom are different generations of the same families (Cocksedge
et al. 2011).
Although there is no accurate official number, it was estimated that approximately 98%
of the total UK population (N > 59 million) are registered with primary care GPs under
the National Health Service (NHS), through which the medical services provided are
mostly free of charge (Baker 2011, HSCIC 2012). The rest of the population may not be
registered with a GP owing to special situations such as being homeless, a prisoner or a
member of the armed forces (Lawrenson et al. 1999).
GPs Workforce in the UK
There are 43,009 practising GPs, excluding locums, working in 9,783 GP surgeries across
the UK’s (BMA 2014). The majority of practising GPs in the UK (N = 26,236, 61%) are
female. It is estimated that 340 million consultations are undertaken every year with
people seeing their GP six times a year on average, which is double the number of visits
from the previous decade (BMA 2014). Every day, more than 800,000 people are seen in
GP surgeries by either GPs or practice nurses. In 2014, the estimated average time a GP
spent with each patient was 12 minutes (Knowles and Bliss 2014).
Figure 1 illustrates the 2013 GP workforce distributed across the UK’s four nations. This
number of GPs is insufficient to cope with the current challenges including financial
viability, declined income, GPs quitting the profession, increased workload, demand for
superior care quality and time pressures that potentially prevent GPs from making
informed decisions, particularly for an ageing population with complex health conditions
(BMA 2014). Therefore, the quality of services provided, including prescribing, are likely
to become compromised negatively as a result of this shortage and high demand. A
recently published British Medical Association (BMA) survey of 2,830 GP surgeries
across England showed that 1,202 (46%) had GPs in their workforce (N = 294, 10%) who
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were intending to leave the UK because they believe it to be financially ‘unsustainable’
(BMA 2016).
1.3 Antibiotics
There is no doubt that the introduction of antibiotics in 1941 revolutionised medicine; it
was one of the landmark advances in clinical practice of modern medicine (Powers 2004).
Worldwide, infections such as pneumonia, diphtheria, tuberculosis and diarrhoea were
the  main  causes  of  death  in  children  and  adults  during  the  19th  century  (Zaffiri et al.
2012). The discovery and introduction of antibiotics to treat infections allowed for such
a remarkable increase in human life expectancies that, in 1967, William Stewart, the
Surgeon General of the United States of America (USA), said:
‘It is time to close the book on infectious diseases, and declare the war against
pestilence won’ (Martinez and Baquero 2014, p. 68).
Furthermore, the added value of antibiotics for prophylactic and therapeutic purposes was
so persuasive that many older antibiotics never underwent any randomised controlled
clinical trials (RCTs) to assess their efficacy and safety (Hulscher et al. 2010).
The term ‘antibiotics’ was first used in literature by American biochemist and
microbiologist Selman Waksman, in 1942, to describe a substance produced by an
organism known as Actinomyces antibioticus with the capability to kill  and inhibit  the















The GP workforce in the UK for 2013
General practice surgeries Practicing GPs
Chapter One: Introduction
21
growth of bacteria (Waksman and Tishler 1942). Later, during his inaugural speech at the
Nobel Prize awards ceremony in 1952, he defined antibiotics as:
‘Chemical substances which have the capacity to inhibit the growth and even to
destroy pathogenic organisms’ (Waksman 1952, p. 370).
Originally, the word ‘antibiotic2’ was coined to describe compounds with antimicrobial
properties that come from natural sources, such as specific strains of fungus or bacteria,
as opposed to ‘antibacterial’, which was used to describe synthetic compounds with
similar activity. However, antibiotics no longer refers only to compounds from natural
origin (Pelaez 2006).
Historical Overview
The history of antibiotics was linked to several scientists including Paul Ehrlich,
Alexander  Fleming,  Gerhard  Domagk,  Howard  Florey,  Ernst  Chain  and  Selman
Waksman (Aminov 2010). All of these received Nobel Prize, the most prestigious awards
for intellectual achievement in the world, for their valuable contributions to the discovery
and development of antibiotics (Nobelprize.org 2007a, Nobelprize.org 2007b,
Nobelprize.org 2007c).
In 1904, Paul Ehrlich, a German bacteriologist, introduced the concept of the ‘magic
bullet’, which was based on laboratory observation. It described how a substance can
selectively target or attack only the microorganisms that cause diseases but not the host.
This observation led him to start a series of large-scale, systematic screening trials to find
a drug that was active against Treponema pallidum,  a syphilis-causing microorganism
that was widespread and incurable at that time. He and his colleagues discovered the first
chemical cure for syphilis in 1909 (Strebhardt and Ullrich 2008).
Then, in 1928, Scottish bacteriologist and immunologist Alexander Fleming left
uncovered culture plates of Staphylococci in the laboratory of Saint Mary’s Hospital in
London whilst he went on holiday. When he returned, he noticed that many culture plates
were contaminated with a mould that had produced a yellow substance, which in turn had
created what appeared to be a zone of lysed bacteria, that is, it had inhibited the bacterial
2 The terms ‘antibacterials’, ‘antibiotics’ and ‘antimicrobials’ are different and have specific definitions.
However, they are often used interchangeably in the relevant literature. Thus, in this thesis they are used
interchangeably to refer to natural and synthetic compounds that target bacteria.
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growth. Fleming consequently investigated this phenomenon by culturing the mould,
which he later described as Penicillium notatum, and successfully isolating an active
substance that had the ability to inhibit bacterial growth. He called it penicillin (Hoff et
al. 2008).
In 1932, Gerhard Domagk, a German pharmacologist, started testing the antibiotic
properties of a red dye used to colour cloths and known as prontosil red, because of its
brilliant colour. Gerhard discovered that this dye was capable of curing Streptococcal
infections in mice. Through doing this, he discovered sulphanilamide, a sulphonamide
compound produced as a result of prontosil dye metabolism. In 1943, Domagk’s six-year-
old  daughter  became  seriously  sick  because  of  infection  with  a Streptococcal
microorganism. Her desperate father injected his daughter with prontosil, thus saving her
from arm amputation and death (Iyer 2008, Maruta 2009).
Taking matters further still, in 1940, Australian pathologist Howard Florey, with the
assistance of Ernst Chain, a German chemist, successfully extracted, purified and
described the protocol for penicillin production. This led to penicillin being produced in
commercial quantities to treat infections in injured soldiers during World War II (WWII).
These soldiers were among the first people in history to benefit from antibiotics, and
thousands of young soldiers’ lives were saved (Kardos and Demain 2013).
In 1943, Selman Waksman, an American biochemist and microbiologist, discovered
streptomycin while screening soil-derived Streptomycetes for their antimicrobial
activities against a susceptible test microorganism by detecting zones of growth inhibition
on an overlay plate. Waksman’s assistants, Elizabeth Bugie and Albert Schatz, performed
preliminary investigations on streptomycin and results showed that it had antibiotic
activity against a wide range of bacteria including Mycobacterium tuberculosis, which
causes tuberculosis infection (Woodruff 2014). Figure 2 illustrates the timeline for the




Figure 2: Antibiotics discovery, market introduction and resistance development timeline and classification according to chemical structure, activity and
site of action (Compound Interest 2014)










Demand for new generations of antibiotics to replace the old, relatively ineffective ones
has increased dramatically in recent years. However, the development pipeline is strained,
with only a few novel classes of antibiotics – glycylcycline, lipopeptide, pleuromutilin,
novel glycolipopeptide, macrocyclic and diarylquinoline – having been marketed since
2000 (Butler et al. 2013, Laxminarayan 2014). Unfortunately, none of these new classes
targets bacterial strains, which are often deadly such as Klebsiella pneumoniae
carbapenemase (KPC) and known to adapt more readily to antibiotics (Renwick et al.
2016). In 2015, a new antibiotic class known as teixobactin was discovered in the USA
(Piddock 2015). Although it has been found to be active against many bacteria such as
Staphylococcus aureus, Clostridium difficile, Bacillus anthracis and Mycobacterium
tuberculosis, it is still at an early stage of development and there are no guarantees that it
will reach the market (Piddock 2015). There are currently at least 19 antibiotics in clinical
development in the European Union (UN) and the USA, although there is no known
development timeline for these (Renwick et al. 2016).
Antibiotics Classification
More than 100 antibiotics have been identified since the discovery of penicillin, which
has led to the creation of a more practical and convenient method for classifying
antibiotics. As any classification system can provide researchers and HCPs with a
framework for remembering and understanding the use of different agents (Goering et al.
2012), it was necessary to highlight some key terms that will be used frequently in this
thesis.
The first classification system was based on antibiotic chemical structure alone, which
had no place in practice because of the diversity of this method. However, when chemical
structure  is  combined  with  the  antibiotic  site  of  action  it  provides  a  useful  working
classification. The key groups in this classification are beta-lactam, macrolides,
lincosamides, aminoglycosides, tetracyclines, polypeptides, sulphonamides,
fluoroquinolones and miscellaneous (Genao and Buhr 2012, Murray et al. 2013b). A
second classification system was based on antibiotic spectrum of activity, which can be
either narrow or broad depending on the number of different bacterial species against
which they exert their activity (Genao and Buhr 2012, Murray et  al. 2013b). A third
Chapter One: Introduction
25
classification system was based on antibiotic site of action, which was considered more
convenient than using chemical structure. Antibiotics can exert action on cell wall
synthesis, protein synthesis, nucleic acid synthesis, metabolic pathways and cell
membrane function. Other classifications that may be used to describe antibiotics include
route of administration, for example whether oral or parenteral, and type of activity,
which can be either bactericidal, that is, it kills the infecting microorganisms directly, or
bacteriostatic, that is, it inhibits the growth and replication of the infecting pathogens and
limits the spread of infection, allowing the immune system to eliminate the bacteria
(Genao and Buhr 2012, Murray et al. 2013b). Figure 2 illustrates examples of antibiotic
groups classified according to activity type and chemical structure.
Antibiotics Use and Resistance
Unlike other drugs, antibiotics act on living pathogens, rather than on just the patient
(Zaffiri et al. 2012). This has caused bacteria to evolve and develop traits that enable them
to survive exposure to antibiotics, that is, antimicrobial resistance (AMR) (Smith et al.
2014), which can be defined as:
‘Resistance of a microorganism to an antimicrobial drug that was originally
effective for treatment of infections caused by it’ (Ashiru-Oredope et al. 2014, p.
6)
Alexander Fleming predicted resistance in 1945 when he received his Nobel Prize for
discovering penicillin. During the award ceremony he delivered a lecture to the audience
in which he stated:
‘The time may come when penicillin can be bought by anyone in the shops. Then
there is the danger that the ignorant man may easily under-dose himself and by
exposing his microbes to nonlethal quantities of the drug make them resistant’
(Fleming 1945b, p. 83).
Fleming’s increasing worries about resistance made him repeat his warning every time
he gave a speech or interview as if he felt strongly that this was an upcoming threat, for
example when he stated:
‘The public will demand penicillin…then will begin an era…of abuses. The
microbes are educated to resist penicillin and a host of penicillin-fast organisms
is bred out which can be passed to other individuals and perhaps from there to
others until they reach someone who gets a septicaemia or a pneumonia which
penicillin cannot save. In such a case the thoughtless person playing with
penicillin treatment is morally responsible for the death of the man who finally
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succumbs to infection with the penicillin-resistant organism. – I hope the evil will
be averted .’(Fleming 1945a, p. 21).
Resistance is a natural phenomenon and it can be either clinical, resulting from an
inadequate level of antimicrobial concentration within the tissue or fluid, or
microbiological, where the pathogen possesses a resistant mechanism (Blair et al. 2015).
The latter can be divided into either intrinsic (primary) or acquired (secondary) and is
determined genetically by pathogen characteristics that include the cell wall, enzymes
and biochemistry (Blair et al. 2015).
In the past two decades, AMR has increased dramatically to the extent where it has created
the fear that the world might return to the era of pre-antibiotics (Tomaras and Dunman
2015).  This  rise  in  AMR  was  a  result  of  several  factors  such  as  reduction  in  the
development of novel antibiotics by many large pharmaceutical companies because of
both the low return on investment, since they are prescribed for short duration and have
the potential to lose their activity owing to resistance, and the implementation of
antimicrobial stewardship programmes that keep the new antibiotics in reserve. In
addition, research and development of new antibiotics is more expensive because of
complicated regulatory requirements. Moreover, the new screening methods for possible
compounds have not been as successful as was expected (MacGowan and Macnaughton
2013). Other reasons for the increase in AMR include overuse or misuse of antibiotics in
human as well as increased use of antibiotics in food industry, veterinary medicine and
for growth promotion and disease prevention in agriculture (Laxminarayan et al. 2013).
Recently, Public Health England (PHE) report for combined antibiotic use in humans and
animals in the UK showed that the total UK antibiotics use across humans and animals
was 949.9 tonnes of active ingredients in 2013, with 531.9 tonnes (56%) used by humans
alone (Borriello et  al. 2015). Analysis of IMS (Intercontinental Marketing Service)
Health sales data aimed at estimating global human antibiotics consumption from 2000
through 2010, combining direct sales data from manufacturers and indirect sales data
from wholesalers to estimate the total volume of antibiotics sold in hospitals and retail
pharmacies in 71 countries including the UK, showed an increase of 36%, from
approximately 4,083,964,813 standard units3 to 73,620,748,816 standard units (van
Boeckel et al. 2014).
3 The number of sold doses. A dose can be a pill, a capsule or an ampoule.
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Relating to humans, several studies (Steinke et al. 2001, Goossens et al. 2005), a meta-
analysis (Bell et al. 2014) and a systematic review (Costelloe et al. 2010) have linked the
emergence of AMR with excessive antibiotics consumption, exposure and overall uptake
of antibiotics. Additionally, antibiotics misuse and overuse have been identified as key
drivers for AMR in a systematic review (Kardas et al. 2005). Moreover, the link between
level of antibiotics prescribing and prevalence of AMR has been recognised at the
individual (Costelloe et al. 2010), general practice (Schmiemann et al. 2012) and country-
wide level (Goossens et al. 2005).
The impact of AMR can be catastrophic and should not be underestimated as it can lead
to several negative consequences such as increased length and severity of infection
experienced by individuals, spread of infection, limited use of techniques that require
infection control, use of alternative antibiotics with lesser-known safety profiles,
increased financial cost of treatment and care, increased morbidity and increased time off
work (Maragakis et al. 2008, Llor and Bjerrum 2014). A technical report by the European
Centre for Disease Prevention and Control (ECDC) showed that AMR was responsible
for almost 400,000 patients getting infected with multiple drug resistance bacteria and
about 25,000 patient deaths each year (Norrby et al. 2009). Furthermore, the report
estimated the annual cost associated with AMR to be at least €1.5 billion on extra
healthcare costs and productivity losses alone. If complications associated with AMR are
considered, the estimated annual cost can jump to €9 billion just within Europe (Verhoef
et al. 2005).
If the current AMR scenario continues to rise, it is estimated that it will lead to the death
of 300 million people over the next 35 years, with expected financial losses, in terms of
economic output, of $60 trillion to $100 trillion (Taylor et al. 2014). A recently published
governmental report by the Cabinet Office showed that the UK government also expects
a dramatic increase in AMR over the next 20 years. Furthermore, if this increase in
resistance becomes an outbreak, almost 200,000 people will be affected by bacterial blood
infection that might not respond effectively to the currently available antibiotics and
might cause the death of 80,000 people (Cabinet Office 2015).
To assist in the reduction of these negative consequences of resistance, the UK
government has therefore developed a five-year AMR strategy with the overarching aim
of  slowing  the  development  and  spread  of  AMR  by  focusing  on  three  strategic  aims:
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improving the knowledge and understanding of AMR; conserving and stewarding the
effectiveness of existing treatments; and stimulating the development of new antibiotics,
diagnostics and novel therapies (Davies and Gibben 2013).
Inappropriate Antibiotic Prescribing in Primary Care
The efficacy of currently available antibiotics is fading just when practitioners are facing
serious mounting issues relating to antibiotics. Many practitioners even prescribe
antibiotics to patients using the maxim ‘It cannot hurt’ meaning that, even if it does not
exert an action as intended, the risk of harm is relatively minimal (McDonnell Norms
Group 2008). This mistaken perception is probably because of antibiotics use coming at
no cost to either patients or society (McDonnell Norms Group 2008). Other factors such
as HCPs’ attitudes, patients’ satisfaction, demands and expectations (Lopez-Vazquez et
al. 2012, Teixeira Rodrigues et al. 2013, Teixeira Rodrigues et al. 2016) as well as end
of patency of most antibiotics, making them cheaper owing to the availability of several
generic preparations, have resulted in increased inappropriate antibiotics prescribing,
neglecting the fact that they can cause harm (Ebert 2007, Powers 2009). Worldwide, it
was found that around 20%–50% of antibiotics were prescribed inappropriately or
unnecessarily (Tonna 2009, Ashiru-Oredope et al. 2012).
The World Health Organization (WHO) defined appropriate antibiotics use as:
‘The cost-effective use of antimicrobials which maximises their clinical
therapeutic effect, while minimising both drug-related toxicity and the
development of antimicrobial resistance’ (Stamm et al. 2001, p. 15).
In the UK, the Clinical Prescribing Subgroup (CPSG) of the Interdepartmental Steering
Group on Antimicrobial Resistance (IDSG) defined appropriate antimicrobial use as:
‘The use of antimicrobials in the most appropriate way for the treatment or
prevention of human infectious diseases, having regard to the diagnosis (or
presumed diagnosis), evidence of clinical effectiveness, likely benefits, safety, cost
(in comparison with alternative choices), and propensity for the emergence of
resistance. The most appropriate way implies that the choice, route, dose,
frequency and duration of administration have been rigorously determined
(Clinical Prescribing Subgroup 2001, p. 8).
Furthermore, the CPSG steering committee, has introduced the following statement to
describe the prudent prescribing of antibiotics:
‘In line with this definition, the CPSG considered that prudent (or optimal) use
meant both ‘less’, there still being leeway to reduce unnecessary use, and
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‘appropriate’ (not only the right antibiotic but also the right dose, administered
by the most appropriate route and for the right length of time to effect a clinical
cure, while minimising side effects and the development of resistance).’ (Clinical
Prescribing Subgroup 2001, p. 8).
Unlike the WHO definition, the CPSG definitions were comprehensive and covered all
aspects of antibiotic use. Moreover, the definitions provided an insight into how
appropriate antibiotics use can be a multifaceted and intricate process integrating both the
decision and the selection in the prescribing process.
In  general,  it  is  clear  that  appropriate  use  of  antibiotics  does  not  simply  mean that  all
antibiotics prescribing should be widely and blindly reduced. Although withholding
antibiotics is prudent if they are not clinically indicated, there are many circumstances in
which they are. Linking between falls in antibiotics prescribing for some infections can
cause death owing to pneumonia, for instance (NHS 2003). Even when antibiotics are
clinically indicated they are sometimes prescribed and used inappropriately. Therefore,
GPs must satisfy several important criteria before they can consider their prescribing to
be appropriate (Slama et al. 2005, Leekha et al. 2011). Table 1 summarises appropriate
prescribing criteria as well as the common forms of inappropriate prescribing in clinical
practice.
Table 1: Summary of criteria for appropriate antibiotics prescribing and some common forms of
inappropriate antibiotics prescribing in clinical practice
Criteria for appropriate antibiotics
prescribing (Slama et al. 2005, Leekha et al.
2011)
Common forms of inappropriate antibiotics
prescribing (Leekha et al. 2011, McCoy
2013)
 Accurate diagnosis
 Understand the difference between
empiric and definitive therapy
 Select the appropriate dosage, route,
interval and identify when to switch to
narrow-spectrum, cost-effective oral agent
for the shortest duration necessary
 Understand drug characteristics factors
that are peculiar to antimicrobial agents
 Consider patient’s characteristics factors
which might influence antibiotic activity
 Recognise the adverse effects of
antibiotics on the patient
 Prescribing antibiotics for non-bacterial
infections
 Not prescribing antibiotics for infections
that require treatment
 Prescribing expensive antibiotics
compared with a similar spectrum agent
 Prescribing too broad-spectrum
antibiotics; prescribing too narrow-
spectrum antibiotics; prescribing for too
long or too short a duration
 Prescribing an inappropriate route
 Prescribing an inappropriate dose
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In primary care, prescribing practice can be challenging since it involves autonomy – of
GPs, especially with regards to decision-making, on one hand and of patients, in terms of
having the right to make their own medical decisions, without the influence of any HCPs
on the other (Stiggelbout et al. 2004). However, this can creates ethical dilemmas over
which takes priority, which sometimes exposes patients to higher risk of complications,
longer illness duration and increased risk of mortality if the expected benefit of antibiotics
therapy is not sufficiently substantial (Littmann and Viens 2015).
In the UK, GPs are regularly blamed for inappropriate antibiotics prescribing and there
have been many calls to penalise ‘soft-touch’ GPs who prescribe too many antibiotics
(McCartney 2015, NICE 2015a). Professor Mark Baker, director of the Centre for Clinical
Practice at the National Institute for Health and Care Excellence (NICE), UK, highlighted
on GPs’ inappropriate antibiotics prescribing when he stated:
'In England, GPs are responsible for 10 million inappropriate prescriptions each
year’ (NICE 2015a).
Results from a Longitude Prize4 survey of 1,004 GPs across the UK showed that 49% (N
= 492) admitted to prescribing antibiotics at least once a week without knowing whether
they were necessary, 45% (N = 452) prescribed antibiotics for viral infections knowing
that they would not be effective, 44% (N = 444) prescribed antibiotics to get a patient to
leave the consulting room and 72% (N = 723) prescribed antibiotics despite being unsure
whether the infection was bacterial or viral. Moreover, 90% (N= 904) of GPs said they
feel under pressure to prescribe antibiotics (NESTA poll 2014) and 97% of patients who
requested antibiotics get them (McNulty et al. 2013). This irrational prescribing is likely
to aggravate the growing AMR crisis and threaten both healthcare and the public.
Increased inappropriate antibiotics prescribing by GPs has led many governmental
organisations  within  the  UK,  such  as  NICE,  PHE  and  RCGP,  to  develop  a  wealth  of
initiatives and interventions targeting GPs with the aim of increasing the appropriateness
of antibiotics prescribing in part through changing GPs’ knowledge, attitudes and
practices (Harris 2013). One of the most important interventions was developing of
antibiotics prescribing stewardship competence programmes, which refer to:
‘An organisational or healthcare-system-wide approach to promoting and
monitoring judicious use of antimicrobials to preserve their future effectiveness’
(Cefai et al. 2015, p. 7).
4 A national science prize in which the public vote for the most pressing issue facing humanity.
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This was achieved through the implementation of the Treat Antibiotics Responsibly,
Guidance, Education, Tools (TARGET) Antibiotics Toolkit resources programme, which
was developed through PHE and RCGP collaboration and launched in November 2012.
TARGET resources included local and national guidance on antibiotics treatment
recommendations, educational materials and tools GPs can share with patients during
consultations including information on expected duration of infection, self-care and back-
up prescriptions and suggested antibiotics practice audits. TARGET materials were
updated in 2013 following preliminary users testing and evaluation (Ashiru-Oredope et
al. 2016).
Another intervention included appointing prescribing advisors, mainly pharmacists with
specialised knowledge of drugs and prescribing issues in primary care (Pinder et al.
2015). These pharmacists were employed by the local Clinical Commission Group (CCG)
mostly to support and advise GPs on all aspects of drugs prescribing and the therapy
process to promote rational prescribing with improved pharmaceutical care, promoting
patient safety, ensuring that GPs adherence to local formularies and curbing prescribing
cost (Duerden et al. 2011). Prescribing advisors have made considerable efforts in recent
years to steer GP choice away from broad-spectrum antibiotics such as quinolones and
cephalosporins, which has resulted in significantly reduced Clostridium difficile infection
and resistance owing to these drugs (Ashiru-Oredope et al. 2012).
A third intervention involved auditing of antibiotic prescribing with feedback. For many
years, audit and feedback was used widely to promote the implementation of research
evidence and evaluate the quality of antibiotics prescribing by comparing GPs’
prescribing patterns with guidelines and peers (Pinder et al. 2015). Audit and feedback
was found to be one of the most effective methods of encouraging behaviour change,
according to a NICE guide aimed at encouraging HCPs to change their practice to
improve patient care (Eccles et al. 2007). Auditing activity is usually carried out by a
prescribing advisor or a medicine management team, either pharmacist-led or GP-led, and
can include all aspects of the supply and use of drugs, from individual drug reviews to
health promotion programmes (Blenkinsopp and Bond 2008), on behalf of GP surgeries,
particularly those participating in antibiotics incentive scheme or known for over-
prescribing behaviour. The number of performed audits may be subject to time
availability as it is a labour-intensive process and could require educational feedback on
over-prescribing (McNulty and Francis 2010). It was found that delivering audit feedback
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to GPs individually can influence their prescribing on a personal or local level. However,
to extend the influence to the macro-level, a national feedback action must be carried out
to disseminate key messages to as many GPs as possible (Watt et al. 2007). The impact
of national feedback was reported to substantially reduce antibiotics prescribing at low
cost as it was evident by a recently published RCT in the UK aimed to reduce unnecessary
prescriptions of antibiotics by GPs in England. (Hallsworth et al. 2016).
A fourth intervention included antibiotics incentive scheme that focused on linking
payments to the achievement of previously set targets designed to reward and motivate
GPs to achieve higher levels of performance and improve prescribing cost-effectiveness
(Mason et  al. 2005, Goodwin et al. 2011). This is usually done by examining the total
number of antibiotics items and the number of broad-spectrum antibiotics prescribed by
GPs participated in the scheme in relation to patient population. This incentive has been
found to improve antibiotics prescribing, reduce prescribing cost and change GPs’
prescribing behaviour (McNulty and Francis 2010). Recently, NHS England launched the
world’s largest healthcare incentive scheme to reduce the number of antibiotics prescribed
in primary care by 4%, or to the average performance levels of 2013/14, by supporting
each CCG with up to £150,000 a year (NHS 2016).
Additional activities included European Antibiotic Awareness Day, which falls on 18
November each year, the Antibiotic Guardian pledge campaign, to slow resistance and
cut unnecessary use of antibiotics and antibiotics prescribing leads (Harris 2013, Pinder
et al. 2015). Moreover, these organisations have encouraged all GPs to get involved in
educational and training programmes, use local and national guidelines, delayed
prescribing approach, use the decision support system, pathways and tools, and enhance
communication skills with patients (Harris 2013, Llor and Bjerrum 2014, Pinder et al.
2015).
GPs’ Antibiotics Prescribing Behaviour
GPs’ prescribing behaviour is a very broad concept that incorporates a variety of
dimensions. To date, there is no precise consensus on the definition of behaviour (Stålsby
Lundborg and Tamhankar 2014). Human behaviour might describes the collective range
of behaviours performed by individual, influenced by a number of factors such as
attitudes, culture, ethics, emotions, values, rapport, authority, persuasion, coercion and/or
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genetics; while the way a human being acts is determined more by their attitudes,
genetics, core faith and social norms (Ajzen 2005).
In practice, the decision to prescribe antibiotics is made during consultation with a patient.
The  process  of  prescribing  an  antibiotic  is  not  a  simple  one-way  process  from  GP  to
patient; rather, it is the result of considering complex behavioural interactions among
different stakeholders, including the GP, the patient and the healthcare system (Ranji et
al. 2006, Lopez-Vazquez et al. 2012, Teixeira Rodrigues et al. 2013). In the UK, Bradley
(1992) conducted a qualitative interview study in northern England to explore the
discomfort experienced by 74 GPs in relation to decisions about whether or not to
prescribe. The findings revealed that GPs consider antibiotics prescribing one of the most
uncomfortable prescribing decisions they make owing to pharmacological reasons such
as toxicity and efficacy and non-pharmacological reasons such as workload, anger and
ignorance (Bradley 1992).
GPs’ antibiotics prescribing behaviour can be influenced by a number of factors – on five
main ecological levels – emphasising the interaction between, and interdependence of,
factors within and across all levels of a health problem as highlighted by literature (Rimer
and Glanz 2005, Teixeira Rodrigues et al. 2013, Stålsby Lundborg and Tamhankar 2014).
Moreover, some of these factors can be changed or modified through changing GPs’
behaviour, as shown by a qualitative semi-structured interview study of 18 UK GPs
(Armstrong et  al. 1996). These ecological levels are: 1) individual-level knowledge,
attitudes, beliefs and personality, for example prescribing in case of diagnostic
uncertainty; 2) interpersonal-level social identity, for example GP–patient relationship;
3) institutional-level rules, guidelines, regulations and informal structures; 4) community-
level social networks and norms, for example, prescribing liberally or restrictively; and
5) public policy-level regulations and laws, for example restricting policy on antibiotics
(Stålsby Lundborg and Tamhankar 2014). In the literature, factors that influence
antibiotics prescribing were grouped contextually into intrinsic factors (GPs’ knowledge,
attitudes and socio-demographics) and extrinsic factors (patients, the pharmaceutical
industry and the healthcare system) as it  was shown in two systematic reviews one for
qualitative literature (Teixeira Rodrigues et al. 2016) and one for quantitative literature
(Lopez-Vazquez et al. 2012). Table 2 summarises the intrinsic and extrinsic factors that
affect GPs’ antibiotics prescribing behaviour, as in-depth understanding these is essential
for combating inappropriate antibiotics prescribing, minimising AMR and designing
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effective interventions (Tonkin-Crine et  al. 2015, Teixeira Rodrigues et al. 2016). A
systematic review by Arnold and Straus (2005) showed that the effectiveness of any
intervention to improve antibiotics prescribing depends on physicians’ behaviour and the
barriers within the community setting (Arnold and Straus 2005). Since exploring the
factors influencing GPs’ antibiotics prescribing practice in UTIs is one of this thesis’ main
objectives, the factors are discussed in more detail in Chapter Two.
Table 2: Summary of the intrinsic and extrinsic factors that inÀuence GPs’ antibiotics prescribing
behaviour(Lopez-Vazquez et al. 2012, Teixeira Rodrigues et al. 2013)
Each of these factors plus others such as the influence of the media (Hawkings et al. 2007,
Lambert et  al. 2007, Holloway 2011) and society’s experience and expectations
5 A general feeling or evaluation – positive or negative – about some person, object or issue (Hogg and
Vaughan 2014, p. 136).
6 Attitude that motivates the prescribing of antibiotics to ful¿l professionals’ perceptions of their
patients’/parents’ expectations.
7 Attitude relating to fear of possible future complications in the patient and/or fear of losing patients.
8 Lack of relationship between over-prescribing and antibiotic resistance, linked to lack of knowledge.
9 Lack of motivation to feel positively or negatively inclined to the problem of antibiotic prescribing.
10 Attitude underlying the belief that responsibility for generating antibiotic resistances lies other
professionals.
11 Describe the self-reliance felt by physicians when prescribing antibiotics.
Intrinsic factors






 Years of practice
 CME






 Responsibility of others10
 Con¿dence11
 Awareness of evidence
regarding antibiotics
efficacy
 Awareness of resistance
and over-prescribing
 Awareness of guideline
Extrinsic factors











 Desire to have a speedy
recovery






 Ownership of the practice
location
 Type & location of the
healthcare centre
 Private or public
 Accreditation level
 Implemented policies and
guidelines
 Cost savings and
financial incentives
 Prescribing pressure
CME: Continuing Medical Education
Chapter One: Introduction
35
(McDonnell Norms Group 2008) belong to one of the three levels of the healthcare system
paradigms – the macro (national/international) level, the meso (CCG and practice) level
or the micro (GP–patient) level – or they can operate across all three levels as shown in
Figure 3 which illustrates the factors that can impact prescribing across the healthcare
system level (Watt et al. 2007).
Figure 3: Factors influencing GPs’ prescribing behaviour at the macro, meso and micro levels of the
healthcare system (Watt et al. 2007, p. 10)
These factors in addition to the previously highlighted challenges may aggravate the
status of inappropriate antibiotics prescribing and spread AMR by preventing GPs from
prescribing antibiotics more prudently. Furthermore, no theoretical framework model has
been able to describe the interrelationships among these factors. As a result, no one has
been able to explain why the different interventions implemented such as GPs education
and training, diagnostic testing and restriction policies have not been as effective as was
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interrelationships among the factors was proposed by Teixeira Rodrigues et al. (2013), as
shown in Figure 4. This framework was based on the original knowledge, attitudes and
practices (KAP) model, which was developed in the 1950s to explain what is known,
believed  and  done  in  relation  to  a  particular  topic,  to  explain  the  possible
interrelationships. However, this framework was not validated.
Figure 4: Proposed theoretical framework of interrelationships among factors influencing antibiotics
prescribing (Teixeira Rodrigues et al. 2013, p. 210)
On the contrary, Stålsby Lundborg and Tamhankar described the interrelationships
between these factors using the word ‘chaos’ owing to the lack of a structured interrelated
framework (Stålsby Lundborg and Tamhankar 2014). This means that the problem of
inappropriate antibiotics prescribing is much more difficult than it seemed and might need
multifaceted interventions and strategies that incorporate all of these multiple,
independent interrelationship factors to resolve it. Changing GPs’ antibiotics prescribing
behaviour is a challenging mission; however, facilitating the process of behavioural
change in addition to using multifaceted behavioural science interventions seems to be a
feasible approach (Stålsby Lundborg and Tamhankar 2014, Pinder et al. 2015).
SDF: Sociodemographic factors
PI: Pharmaceutical industry
PRF: Patient related factors
HCSRF: Healthcare system related factors
KAP Model
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Antibiotics Consumption in UK Primary Care
AMR was found to be driven by the volume of antibiotics use, regardless of whether such
use is appropriate or not (Goossens et al. 2005, Laxminarayan and Heymann 2012).
Therefore, it is crucial to understand how antibiotics use is reported and what the sources
of reporting are for antibiotics consumption.12 Information on antibiotics consumption in
primary care is of great importance to those HCPs and policy-makers in developing
strategies to rationalise antibiotics use and slow the development of resistance,
monitoring progress towards a more prudent use of antibiotics, benchmarking
comparisons and evaluating the outcomes of antibiotics stewardship programmes and
interventions (Aarestrup et al. 2014, Weist et al. 2014).
Antibiotics use can be measured with metrics that reflect an aggregate or average amount
of antibiotics being consumed at the level of the patient, a unit or service, an entire
institution  or  at  the  national  level  (Morris  2014).  They  consist  of  a  numerator  and  a
denominator, for example, a unit of measure per 1,000 inhabitants per day. Table 3
summarises the measurement units commonly used to report antibiotics consumption,
with their advantages and disadvantages. Monitoring of consumption is usually presented
in combination with a consumption period, for example annual; a setting, for example
primary care; an indication, for example UTIs; and a level of data aggregation, for
example trimethoprim (Grau et al. 2013, Schechner et al. 2013).
These metrics can be used to describe the amounts of ordered antibiotics, dispensed
antibiotics and administered antibiotics, benchmarking and the ecological impact of
antibiotics use on resistance (Ibrahim and Polk 2014). The most widely used and accepted
unit of measurement for antibiotics consumption is defined daily dose (DDD), which was
developed in the 1970s and has been further refined and promoted by WHO methodology
(WHO Collaborating Centre 2015). However, owing to its lack of clinical relevance, it
should not be used to evaluate the impact of antimicrobial stewardship strategies. Days
of therapy (DOT) offers more clinical relevance to the healthcare provider than does DDD
(Morris 2014).
12 ‘Use’ and ‘consumption’ are used interchangeably to reflect the same meaning.
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Table 3: Summary of measurement units commonly used to report antibiotics consumption with
advantages and disadvantages (Grau et al. 2013, Schechner et al. 2013, WHO Collaborating Centre 2015)




maintenance dose per day
for a drug used for its main
indication in adults
 Common and easy to
collect
 Allows benchmarking
between drugs and settings
 Subject to bias when dose differs
significantly from the reference
value
 Longitudinal comparisons
difficult owing to WHO
continuous revision for reference
values
 Some WHO reference values





prescribed according to a
representative sample of
prescriptions
 Adjusted to the real
situation of the setting or
type of patient
 Not standardised
 Does not allow for benchmarking
between different settings
Days of Therapy (DOT):
The number of days that a
patient receives a certain
antibiotic, independently of
the quantity and used
doses
 Accurate estimation of
multiple drug therapy
 Not influenced by
discrepancy between DDD
and PDD
 Can be used in children
 Independent of DDD
changes
 Patient-level data are needed
 Does not reflect the given dose
Length of Therapy (LOT):
The number of days that a
patient receives an
antibiotic irrespective of
the number of different
drugs
 Accurate estimation of
duration of therapy
 Not influenced by
discrepancy between
administered drugs which
makes it suitable for
children
 Patient-level data are needed
 No reflection of multiple therapy
 No reflection of the dosage given
 Cannot be used to compare usage
of individual drugs
WHO: World Health Organisation
In the UK, information about antibiotics consumption can be obtained from different
local, national and international sources, sorted into primary care, secondary care or both
according to the setting and level of consumption required (Ashiru-Oredope et al. 2014).
The first source is the Electronic Prescribing Analysis and Cost database (ePACT.net),
which was established by the NHS-Business Services Authority (NHS-BSA) in 1988 to
provide primary care prescriptions data without patients’ specific information at local and
national levels. Recently, the system was upgraded to provide secondary care data as well.
This database provides information about all dispensed NHS prescriptions by community
pharmacists, GPs, nurses and dentists from all over the UK. Information about costs and
volumes from this database can be used for benchmarking between different
organisations (Ballarín et al. 2015). However, these data have many limitations such as
lack of indication records for which each antibiotic was prescribed, missing patients’
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gender and age information and inability to estimate what proportion of patients received
prescriptions (Hayward et al. 2007).
A second source is the European Surveillance of Antimicrobial Consumption-Network
(ESAC-Net). This is a Europe-wide network of national surveillance systems that
includes 29 EU countries for community data and 18 countries for hospital data and is
coordinated by the ECDC. ESAC-Net was launched in 2001 to monitor antibiotics
consumption in community and hospital care using standardised data. The network
publishes a variety of reports on subjects related to the prevention and control of
communicable diseases as well as annual surveillance and consumption reports (ECDC
2015). One of the main drawbacks of these data is their inability to provide individualised
hospital consumption information. A key advantage for these data is their ability to
provide community consumption information that is adjusted for regional population size
(ECDC 2015).
A third source is the English Surveillance Programme for Antimicrobial Utilisation and
Resistance (ESPAUR). This programme was established by PHE in 2013 in response to
the threat posed by AMR, as highlighted in the 2011 annual report of the UK Chief
Medical Officer (Davies 2013) and as part of the UK’s five-year strategy for tackling
AMR (Davies and Gibben 2013). The main aim of this programme was to monitor
antimicrobial  utilisation  and  resistance  in  both  primary  and  secondary  care,  and  to
monitor any unintentional clinical outcomes of future antimicrobial stewardship and
behaviour change interventions, that is, to act as a benchmark for organisations to
compare their quality measures and methods against regional and national standards
(Ashiru-Oredope and Hopkins 2013).
In September 2015, NHS England and the Health and Social Care Information Centre
(HSCIC) introduced a newer GP record and monitoring system known as care.data. This
system had the ability to link patients’ data from GP record systems with hospital data for
secondary uses. Data from this system included patients’ demographics, clinical
information, prescribing data and referrals (Barr 2015). However, the release of this
system was associated with debate about patients’ information security and ethics
associated with patients’ data sharing without obtaining their own consent (Barr 2015).
Owing to this debate and recommendation by a recent report published by the National
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Data Guardian for Health and Care, NHS England has made the decision to shut down
the system permanently (Freeman 2016).
All these sources have numerous advantages such as identifying trends in antibiotic
resistance, assessing the magnitude of new resistance threats, following the dynamics of
resistance trends, detecting new resistance mechanisms, monitoring the impact of
empirical prescribing and generating consumption and surveillance reports (Critchley and
Karlowsky 2004). However, none of these sources can record or document the proportion
of antibiotics prescriptions that was actually administered by patients (Shallcross and
Davies 2015). Perhaps one reason for this is the lack of infrastructure for measuring it,
especially with patients’ poor compliance (Morris 2014).
A recently published antimicrobial utilisation and resistance surveillance report by PHE
showed that the total measured consumption of antibiotics in England in 2013 was 27.4
DDD  per  1,000  inhabitants  per  day.  The  highest  consumption  was  reported  in  GP
surgeries (79%); and the individual prescription items of antibiotics for GP surgeries
numbered 1.9 items per 1,000 inhabitants per day (Ashiru-Oredope et  al. 2014). To
translate this number to prescriptions, it is equivalent to 41.6 million antibiotics
prescriptions at a cost to the NHS of £192 million (HSCIC 2014b) compared with 39.2
million antibiotics prescriptions during 2007 (HSCIC 2008). Figure 5 illustrates the
number of antibiotic items dispensed in UK primary care between 2004 and 2014. It
shows that both penicillin and macrolide consumption increased up to 2012 but decreased
in 2013. Nitrofurantoin consumption increased 41% between 2010 and 2013 owing to its
use for UTI, which was the largest increase observed. Broad-spectrum antibiotics such as
ciprofloxacin and cephalexin decreased, though amoxicillin-clavulanic acid (co-




Figure 5: Number of antibiotic items dispensed13 in the community between 2004 and 2014
(HSCIC 2015)
However, this figure may be underestimating the true consumption because it was
generated from a surveillance system that lacks consumption data from the private
13 Prescriptions dispensed in the community by community pharmacists and dispensing doctors in the UK.
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sectors. Furthermore, an increase of 4% in antibiotics consumption in GP surgeries
between 2010 and 2013 was also reported without knowledge of the exact causes behind
it. Proposed explanations for this increase include a higher number of patients presenting
with infections and requiring antibiotic therapy and GPs over-prescribing antibiotics
(Ashiru-Oredope et al. 2014).
Additionally, the report mentioned that only 15 antibiotics represented 98% of the total
antibiotics consumption via GP surgeries in England. Table 4 lists the top 15 antibiotics
prescribed in general practice in England in 2013. The trend of these items prescribing
shows a decrease in broad-spectrum antibiotics ciprofloxacin and cefalexin, but a
significant increase in co-amoxiclav. The findings from this report might suggest that
bacteria that used to be sensitive to these antibiotics might become resistant in the future
if the consumption continues to increase. Furthermore, caution is needed when
interpreting the relative changes in consumption of each antibiotic as an increase in one
antibiotic may cause a reduction in another, where an alternative drug is used for the same
clinical indication (Ashiru-Oredope et al. 2014).
Table 4: Ranks and relative consumption of the top 15 consumed agents in general practice in England,
2013 (Ashiru-Oredope et al. 2014)
Antibiotic Rank Proportion of all antibiotic Relative to 2010
Amoxicillin 1 29.3% í
Clarithromycin 2 7.9% Ĺ
Doxycycline 3 7.9% Ĺ
Lymecycline 4 7.9% Ĺ
Flucloxacillin 5 7.2% Ĺ
Trimethoprim 6 6.4% Ĺ
Erythromycin 7 6.1% Ĺ
Co-amoxiclav 8 6.0% Ĺ
Phenoxymethylpenicillin 9 5.3% Ĺ
Oxytetracycline 10 4.2% Ļ
Nitrofurantoin 11 3.8% Ĺ
Azithromycin 12 1.8% Ĺ
Ciprofloxacin 13 1.5% Ļ
Cephalexin 14 1.5% Ļ
Metronidazole 15 0.7% í
í: No change; Ĺ: Increased; Ļ: Decreased
Shallcross and Davies reported that there is marked variation in antibiotics prescribing
and consumption across the UK with some practices prescribing at double the rate of low-
prescribing practices. For instance, in England there was consistently higher consumption
of antibiotics in the northern regions compared with the southern regions (Shallcross and
Davies 2014). Figure 6 shows the proportion of patients in each CCG who received an
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antibiotic in 2012, with yellow representing the lowest consumption and dark blue
showing the highest. However, high consumption is not always synonymous with
inappropriate prescribing. Although high consumption might be responsible for
resistance, as shown earlier, inappropriate prescribing can be associated with other
negative outcomes such as adverse drug reactions (ADRs) and deterioration of patients’
clinical outcomes (Levent et al. 2012).
Figure 6: Proportion of registered patients in each CCG who received an antibiotic in 2012
(Shallcross and Davies 2014, p. 604)
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1.4 Ageing and the Elderly
An Ageing and Elderly Population
Ageing by itself is a diverse, inevitable, natural, complex and multi-factorial process in
which populations age at different rates and different stages because of both differences
in population genetics and the influence of a wide range of environmental factors such as
diet, exercise, exposure to pathogens, pollutants and ionising radiation (Nigam et al. 2012,
Shrivastava et al. 2013). The term ‘ageing’ does not have a concrete definition that can
be generalised to all individuals (Albert and Freedman 2010). However, it is usually
measured by chronological age, that is, time elapsed since birth; and any person aged 65
years or over is often referred to as ‘elderly’ (Orimo 2006, Shi et al. 2008, WHO 2010,
Singh and Bajorek 2014). From the age group perspective, people 65 years old are
classified as ‘old’ or ‘older’, while those from 65 through 74 years old are classified as
‘early-elderly’ and those over 75 years old are classified as ‘late-elderly’. However, the
evidence on which this definition is based is unknown (Orimo 2006).
Worldwide, there has been a dramatic shift in societies’ demographic structures in terms
of the ageing phenomenon. Population ageing has become a universal phenomenon with
a historic increase of individuals aged 65 by 10 million per year (Kinsella and Velkoff
2002, Lunenfeld 2008). WHO has predicted that, by 2050, the population aged 60 years
and over is expected to increase from 900 million in 2015 to 2 billion people, which
equates to an increase from 12% to 22% of the total global population. Furthermore, by
2050, the world will have almost 400 million people aged 80 years or older (WHO 2012a).
This change in societies’ demography has been driven by declines in population death
rates, caused by longevity, as well as declines in population fertility rates in both
developed14 and developing countries, the introduction of immunisation and improved
living standards especially in terms of drinking water, food and sewage (Suzman and
Beard 2011). This remarkable improvement in population life expectancy over the past
century has perhaps come about as part of the shift in diseases being the leading causes
of death. At the dawn of the 20th century, it was infectious diseases that most often
claimed the lives of the populations. Currently, non-communicable diseases, that is,
14 These comprise all regions of Europe and North America, Australia, Japan and New Zealand, while
developing countries are those not listed under developed countries (UN 2015).
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mainly cardiovascular diseases (CVDs), diabetes mellitus (DM) and stroke, more
commonly affect adults and the elderly and impose the greatest burden on global
healthcare (Suzman and Beard 2011). Consequently, the global trend in the phenomenon
of population ageing will have a dramatic impact on public health, healthcare financing
and the delivery of healthcare systems throughout the world (Rechel et al. 2013).
Although developed countries, those with an effective rate of industrialisation and
individual income (UN 2015), have the oldest elderly profile, the majority of older people
and the most rapidly ageing populations are in developing countries, which have a slow
rate of industrialisation and low per capita income (UN 2015). Between 2010 and 2050,
the number of elderly people in developing countries is projected to increase by more
than 250%, compared with a 71% increase in developed countries (Suzman and Beard
2011). Moreover, developed countries, which have already shown a dramatic increase in
people over 65 years of age, will experience a progressive ageing of the elderly population
(Lunenfeld 2008). Figure 7 lists some examples of countries ranked by population age 60
years and over.

























Examples of countries ranked by percentage of population


































In the UK, the population aged 65 and over has grown by 47% since mid-1974 to make
up nearly 18% (N = 11,627,424) of the total UK population in mid-2014. Furthermore,
the number of people aged 75 and over has increased by 89% over the same period and
now makes up 8% (N = 5,167,744) of the UK population. Compared with mid-2013, the
number of older people has grown from 11.1 million (17.4%) in mid-2013 to over 11.6
million (18%) in mid-2014 (ONS 2015b). It has been projected that by 2033 nearly 23%
(N = 16,473,290) of the UK population will be over 65 years old compared with 16.4%
(N = 9.2 million) in 2011 (Hestbaek et al. 2014). Figure 8 compares the percentage of
aged population in the UK between 2011 and 2033. Therefore, the coming years will see
high demand for healthcare services and resources, particularly for elderly care (Orlu-Gul
et al. 2014).
Figure 8: Comparison between the UK population aged 65 in 2011 and the projected elderly
population in 2033 (Hestbaek et al. 2014)
In the UK, preliminary data from a recently published ONS report revealed that elderly
population mortality rates increased in 2015 by 5.4% equating to almost 27,000 extra
deaths in just one year (ONS 2016). ONS figures show that mortality numbers have fallen
steadily since the 1970s, but the trend began to reverse in 2011 (ONS 2014). This rise in
mortality rate has made many health experts call for an urgent investigation into this






Changes Associated with Ageing
When ageing occurs, the progressive change in physiology starts to affect the whole body,
causing a decline in the function of multiple organs and systems such as the central
nervous systems (CNS), the cardiovascular system (CVS), the gastrointestinal tract
(GIT), the musculoskeletal system and the immune system. However, the magnitude of
these changes is hard to estimate (Homeier 2014). As a consequence of this loss from the
body’s functional reserve, elderly people become more susceptible to triggers to the
extent that any weak trigger may result in major morbidity and perhaps mortality (Durso
et al. 2010). This in part might explain why the prevalence of many diseases usually
increases exponentially with advancing age (Shi et al. 2008). Hence, ageing is associated
with many physiological changes in addition to increased risk of co-morbidity, which can
be defined as ‘combination of additional diseases beyond an index disorder’ (Marengoni
et al. 2011, p. 430) or multi-morbidity which can be defined as ‘the coexistence of
multiple chronic diseases’ (Marengoni et al. 2011, p. 430). Therefore normal ageing-
related physiological changes must be distinguished from specific diseases that usually
develop in old people (Timiras 2007).
Among others,  the  ageing  process  affects  the  urinary  system,  also  known as  the  renal
system. Anatomically, it consists of six organs: two kidneys, two ureters, the urinary
bladder and the urethra (Scanlon and Sanders 2011). The system is almost identical in
both genders except for a smaller bladder capacity and shorter and straight urethra in
females compared to males (Tortora and Derrickson 2008). Additionally, the urethra in
males serves not only the urinary system but also the reproductive system, by carrying
semen, that is, fluid that contains sperm (van De Graaff 2002). Within the urinary system,
the kidneys perform most of the functions compared with the other organs, which act
mainly as either passageways or storage areas. The kidneys are responsible for urine
formation (McCorry 2004). Other important functions of the kidneys are mainly
regulatory in nature and directly related to blood. These functions include regulation of
blood pressure, blood pH, blood electrolytes composition, blood volume and blood
glucose level; maintenance of blood osmolarity; hormone production; and excretion of




With advancing age, many anatomical and functional changes can occur in the urinary
system. Anatomically, the kidneys can shrink and blood supply can decrease, as can the
number of nephrons – the kidneys’ functional and structural units – often to half the
original number by the age of 70 to 80. This reduction in nephrons can lead to loss of
some of the kidneys’ concentrating abilities. Other changes in the urinary system may
include reduced urinary bladder size and decreased tone of the detrusor muscle, which
can lead to frequent urination and poor urine voiding, which can leave a residual volume
of urine in the bladder and predispose elderly to infection (ýukuranoviü and Vlajkoviü
2005, Macias Nuñez et al. 2008).
Infections in the Elderly
Infections in elderly people compared with younger persons are relatively more frequent,
severe and serious as a result of reduced body functional status (Heppner et al. 2013).
Thus, it should never be underestimated (Norman and Yoshikawa 2009). The elderly are
more prone to get colonised and infected with resistant pathogens, which can be
associated with increasing treatment failure and risk of complications and eventually
contribute to a higher mortality rate since infections are considered a leading cause of
death in this age group (Bradley 2007, Beckett et al. 2015). Frequently isolated resistant
pathogens in elderly people include methicillin-resistant Staphylococcus aureus (MRSA),
penicillin-resistant Streptococcus pneumoniae (PRSP), vancomycin-resistant enterococci
(VRE) and multiple-drug-resistant gram-negative bacilli (MDRGNB) (Yoshikawa 2002,
Heppner et al. 2013). Infections caused by these resistant pathogens are associated with
two- to 20-fold higher mortality rates compared with infections caused by antibiotic-
susceptible pathogens (Denkinger et al. 2013).  Figure 9 illustrates the mortality rate in
the elderly compared with younger individuals for common infections.
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Elderly susceptibility to infection was found to be multi-factorial; however, no single
factor has been identified as being solely responsible (Adedipe and Lowenstein 2006).
The relationships between these risk factors may be very complex (Bradley 2007, Weber
et al. 2009). These factors include ageing; immune system changes and developing
immunosenescence, that is, diminished host defences; presence of underlying co-
morbidities such as DM, malignancy and cerebrovascular accidents (CVA); malnutrition;
impaired functional status; increased exposure to infections particularly nosocomial
infections; complications from diagnostic and therapeutic procedures; and delays in
diagnosis and treatment as well as ADRs associated with antibiotics and complications
of polypharmacy (Htwe et al. 2007, Heppner et al. 2013). For example, the elderly have
an increased prevalence of UTIs because of age-related anatomic changes in the urinary
system, including prostatic enlargement in males, altered physiology and increased
bladder residual volume (Htwe et al. 2007, Heppner et al. 2013).
Special Considerations in Antibiotics Prescribing: An Elderly Perspective
Owing to the world population increasingly ageing and the high incidence of infection
that might be associated with risk of mortality, it is crucial for all HCPs to ensure that use
of antibiotics for suspected infection is appropriate and rational (Herring and Williamson
2007, Weber et al. 2009). In England, more than 30% (N = 11,760,000) of the 39.2 million
Figure 9: Common infections in the elderly and comparative mortality with younger adults
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antibiotic prescriptions that were reported in 2007 were dispensed to patients aged 60
years or over (Wang et  al. 2009). Therefore, GPs must carefully balance antibiotics
efficacy, safety and tolerability (Pea 2015) and avoid significant consequences such as
ADRs which can be defined as:
‘A response to a drug that is noxious and unintended and occurs at doses normally
used in man for the prophylaxis, diagnosis or therapy of disease, or for
modification of physiological function’ (Cluff et al. 1972, p. 9),
drug interactions and risks associated with drug-resistant pathogens and Clostridium
difficile (Beckett et al. 2015) whenever there is a need to prescribe an antibiotic for an
elderly patient.
In the elderly, several issues should be considered before prescribing an antibiotic. These
issues include the patient’s multi-morbidities or co-morbidities, poor compliance and
impaired mental and functional state, age associated pharmacokinetic (PK) and
pharmacodynamic (PD) changes, infected pathogens, as well as polypharmacy with the
inherent risk of ADRs and drug–drug interactions (Borrego and Gleckman 1997, Stalam
and Kaye 2004, Corsonello et al. 2015). Most of the literature about the effects of ageing
on antibiotics is relatively new (Herring and Williamson 2007) and the use of antibiotics
in elderly patients has been found to bring numerous challenges (Beckett et  al. 2015).
This could be owing to the elderly population were excluded from clinical trials of old
antibiotics and underrepresented in clinical trials of recent ones (Beckett et al. 2015).
Therefore, it is important to understand the relationship between ageing and antibiotics to
avoid any risk or form of inappropriate prescribing in this vulnerable age group.
1.4.4.1 Antibiotics and Age-related PK and PD Changes
Several age-related physiological changes can influence and alter the four main
components  of  PKs,  that  is,  what  the  body  does  to  the  antibiotic,  namely,  absorption,
distribution, metabolism and excretion (Weber et al. 2009, Asin-Prieto et al. 2015). PK
changes must be considered when treating infection in elderly patients as understanding
these could lead to significant improvement in the quality and appropriateness of
antibiotics prescribing in relation to choice, dose, frequency and route of administration
(Bergman et al. 2007). Ageing can affect PD, which include the pharmacological effects
of antibiotics on receptors, tissues and organs. These changes may alter the number of
receptors and affinity, signal transduction and homeostatic mechanisms. The effects may
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result in greater therapeutic benefits as well as increased potential for antibiotic toxicity
and sensitivity (Aymanns et al. 2010). Table 5 summarises and provides examples of the
common  changes  in  PK  components  and  PD  in  the  elderly  and  the  influence  of  these
changes on antibiotics.
Table 5: PK and PD issues to consider when prescribing antibiotics for elderly patients(Herring and
Williamson 2007, Bellmann-Weiler and Weiss 2009)










































protein binding site by
other molecule such as
uric acid, bilirubin or









Ĺ Į1-acid glycoprotein Ļ free concentrationof basic antibiotic Macrolides
Clearance
Ļ liver blood flow Slower rate ofclearance
Quinolones
Macrolides




Metabolism Ļ liver blood flow andmass
Ĺ oral bioavailability
due to reduced first
pass metabolism
Clarithromycin
Excretion Ļ renal blood flow andGFR
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1.4.4.2 ADRs Associated with Antibiotics in the Elderly
It is well documented that with advancing age, the risk, frequency and severity of
developing ADRs are increased (Norrby 1987, Herring and Williamson 2007). Although
elderly individuals have a two- or three-fold higher chance of developing ADRs from
antibiotics compared with younger age groups (Routledge et al. 2004, Bellmann-Weiler
and Weiss 2009), age by itself has not been identified as a consistent independent risk
factor for ADRs in elderly patients. Other risk factors may include multi-morbidities or
co-morbidities, disease severity, host sensitisation owing to previous administration of
antibiotics, metabolic conversion, increased drug deposition in the body, impaired renal
function, administration of unnecessarily large doses of antibiotics for long periods,
concomitant drugs use or concurrent therapy administered simultaneously with
antibiotics, poor compliance and age-related PK and PD changes (Faulkner et al. 2005,
Herring and Williamson 2007).
In the UK, one systematic review showed that antibiotics were one of the six classes of
drugs responsible for 60%–70% of all ADR hospital admissions in elderly patients
(Wiffen et al. 2002). Two prospective European studies showed that administration of
antibiotics in the elderly may result in emergency department visit and hospital admission
(Olivier et al. 2009, Conforti et al. 2012). ADRs associated with antibiotics in the elderly
can range from simple GIT manifestations such as nausea, vomiting and diarrhoea to
more serious ADRs such as arrhythmia and bone marrow suppression (Bolon and Weber
2009). Table 6 lists some of the commonly used antibiotics and the associated ADRs that
can occur in elderly patients.
Table 6: Examples of ADRs of commonly used antibiotics in the elderly for UTIs(Bolon and Weber
2009, p. 1522)
Antibiotic class/drug Common ADRs
Beta-lactam agents
Rash, hypersensitivity reactions, bone marrow toxicity, CNS
toxicity (seizure), interstitial nephritis, antibiotic-associated
diarrhoea, Clostridium difficile-associated diarrhoea
Fluoroquinolones
QT prolongation, torsade de pointes, CNS toxicity, peripheral
neuropathy, tendon rupture, Clostridium difficile-associated
diarrhoea
Nitrofurantoin Pulmonary infiltrates, peripheral neuropathy
Sulphonamides
Rash, hypersensitivity, Stevens-Johnson syndrome, GIT




1.4.4.3 Antibiotics and Polypharmacy
In elderly patients, concomitant administration of multiple drugs, that is, polypharmacy,
is often the rule rather than the exception (Mangoni 2012, Corsonello et al. 2015).
Definitions of polypharmacy in the elderly vary greatly across the literature. In the
European literature, researchers defined polypharmacy quantitatively according to the
number of drugs administered; whereas in the American literature researchers used
qualitative measures to define polypharmacy such as whether the administered drug was
clinically indicated or not (Fulton and Allen 2005). Some literature defined polypharmacy
as concurrently taking two or more drugs for 240 days or more (Veehof et al. 2000). Other
literature arbitrarily defined polypharmacy as administering two to nine drugs
concurrently (Bjerrum 1999, Bikowski et al. 2001, Jorgensen et al. 2001, Linjakumpu et
al. 2002, Fulton and Allen 2005). Other definitions based on qualitative measures include
the prescription, administration or use of more drugs than are clinically indicated in a
given patient (Montamat and Cusack 1992) or untoward iatrogenic sequela caused by the
use of multiple, interacting drugs (Fillit et al. 1999). In the UK, 80% of people aged 75
years or over were prescribed at least one drug and more than 66% are prescribed four or
more medications (Fitzgerald and Pirmohamed 2007).
Polypharmacy in the elderly has been recognised as being associated with negative
outcomes such as risk of developing serious drug–drug interactions (Shah and Hajjar
2012, Maher et al. 2014). However, these interactions can be predictable and avoidable
(Mangoni 2012, Corsonello et al. 2015). Antibiotics may interact with other drugs in
different ways, including displacing a drug from plasma protein binding sites, interacting
with liver enzymes and competing for tubular secretion in the kidney (Biedron and
Chopra 2013). An example of common drug–drug interaction resulted from
polypharmacy in elderly patients using antibiotics is trimethoprim-sulfamethoxazole
(TMP-SMX) with warfarin, which can cause severe elevation in the international
normalisation ratio (INR) and bleeding or TMP-SMX with spironolactone, resulting in
elevation  of  the  blood  potassium  level  (hyperkalaemia),  which  in  turn  can  lead  to
hospitalisation and expose elderly patient to sudden death (Wei et al. 2011, Fralick et al.
2014). Therefore, GPs must be careful while prescribing antibiotics to ensure that the
resulting polypharmacy does not expose the elderly patient to negative consequences
(Wallace and Paauw 2015). Table 7 lists some of the antibiotics commonly used in the
elderly along with examples of the drug–drug interactions that can occur.
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Table 7: Common drug–drug interactions involving antibiotics prescribed to elderly patients for UTIs
(Nicolle 2009a)
Antibiotic class/drug Interacting drugs ADRs
Cephalosporins Aminoglycosides Ĺ NephrotoxicityFurosemide Ĺ Nephrotoxicity
TMP-SMX ACE-I/ARBs Ĺ Risk of sudden death due to hyperkalaemiaSpironolactone Ĺ Risk of sudden death due to hyperkalaemia
Nitrofurantoin Antacids Possible Ļ nitrofurantoin effectFluoroquinolones In vitro antagonism of quinolone activity
Fluoroquinolones
Antacids Ļ Floroquinolone effect
Oral anticoagulants Prolonged prothrombin times
Cyclosporine Ĺ Risk of nephrotoxicity; increased serumcyclosporine concentrations
Iron Ļ Serum Àuoroquinolone concentrations
NSAIDs Possible Ĺ risk of CNS stimulation
Sucralfate Ļ Serum Àuoroquinolone concentrations
NSAIDs. Nonsteroidal Anti-Inflammatory Drugs; ACE-I: Angiotensin-Converting Enzyme Inhibitors; ARBs:
Angiotensin II Receptor Blockers; Ļ: decreased; Ĺ: increased
1.4.4.4 Appropriate Antibiotics Prescribing in the Elderly
Given the issues applicable to elderly patients, a somewhat modified approach is needed
for treating their infections appropriately from that followed traditionally for the rest of
the population (Stalam and Kaye 2004, Herring and Williamson 2007). That said, the
general principles for the treatment of infection are relatively the same. These include
early and rapid diagnosis of infection then rapid initiation of broad empirical therapy with
appropriate microbial coverage of the suspected pathogens followed by the narrowing or
discontinuation of an antibiotic based on the patient’s clinical status and on pathogen
identification following the culture result (Herring and Williamson 2007, Bolon and
Weber 2009, Rho 2009). However, this can be challenging with elderly patients because
they lack many classic signs and symptoms of infection, which can be further hindered
by mental and cognitive impairment and specific complaints from multi-morbidities or
co-morbidities in addition to infection with more diverse and resistant bacteria (Norman
and Yoshikawa 2009). Thus, the process of early and rapid detection and diagnosis of
infection and early initiation of antibiotic therapy can be delayed (Yoshikawa 2000).
Table 8 lists the principles for optimising and promoting appropriate antibiotics
prescribing in elderly patients.
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Table 8: General guiding principles for optimising and promoting appropriate antibiotic prescribing in
elderly patients (Herring and Williamson 2007, p. 482)
Antibiotics choice for elderly patients should be based on identification of the infection
site and severity and the possible causative pathogen, antibiotics efficacy, the patient’s
renal and hepatic function, dosage and route of administration, local AMR patterns, and
the unique PK and PD features of the antibiotic as well as the potential ADRs and drug
interactions (Bolon and Weber 2009, Rho 2009, Beckett et  al. 2015). A careful and
comprehensive history and examination of the patient, as well as careful collection of an
appropriate sample, are prerequisites for any antibiotics prescription. Initially, antibiotic
therapy is empiric, requiring consideration of the most causative pathogen in a given
infection. The choice of empirical antibiotic regimen should be based on the disease
severity, the nature of any underlying diseases and multi-morbidities or co-morbidities,
prior exposures to antibiotics and history of antibiotic allergies. Once empiric therapy is
initiated, the patient’s clinical progress needs to be closely followed and the antibiotic
regimen broadened or narrowed according to the results of the culture and sensitivity tests
(Bolon and Weber 2009, Rho 2009, Beckett et al. 2015).
Risk stratify patients for severe infections and multidrug-resistant pathogens based on
lifestyle and functional status
 Provide early and broad empiric therapy using national guidelines and local resistance
patterns when available
Obtain a complete medication history and carefully select antibiotics to avoid severe
drug-drug interactions and drug-disease interactions
Dosing of antibacterial should consider age-related changes in PK and PD parameters,
but maximal therapeutic dosing should not be sacri¿ced to avoid potential ADRs
De-escalate antibiotic therapy based on the patient’s clinical status and identi¿ed
pathogen
Consider participation in studies of antibiotics in elderly populations and report adverse
drug events when they occur to augment clinical information
Dose reduction may be needed due to decreased lean body mass of the elderly especially
older females
Dose intervals for renally excreted antibiotics may need to be lengthened because of
reduced renal function
Conservative, full-course therapy is usually preferred for all infections
Oral therapy offers more convenience, and avoided antibiotics with a narrow therapeutic
window such as aminoglycosides and vancomycin when possible
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1.5 UTIs in the Elderly
Definition of UTIs
A UTI can be defined as:
‘The presence and multiplication of microorganism(s), in one or more structures
of the urinary tract, with associated tissue invasion’(Cowling et al. 2014, p. 8).
The term UTI is broad and includes a wide range of clinical syndromes that differ from
each other in infection severity and site (Lane and Takhar 2011). UTIs can range from
relatively simple, easy-to-treat infections such as cystitis (infection in the bladder),
urethritis (infection in the urethra), epididymitis (infection in the epididymis of the
testiscles) and prostatitis (infection in the prostate gland) to more complex, difficult-to-
treat infections such as pyelonephritis (infection involving the kidneys and the renal
pelvis) (Cowling et al. 2014, Rudolf et al. 2015). Figure 10 demonstrates the sites for
different types of UTI.




UTIs may spread to the tissue surrounding the kidneys, causing scarring that in turn can
lead to end-stage renal diseases (McGladdery et al. 1992, Cullen et al. 2013), to
perinephric abscess (Neumann et al. 2005, Rudolf et al. 2015) or to the bloodstream,
causing sepsis and death (Tal et al. 2005).  In  the  UK,  a  retrospective  clinical  and
laboratory data analysis of 104 patients showed that more than one-quarter (N = 17) of
elderly patients aged over 70 later diagnosed as having bacteremic UTI initially presented
with confusion and fall (Barkham et al. 1996). Despite there being several available
guidelines (Gupta et al. 2011) with different aims that have been developed by various
related interest groups in recent years, a universally accepted and concise definition of
UTIs and their associated symptoms in the elderly population does not exist (Rowe and
Juthani-Mehta 2014, Detweiler et al. 2015).
Classification of UTIs
Over the past 20 years, many classification systems have been proposed to sub-classify
different types of UTI. Distinctions between the different UTI classes can be important
for selecting the appropriate antibiotic drug, duration of therapy, quality measurement
and for research and teaching purposes (Johansen et al. 2011).
UTIs are frequently classified according to location of infection, presence or absence of
signs and symptoms, presence or absence of complicating factors and frequency of
infection (Nelson and Good 2015). The most widely used UTI classification systems are
those established by the Centre for Disease Control and Prevention (CDC) (Garner et al.
1988), updated in 2008 (Horan et al. 2008); the Infectious Diseases Society of America
(IDSA) (Rubin et al. 1992);  the  European  Society  of  Clinical  Microbiology  and
Infectious Diseases (ESCMID) (Rubin et al. 1992); and the European Association of
Urology (EAU)/European Section for Infections in Urology (ESIU) (Grabe et al. 2010),
updated in 2015 (Grabe et al. 2015).  Table  9  summarises  the  different  UTI  classes
according to site, signs and symptoms, recurrence and completed co-morbidities, and
predisposing factors using laboratory findings from midstream urine (MSU) samples
obtained from patients and including both the number of infecting microorganisms
(expressed in colony-forming units (cfu)) and the number of white blood cells (WBCs)
within the urine samples. The table was generated as an attempt to collect all the different
types of UTI into one table based on the different classifications.
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Table 9: Classifications and definitions of UTIs according to site, signs and symptoms, recurrence and completed co-morbidities and predisposing factors (SIGN 2012,
McNulty et al. 2014, Grabe et al. 2015)







Pyelonephritis is a clinical syndrome characterised by inflammatory process of the renal
pelvis, renal parenchyma and ureters due to an infection. It can be either acute or chronic
(recurrent). Symptoms may include loin pain, flank tenderness, fever, rigors
> 10 WBC/mm3
> 104 cfu/mL uropathogen in MSU culture
Lower
Infection confined to the tissues of the bladder (cystitis) or urethra (urethritis)
Cystitis is a clinical syndrome characterised by inflammatory process of the bladder
which associated with dysuria or frequency without fever, chills or back pain
Prostatitis (prostate gland): inflammatory condition of the prostate gland that occurs in a
variety of different forms
> 10 WBC/mm3








Presence of bacteriuria in urine revealed by quantitative culture or microscopy in a sample
taken from a patient, or the typical symptoms of lower or upper UTI. The presence of
symptomatic bacteriuria can be established with a single urine sample
ASB
Presence of bacteriuria in urine revealed by quantitative culture or microscopy in a
sample taken from a patient without any typical symptoms of lower or upper UTIs.
Asymptomatic bacteriuria should be confirmed by two consecutive urine
samples
> 10 WBC/mm3
> 105 cfu/mL uropathogen in MSU culture in
two consecutive MSU cultures > 24 hour
apart
10 WBC/mm3 of
uncentrifuged urine in women is not
enough to diagnose a UTI in men
rare to have contaminated urine
samples
Recurrent
The occurrence of  3 UTIs within a 12-month period or  2 UTIs within a 6-month
period. Recurrence can be either relapse which can be defined as persistent infection with
the same pathogen isolated before the therapy, despite adequate therapy, or reinfection
which can be defined as isolation of a pathogen which may be either a new bacterial strain
or a previously isolated strain that has colonised another area of the urinary tract






Uncomplicated Infection in a structurally, functionally, and neurologically normal urinary tract
105 cfu/mL uropathogen in MSU culture
Culture may be omitted if patient is
symptomatic and dipstick is + for leukocyte
esterase and nitrites
Check for negative culture after
therapy to prevent partial treatment
or resistance
Complicated
Infection in urinary tract due to the presence of factors that predispose to persistent or
relapsing infection, such as medical condition, co-morbidities or predisposing factors that
interfere with normal flow of urine or voiding mechanism
> 10 WBC/mm3
> 105 cfu/mL uropathogen in MSU culture in
women
> 104 cfu/mL uropathogen in MSU culture in
men, or in straight catheter urine in women
Have low-threshold for imaging
studies or cystoscopy to rule out
urinary stasis and/or stones
ASB: Asymptomatic Bacteriuria, CFU: Colony-Forming Units, WBC: White Blood Cells, MSU: Midstream Urine
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Burden and Epidemiology of UTIs in the Elderly Population
UTIs were found to pose a huge burden on both patients and healthcare funding systems,
being common and costly (Keating et al. 2005). A survey conducted in the USA estimated
the total cost of UTI illness to be $1.6 billion in 1995 and was projected it to be $2.8
billion in 2014 (Foxman et al. 2000). The global incidence of UTIs was estimated to be
at least 250 million cases annually (Ronald et al. 2001). According to NICE, UTIs account
for  1%–3%  of  all  general  practice  consultations  per  annum  in  the  UK  (NICE  2015b).
Furthermore, a HSCIC report based on NHS England statistical data for 2012–2013
demonstrated that UTIs were one of the most frequent reasons for emergency hospital
admissions, despite NHS England indicators (NHSOF 3a) showing conditions that should
be managed without patients having to be admitted. The report showed that UTIs resulted
in 67 admissions per 100,000 population, per quarter, on average for 2012–2013 (HSCIC
2014a). Further, a medical database analysis of 179 GP surgeries in the UK showed that
UTIs were responsible for 7% (N = 89,795) of all infectious disease consultations in
1990–2001 (Petersen and Hayward 2007a, Petersen and hayward 2007b).
Worldwide, almost 10% of elderly people get infected with UTIs (Kelly-Fatemi 2015).
In primary care, UTIs comprise the second most common type of infection in the elderly
after respiratory tract infections (RTIs) (Robichaud and Blondeau 2008, Matthews and
Lancaster 2011) and are ranked the second most common cause of infectious disease
hospitalisation  in  the  elderly  after  lower  RTIs  according  to  a  study  of  the  Discharge
Survey database from 1 January 1990 through 31 December 2002 (Curns et al. 2005). In
the UK, it was reported that UTIs in the elderly resulted in over 150 consultations per
1,000 patients in 2000 alone (Petersen and Hayward 2007a, Petersen and hayward
2007b). Figure 11 shows the UK general practice consultations for UTIs among all age
groups including the elderly from 1991 to 2000. In 2010, UTIs were reported as cause
number 19 of death in the UK for patients older than 70, after they were cause number 41
in 1990 (IHME 2010). Since estimation of the prevalence15 of UTIs in elderly patients in
the  UK  is  one  of  this  thesis’  main  objectives,  the  epidemiology  of  UTIs  in  elderly
populations is discussed in more detail in Chapter Two.




Figure 11: UTI general practice consultations per age group in the UK between 1991 and 2000
(Petersen and Hayward 2007a, Petersen and hayward 2007b)
Pathophysiology and Risk Factors of UTIs in the Elderly
Normally, urine is a sterile fluid, but in some conditions it might become a good medium
for bacterial growth when bacteria invade and colonise the urinary bladder (McCorry
2004). In UTIs, bacteria can reach the urinary tract system and cause infection by two
major routes. The first, the ascending route, is the most common, whereby bacteria from
the GIT flora usually colonise the periurethral region before penetrating and colonising
the urinary tract through the urethral opening. The second route is haematogenous seeding
of the kidney during bacteraemia (Nelson and Good 2015).
Numerous factors may contribute to the high frequency of UTIs in elderly populations,
although they are not all fully understood. Factors related to genetics, gender, anatomy
and age-associated changes in immunity are considered to be responsible for UTIs in
elderly patients (Beveridge et al. 2011); whereas disability in daily living, cognitive
impairment, urinary incontinence and prior or recent UTI history are considered to be the
strongest predictors of UTI risk (Hu et al. 2004, Foxman 2014). In post-menopausal
females, the lack of oestrogen has been linked with UTI recurrence (Perrotta et al. 2008).
The change in post-menopausal females’ vaginal flora in which the lactobacilli that
maintain the vaginal pH are replaced by Escherichia coli (E. coli) and the enterococcus
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species is another predisposing factor for UTIs in elderly people (Nicolle 2009b). Sexual
activity has also been found to increase the risk of UTIs in elderly females; although these
findings are not as strong as in pre-menopausal females (Moore et al. 2008).
Additionally, the presence of co-morbidities such as DM with poor glycaemic control can
also increase the risk of developing UTIs (Ronald and Ludwig 2001). Cerebrovascular
diseases or neurologic abnormalities can cause impaired bladder voiding, urinary
retention and urinary incontinence, which might require insertion of a catheter (Nicolle
2002). Use of urine-collection devices or catheters may allow bacteria to migrate to the
bladder, which may result in UTIs (Matthews and Lancaster 2011).
Furthermore, there is a strong association between the presence of certain urologic
conditions or abnormalities and increased frequency of UTIs. For instance, conditions
such as urolithiasis or tumour are associated with urine flow obstruction (Beveridge et al.
2011) and conditions such as cystocele, which increase post-void residual volumes in
females, can increase the risk of UTIs (Raz 2011). In males, prostatic diseases such as
benign prostatic hypertrophy are associated with urinary retention and high post-void
residuals may be associated with developing UTIs (Nicolle 2009c). Table 10 gives





















Table 10: Factors increasing the risk of UTIs and complexity in the elderly (Wilson and Markland 2014,
Sobel and Kaye 2015)
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The gold standard for UTI diagnosis is the presence of clinical symptoms and detection
of bacteria in a urine sample (SIGN 2012, McNulty 2015). Clinical presentations of UTIs
in the elderly have been well described in much of the literature in relation to polyuria,
frequency, urgency, dysuria, new-onset or worsening incontinence, suprapubic pain or
tenderness, flank pain and fever greater than 38° Celsius (Juthani-Mehta 2009, Woodford
and George 2011). Different types of UTI can vary markedly in terms of clinical
symptoms (Sobel and Kaye 2015).
In  the  UK,  PHE  and  the  British  Infection  Association  (BIA)  recommend  diagnosis  of
UTIs when at least three of the following symptoms are present: polyuria, frequency,
urgency, dysuria, suprapubic tenderness and haematuria (McNulty 2015). However, this
is  not  the  case  with  elderly  patients.  Diagnosis  of  UTIs  in  elderly  people  can  be
challenging for HCPs (Ninan et al. 2014)  as  they  often  present  to  GP  surgeries  with
atypical disease symptoms that are non-specific to infection such as nausea, vomiting,
dehydration, increased weakness, lethargy, change in mental status and confusion, all of
which are very common in this age group (Jaff and Paganini 1989, Cohen et al. 2011,
Nicolle 2013). Moreover, the presence of multiple co-morbidities such as cognitive
impairment in addition to limited communication abilities and poor baseline function can
make it difficult to obtain an accurate history from the patient (Matthews and Lancaster
2011). The presence of classical UTI symptoms in elderly patients is often not diagnostic
because elderly people have other chronic genitourinary symptoms and it is important to
recognise that these are not synonymous with UTIs (Stamm and Raz 1999). Furthermore,
some or all of these symptoms may be absent in elderly patients despite how serious UTIs
are (Jaff and Paganini 1989, Cohen et al. 2011, Nicolle 2013). The Scottish Intercollegiate
Guidelines Network (SIGN) thus recognises all of these challenges in diagnosing elderly
patients with suspected UTIs and recommends full clinical assessment, including vital
signs, for all patients aged over 65 (SIGN 2012).
1.5.5.2 Laboratory Evaluation
The wide varieties of potentially infecting pathogens and the increased likelihood of
AMR in elderly people have made urine culture testing a gold standard in UTI diagnosis
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(SIGN 2012, McNulty 2015). A urine specimen for culture is essential to confirm the
diagnosis, identify the specific infecting pathogen and determine the pathogen’s
susceptibilities to antibiotics (Cowling et al. 2014). The PHE guideline states that urine
should  only  be  sent  for  culture  if  the  patient  has  two  or  more  symptoms  of  infection,
especially fever, dysuria or new incontinence (McNulty et al. 2014). A definitive UTI
diagnosis requires isolation of appropriate quantitative counts of bacteria from an
optimally collected urine specimen before initiating antibiotic therapy in an elderly
patient with suspected UTI (SIGN 2012).
Urine specimen must be collected in a way that minimises sample contamination (SIGN
2012). The UK Standards for Microbiology Investigations recommend the MSU clean-
catch technique for culturing purpose (Cowling et al. 2014). A voided clean-catch urine
specimen can be obtained from most elderly patients with suspected UTI. If the patient is
confused, incontinent or uncooperative, a specimen can be collected by using an in-and-
out catheter in females or an external condom catheter after applying a clean condom and
leg bag in males (Genao and Buhr 2012). If the elderly patient already uses a catheter, a
new catheter must be used to collect a fresh urine sample for culture (Nicolle 2014). That
said, adherence to these standards is lacking in many practices (Pallin et al. 2014).
Urinalysis (UA) is a relatively simple, easy-to-use, office-based test to evaluate patients
with urinary manifestations (Gibson and Toscano 2012). The urine dipstick tests that are
usually used for UA to detect the presence of nitrites and leucocyte esterase are often used
as surrogate markers of an elevated urinary pyuria and gram-negative bacteriuria,
respectively (Ninan et al. 2014). However, the presence of pyuria or bacteriuria does not
necessarily mean that the person has a UTI (Woodford and George 2011). A urine dipstick
is  of  limited  value  for  diagnosing  elderly  patients  with  suspected  UTIs.  The  SIGN
guidelines instruct practitioners against using this test for elderly patients owing to the
variations in its accuracy for predicting infection, with nitrites having the highest
specificity with poor sensitivity (SIGN 2012).
Microbiology of UTIs in the Elderly
The majority of elderly UTI cases in primary care are the result of infection by a single
form of bacteria (Wang et al. 2013). Greater varieties of pathogens are isolated from
elderly persons with UTIs when compared with younger age groups. The most commonly
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isolated bacterium accounting for 60%-75% of UTI cases in elderly females and 18%–
50% of UTI cases in elderly males is gram-negative E. coli (Yoshikawa and Rajagopalan
2006, Nicolle 2009b, Nicolle 2009a). Table 11 lists common bacteria isolated from the
community and responsible for UTI in the elderly population.
Table 11: Distributions of UTI bacteria isolated from elderly patients in the community (Yoshikawa and
Rajagopalan 2006, Nicolle 2009b, Nicolle 2009a)
 Bacteria Percentage of isolation (%)Female Male
E. coli 60-75 18-50
Klebsiella pneumoniae 7-21 0.6-6.9
Proteus mirabilis 0.8-11 0.6-19
Enterobacter species 3.5 1.7-25
Providencia species - 1
Pseudomonas aeruginosa 2 7-19
Morganell morganii - 0.7
Coagulase-negative staphylococci 5.6 8.9–53
Group B streptococci 3-10 9.6
Staphylococcus aureus - 5
Others - 5-20
Antibiotics for UTI Therapy in the Elderly
Antibiotic therapy for UTIs in elderly patients should be based on the most frequent
causative bacteria, spectrum of antibiotic activity, efficacy, safety, local and national
AMR patterns, tolerability and cost to provide clinically appropriate and cost-effective
therapy and to reduce therapy failure and the emergence of bacterial-drug-resistant strains
(Gupta et al. 1999, Dromigny et al. 2002, Bellmann-Weiler and Weiss 2009). Oral
antibiotics for UTIs include TMP-SMX, trimethoprim, nitrofurantoin, fluoroquinolones,
amoxicillin, co-amoxiclav and cephalosporins. Parenteral antibiotics are indicated for
patients who are unable to tolerate oral therapy, have absorption problems or are infected
with pathogens resistant to oral options. Aminoglycoside, with or without ampicillin,
cephalosporins or fluoroquinolone, is recommended depending on bacteria susceptibility
(Blair 2007). Appendix 1 lists examples of antibiotics suitable for use in elderly patients
with UTIs with different routes of administration, doses and intervals.
AMR in UTIs
More resistant bacteria are often isolated in UTIs in elderly patients as a result of repeated
exposure to antibiotics and urologic interventions (Nicolle 2009c). In the USA, a
retrospective case series study of 435 UTI patients aged 16 or older was conducted to
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describe resistance patterns of infecting organisms and determine risk factors for multiple
drug resistance. The multivariate analysis showed that all patients aged 65 or greater who
used a urinary catheter and had recently used antibiotics had increased risk of infection
with multiple drug-resistant bacteria (Wright et al. 2000).
Several studies have shown increased antibiotic resistance levels in community-acquired
UTIs in general populations including the elderly (Barrett et al. 1999, Farrell et al. 2003,
Bean et al. 2008, Jones et al. 2015). However, some researchers have suggested that these
studies were subject to selection bias because the empirical UTI therapy started before
the culture and sensitivity tests came back or because the decision to prescribe in some
cases was based on MSU (Butler et al. 2006, Marques et al. 2012, Vellinga et al. 2012).
In many countries, more than 20% of UTI causative bacteria are resistant to first-line UTI
antibiotic  therapy  such  as  TMP-SMX,  cephalosporins  and  even  fluoroquinolones  with
resistance rates increased to 10% as reported in two surveys aimed at estimating the
microbial susceptibility of uropathogens over years (De Backer et al. 2008, Schito et al.
2009). In the UK, there is a lack of nationally collated data on resistance levels in
pathogens identified among urine specimens in primary care (Hayward et al. 2007). This
is particularly concerning given the dramatic increase in cefotaxime and ceftazidime
resistance in E. coli bacteraemia because of the emergence of extended spectrum beta-
lactamase (ESBL) producing strains. Moreover, there has also been a marked increase in
quinolone resistance in E. coli and other Enterobacteriaceae from bacteraemia (Hayward
et al. 2007).
In 1997, a study to determine the sensitivities of urine isolates to eight commonly used
antibiotics in general practice in 12 different laboratories in the UK examined 962
community acquired urinary bacterial isolates. The predominant isolated uropathogen
was E. coli in 65.1% (N = 626) of the samples, followed by 23.4% (N = 225) ‘coliforms’
other than E. coli, 4.6% (N = 44) Proteus and Morganella species, 2.4% (N = 23)
Enterococci, 1.8% (N = 17) Pseudomonas species, 1.5% (N = 14) coagulase-negative
Staphylococci,  0.7%  (N  =  7)  group  B Streptococci and  0.5%  (N  =  5) Staphylococcus
aureus. As for sensitivity, 98.9% (N = 951) of all isolates were found to be sensitive to
norfloxacin and to ciprofloxacin, 95.7% (N = 921) to co-amoxiclav, 86.8% (N = 835) to
nitrofurantoin, 77.4% (N = 745) to cephalexin, 75.6% (N = 727) to trimethoprim, 75.0%
(N = 722) to cephradine and 51.7% (N = 497) to amoxicillin. Furthermore, there was
some variation in sensitivities among laboratories, mostly by overestimating
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nitrofurantoin and cephalosporins sensitivities and underestimating quinolones and co-
amoxiclav sensitivities (Barrett et al. 1999).
Another UK multicentre study to determine the distribution of uropathogen resistance to
antibiotics used to treat UTIs between 1999 and 2000 included 1,291 uropathogen isolates
from  eight  centres  in  the  UK.  The  isolates  were  cultured  from  four  different  groups:
patients with community-acquired UTIs and younger than 65 (N = 397, 30.75%), patients
with community-acquired UTIs and older than 65 (N = 392, 30.36%), patients with
hospital-acquired UTIs other than those admitted with pyelonephritis (N = 394, 30.52%)
and patients with hospital-acquired pyelonephritis (N = 108, 8.37%). The results showed
that E. coli was the predominant uropathogen in all four groups; however, the percentage
for each group varied. For example, it was 77.3% for patients younger than 65 with
community-acquired UTIs versus 66.6% for patients older than 65 with community-
acquired UTIs. Overall, amoxicillin’s susceptibility against E. coli was  51.3%.  It  was
greatly reduced because of beta-lactamase production and only partially restored by the
addition of clavulanic acid with a susceptibility rate of 78.8%. Oral cefuroxime was active
against E. coli by 68.6%; however, cefuroxime was inactive against both Pseudomonas
and Enterococcus species. Nitrofurantoin was very active against E. coli isolates  by
96.3% as well as Enterococcus faecalis, but not against Klebsiella pneumoniae, Proteus
mirabilis or Pseudomonas aeruginosa. Overall, susceptibility to trimethoprim was
58.1%–84.5% for the most prevalent pathogens. Ciprofloxacin was highly active with
susceptibilities of 88.6%–97.7% for the most prevalent pathogens including E. coli with
a 97.7% susceptibility rate. It was the only oral agent tested against Pseudomonas species
(Farrell et al. 2003).
Another study in East London sought to determine the level of bacterial resistance among
all E. coli isolates collected from both the community and hospitals against eight
commonly used antibiotics – ampicillin, co-amoxiclav, cefalexin, ciprofloxacin,
gentamicin, nitrofurantoin, trimethoprim and cefpodoxime – over a 12-month period.
Any samples collected from general practice, emergency or other primary care surgeries
were considered representative of community isolates; whereas samples collected from
patients hospitalised for 48 hours or more on general or specialised wards were considered
hospital representative. The study successfully cultured 11,865 E. coli isolates over the
study period, of which 88.7% (N = 10,521) were from the community. The results for E.
coli resistance for the eight community antibiotics were: ampicillin 53.9%, co-amoxiclav
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12%, cephalexin 8.3%, ciprofloxacin 9.3%, gentamicin 4.6%, nitrofurantoin 5.3%,
trimethoprim 39.1% and cefpodoxime 5.7%. Multiple drug resistance was rare in the
isolates; however, resistance to cefpodoxime indicated positive ESBL production in the
community with higher extent in the hospital isolates. The study suggested that resistance
to commonly used empirical oral antibiotics for UTI therapy was extremely high except
for nitrofurantoin. Furthermore, the high level of E. coli resistance to ampicillin and
trimethoprim has made them inappropriate oral antibiotics for empirical therapy (Bean et
al. 2008).
In the UK, retrospective analysis of 70,313 uropathogen isolates took place across West
London between April 2009 and March 2012 to recognise the susceptibility patterns in
uropathogens against co-amoxiclav, gentamicin ,cephalexin, nitrofurantoin, ciproÀoxacin
and trimethoprim. The study collected isolates from more than 100 community practices
(N = 38,768; 55.14%) and 1,600 beds from secondary care hospitals (N = 31,545,
44.86%). All collected isolates were requested based on clinical suspicion of UTI. The
results showed that E. coli was the predominant uropathogen in 60.2% (N = 23,338) of
the community isolates and 47.7% (N = 15,047) of the secondary care isolates. In respect
of uropathogen susceptibility, the study detected a small fall in the antibiotics
susceptibility rate from 2009–2010 to 2010–2011, followed by some recovery in 2011–
2012 (primary care 94% in 2009–2010, 86% in 2010-2011 and 90% in 2011–2012;
secondary care 91% in 2009–2010, 82% in 2010–2011 and 87% in 2011–2012). The
reported susceptibilities for primary care were 75%–80% for co-amoxiclav, 86% for
ciproÀoxacin, 67% for trimethoprim, 88% for gentamicin and 94% for nitrofurantoin;
whereas the susceptibilities for secondary care were 79% for ciprofloxacin, 60% for
cefuroxime, 81% for cephalexin, 45%–60% for TMP-SMX, 82% for gentamicin and 92%
for nitrofurantoin (Jones et al. 2015).
In Europe, a study of 908 E. coli urine cultures from Austria, Greece, Portugal, Sweden
and the UK showed different rates of E. coli resistance for different antibiotics including
trimethoprim, co-amoxiclav, TMP-SMX, nitrofurantoin and ciprofloxacin (Kahlmeter
and Poulsen 2012). A 2014 WHO global surveillance report showed that ¿ve of the six
WHO regions (Region of the Americas/Pan American Health Organization, Eastern
Mediterranean Region, European Region, South-East Asia Region, and Western Pacific
Region) reported more than 50% E. coli resistance  to  commonly  used  antibiotics,
particularly Àuoroquinolones and third-generation cephalosporins (Aarestrup et al. 2014).
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Thus, the changing epidemiology and resistance patterns of UTI bacteria are making
effective treatment of UTIs more difficult. The findings indicate that ciprofloxacin and
co-amoxiclav remain reasonable options for UTI treatment in the UK. However, the rates
of fluoroquinolone and co-amoxiclav resistance suggest that prudent use of these agents
is necessary. E. coli. resistance to nitrofurantoin continues to be low compared with
ciprofloxacin and co-amoxiclav. However, nitrofurantoin might not be a good choice for
patients infected with Enterobacteraciae species, as these may have intrinsic resistance
to it (Rowe and Juthani-Mehta 2013).
If an elderly patient with a UTI was thought to be infected with a resistant pathogen, it
may be appropriate to use a combination of antibiotics from different classes (Chen et al.
2013). The rationale behind this approach is to increase the likelihood that the
administered antibiotics are effective against the known or suspected pathogen. However,
caution must be exercised regarding the possibility of increased toxicity, additional cost
and further resistant in susceptible pathogen. In general, this approach may be appropriate
for empirical antibiotic therapy when the elderly patient is severely infected, as the
regimen can be narrowed to a single effective antibiotic once a pathogen is isolated,
cultured, identified and susceptibility results are available (Bolon and Weber 2009).
Overview of UK Guidelines for UTI Treatment
Clinical practice guidelines (hereafter referred to as guidelines) have been developed to
help HCPs make decisions about the care of their patients, evaluate and audit clinical
practice, reduce inappropriate variations in clinical care, minimise harm and promote
cost-effective practice (Watine et al. 2014).
In the UK, HCPs can access various guidelines either online or in hard copy. The British
National  Formulary  (BNF)  routinely  encloses  therapeutic  guidelines  from  NICE,  the
Scottish  Medicines  Consortium  (SMC)  and  SIGN.  BNF  recommendations  are  always
checked against guidelines produced by expert organisations (Wright et  al. 1999,
Colodner et al. 2008). Access to infectious diseases-related recommendations, guidelines
and reports can be retrieved from the PHE website. Other sources from which to retrieve
guidelines include the NICE and SIGN websites. Additionally, each CCG publishes its
own local prescribing policies, microbiology and antibiotics guidance as well as local
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prescribing formulary to assist and control GPs’ prescribing decisions and cost (Knowles
and Bliss 2014).
Worldwide, only eight guidelines for the treatment of UTIs in adults are written in English
and listed by the Guidelines International Network (G-I-N), which includes 1,000
organisations from 48 countries (Henig et al. 2013, G-I-N 2015). Only one guideline
represents the UK in this group: that published by SIGN in 2006 then updated in 2012
(SIGN 2012). It provides evidence-based recommendations for managing community-
acquired UTIs in adults and includes adult females (including pregnant females) and
males, patients with in-dwelling catheters and patients with co-morbidities such as DM.
However, the guideline does not take into account prophylaxis to prevent UTIs after
instrumentation or surgery, or treatment of recurrent UTIs (SIGN 2012). In 2015, PHE
published a ‘Management of Infection Guidance for Primary Care for Consultation and
Local Adaptation’ that contained UTIs; however, it was only a summary of other national
evidence-based recommendations from different organisations such as SIGN, NICE and
NICE Clinical Knowledge Summaries (CKS). This guidance was first produced in 2000
and was updated regularly (McNulty 2015).
UK guidelines recommend first-line lower UTIs (LUTIs) therapy to be nitrofurantoin or
trimethoprim for three days in females and seven days in males. Amoxicillin, ampicillin
or cephalosporin may be used as second-line therapy. In the case of acute pyelonephritis,
first-line therapy includes co-amoxiclav or broad-spectrum cephalosporin for 10 days for
uncomplicated cases and 14 days for complicated ones. Alternatively, GPs might
prescribe ciprofloxacin for seven days (JFC 2012, SIGN 2012, McNulty 2015). Table 12
summarises the treatment recommendations of different UK organisations and agencies
for UTIs in adults.
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Table 12: Summary of the different UK agencies’ treatment guidelines for adults with UTIs
Treatment choices
Type of UTIs First-line Second-line
Uncomplicated UTI in males and (non-pregnant)
females, no fever or flank pain
(SIGN 2012, NICE 2014, McNulty 2015, NICE 2015b).
Nitrofurantoin:
50-100mg every 6 hours orally OR 100mg Modified Release
every 12 hours orally for 3 days in female and 7 days in male
OR
Trimethoprim
200mg every 12 hours orally for 3 days in female and 7 days
in male
-Perform culture in all treatment failures.
-Further treatment should be based on culture results.
-If further empirical treatment is necessary consider nitrofurantoin
(if failed on trimethoprim).
-If failed on nitrofurantoin consider an oral first generation
cephalosporin.
UTI in pregnancy
(SIGN 2012, McNulty 2015, NICE 2015b).
Nitrofurantoin:
50mg every 6 hours orally OR 100mg Modified Release every
12 hours orally for 7 days.
Cefalexin
500mg every 12 hours orally OR 250mg every 6 hours orally for 7
days. If upper tract/systemic symptoms treat for 10-14 days.
Acute Pyelonephritis
(SIGN 2012, NICE 2013, McNulty 2015).
Co-amoxiclav 625mg every 8 hours orally
for 14 days.
Ciprofloxacin
500mg every 12 hours orally for 7 days.
Catheter associated UTI*
(SIGN 2012, McNulty 2015).
Symptomatic Patients Only*
Presumed Upper Tract Infection or Presumed
Bacteraemia:
Co-amoxiclav 625mg every 8 hours orally OR
Ciprofloxacin
500mg every 12 hours orally OR – If sensitivity has been
shown previously:
Trimethoprim
200mg every 12 hours orally for 7-14 days.
If known previous MRSA Bacteriuria:
Trimethoprim
200mg every 12 hours orally for 7 days.
Do NOT use co-amoxiclav or quinolones owing to resistance.
Proven Recurrent UTI in non-pregnant females
3/year
(McNulty 2015, NICE 2015b)
Prophylactic for 6-month trial:
Nitrofurantoin: 50mg-100mg every night orally OR STAT post-coital dose to be taken within 2 hours of intercourse (off-label use)
OR
Trimethoprim: 100mg every night orally OR STAT post-coital dose to be taken within 2 hours of intercourse (off-label use)
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The majority of practice guidelines do not adequately address elderly people in relation
to use of different drugs, patient assessment or decision-making (Singh and Bajorek
2014). A recent UK Study evaluated 12 national guidelines and identified a potential for
drug-disease and drug–drug interactions, especially in patients with co-morbidities, if the
recommendations in these guidelines were adhered to (Dumbreck et al. 2015). Although
this study included guidelines for chronic conditions, the authors highlighted on the
importance of considering recommendations for drugs used for acute conditions like
antibiotics. Unfortunately, none of the available guidelines for UTIs explore or address
treatment options for elderly patients visiting GP surgeries appropriately as compared
with other age groups (Beveridge et al. 2011, Cohen et al. 2011). Furthermore, all the
recommendations for therapeutic regimens listed in the guidelines have been extrapolated
from existing recommendations for adult populations and adult guidelines such as SIGN
and IDSA/ESMID (Gupta et al. 2011) or cited as reference guidelines for elderly patients
(Matthews and Lancaster 2011, Nicolle 2011, Rowe and Juthani-Mehta 2013).
In 2013, the Scottish Antimicrobial Prescribing Group (SAPG), an SMC group, published
a decision-aid document for diagnosing and managing suspected UTIs in older people,
containing summary lists adopted from PHE and SIGN recommendations for adults
(SAPG 2013). It listed good practice points for obtaining urine culture, antibiotic therapy
prescribing and managing prophylaxis in UTIs, all of which were particularly specific to
older people at increased risk of developing ADRs. Further, the document emphasised
the importance of avoiding broad-spectrum antibiotics such as ciprofloxacin, co-
amoxiclav and cephalosporins since the elderly are more vulnerable to infection,
particularly Clostridium difficile infection. It also discussed avoiding development of
AMR; the benefits of using culture testing to guide appropriate prescribing; and using
cranberry for prophylaxis rather than antibiotics for elderly patients (SAPG 2013). For
the complete document see Appendix 2.
Despite the great efforts that have been invested into creating guidelines such as
identifying evidence, assessing evidence quality and determining the strength of each
statement (Wolf et al. 2011), they are often not followed by GPs (Cabana et al. 1999,
Lugtenberg et al. 2009).  In  the  UK,  as  in  many  other  European  and  North  American
countries, GPs do not always adhere to antibiotic prescribing guidelines, which may result
in negative consequences such as AMR and reduced health outcomes (Jelinski et al. 2005,
Murphy et al. 2012). Several barriers and factors such as lack of familiarity, lack of
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awareness and lack of agreement have been found to hinder GPs’ adherence to guidelines
as reported by one systematic review and meta-synthesis aimed to explore GPs’ attitudes
to and experiences with regard to guidelines (Carlsen et al. 2007) and another systematic
review aimed to identify barriers preventing GPs from adhering to guidelines (Cabana et
al. 1999). The expanding body of research, workloads and time pressures made it difficult
for GPs to be aware of and follow every applicable guideline (Cabana et al. 1999).
Although there is wide awareness of many guidelines, a good number of GPs are unaware
of their existence owing to factors such as volume of information, guideline accessibility
and lack of time (Casey 2013). Moreover, awareness of guidelines does not guarantee
familiarity with recommendations or ability to apply them correctly. GPs may not agree
with a specific guideline or the concept of guidelines in general owing to applicability to
patients, lack of confidence in guideline developers, their being ‘too cookbook’ or too
rigid to apply, biased synthesis and challenge to autonomy (Casey 2013). Several studies
have explored how well GPs follow UTI guidelines for adults and the results confirm the
general lack of adherence (Taur and Smith 2007, Lugtenberg et al. 2010, Llor et al. 2011).
However, none of these studies have focused on GPs’ adherence to guidelines in the case
of elderly patients. Since evaluation of GPs’ adherence to UTI treatment good practice
points in the UK is one of this thesis’ main objectives, relevant studies are discussed in
more detail in Chapter Two.
1.6 Summary
This chapter has brought together a general overview of antibiotics prescribing in primary
care, along with ageing and ageing-associated issues in respect of antibiotics and UTIs as
some of the most common infections in this population worldwide. Considering that UTIs
have gained their importance in elderly populations because of their high incidence and
prevalence, it is no surprise that they are one of the most common reasons for GP surgery
visits and antibiotics prescribing, with a high rate of recurrences and frequent
administrations of antibiotics in the same person (Reeves 1994, Petersen and Hayward
2007a). Additionally, UTIs have been found to be over-diagnosed and over-treated in
elderly populations in primary care settings on the basis of atypical patient presentation
(Beveridge et  al. 2011). Moreover, there is growing global concern about LUTIs that
responded readily to oral antibiotics in the past, but that now may need to be treated with
injected antibiotics – imposing additional costs on patients and healthcare systems – or
become untreatable (Aarestrup et al. 2014). Since elderly people have several issues such
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as ageing-associated physiological changes, atypical UTI presentations, infections with
more resistant pathogens, multi-morbidities or co-morbidities and polypharmacy, UTIs
are unique in this population. Therefore, it is important for GPs to understand more about
their current antibiotic prescribing practices in such a vulnerable age group to avoid
inappropriate, perhaps wasteful and risky management that might squander resources,
create iatrogenic problems, increase AMR and lead to negative clinical outcomes. The
next chapter provides an in-depth and extensive literature review to inform this research
and identify the limitations and gaps of the previously published research.
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Chapter 2 Literature Review
2.1 Introduction
The main aim of this chapter was to provide an extensive structured theoretical review of
previously published studies and ongoing research that is closely linked and relevant to
this thesis. The review was achieved through identifying, exploring and discussing the
available information while highlighting the significance of relevant research and
identifying gaps in the current knowledge (Cronin et al. 2008).
The chapter begins with a definition of a literature review and its objectives followed by
details of the literature search strategy, inclusion and exclusion criteria and literature
review process. Studies relevant to prevalence, antibiotic prescribing, adherence to
guidelines and antibiotics prescribing behaviour and practice are all discussed from GPs’
perspective in relation to elderly patients with UTIs. The limitations of these studies were
also discussed to highlight further research opportunities. Finally, the thesis aims and
questions are presented to target this research towards closing those identified gaps that
are impairing the body of knowledge about GPs’ antibiotics prescribing for elderly
patients with UTIs.
2.2 Definition and Uses
A literature review can be described as a comprehensive study and interpretation of
literature that relates to a particular topic (Aveyard 2014, p. 1). It may be used to influence
different stages of the research process in both qualitative and quantitative research. In
qualitative research, the literature review can be used to place the findings of the research
within the context of what is already known, that is, it is not used to confirm or argue
existing findings but instead to enlighten readers about how the research findings fit into
the existing knowledge about the phenomenon under investigation (Speziale and
Carpenter 2010). On the other hand, a quantitative research literature review may be used
for different purposes such as (Aveyard 2014):
x suggesting a conceptual or theoretical framework;
x stating the research purpose;
x verifying the significance of the research problem;
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x assisting in research design selection;
x clarifying the research topic or problem;
x describing relevant studies;
x summarising and evaluating current knowledge;
x guiding data collection and analysis;
x pinpointing assumptions and limitations; and
x assisting in interpreting findings.
In order to set up the research background context for this thesis, an extensive in-depth
review of literature that described GPs’ antibiotics prescribing for elderly patients with
UTIs was undertaken.
2.3 Search Strategy
A computerised literature search was performed, which was driven by the thesis aims and
research questions and focused on all relevant published works including peer-reviewed
journals, books, websites, guidelines and professional-body publications. Additional
searches were carried out to identify any ‘grey’ literature sources, that is:
‘Literature which is produced on all levels of government, academics, business
and industry in print and electronic formats, but which is not controlled by
commercial publishers’ (Farace and Frantzen 1998, p. iii).
Searched grey literature included theses, conferences, white papers and proceedings.
Another search strategy was performed through the use of a snowball technique, where
the references lists from relevant journals were searched to identify additional relevant
literature. Literature searches were performed and updated constantly at different stages
of the research to update the literature (Aveyard 2014).
Seven medical databases were searched for relevant literature. These databases were
recommended by King’s College London (KCL) library services and Aveyard for
students and researchers undertaking research related to health and medicine (Aveyard
2014, KCL Library Services 2014). The searched databases included:
x National  Library  of  Medicine  (MEDLINE)  including  In-Process  &  Other  Non-
Indexed Citations;
x BioSciences Information Service (BIOSIS);
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x Excerpta Medica Database (EMBASE);
x Cumulative Index of Nursing and Allied Health Literature (CINAHL);
x NICE Evidence Search;
x International Pharmaceutical Abstracts (IPA); and
x Cochrane Library Database of Systematic Reviews.
These electronic medical databases were used because of their relevance to the healthcare
field. However, they cited only published literature. In order to avoid publication bias
from impacting the research literature review, a search of grey literature databases was
also performed using additional sources such as:
x Health  Management  Information  Consortium  (HMIC)  database,  which  consists  of
two health management databases: Department of Health’s DH-Data and King’s Fund
database;
x Online Computer Library Center (OCLC) WorldCat Dissertations and Theses database;
x Google Scholar;
x Web of Science; and
x OpenGrey (the system for information on grey literature in Europe).
All were searched for any publication or grey literature. The searched medical databases
and additional sources were available from the KCL library’s online portal. Potentially
relevant literature was retrieved either manually or electronically or requested from the
library interloan system and downloaded into Endnote®, publishing and managing
bibliographies, citations and references software, version 7, Thomson Reuters
Corporation, Philadelphia, USA.
2.4 Searched Terms
Five searches were performed to cover the four aspects of the research questions. The
five searches focused on: 1) epidemiology of UTIs in elderly; 2) GPs’ antibiotics
prescribing for elderly patients with UTIs; 3) GPs’ adherence to UTI recommendations
for elderly patients; 4) GPs’ views and perceptions of antibiotics prescribing for UTIs in
elderly patients; and 5) factors influencing GPs’ antibiotics prescribing for UTIs in adults
and the elderly.
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All searched keywords and search strategies were verified and confirmed by Medical
Information Specialists from KCL library. For full search keywords used and search
strategy, see Appendix 3. To ensure that all potentially relevant literature was identified,
various search strategy enhancing techniques were used, including:
x searching for a combination of relevant keywords and their synonymous using free-
text and ‘medical subject heading’ (MeSH) terms with and without truncation (‘$’ or
‘*’) to facilitate the inclusion of stem words;
x searching for phrases in quotation marks; and
x using the Boolean operators (AND, OR, NOT) to combine keywords.
2.5 Inclusion and Exclusion Criteria
Literature was considered relevant only if it met a list of inclusion criteria. Any literature
failing to meet this list was excluded. Moreover, any study that failed to distinguish
between the age of the studied population or between symptomatic UTIs and
asymptomatic bacteriuria (ASB) was considered irrelevant as ASB does not require
antibiotic therapy. The search inclusion and exclusion criteria that were used in this thesis
can be found in Table 13. These criteria were used to serve this thesis’ research questions
and to narrow the search findings.
Table 13: Search inclusion and exclusion criteria for research approaches
Quantitative research Qualitative research








English English English English
Quantitative Quantitative Qualitative Qualitative
Any country Any country Any country Any country
Between 2000-2015 Between 2000-2015 Between 2000-2015 Between 2000-2015
Elderly Elderly Elderly Elderly
Primary care/GPs Primary care/GPs Primary care/GPs Primary care/GPs
UTIs UTIs UTIs UTIs
With abstract or full
text
With abstract or full
text
With abstract or full
text







None English None English None English None English
Qualitative Qualitative Quantitative Quantitative
Before 2000 Before 2000 Before 2000 Before 2000
None elderly None elderly None elderly None elderly





























ASB: Asymptomatic bacteriuria; LTCF: Long term care facilities; ED: Emergency departments; HCAI:
Healthcare-associated infection
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2.6 Literature Review Process
All retrieved literature abstracts and full texts were screened to identify any duplication
and determine the relevance to the research inclusion criteria. This was achieved through
screening literature titles, abstracts and content using a pragmatic process. This process
was ongoing and continuous during the literature search and update process. Studies were
considered for inclusion in the review if they:
x provided an abstract or full text (the decision was made based on the literature
content);
x abstract or full text contained these keywords ‘GPs’, ‘antibiotic’ and ‘urinary tract
infection’ or their synonyms; and
x abstract  or  full  text  contained  substantial  detail  about  the  method  used,  that  is,
‘qualitative’, ‘interview’, ‘drug utilisation’, ‘observational’, ‘cross-sectional’ and
‘epidemiological’.
All literature deemed to be directly relevant to the research was explored and critically
appraised later in this chapter (Coughlan et al. 2007, Ryan et al. 2007, Aveyard 2014).
Searches were repeated at least once every four months, with regular checks for newer
literature that might have been published or cited after the initial or previously updated
search. The final literature update was done on 1 February 2016, identifying one article.
All relevant literature was critically appraised using the Critical Appraisal Skills
Programme (CASP) check list recommended by KCL and available at: (www.casp-
uk.net/#!casp-tools-checklists/c18f8). This tool was developed by the Public Health team
and the programme of the North Thames Research Appraisal Group (NTRAG) in Oxford
in 1993. CASP is for new researchers and those who require quick, simple and easy-to-
understand tools for appraising different types of literature such as qualitative research
and cohorts (Taylor et al. 2004, Singh 2013).
2.7 Literature Review Results and Discussion
The search identified a few similar research though not with identical inclusion and
exclusion criteria. The lack of identical research especially in the UK was also confirmed
by KCL Medical Information Specialists after an independent literature search. The
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search was thus expanded to include any published research since 1995 with mixed study
settings or mixed patient ages as long as results relating to elderly people were
distinguished from other age groups. If this was not possible, published research on the
general population in primary care was included to inform the research about the current
situation. Figure 12 illustrates the expanded approach used in this thesis. This section
summarises the identified literature followed by discussion and rationale for research.
Figure 12: Expanded approach for literature inclusion
Literature search based on presumed





Expand search with similar presumed criteria but in





Expand search with similar presumed criteria but in
adult population
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2.7.1 Literature Review Results
The Epidemiology of UTIs in Elderly Patients
The epidemiology of UTIs in the elderly can be challenging (Stamm and Norrby 2001)
for many reasons: the atypical UTI presentations of elderly people compared with other
age groups; the difficulty of differentiating between symptomatic UTIs and ASB, which
can lead to disease misclassification; and the lack of a universally accepted definition and
diagnostic criteria for UTIs in the elderly. Although there was a considerable amount of
literature on the epidemiology of UTIs, the diagnostic criteria adopted across these studies
varied significantly, which might result in either under- or overestimation of the
epidemiology of UTIs (Rowe and Juthani-Mehta 2013, Rowe and Juthani-Mehta 2014,
Detweiler et al. 2015).
As at younger ages, it has been found among elderly people that UTI incidence was higher
in the female gender with the female-to-male ratio ranging between 2:1 (Wilson and
Markland 2014) and 3:1 (Nicholl and Wilson 2012). This is explained by females having
a shorter urethra compared with males. In addition, males can have antibiotic substances
in their prostatic fluid that act as a natural defence mechanism against infection (Foxman
2010). Although the prevalence of UTIs increases substantially with advancing age for
both males and females (Nicolle 1994), the female:male infection ratio falls with
advancing age from 30:1 cases in younger adults to 2:1 cases in those aged over 65
(Schaeffer 1991). The literature review identified 12 studies on the epidemiology of UTIs
in elderly patients that were reviewed and critiqued in the next paragraphs and
summarised in Table 14.
In the USA, a prospective, observational epidemiological study aimed at estimating the
incidence and possible risk factors of infections in non-institutionalised, urban elderly
people aged 65 and over between July 1986 and June 1988 recruited 417 elderly people
from two local healthcare centres. Of the participants, 33% (N = 138) were male and 67%
(N = 279) were female, with the majority younger than 74 (N = 254, 61%). Over the 24-
month period, all recruited elderly people were asked to complete a form listing 26
symptoms every  time they  visited  or  phoned  a  clinic  or  hospital  for  an  infection.  The
study recorded 494 infections and UTIs were the second most common type of infection
after colds with a total of 93 (18.83%) representing an overall incidence of 13 per 100
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persons per year. Female incidence was higher compared with male with rates of 14 per
100 persons per year and 10.9 per 100 persons per year, respectively, with no statistical
significance. From an age perspective, UTIs were higher in elderly people younger than
74 with an incidence of 15.1 per 100 persons per year compared with 11.6 per 100 persons
per year for those aged 74 and older. This study was the first to explore the incidence of
infectious diseases in elderly people aged 65 and older and not in nursing homes. Also, it
successfully demonstrated that infectious diseases are common and vary a lot among the
elderly. However, it did have significant limitations related to infection symptoms in this
population, in particular for UTIs, where symptoms and presentations can be atypical and
distinguishing between UTIs and ASB is difficult. In addition, screening for infection in
this study was based on symptoms reporting rather than on clinical examinations or
laboratory  tests,  which  might  have  resulted  in  incidence  bias  for  some  conditions.
Moreover, some infections might have been incompletely captured owing to their nature
or to certain elderly co-morbidities or diseases potentially associated with clinical
presentations that could be similar to the clinical presentations of infections, leading to
wrong diagnosis (Ruben et al. 1995).
A cohort study using a postal questionnaire was undertaken in Sweden to estimate the
prevalence of urinary incontinence and other urogenital symptoms including UTIs in a
random sample of 10,458 male patients aged 45 and older, 74% (N = 7,763) of whom
completed the questionnaire successfully. Results revealed that UTI prevalence within
the previous 24 months among the responded sample for ages 65, 70, 75, 80, 85–89 and
90 years and older was 6.4% (N = 500), 4.5% (N = 349), 8% (N = 621), 10.7% (N = 831),
13.9% (N = 1,079) and 16.5% (N = 1,281), respectively. Additionally, the prevalence of
UTIs was found to increase significantly with advancing age (p < 0.001) with the highest
prevalence identified among elderly people aged 90 and above. Although the study
successfully linked ageing with high prevalence of UTIs in males, this prevalence may
have been under- or overestimated because the study included patients from mixed care
settings. Furthermore, the prevalence calculation was based on a self-reported
questionnaire with no diagnostic or microbiological investigations to confirm the
diagnosis of UTIs or to distinguish UTIs from ASB, which was treated by antibiotics at
that time (Malmsten et al. 1997).
Another Swedish longitudinal cohort study sought to estimate the prevalence of UTIs,
urinary incontinence, oestrogen use and overall mortality in female patients aged 66 to
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86 who received antibiotic treatment for UTIs in the period between 1985 and 1986 with
a follow-up re-estimation of UTI prevalence for the same studied group in 1995. In 1986,
6,000 female participants were invited to complete a questionnaire about urogenital
complaints. Only 70% (N = 4,206) completed the questionnaire successfully and, of
those, only 16.36% (N = 688) reported receiving antibiotic treatment for UTI between
1985 and 1986. Ten years later, 63% (N = 434/688) of the females were still alive and
were invited to participate in a second questionnaire about urogenital complaints. This
time 83% (N = 361) completed the questionnaire successfully, of whom 61% (N = 219)
reported receiving antibiotic treatment for at least one UTI within the last nine years. The
number of reported UTI episodes varied: 35% (N = 77) had one to two, 28% (N = 61)
had three to four, 27% (N = 59) had five to 10 and 10% (N = 22) had more than 10.
Although the study positively linked high UTI occurrence in elderly females having had
previous episodes, it could not establish an association between UTIs and increased
mortality in the elderly. In terms of weaknesses and limitations, first, the study did not
identify the care settings of patients from which the 1986 questionnaire responses were
received as UTI prevalence can differ dramatically from one setting to another. Second,
it included responses from mixed care settings in 1995 and analysed them collectively,
which may have led to bias in prevalence estimation. Third, the study did not compare
the findings about UTI prevalence with any previously published work. Fourth, it was
based totally on questionnaires, which might make respondents subject to bias. Finally,
UTI prevalence in this study may have been under- or overestimated because there were
no diagnostic or microbiological results to confirm the diagnosis of UTIs or to distinguish
UTIs from ASB, which was treated by antibiotics at that time (Molander et al. 2000).
In the USA, survey analysis covering March 1995 through February 1996 aimed at
estimating the annual incidence, age cumulative probability and direct medical and non-
medical associated social costs for over age 18 female participants with UTIs using
random phone number dialling for data collection. Estimated results showed that 180
females aged 65 and older (9%) reported a single UTI during the last 12 months, of whom
20 (1%) reported a first lifetime UTI during those 12 months. What is more, UTI
incidence was not found to increase with age among elderly females. Although this
investigation was one of the first to determine the incidence and associated social costs
of UTIs, it had limitations, a major one of which was recall bias for either the diagnosis
or the timing of the diagnosis or both. Another was the failure to compare the findings
regarding prevalence with previous literature and a third was not considering co-
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morbidities and risk factors, since the presence of these can either over- or underestimate
the incidence, making the results subject to bias (Foxman et al. 2000).
In South Korea, a 2004 retrospective study sought to determine the incidence, recurrence,
seasonality, mortality and medical costs associated with acute pyelonephritis in outpatient
and inpatient settings between 1 January 1997 and 30 September 1999 using their
nationwide health insurance claims database. The database recorded 496,289 claims for
acute pyelonephritis diagnosis: 164,661 claims in 1997, 166,436 claims in 1998 and
165,192 claims in 1999. Female patients had higher overall outpatient incidence with 49.1
per 10,000 populations compared with 11.4 per 10,000 populations for male patients. The
average annual outpatient incidence for females was 57.15 per 10,000 populations for the
60–79 age group and 28.07 per 10,000 populations for the 80 and over age group; while
for outpatient males the average incidence was 20.51 per 10,000 populations for the 60–
79 age group and 25.10 per 10,000 populations for the 80 and over age group. Acute
pyelonephritis incidence among male outpatients was found to increase gradually with
advancing age, reaching its peak at the age of 80 and over. The incidence among female
outpatients was found to decrease sharply from the age of 80. The ratio of outpatients to
inpatients was higher for males than for females but decreased with age for both genders.
The study proved that acute pyelonephritis occurs more frequently in elderly patients aged
60 years or older compared with other age groups; female outpatient acute pyelonephritis
incidence was five times higher than for inpatient treated females and 10 times higher
than for males. The study showed some limitations related to the validity of the insurance
database, which was not established, in addition to diagnosis reliability for retrieved
cases. It was also subject to bias in estimating UTI incidence for several reasons such as
the lack of clinical data and laboratory tests from the insurance database, disease
misclassification and imprecise use of the disease classification system resulting in
incomplete capture of all cases and the antibiotics purchasing policy in South Korea,
which until 2000 allowed individuals to purchase antibiotics without a prescription (Ki et
al. 2004).
Galatti et al. (2006) conducted a retrospective analysis to identify Italian GPs’ antibiotics
prescribing patterns as well as patient-related variables associated with prescriptions for
acute and recurrent cystitis in the general population using the Health Search Database
(HSD), an Italian GP research database, between 1999 and 2002. The study included
35,129 cases, of which 31.35% (N = 11,013) were elderly patients aged over 65. The
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prevalence of acute complicated cystitis in elderly patients was 50.1% (N = 10,266) of
the total number of acute complicated cystitis cases in the general population, whereas
the prevalence of recurrent cystitis was 53.2% (N = 747) of the total number of current
cystitis cases. Elderly patients were more likely to receive antibiotic treatment for both
conditions with 81.0% (N = 8,313) for acute complicated cystitis  (OR16: 1.63; 95% CI
1.43–1.86) and 85.5% (N = 6,39) for recurrent cystitis (OR: 1.96; 95% CI 1.39–2.76).
Although Galatti et al.’s (2006) study confirmed the high prevalence of both acute
complicated and recurrent cystitis in elderly patients compared with other age groups, it
had significant limitations related to imprecise use of the disease classification system,
disease misclassification, incomplete capture of all cases and missing laboratory data for
some patients (Galatti et al. 2006).
Czaja et al. (2007) carried out a population-based analysis in the USA from January 1997
to December 2001 intended to estimate acute pyelonephritis incidence, microbial
aetiology, AMR and antibiotic therapy use for outpatient and inpatient settings using a
computerised database from a health maintenance organisation. The data identified 4,887
individuals with 10,330 acute pyelonephritis diagnoses over the five-year study period.
Elderly outpatient findings revealed that females had higher UTI incidence compared
with males across all elderly age groups. Female outpatient incidence was estimated to
be nine (expressed in 10,000 person-years) for the 65–69 age group, 11 for the 70–74 age
group, 12 for the 75–79 age group, 13 for the 80–84 age group and 12 for the 85 and over
age group. For male outpatients, the estimated incidence was five for the 65–69 age group,
six for the 70–74 age group, seven for the 75–79 age group, five for the 80–84 age group
and six for the 85 and over age group, all expressed in 10,000 person-years. Additionally,
the  outpatient  UTI  incidence  rates  for  elderly  patients  were  higher  compared  with  the
inpatient rates for both genders. Peak incidence was seen in outpatients aged 82 for
females and 88 for males. Although this study demonstrated the relationship between
pyelonephritis and ageing, it had significant limitations, including imprecise use of the
disease classification system, disease misclassification, incomplete capture of all cases
and missing laboratory data for some patients. Furthermore, the study mentioned that UTI
incidence can vary substantially according to sex and age; however, no age–sex
adjustment was performed for rates to eliminate their influence on incidence (Czaja et al.
2007).
16 Odds ratio.
Chapter Two: Literature Review
86
Laupland et al. (2007) performed a Canadian population-based, laboratory surveillance
study to estimate community onset UTI incidence, demographic risk factors, AMR and
aetiological pathogens among a non-selected large population using microbiology results
from one laboratory between 2004 and 2005. Results revealed that elderly females had
higher UTI incidence compared with males. The estimated incidence for females was 40
for those aged 60–69, 46 for those aged 70–79 and 110 for those aged 80–89, all expressed
in 1,000 per year; whereas the estimated male incidence was 10 for those aged 60–69, 15
for those aged 70–79 and 60 for those aged 80–89, all expressed in 1,000 per year. The
overall incidence in elderly people with UTIs was found to increase substantially with
advancing age in both genders. The overall incidence per age group was 25 for those aged
60–69, 33 for those aged 70–79 and 100 for those aged 80–89, all expressed in 1,000 per
year. Interestingly, elderly people who were 90 or older had the highest UTI incidence
among all age groups with 925.7 for females, 637.8 for males and 850.6 overall per 1,000
per year. Although Laupland et al. (2007) had several interesting findings related to the
increase  in  UTI  incidence  with  advancing  age,  their  study  was  limited  by  the  lack  of
patients’ clinical presentations to distinguish between different subclasses of UTI.
Moreover, the study included microbiological cultures from community clinics, nursing
homes and emergency departments in addition to samples from acute care hospitals for
inpatients within their first two days of admission. Therefore, the incidence may have
been biased since some of these settings are associated with high UTI incidence, not to
mention the nature of patients who visit some of these settings as well as the severity of
their conditions.
Eriksson et al. (2010) conducted a cross-sectional, population-based study in Sweden and
Finland from 2005 to 2006 aimed at describing the prevalence of UTIs as well as the
factors associated with them in a sample of 395 female patients aged 85 and older. Data
were collected by nurses, physicians, medical students and physiotherapists through home
visits and medical records review. Results showed that 29.6% (N = 117) of the
participants were diagnosed to have had at least one UTI episode during the last 12
months. Estimated UTI prevalence per age was 25% (N = 33) of 85-year-olds, 29.6% (N
= 35) of 90-year-olds and 34.4% (N = 40) of those aged 95 and over. Results for
prevalence estimation were not shown to be statistically significant. Furthermore, 60%
(N = 233) had at least one UTI diagnosis during the previous 60 months. Although the
study identified UTI prevalence and associated risk factors, the prevalence might be
overestimated as a result of including patients from different settings such as community
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clinics, nursing homes and hospitals. Another key fact was that patients from hospital
setting tend to have more UTIs than community patients, especially if they are
catheterised. Furthermore, the researchers did not consider collection of urine samples
and microbial cultures during home visits to confirm UTI diagnoses.
Omoregie et al. (2010) carried out a study in Nigeria to determine the prevalence of UTIs
among elderly patients aged 60 and older and visited different outpatient clinics in
teaching hospitals from 1 September 2009 to 31 May 2010. Researchers collected clean-
catch MSU from 943 patients with UTI signs and symptoms, of whom 61.62% (N = 581)
were female and 38.38% (N = 362) were male. Results showed the overall estimated UTI
prevalence to be 11.03%. Moreover, being of the male gender was found to be a
significant risk factor for UTIs: 23.1% (N = 80) (OR: 6.584; 95 CI 4.081í10.62) versus
4.13% (N = 24) (OR: 0.152; 95% CI 0.094í0.245) in female elderly patients (p < 0.0001).
Additionally, the study found that the prevalence of UTIs significantly decreased with
advancing age from 14.46% for those aged 60í69, 10.94% for those aged 70í79, 8.26%
for those aged 80í89 and 3.2% for those aged 90í99 (p = 0.023). Furthermore, the
prevalence in this study might be biased as a result of the nature of patients who tend to
visit hospital outpatient clinics who could have multiple co-morbidities, disabilities and
severe illnesses as well as risk factors for developing UTIs. Moreover, the findings
showed results that were inconsistent with previously published studies regarding gender
and age without reasonable explanations. That said, some postulated justification might
be the life expectancy of the Nigerian population, which is between 54 and 55 years
according to WHO.
In  the  Netherlands,  Caljouw et al. (2011) performed a population-based, prospective
follow-up study of UTI incidence and predictive factors in elderly patients aged 85
between September 1997 and September 1999. The study included 479 patients, of whom
67.2% (N = 322) were female and 32.8% (N = 157) were male. Data were collected during
researchers’ visits to participants’ places of residence. Results revealed that 15% (N = 72)
of the participants had a history of at least one UTI episode between the ages of 85 and
86. Further analysis showed that 18.3% (N = 59) of female and 8.3% (N = 13) of male
patients had a history of at least one UTI episode between the ages of 85 and 86 (p =
0.004). The overall reported incidence of UTIs was found to be 11.2 (95% CI 9.4í13.1)
per 100 person-year at risk. The incidence of UTIs was greater in females with 12.8 (95%
CI 10.4í15.2) per 100 person-year at risk than males with 7.8 (95% CI 5.1í10.6) per 100
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person-year at risk. This significant result means that females had a 1.7-fold increased
risk of developing UTIs compared with males (HR17: 1.7; 95% CI 1.1í2.5) (p = 0.012).
Although this study successfully described the incidence and predictive risk factors, it
had certain limitations. The old data used to estimate the incidence of UTIs did not
represent the real incidence at the time of the study. Another key fact is that advancing
age is often associated with changes in the immune system and urinary tract, which could
explain the high incidence of UTIs in the elderly; therefore, more reflective estimates
would have been provided by estimating the annual incidence of UTIs rather than one-
point incidences. Another limitation related to UTI diagnosis, which was not performed
in accordance with the standardised diagnostic procedures. Furthermore, the incidence in
this study might be biased owing to overlapping between UTIs and ASB in addition to
including institutionalised patients from long-term care facilities who are usually
catheterised, which can increase the risk of developing UTIs and ASB and therefore
overestimate the incidence of UTIs.
Marques et al. (2012) carried out a prospective, population-based study in Brazil to
estimate the epidemiology and clinical characteristics of UTIs for community-dwelling
females over the age of 65 from January to June 2010. This study included 598 female
patients who were recruited during their first visit to a GP or nephrologist clinic at a
university hospital. Results showed high prevalence of UTIs in the studied sample (N =
99; 16.55%) with significantly higher prevalence in older women (p < 0.001). Among the
UTI cases, 97.98% (N = 97) presented with cystitis and 2.02% (N = 2) presented with
pyelonephritis. Moreover, 28.28% (N = 28) had recurrent UTIs. From a therapeutic
standpoint, nitrofurantoin was used as an oral therapy for seven days for all cystitis
patients; while pyelonephritis patients were treated with intravenous co-amoxiclav
followed by oral therapy for 14 days. This study successfully linked the prevalence of
UTIs with ageing and previous UTI history. However, it had limitations. First, the sample
size was small for a population-based study in addition to there being only a short period
of follow-up. Second, the study recruited patients from a tertiary care hospital who tend
to have multiple co-morbidities, risk factors, disabilities and severe conditions that might
predispose these patients to UTIs more frequently and result in prevalence bias. Having
said that, another potential source for prevalence bias was the exclusion of severely
disabled patients’ laboratory investigations.
17 Hazzard ratio.
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In conclusion, twelve studies were identified to estimate UTI epidemiology in elderly
people, of which only nine described UTI epidemiology in general (Ruben et al. 1995,
Malmsten et al. 1997, Molander et al. 2000, Galatti et al. 2006, Laupland et al. 2007,
Eriksson et al. 2010, Omoregie et al. 2010, Caljouw et al. 2011, Marques et al. 2012),
one studied cystitis (Ki et al. 2004) and two studied pyelonephritis (Foxman et al. 2000,
Czaja et al. 2007). Six studies were designed specifically for the elderly population
(Ruben et  al. 1995, Molander et  al. 2000, Eriksson et al. 2010, Omoregie et  al. 2010,
Caljouw et al. 2011, Marques et al. 2012) and the rest included elderly people as part of
the studied population with three studies lacking a specified number of elderly people (Ki
et al. 2004, Czaja et al. 2007, Laupland et al. 2007). Only four studies included female
patients (Foxman et al. 2000, Molander et al. 2000, Eriksson et al. 2010, Marques et al.
2012), one included male patients (Malmsten et al. 1997) and seven included both
genders. There were five studies from four European countries, namely, Sweden, Italy,
Finland and the Netherlands (Malmsten et al. 1997, Molander et al. 2000, Galatti et al.
2006, Eriksson et al. 2010, Caljouw et al. 2011), three from the USA (Ruben et al. 1995,
Foxman et al. 2000, Czaja et al. 2007), one from South Korea (Ki et al. 2004), one from
Canada (Laupland et al. 2007), one from Nigeria (Omoregie et al. 2010), one from Brazil
(Marques et al. 2012) and none from the UK. Six studies estimated UTI prevalence as a
percentage (Malmsten et al. 1997, Molander et al. 2000, Galatti et al. 2006, Eriksson et
al. 2010, Omoregie et  al. 2010, Marques et al. 2012) whereas the other six studies
expressed UTI incidence in different units. The studies varied in research design and data
sources, ranging from questionnaires and surveys in four studies (Ruben et  al. 1995,
Malmsten et al. 1997, Foxman et al. 2000, Molander et al. 2000), databases in four studies
(Ki et al. 2004, Galatti et al. 2006, Czaja et al. 2007, Laupland et al. 2007) and medical
records in three studies (Eriksson et al. 2010, Caljouw et al. 2011, Marques et al. 2012)
and one based on results from urine analysis alone (Omoregie et al. 2010). Only three
studies considered laboratory results while taking into account culture and MSU analysis
to confirm UTIs (Laupland et al. 2007, Caljouw et al. 2011, Marques et al. 2012).
Epidemiological studies might be subject to varied bias conceptualised through a lack of
internal validity or incorrect assessment of the association between an exposure and an
effect in the target population (Delgado-Rodriguez and Llorca 2004). Selection bias was
a problem in some studies. The studies describing UTI incidence or prevalence based on
urine  sample  detected  UTIs  in  samples  requested  by  the  GP  because  they  already
suspected UTI (Laupland et  al. 2007, Caljouw et  al. 2011, Marques et al. 2012). This
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means that erroneous overestimation of the incidence or prevalence is possible because
only  those  with  a  high  likelihood  of  UTI  were  selected  to  form  the  population  in  the
calculated UTI rate. Or the rate could be erroneously underestimated if clinical suspicion
is  a  poor  indicator  of  UTIs  and  many patients  with  UTIs  were  unselected,  hence  their
UTIs went undetected. A number of studies failed to include a representative sample of
elderly population from the community setting by including patients from other settings
together with different age ranges, which complicates the interpretation and comparison
of these rates (Malmsten et al. 1997, Molander et al. 2000, Laupland et al. 2007, Eriksson
et al. 2010, Omoregie et al. 2010, Marques et al. 2012). Additionally, some studies did
not report or consider patients with co-morbidities when they recruited them, as UTIs
increase with the presence of certain co-morbidities such as DM (Ruben et  al. 1995,
Foxman et al. 2000). Self-reporting studies were subject to recall bias, especially in the
elderly as this population group might have issues with memories and remembering
events (Ruben et  al. 1995, Foxman et al. 2000). Also, systematic differences in the
recording or interpretation of data could cause interview bias (Eriksson et al. 2010,
Caljouw et al. 2011). Another important consideration is UTI code misclassification bias.
In the case of elderly people, given the problems with diagnosis, contamination, mixed
cultures and ASB, a UTI could easily be misclassified as a non-UTI or vice versa
(Laupland et al. 2007, Caljouw et al. 2011, Marques et al. 2012). Variations in defining
UTIs over time as well as across guidelines and laboratories might result in rates being
either over- or underestimated. In database studies, variations in coding, disease coding
misclassification and incomplete capture of all UTI cases might influence the rate
estimation (Ki et al. 2004, Galatti et al. 2006, Czaja et al. 2007, Laupland et al. 2007).
Furthermore, a number of studies were limited by small sample size and therefore could
not estimate prevalence or incidence rates precisely (Ruben et al. 1995, Eriksson et al.
2010, Caljouw et al. 2011). A criticism of studies that estimate epidemiology based on
urine samples is that samples sent for analysis are more likely to be taken from patients
that have developed complications or are suffering from co-morbidities, making it
difficult to discover the true epidemiology of UTIs.
Six studies included both genders (Ruben et al. 1995, Ki et al. 2004, Galatti et al. 2006,
Czaja et  al. 2007, Laupland et al. 2007, Caljouw et al. 2011), of which one concluded
that UTIs were significantly higher in females than males. Conversely, another found that
UTI prevalence was higher in males than females (Omoregie et al. 2010). Several studies
linked increased UTI incidence or prevalence with advancing age in all age groups
Chapter Two: Literature Review
91
(Ruben et al. 1995, Malmsten et al. 1997, Molander et al. 2000, Galatti et al. 2006, Czaja
et al. 2007, Eriksson et al. 2010, Marques et al. 2012). This could be owing to elderly
weak immunity, the presence of co-morbidities, recurrent UTI infections, urinary tract
system surgery, and impaired functional and cognitive status (Caljouw et al. 2011). That
said, one study found that UTIs do not increase with age in females (Foxman et al. 2000)
and another concluded that UTI prevalence decreased with advancing age (Omoregie et
al. 2010).
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Table 14: Summary of epidemiological studies of UTIs in elderly patients
Author Country Study Design Data Source Measured Rate N* Results
Ruben et al. 1995 USA Prospective, observational Visit and phone screening Incidence 417
Overall: 13 per 100 persons per year
Female: 14 per 100 persons per year
Male 10.9 per 100 persons per year







Molander et al. 2000 Sweden Cohort Questionnaire in female Prevalence 4,206 1986: 16.36%1995: 61%
Foxman et al. 2000 USA Prospective Random phone numbersdialling survey in female Incidence 2,000 Pyelonephritis: 9%
Ki et al. 2004 South Korea Retrospective Insurance claims database Incidence N/A
Female cystitis (per 10,000):
60-79: 57.15
 80: 28.07
Male cystitis (per 10,000):
60-79: 20.51
 80: 25.10
Galatti et al. 2006 Italy Retrospective Health Search Database Prevalence 11,013 Acute complicated cystitis: 50.1%Recurrent cystitis: 53.2%
Czaja et al. 2007 USA Population-based, retrospective Health MaintenanceOrganisation database Incidence N/A













Author Country Study Design Data Source Measured Rate N* Results
Laupland et al. 2007 Canada Population-based, retrospective Microbiology laboratorysurveillance database Incidence N/A








Eriksson et al. 2010 Sweden andFinland
Population-based, retrospective,
cross-sectional
Home visits and medical










Caljouw et al. 2011 Netherlands Population-based, prospective,follow-up
Medical records and
interviews Incidence 479 11.2 per 100 person-years.
Marques et al. 2012 Brazil Population-based, prospective Medical records and MSU infemale Prevalence 598 16.55%.
* N: Number of elderly patients within study sample size N/A: Not available MSU Midstream urine
Continued Table 14
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Antibiotics Prescribing and Appropriateness for Elderly Patients with UTIs
It has been reported that antibiotics utilisation research in community settings is not as
well established as it is in inpatient settings (Carrie and Zhanel 1999, Carrie et al. 2000).
In-depth research on antibiotics prescribing for elderly population in primary care setting
was reported to be scarce (Haeseker et al. 2012). Antibiotics gained special attention over
several drugs classes to reduce their unnecessary and inappropriate use, slowing the
spread of AMR as well as cutting down associated costs (Hasan et al. 1997). Excessive
antibiotics use by GPs can lead to unnecessary ADRs, encouraging patients to re-consult
their  GPs  for  subsequent  similar  problems,  possible  development  of  resistance  and
unnecessary utilisation for healthcare resources as well as services (Ong et al. 2008).
A number of studies revealed that antibiotics are one of the most commonly prescribed
classes of drugs for elderly people (Norris et  al. 2011, Pan et  al. 2011, Haeseker et al.
2012). One study observed the highest use of antibiotics in elderly people aged 80 or older
with 26 DDD/1,000 inhabitants per day followed by patients between the ages of 60 and
79 with 21 DDD/1,000 inhabitants per day (Pan et al. 2011).
In New Zealand, Norris et al. (2011) explored antibiotics use according to age, gender,
ethnicity, socio-economic status and rurality using dispensed prescriptions electronic data
from community pharmacies from 1 October 2005 to 30 September 2006. Findings
showed a high prevalence of antibiotics prescribing among elderly individuals with an
annual prevalence of 49% for those aged 65–74, 56% for those aged 75–84 and 69% for
those aged 85 and over, making this prevalence the highest compared with middle-aged
people and children. Similarly, the amount of prescribed antibiotics expressed in DDD
per person per year broadly mimicked this pattern with 13.07 DDD per person per year
for those aged 65–74, 14.68 DDD per person per year for those aged 75–84 and 19.03
DDD per person per year for those aged 85 and over making them again the highest
compared with other age groups.
Haeseker et al.’s (2012) retrospective cohort analysis used the Dutch Registratie Netwerk
Huisartsen (RNH) GP database to estimate the prescribing of different antibiotic classes
among different age groups in Netherlands general practice from 2000 to 2009. The study
included 65,894 patient years aged over 18. Elderly patients represented 21% (N =
140,999) of the total patient years, of which 16% (N=108,131) were aged 65–79 and 5%
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(N = 32,868) were aged 80 or older. The highest increase in antibiotics prescribing was
reported in elderly patients: 9% in 2000 rising to 22% in 2009 as a result of an increased
number of RTI and UTI general practice consultations. The total number of patient years
for elderly patients aged 65–79 who received at least one antibiotic was 15,440 (20%)
and for those aged 80 or older the number was 5,478 (7%). Additionally, antibiotics were
frequently prescribed in the elderly with significant association between age and
antibiotics prescribing across all years (p < 0.001). The rate of antibiotics prescribing in
elderly patients significantly increased over time with the highest increase in elderly
patients aged 80 or older (p < 0.001). Two or more antibiotics per year were prescribed
most often in elderly patients with 23% (N = 3,581) aged 65–79 and 29% (N = 1571)
aged 80 or older. This increase in the number of antibiotics with age was found to be
statistically significant (p < 0.001) with an independent increase over time and age.
In the UK, a medical database analysis of 179 GP surgeries showed that UTIs were found
to be the fourth leading indication for antibiotic prescribing by (N = 44,826; 10%) in
2000–2001 after upper RTIs, lower RTIs and sore throat (Petersen and Hayward 2007a).
UK GPs write about 5.5 million prescriptions for UTI treatment each year. A substantial
number of these are for treating UTIs in the elderly (N = 1,595,000; 29%), of which
68.96% (N = 1,100,000) are for female patients (Reeves 1994). This frequency of
prescribing as well as the substantial and serious consequences for patients, particularly
elderly individuals, the healthcare system and society mean that attention must be paid to
the utilisation and appropriateness of antibiotics for elderly patients (Leistevuo et al.
1997). The earlier literature review identified 12 studies on GPs’ antibiotics prescribing
and appropriateness for UTIs in elderly patients that were reviewed and critiqued in the
following paragraphs. Table 15 summarises reviewed studies relevant to antibiotics
prescribing for elderly patients with UTIs and GPs’ adherence to UTI guidelines.
Friis et al. (1989) studied five of Denmark’s 13 counties to explore Danish GPs’ uses and
choices of antibiotics for all ages. They recruited 1,012 GPs to collect data on patients,
diagnosis and antibiotics used from 23 March 1987 to 27 March 1987. Results revealed
that 60% (N = 602) of GPs prescribed antibiotics for 7,607 patients, of whom 12.69% (N
= 966) were aged 65 or older. UTIs were the fourth most common infection diagnosed (N
= 819; 10.76%) and were the most common cause for antibiotics treatment in the elderly
(N = 290; 30%). Sulphamethizole was the most commonly prescribed antibiotic for UTIs
(N = 451; 59%) with an average duration of 6.2 days, followed by ampicillin (N = 150;
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20%) with an average duration of 6.8 days then TMP-SMX (N = 28; 4%) with an average
duration of 11.5 days. The study had some significant limitations, though. First was the
inappropriate use of DDD for children patients since this unit is appropriate only for adult
measures. Second, no age–sex adjustment for rates of infections was performed; some
infections are common at specific ages and in specific genders. Third, the study did not
consider confounders such as seasonality in reporting certain infections such as RTIs.
Fourth, no standard diagnostic criteria were used to eliminate the variation factor in
diagnosis by different GPs, which could influence prescribing. Finally, the population
from Denmark was relatively small and therefore not representative of other countries.
Leistevuo et al. (1997) conducted a retrospective study in Finland to describe the
frequency of antibiotics prescribing for elderly people as well as identifying physician
prescribing practice in Lieto’s municipal healthcare centre, a mixed setting facility where
the majority of working physicians were GPs for the period 1990–1991. The study
included 1,196 elderly patients, representing 94% (N = 1,208) of Lieto’s municipal
elderly population. Of these, 41% (N = 488) were male and 59% (N = 708) were female.
Also, 62% (N = 739) were aged 64–74, 31% (N = 374) were aged 75–84 and 7% (N =
83) were aged 85 or older. Non-institutionalised patients were higher in both genders and
represented 94% (N = 662) of female patients and 96% (N = 469) of male patients. Before
the researchers examined the patients, they retrieved the preceding year’s data for
patients’ antibiotics prescriptions from patients’ medical records. The findings showed
that 27.1% (N = 127) of non-institutionalised male patients and 33.1% (N = 219) of non-
institutionalised female patients were prescribed at least one antibiotic in the preceding
year. UTI was the most common type of infection for antibiotics prescribing in both
genders. Female patients received more antibiotics prescriptions for UTIs (N = 153; 60%)
than male patients (N = 25; 18%). Of the non-institutionalised female patients with UTIs,
58% (N = 74) received antibiotic therapy, whereas 10% (N = 13) of non-institutionalised
male patients did. Most male patients with UTIs were prescribed first generation
cephalosporins (N = 50; 36%), TMP-SMX or trimethoprim alone (N = 43; 31%) and
quinolones (N = 17; 12%). Female patients were prescribed TMP-SMX or trimethoprim
alone (N = 94; 37%), pivmecillinam (N = 61; 24%) and first-generation cephalosporins
(N = 56; 22%). Interestingly, although the findings were in line with national figures for
Finland, there were limitations to the study. First, it failed to distinguish between
institutionalised and non-institutionalised patients in terms of antibiotics prescribed for
UTIs for each gender. Second, it could not compare the findings with any similar studies
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especially in non-institutionalised patients. Third, the population from Finland was
relatively small and therefore not representative of other countries.
In one Norwegian county, Straand et al. (1998) performed a prospective, cross-sectional,
observational study of GPs’ prescribing patterns for antibiotics with regard to type,
quantity, patients’ ages and genders compared with guidelines for November 1988 to
November 1989. Data were collected by 149 GPs who represented 96% of the county’s
total GPs. The GPs issued 56,758 prescriptions, of which 14% (N = 7,905) were for
systemic antibiotics. In total, 1,649 (22.26%) prescriptions were issued for elderly
patients aged 60 and older. Of these, 1,097 (14.81%) were for females and 552 (7.45%)
were for males. Tetracyclines (N = 166; 30.07%) followed by TMP-SMX (N = 142;
25.72%) were the most commonly prescribed antibiotics for male elderly patients. In
females, TMP-SMX (N = 323; 29.44%) was followed by tetracyclines (N = 181; 16.49%).
In  general,  UTIs  were  the  most  common  cause  of  antibiotics  prescribing  (N  =  1,871;
23.66%), for which TMP-SMX was the most commonly prescribed drug (N = 844;
45.1%) followed by trimethoprim (N = 365; 19.5%) then extended spectrum penicillins
(N = 344; 18.4%). GPs did not prescribe according to UTI guidelines since almost half of
all UTI prescriptions were co-trimoxazole when the recommendations suggest using
trimethoprim and sulphonamides as first-line antibiotics for UTIs. One significant
limitation of the study related to antibiotics prescriptions issued through indirect contact,
whether by telephone, letter or a third person, which can result in either over-prescribing
or under-prescribing in certain infections such as UTIs that require laboratory test and
microbiology to confirm diagnosis, especially in elderly patients with atypical
presentations.
In  the  UK,  Wrigley et al.’s (2002) retrospective analysis examined GPs’ antibiotics
prescribing trends and investigated the influence of published guidelines and literature on
GPs’ prescribing practice in England and Wales from 1994 to 1998. Data were retrieved
from the General Practice Research Database (GPRD) and included patients’ medical
information from 210 general practices, among which 843,767 systemic antibiotics
prescriptions were found. Findings showed that elderly patients had the second highest
exposure to antibiotics after children under five years, with antibiotics prescriptions
numbering 712 (31.1%) in males and 852 (36.1%) in females aged 65–74, 854 (34.5%)
in males and 914 (37%) in females aged 75–84 and 1,007 (37%) in males and 1,042 (40%)
in females aged 85 years or older. Moreover, the analysis showed a marked variation in
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the use of sulphonamides, cephalosporins, broad-spectrum penicillins and trimethoprim,
which was justified by the difference in the use of these antibiotics for the treatment of
UTIs. The study, however, failed to measure GPs’ adherence to UTI recommendations,
owing to a lack of prescription duration information, or to distinguish between antibiotics
prescribed and those dispensed, since the numbers included delayed prescriptions,
meaning that an overestimation of antibiotics prescriptions cannot be ruled out.
Additionally, there was no data linking between prescriptions, which could have provided
useful information about the trend of antibiotics prescribing for specific types of
infection.
Kahan et al. (2005) carried out retrospective data analysis on computerised medical
records to evaluate physicians’ adherence to recommendations for the empiric treatment
of uncomplicated UTIs in adult female patients in a community setting in Israel between
July 2000 and June 2002. Retrieved data included visit date, patient and physician
identification numbers, diagnosis code, drug prescribed and referrals. In this study, which
identified 64,236 cases of uncomplicated UTI, guidelines recommended the use of
nitrofurantoin and TMP-SMX as first-line drugs. Results showed that only 35.55% (N =
22,833) of cases received antibiotics that were in line with recommendations. TMP-SMX
and nitrofurantoin were prescribed in 17.04% (N = 10,945) and 18.51% (N = 11,888) of
all cases respectively. Although not recommended, fluoroquinolones were the most
commonly prescribed antibiotics in 25.57% (N = 16,428) of cases, with 52.01% (N =
5,692) ofloxacin, 47.71% (N = 5,222) ciprofloxacin and 0.28% (N = 31) levofloxacin and
norfloxacin. The study concluded that adherence to guidelines among community-setting
physicians was poor. This study had limitations such as imprecise use of the disease
classification system, disease misclassification and incomplete capture of all cases.
Additionally, the study lacked patients’ clinical information, culture results and
laboratory results, which could have influenced physicians’ antibiotic choices.
Retrospective data analysis was performed in the UK by the Specialist Advisory
Committee  on  Antibiotic  Resistance  (SACAR)  to  explore  antibiotics  prescribing  in
primary care settings and the usefulness of GPRD as a database for antibiotics
surveillance between 1998 and 2001. Of 53,748 patients with UTIs, only 83.4% (N =
44,826) received antibiotics: trimethoprim (N = 25,147; 56.1%), cephalexin (N = 6,365;
14.2%), amoxicillin (N = 2,779; 6.2%), nitrofurantoin (N = 2,286; 5.1%), ciprofloxacin
(N = 1,838; 4.1%), co-amoxiclav (N = 1,748; 3.9%), cefradine (N = 1,614; 3.6%),
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cefadroxil (N = 941; 2.1%), norfloxacin (N = 807; 1.8%), cefaclor (N = 493; 1.1%) and
others (N = 807; 1.8%). Although the study demonstrated GPRD’s usefulness as a
database for monitoring antibiotics, it was limited by under-recording of UTIs by some
GPs who tended to record only major infections during consultations, which may have
resulted in prescriptions overestimation for these infections compared with the minor
infections. Another limitation related to the lack of distinguishing between antibiotics
prescribed and those dispensed, since the numbers included delayed prescriptions,
meaning that an overestimation of antibiotics prescriptions cannot be ruled out. The study
also reported that prescribing in primary care was most often in line with current
recommendations without reporting any results or details about GPs’ adherence (Petersen
and Hayward 2007a).
In the USA, retrospective, cross-sectional analysis of data retrieved from an ambulatory
medical services database18 between 1996 and 2001 examined prescribing practices for
treating uncomplicated UTIs in females aged 18 or older and the influence of the IDSA
1999 guidelines. The study identified 2,339 uncomplicated UTI cases, which was
projected to be 41.6 million patient visits (95% CI 37.9–45.4) to a healthcare provider in
the USA during the study period with an average of almost 7 million patient visits per
year. Of these cases, 24.48% (N = 582) were patients aged 60–79 with weighted visits of
27.8% (95% CI 25.7–32.9) and 8.46% (N = 198) were patients aged 80 or older with
weighted visits of 9.5% (95% CI 7.1–11.9). The most commonly prescribed antibiotics
were TMP-SMX in 26.5% (N = 620) of visits with weighted visits of 29.8% (95% CI
25.9–33.7), ciprofloxacin in 14.02% (N = 328) of visits with weighted visits of 24.2%
(95% CI 20.1–28.4), nitrofurantoin in 11.07% (N = 259) of visits with weighted visits of
18.8% (95% CI 15.0–22.6), fluoroquinolones excluding ciprofloxacin in 5.55% (N = 130)
of visits with weighted visits of 11.2% (95% CI 8.6–13.8) and amoxicillin in 2.09% (N =
49) of visits with weighted visits of 2.6 % (95% CI 1.3–3.8). Use of ciprofloxacin
increased since the introduction of the IDSA guidelines by approximately two-thirds (OR
1.75; 95% CI 1.11–2.75) and (p =  0.016)  whereas  the  use  of  other  antibiotics  did  not
significantly change, which made ciprofloxacin the preferred drug. Overuse of
fluoroquinolones made TMP-SMX, which was the recommended antibiotic for
uncomplicated UTIs, not the drug of choice. The study confirmed that primary care
physicians generally lack adherence to IDSA guidelines. However, it had limitations
18 A database that included non-federally employed patients visiting primary care.
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related to UTI misclassification and the possibility of treating other UTI classes as
uncomplicated UTIs. Additionally, some cases were given antibiotics based on microbial
culture results making the decision in these cases more directed than empirical (Taur and
Smith 2007).
McIsaac et al. (2008) performed a retrospective, cross-sectional study to determine
Canadian primary care physicians’ first-line antibiotics choices for treating adult female
patients with symptoms suggestive of acute cystitis between April 2002 and March 2003.
The study recruited 418 full-time family physicians who detected 446 cases of cystitis in
female patients, of whom 79 (17.7%) were elderly, aged 65–99. The results revealed that
86.9% (N = 365) of female patients with suggestive cystitis received an antibiotic
prescription (95% CI 83.3–90.0). Urine culture testing was requested for 311 of the 365
patients with antibiotic prescriptions, with culture results returned negative in 102 cases
(32.8%). In other words, 32.8% of female patients received unnecessary antibiotic
therapy. TMP-SMX was the most commonly prescribed first-line antibiotic drug (N =
149; 40.8%) (95% CI 35.7–46.1). Most TMP-SMX treated patients received a
prescription for a course of seven or more days (N = 55; 36.9%), followed by three days
(N = 54; 36.2%) then five days (N = 40; 26.8%). The mean duration of antibiotic therapy
in elderly females was 5.4 days, which was not shown to be significant if compared with
young females (p = 0.39). Fluoroquinolones were the second most commonly prescribed
empirical antibiotics after TMP-SMX in 27.4% (N = 100) of cases (95% CI 22.9–32.3).
Patients who received fluoroquinolones used them for durations of three days in 37.4%
of cases (N = 37/99), five days in 29.3% of cases (N = 29/99) and seven or more days in
33.3% of cases (N = 33/99). Females aged 65 or older were prescribed fluoroquinolones
as a second-line empirical therapy (N = 21/65; 32.3%) with no statistical difference
compared with young females (p = 0.50). Nitrofurantoin was the third most commonly
prescribed antibiotic in 26.6% (N = 97) of cases (95% CI 22.1–31.4). The majority of
patients were prescribed nitrofurantoin for the recommended seven days (N = 52/97;
53.6%), although 46.4% (N = 45/97) were prescribed for fewer days. A three-day course
was prescribed in 19.6% (N =19) of cases. There was no difference in nitrofurantoin use
among all age groups (p = 0.56). The study concluded that prescribing in Canada was
associated with a high level of unnecessary antibiotics use and physicians had a habit of
prescribing fluoroquinolones more frequently, which can lead to increased
fluoroquinolones bacterial resistance. One of its limitations was the use of old collected
data to measure adherence levels with an updated recommendation, as the prescribing at
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that time would not have been a fair representation of current antibiotics prescribing
practice. Additionally, the results from this study might not represent family physicians’
antibiotics prescribing practice in Canada since the participating number of family
physicians was small compared with the total number of physicians contacted, which was
2,000.
In Ireland, a prospective study evaluated the management and appropriateness of GPs’
antibiotics therapy for UTIs in adult patients including the elderly in relation to urine
sample laboratory results from 14 September 2009 to 9 November 2009. The study
examined urine samples from 866 patients from 22 GP surgeries using microscopy and
semi-quantitative culture testing. The culture was positive in 21% (N = 183) of patients,
8.8% (N = 76) of patients had pyuria and there was no evidence of UTI in 70.1% (N =
607) of patients. In total, 56% (N = 481) of patients received an antibiotics prescription,
of whom 55.7% (N = 268) had no laboratory evidence of UTIs and 37.2% (N = 179)
received first-line antibiotics (nitrofurantoin or trimethoprim). Co-amoxiclav was the
most commonly prescribed antibiotic, prescribed to 159 patients (33.1%), of whom 87
(54.7%) had no laboratory evidence of UTI; followed by trimethoprim, prescribed to 126
patients (26%), of whom 60 (48%) had no laboratory evidence of UTI; then
fluoroquinolone, prescribed to 82 patients (17%), of whom 54 (65.9%) had no laboratory
evidence of UTI; and nitrofurantoin, prescribed to 57 patients (11.9%), of whom 29
(50.9%) had no laboratory evidence of UTI. Empirical antibiotics therapy appropriateness
was evaluated based on three simulated scenarios that showed general antibiotics
prescribing was appropriate in 55.2% of cases (N = 478), with 57.5% (N = 498) for
nitrofurantoin, 52.5% (N = 455) for trimethoprim and 57.6% (N = 499) for
fluoroquinolones. Overall, 55% of the patients received appropriate antibiotics treatment
for uncomplicated UTIs. However, the study had limitations in terms of categorisation of
appropriateness of empirical UTI therapy, which was based on non-validated simulated
scenarios against the first-line therapy recommended in the guidelines. Additionally, the
use of pyuria as an indicator for UTI was not reliable since pyuria can be associated with
other conditions (Vellinga et al. 2011).
Llor et al. (2011) conducted a cross-sectional study to determine Spanish GPs’ adherence
to diagnostic and therapeutic guidelines for LUTIs in females using a data registry to
collect clinical data between March 2009 and July 2009. The registry data were completed
by 176 GPs who identified 658 females with LUTIs. Results revealed that antibiotics
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were prescribed in 634 (96.4%) cases, of whom 545 (82.82%) had uncomplicated UTIs
and 113 (17.17%) had complicated UTIs. Antibiotics were prescribed for all complicated
cases but only 521 (95.59%) uncomplicated cases. First-line drug therapy was prescribed
to 111 (17.5%) females, of whom 92 (16.88%) had uncomplicated UTIs and 19 (16.81%)
had complicated UTIs. Fosfomycin was the most often prescribed antibiotic for UTIs in
299 (47.16%) cases with the majority receiving a prescription for a two-day course (N =
241; 80.60%) and 19.39% (N = 58) receiving a prescription for a single dose. Co-
amoxiclav was the second most commonly prescribed antibiotic in 97 (15.29%) cases
with the majority receiving a prescription for a seven-day course (N = 75; 77.31%) and
22.68% (N = 22) receiving a prescription for a five-day course. Fluoroquinolones were
the third most commonly prescribed antibiotics in 75 (11.82%) cases, who received
norfloxacin mainly for seven days (N = 51; 68%) followed by three days (N = 18; 24%)
then five days (N = 6; 8%); ciprofloxacin was also prescribed in 63 (9.93%) cases for
seven days (N = 36; 57.14%) and five days (N = 26; 41.26%). Overall, prescribing short
antibiotics courses was preferred by 60.7% (N = 385) of GPs; however, short duration
courses were prescribed more often in uncomplicated UTI cases (N = 347; 66.6%)
compared with (N = 174; 33.4%) longer courses, whereas longer duration courses were
more often used in complicated UTI cases (N = 75; 66.4%) compared with (N = 38;
33.6%) shorter courses. Spanish GPs had poor adherence to guideline recommendations
with low utilisation of ¿rst-line antibiotics. The study was limited by the small number of
recruited GPs, and by failing to link the results of antibiotics duration with the
complicatedness of UTI cases. Also, performing an audit study may influence GPs’
prescribing habits by exposing them to the Hawthorne effect.19 Finally,  the  study  was
sponsored by a pharmaceutical company, which could have resulted in biased findings.
In France, a prospective study evaluated whether French GPs adhere to the 2008 UTI
guidelines by comparing urine analysis results with prescribed antibiotics during
September 2010. The study included 185 urinalyses samples requested by 122 GPs. The
results showed that only 20% (N = 37) of patients received antibiotics prescriptions that
were in line with the recommendations. Moreover, 71.35% (N = 132) of patients received
an antibiotic that was not recommended as a first-line drug, including 70.1% (N = 94) of
all cystitis cases. Although antibiotics prescribing was in line with recommendations in
8.64% (N = 16) of patients, these patients received a prescription with either an incorrect
19 Where a study subject’s behaviour and/or the study outcomes are altered as a result of the subject’s
awareness of being under observation (Mangione-Smith et al. 2002, p. 1604).
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dose and/or an incorrect treatment duration. Ciprofloxacin and nitrofurantoin were mostly
associated with dose error, with GPs prescribing only 50% of the recommended dose,
whereas short courses for prostatitis and long courses for cystitis were the two main
problems associated with incorrect antibiotics duration. Furthermore, GPs prescribed
fluoroquinolones in 59.49% (N = 110) of all UTI cases, of which 77.27% (N = 85) were
not in line with recommendations. The majority of cystitis patients were treated with
fluoroquinolones then nitrofurantoin. The study concluded that GPs were not following
the  guidelines  sufficiently  and  that  the  majority  of  UTIs  were  being  treated
inappropriately with fluoroquinolones. One of its limitations related to the process of
treating patients with cystitis without the use of urinalyses, which might result in UTI
population misrepresentation. Another was that the treatment comparison with the
guidelines was based on diagnoses established by the GPs, which could have deviated
from the recommendations according to the patients’ condition. Additionally, the
accuracy  of  the  GPs’  diagnoses  was  not  established,  which  could  result  in  the  wrong
antibiotic being selected for the wrong condition, which was consequently considered as
a deviation from the guidelines. Moreover, the data from this study were presented in the
form of graphs only, which made the results difficult to interpret especially in terms of
data comparisons (Denes et al. 2012).
Haasum et al. (2013) conducted a retrospective, cross-sectional analysis of the Swedish
Prescribed Drug Register (SPDR) to compare the quality of antibiotic drugs use for
treating UTIs in home-dwelling and institutionalised elderly patients against Swedish and
European guidelines. The study included dispensed drugs data for people aged 65 and
older from 1 July 2008 to 30 September 2008. Of the 12,455 elderly males and females
who used antibiotics for UTIs during the study period, the calculated prevalence was 1.6%
(N = 1,392/86,721) for institutionalised elderly compared with 0.9% (N =
11,063/1,260,843) in the community. Among home-dwelling female UTI patients aged
65–79, pivmecillinam (N = 1,457; 32.1%), trimethoprim (N = 1,210; 26.7%),
nitrofurantoin (N = 1,077; 23.8%) and quinolones (N = 955; 21.1%) were the most
commonly used antibiotics; while for those aged 80 or older the most commonly used
antibiotics were pivmecillinam (N = 1,022; 34.6%), trimethoprim (N = 882; 29.8%),
nitrofurantoin (N= 678; 22.9%) and quinolones (N = 460; 15.6%). For home-dwelling
male UTI patients aged 65–79, the most commonly used antibiotics were quinolones (N
= 1,584; 68.2%), trimethoprim (N = 432; 18.6%), nitrofurantoin (N = 208; 9.0%) and
pivmecillinam (N = 157; 6.8%); while for those aged 80 or older the most commonly
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used antibiotics were quinolones (N = 726; 58.1%), trimethoprim (N = 327; 26.2%),
pivmecillinam (N = 115; 9.2%) and nitrofurantoin (N = 108; 8.6%). GPs poorly adhered
to the recommendations in both settings. However, use of pivmecillinam for UTIs might
reflect the proper implementation of guidelines in females. Quinolones were used more
frequently than advised in both settings and nitrofurantoin was used to a lesser extent in
females than was recommended. In males, the use of quinolones and trimethoprim was
in line with recommendations in both settings. Conversely, use of nitrofurantoin in males
was higher than recommended, especially in elderly patients aged 80 or older. However,
the lack of patients’ clinical information, the lack of laboratory results for renal function,
urinalysis and cultures, the lack of the reason for antibiotics prescribing for treatment or
prophylaxis, the lack of linking between prescribed antibiotics and those dispensed as
well as the lack of distinguishing between ASB and UTIs were all significant limitations
of this study.
In conclusion, there were 12 studies describing the appropriateness of GPs prescribing
antibiotics for UTIs. Two were from the UK (Wrigley et al. 2002, Petersen and Hayward
2007a), seven were from other European countries, namely, Denmark, Finland, Norway,
Ireland, Spain, France and Sweden (Friis et al. 1989, Leistevuo et al. 1997, Straand et al.
1998, Llor et al. 2011, Vellinga et al. 2011, Denes et al. 2012, Haasum et al. 2013), one
was from the USA (Taur and Smith 2007), one from Canada (McIsaac et al. 2008) and
one from Israel (Kahan et al. 2005). Eight studies evaluated primary care GPs’, doctors’
or physicians’ adherence to UTI guidelines (Straand et al. 1998, Kahan et al. 2005, Taur
and Smith 2007, McIsaac et al. 2008, Llor et al. 2011, Vellinga et al. 2011, Denes et al.
2012, Haasum et al. 2013). Two studies were designed specifically for the elderly
population (Leistevuo et al. 1997, Haasum et  al. 2013) and the rest included elderly
people as part of the studied population, of which six clearly stated the number of elderly
patients included (Friis et al. 1989, Straand et al. 1998, Wrigley et al. 2002, Taur and
Smith 2007, McIsaac et al. 2008, Haasum et al. 2013). Three studies covered antibiotics
prescribing for female patients with UTIs in general including elderly people (Kahan et
al. 2005, McIsaac et  al. 2008, Llor et al. 2011). Additionally, the studies varied in
research design and data sources, ranging from manual data collection in three studies
(Friis et al. 1989, Leistevuo et al. 1997, Llor et al. 2011), databases in five (Wrigley et
al. 2002, Kahan et al. 2005, Petersen and Hayward 2007a, Taur and Smith 2007, Haasum
et al. 2013) and urine culture results in three (McIsaac et al. 2008, Vellinga et al. 2011,
Denes et al. 2012).
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Each study on antibiotics prescribing for UTIs in the community setting is unique in its
methodological approach and presentation of results. This makes it challenging to draw
direct comparisons about how and why antibiotics are prescribed for UTIs. Studies from
different countries adopted different guidelines to audit the appropriateness of different
first-line antibiotics. Moreover, first-line treatment recommendations might differ within
the same country as bacteria develop resistance over time. GPs might deviate from
prescribing guidelines when urine sample results show resistance bacteria, or when the
patient has a reason that makes first-line therapy inappropriate, such as drug–drug
interactions or ADRs. Nonetheless, some notable trends were apparent. Elderly females
received more antibiotic prescriptions for UTIs than elderly males (Leistevuo et al. 1997).
‘Poor’ or ‘lacking’ were the two words used to describe GPs’ adherence to UTI guidelines
in all studies designed to evaluate GPs’ prescribing practice (Straand et al. 1998, Kahan
et al. 2005, Taur and Smith 2007, McIsaac et al. 2008, Llor et al. 2011, Vellinga et al.
2011, Denes et al. 2012, Haasum et al. 2013). Additionally, there was notably increased
prescribing of fluoroquinolones for UTIs in six studies (Kahan et al. 2005, Taur and Smith
2007, McIsaac et  al. 2008, Llor et al. 2011, Vellinga et al. 2011, Denes et  al. 2012),
although these are not recommended. This trend could have disastrous consequences for
the growing bacterial resistance problem. Furthermore, TMP-SMX or trimethoprim
appear to be the most frequently prescribed antibiotics by for UTIs (Leistevuo et al. 1997,
Straand et al. 1998, Kahan et  al. 2005, Petersen and Hayward 2007a, Taur and Smith
2007, McIsaac et al. 2008). Critical appraisal of the studies that used urine samples
suggested that some GPs are more likely to send samples for microbiological analysis
than others, for instance, if they have a low tendency to prescribe antibiotics (McIsaac et
al. 2008, Vellinga et al. 2011, Denes et al. 2012).
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Table 15: Summary of studies relevant to antibiotics prescribing for elderly patients with UTIs and GPs’ adherence to UTI guidelines
Author Country Study Design Data Source N* Results
Friis et al. 1989 Denmark Prospective Data collection chart 966 EPats
-UTIs were the most common cause for antibiotic treatment in elderly (N = 290;
30%)
-Frequently prescribed antibiotics for UTIs were:
Sulphamethizole: (N = 451; 59%) average duration of 6.2 days
Ampicillin: (150; 20%) average duration of 6.8 days
TMP-SMX: (N = 28; 4%) average duration of 11.5 days
Leistevuo et al. 1997 Finland Retrospective GPs’ records 1,196 EPats
-UTIs were the most common infection for antibiotic prescribing.
-Female received more antibiotic prescriptions (N = 153; 60%)
-Non-institutionalised female patients with UTIs received more antibiotic
therapy (N = 74; 58%)
-Frequently prescribed antibiotics for UTIs in male:
1st generation cephalosporins: (N = 50; 36%)
TMP-SMX or trimethoprim alone: (N = 43; 31%)
Quinolones: (N = 17; 12%)
-Frequently prescribed antibiotics for UTIs in female:
TMP-SMX or trimethoprim alone: (N = 94; 37%)
Pivmecillinam: (N = 61; 24%)
1st generation cephalosporins: (N = 56; 22%)
Straand et al. 1998 Norway Prospective cross-sectional
GPs collected antibiotic
prescriptions 1,649 EPres
-UTIs were the most common cause of antibiotics prescribing in (N = 1871;
23.66%)
-Frequently prescribed antibiotics for UTIs were:
Co-trimoxazole: (N =844; 45.1%)
Trimethoprim: (N = 365; 19.5%)
Extended spectrum penicillins: (N = 344; 18.4%)
-GPs did not prescribe antibiotic for UTIs according to guideline
recommendations
Wrigley et al. 2002 UK Retrospectiveanalysis GPRD 5,381 EPres
-Marked variation in the use of sulphonamides, cephalosporins, broad-spectrum
penicillins and trimethoprim
Kahan et al. 2005 Israel Retrospectiveanalysis
Computerised medical
records 64,236 cases
-TMP-SMX (N = 10,945; 17.04%)
-Nitrofurantoin (N = 11,888; 18.51%)
-Antibiotics were in line with guideline recommendation in (N = 22,833;
35.55%) cases
-Fluoroquinolones were not recommended by guideline and were prescribed in
(N = 16,428; 25.57%)
-Adherence to guideline was found to be poor
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Author Country Study Design Data Source N* Results
Petersen and Hayward 2007 UK Retrospective dataanalysis GPRD
53,748
patients
- A total of (N = 44,826; 83.4%) patients received antibiotic for UTIs as follow:
Trimethoprim: (N = 25,147; 56.1%)
Cephalexin: (N = 6,365; 14.2%)
Amoxicillin: (N = 2,779; 6.2%)
Nitrofurantoin: (N = 2,286; 5.1%)
Ciprofloxacin: (N = 1,838; 4.1%)
Co-amoxiclav: (N = 1,748; 3.9%)
Cefradine: (N = 1,614; 3.6%)
Cefadroxil: (N = 941; 2.1%)
Norfloxacin: (N = 807; 1.8%)
Cefaclor: (N = 493; 1.1%)
Others: (N = 807; 1.8%)





services database 780 EPats
-Prescriptions for uncomplicated UTIs were as follow:
TMP-SMX in (N = 620; 26.50%)
Ciprofloxacin in (N = 328; 14.02%)
Nitrofurantoin in (N = 259; 11.07%)
Fluoroquinolones other than ciprofloxacin in (N = 130; 5.55%)
Amoxicillin in (N = 49; 2.09%)
-There was increase in ciprofloxacin use by 2/3 (p = 0.016)
-Primary care physicians generally lack adherence to guidelines
McIsaac et al. 2008 Canada Retrospective, cross-sectional
Primary care clinics visits
and urine culture by adult
female
79 EPats
-Prescriptions for acute cystitis were as follow:
TMP-SMX (N = 149; 40.8%) (95% CI 35.7 - 46.1):
 7-day (N = 55; 36.9%)
3-day (N = 54; 36.2%)
5-day course (40, 26.8%)
-Mean duration of therapy in elderly females 5.4 days (p=0.39) compared with
young females
-Fluoroquinolones were the 2nd commonly prescribed empirical antibiotic in (N
= 100; 27.4%) (95% CI 22.9 - 32.3)
-Fluoroquinolones were used for durations between 3 days in (N = 37/99;
37.4%), 5 days in (N = 29/99; 29.3%) and  7 days in (N = 33/99; 33.3%)
-Females 65 years or older were prescribed fluoroquinolones (2nd line) empirical
therapy in (N =21/65; 32.3%) (p=0.50) compared with young females
-Nitrofurantoin was the 3rd commonly prescribed antibiotic in (N = 97; 26.6%)
(95% CI 22.1- 31.4) patients
-Nitrofurantoin were prescribed for 7 days in (52/97, 53.6%)
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Author Country Study Design Data Source N* Results
McIsaac et al. 2008 Canada Retrospective, cross-sectional
Primary care clinics visits
and urine culture by adult
female
79 EPats
-Nitrofurantoin were prescribed for 7 days in (52/97, 53.6%)
-Nitrofurantoin were prescribed for females less than the recommended 7 days
duration in (N= 45/97; 46.4%)
-Three-days course was prescribed in (N =19; 19.6%) patients
-No statistical difference in the use of nitrofurantoin among all age groups
(p=0.56)
-High level of unnecessary antibiotic use was reported
-Physicians had a habit to prescribe fluoroquinolones more frequently
Vellinga et al. 2011 Ireland Prospective urine samples laboratoryresults 866 patients
-A total of (N = 481; 56%) patients received antibiotic prescription (N = 268;
55.7%) with no laboratory evidence of UTIs
-First-line antibiotics (nitrofurantoin/trimethoprim) were received in (N = 179;
37.2%)
-Co-amoxiclav prescribed in (N = 159; 33.1%) patients, of whom (N = 87;
54.7%) with no laboratory evidence of UTIs
-Trimethoprim prescribed in (N = 126; 26%) patients, of whom (N = 60; 48%)
with no laboratory evidence of UTIs
-Fluoroquinolones prescribed in (N = 82; 17%) patients, of whom (N = 54;
65.9%) prescriptions with no laboratory evidence of UTIs
-Nitrofurantoin prescribed in (N = 57; 11.9%) patients, of whom (N = 29; 50.9%)
with no laboratory evidence of UTIs
-Empirical antibiotic simulation showed appropriateness of prescribing by GPs
as follow:
General antibiotic prescribing: (N = 478; 55.2%)
Nitrofurantoin (N = 498; 57.5%)
Trimethoprim (N = 455; 52.5%)
Fluoroquinolones (N = 499; 57.6%)
-Overall, 55% of the patients received appropriate antibiotic treatment for
uncomplicated UTIs
Llor et al. 2011 Spain Cross-sectional Clinical data registry forLUTIs in females 658 cases
Antibiotics were prescribed in (N = 634; 96.4%) cases, of whom (N = 545;
82.82%) uncomplicated UTIs and (N = 113; 17.17%) complicated UTIs
Antibiotics were prescribed for all complicated cases and only in (N = 521;
95.59%) cases of uncomplicated UTIs
-First-line antibiotic was prescribed in (N = 111; 17.5%) females, of whom (N =
92;17.7%) is uncomplicated UTIs and (N = 19; 16.8%) in complicated UTIs.
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Llor et al. 2011 Spain Cross-sectional Clinical data registry forLUTIs in females 658 cases
-Fosfomycin was the most often prescribed antibiotic for UTIs in (N = 299;
47.16) cases with a majority of prescriptions for duration of 2 days (N = 241;
80.60%) whereas (N = 58; 19.39%) cases received a single dose prescription.
-Co-amoxiclav was the 2nd commonly prescribed antibiotic in (N = 97; 15.29%)
cases with majority received a prescription for 7 days (N = 75;77.31%) and (N =
22;22.68%) for 5 days.
-Fluoroquinolones were the 3rd commonly prescribed antibiotics in (N = 75;
11.82%) cases
-Norfloxacin was prescribed for 7 days in (N = 51; 68%) followed by 3 days in
(N = 18; 24%) and then 5 days in (N = 6; 8%)
-Ciprofloxacin was prescribed in (N = 63; 9.93%) for 7 days in (N = 36; 57.14%)
and (N = 26; 41.26%) for 5 days
-Overall, prescribing short antibiotic courses were more preferred by (N = 385;
60.7%) GPs
-Short duration courses where more often in uncomplicated UTIs cases (N = 347;
66.6%) compared to (N = 174; 33.4%) longer courses
-Longer duration courses were more often in complicated UTIs cases (N = 75;
66.4%) compared to (N = 38; 33.6%) shorter courses.
-Spanish GPs had poor adherence to guidelines recommendation with a low
utilisation of ¿rst-line antibiotic
Denes et al. 2012 France Prospective Urine analyses results 185 UAS
-Adherence to 1st line antibiotic choice was seen in (N = 37; 20%) patients
-Incorrect dose and/or duration of treatment was seen in (N = 16; 8.64%) patients
-A total of (N = 132; 71.35%) patients received an antibiotic which was not
recommended as first-line drug, of which (N = 94; 70.1%) of all cystitis cases.
-Ciprofloxacin and nitrofurantoin were mostly associated with dose error by
writing 50% of the recommended dose
-Short courses for prostatitis and long courses for cystitis were the main two
problems associated with incorrect antibiotic duration
-GPs prescribed fluoroquinolones in (N = 110; 59.49%) of all UTIs cases, of
which (N = 85; 77.27%) were not in line with guideline
-The majority of cystitis patients were treated with fluoroquinolones and then
nitrofurantoin.
-GPs were not following the current guideline recommendations sufficiently
-Majority of UTIs treated with fluoroquinolones inappropriately
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-Prevalence for elderly patients who received antibiotics for UTIs was (N =
1,392/86,721; 1.6 %) for institutionalised elderly compared to
(11,063/1,260,843; 0.9 %) in the community.
-Frequently prescribed antibiotics in home-dwelling females aged 65 to 79:
Pivmecillinam (N = 1,457; 32.1%).
Trimethoprim (N = 1,210; 26.7%).
Nitrofurantoin (N = 1,077; 23.8%).
Quinolones (N = 955; 21.1%).
-Frequently prescribed antibiotics in home-dwelling females aged 80:
Pivmecillinam (N = 1,022;34.6%).
Trimethoprim (N = 882;29.8%).
Nitrofurantoin (N= 678;22.9%).
Quinolones (N = 460; 15.6%).
-Frequently prescribed antibiotics in home-dwelling males aged 65 to 79:
Quinolones (N = 1,584; 68.2%).
Trimethoprim (N = 432;18.6%).
Nitrofurantoin (N = 208; 9.0%).
Pivmecillinam (N = 157;6.8%).
-Frequently prescribed antibiotics in home-dwelling males aged 80:
Quinolones (N = 726;58.1%).
Trimethoprim (N = 327;26.2%).
Pivmecillinam (N = 115;9.2%).
Nitrofurantoin (N = 108;8.6%).
-GPs had poor adherence with recommendations in both settings.
-Use of pivmecillinam reflect the proper implementation of guideline in females.
-Quinolones were used more frequently than advised by guideline in both
settings in females.
Nitrofurantoin was used in a lesser extent in females than the recommendations.
-Use of quinolones and trimethoprim were in line with guideline in both settings
in males.
-Use of nitrofurantoin was higher than the recommended in males especially
those aged 80 years or older.
* N: refers to number of elderly patients participated in the study or number for prescriptions for elderly patients) TMP-SMX: Trimethoprim-Sulfamethoxozole EPats: elderly patients EPres: elderly
prescriptions UAS: urinalyses samples; SPDR: Swedish Prescribed Drug Register; GPRD: General Practice Research Database
Continued Table 15
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Variations in GPs’ Views and Perceptions of Antibiotics Prescribing for UTIs
for Elderly Patients in a Primary Care Setting
Considerable works of qualitative research have contributed to the current knowledge
related to understanding the cultures, views and perceptions20, of prescribing antibiotics
for several infectious diseases including RTIs among GPs (Butler et al. 1998, Tonkin-
Crine et al. 2011b) and hospital doctors (Charani et al. 2013, Broom et al. 2014).
However, there is a gap in GP qualitative research in terms of understanding their views
and perceptions especially when treating elderly patients. Therefore, research must be
undertaken to understand why and how GPs prescribe and consume antibiotics for UTIs
(Duane et al. 2016). The literature review identified three studies on GPs’ views and
perceptions about antibiotics according to expanded search criteria that were reviewed
and critiqued compared here and summarised in Table 16.
In Germany, Kuehlein et al. (2011) carried out a mixed methods study (observations,
focus group discussions and interviews) to examine GPs’ prescribing behaviour for
LUTIs. The study was designed as a before–after study with a mixed three-step
intervention between 1 January 2008 and 1 July 2009. The study recruited 18 GPs who
were allocated to two focus groups, one comprising six GPs and the other comprising 12.
Findings revealed that hospital teaching and training as well as letters from other
specialists and hospital referral letters were the main drivers of GPs’ current prescribing
behaviour, which was thought to be more reflex-like than based on cognitive decisions.
As this was a successful regimen in treating UTIs, GPs were not in favour of changing
this practice. They could not see any difference in success between trimethoprim and
fluoroquinolones. A combination of peer-group opinion and personal experience was said
to be the main influence on treatment decisions. Moreover, some GPs admitted that
recommendations were unknown to them, which had led to a noticeably sustained rise in
trimethoprim prescribing. The study showed that GPs’ practice was strongly influenced
by evidence and peer-group opinion. Its limitations related to small sample size, GP
selection bias, since all participating GPs were part of an ongoing project and knew each
other, and the influence of the Hawthorne effect on GPs’ prescribing. Additionally, the
post-intervention change in prescribing behaviour was seen as a result of the study’s
influences on participating GPs, which could not be guaranteed in a larger population.
20 An individual’s or group’s unique way of viewing phenomena, involving the processing of stimuli and
incorporate memories and experiences in the process of understanding. (McDonald 2012, p. 8).
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In Sweden, Bjorkman et al. (2013) conducted qualitative GP interviews between October
and November 2004 to explore GPs’ views on resistance and UTI treatment. The study
used two qualitative research methods: phenomenography to describe different ways of
understanding  AMR  and  content  analysis  to  capture  different  views  of  UTI  treatment
decisions. The study recruited 20 GPs from 15 different primary care centres who were
selected by purposive sampling to maximise variations in age, gender and geography.
Interviews were semi-structured and contained open-ended questions relative to UTI
signs and symptoms, UTI treatment, effects of treatment and resistance as well as probing
questions. The phenomenographic analysis resulted in three different, mutually exclusive
ways of viewing resistance in UTI treatment: 1) ‘No problem, I have never seen
resistance’; 2) ‘The problem is bigger somewhere else’; and 3) ‘The development of
antibiotic resistance is serious and we must be careful’.
The content analysis examined antibiotics choice and duration. During interviews, GPs
discussed the recommendation of using alternative first-line antibiotics therapy with
shorter duration. The common perception was that this applied only when treating a single
patient to prevent recurrence because of resistance. Some GPs stated that each infection
should be treated as a new one, so using a previously prescribed antibiotic agent is
possible.  The  GPs  also  discussed  using  specific  antibiotics  for  safety  reasons,  lack  of
records, patients’ demands, the fear of side effects and costs. Adherence to alternative
recommendations with careful prescribing of fluoroquinolones for UTIs was reported
only among GPs who expressed view 3; GPs who expressed views 1 and 2 stated that
they  did  not  follow guidelines  for  all  aspects  of  UTI  in  addition  to  sporadically  using
fluoroquinolones as a first-line therapy. Many GPs were reluctant to follow guidelines for
shorter durations, too, owing to questionable efficacy or difficulty in changing previous
ways of thinking. GPs with views 1 and 2 said that they followed guidelines but with
longer durations or fluoroquinolones with shorter durations. Only those who expressed
view 3 stated that they followed the guidelines for shorter courses of therapy. Although
GPs with views 1 and 2 were aware of the recommendations and realised that their
practice must change, a common belief was that being cautious would be enough. The
findings suggested a relationship between adherence to UTI treatment guidelines and the
perception that antibiotic resistance is a major problem. This study had inherent and
significant limitations. First, interviews were performed in 2004, so awareness of
resistance may have developed since then. Second, the study did not present the
phenomenographical findings in the form of an outcome space figure, which is part of the
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analysis process. Additionally, it did not observe GPs’ practice sufficiently to enable
generalisation. Finally, content analysis is an analysis technique, not a qualitative method,
and the analysis was thematic, not content based as the research team indicated
(Vaismoradi et al. 2013).
In Ireland, Duane et al. (2016) conducted qualitative research to explore the prescribing
culture and consumption of antibiotics for UTIs from GP and community standpoints.
They carried out 15 interviews with GPs and six community focus groups with 42
participants using purposeful non-probability sampling. Core questions for GPs related to
their practice for treating UTIs, antibiotics prescribing, antibiotics resistance and
interventions to facilitate change in GPs’ prescribing behaviour. Core questions for the
community groups focused on health and GPs’ consultations, antibiotics awareness,
previous UTI experiences and interventions to facilitate community behaviour change in
terms of consumption. Thematic analysis was used to identify emerging themes. Findings
revealed that GPs were knowledgeable about resistance and the associated negative
consequences, although they were more concerned about the long-term societal impact.
They admitted that it was their responsibility to discuss resistance with patients, but saw
diagnosis as simple, viewing antibiotics as necessary and preferring to prescribe them
empirically for UTIs to reduce re-consultations. The study highlighted the importance
and difficulty of capturing the complex interactions associated with antibiotics
prescribing for UTIs. However, the small sample size and geographical constraints on
recruitment were major drawbacks in this study.
In conclusion, three qualitative studies were identified that described GPs’ views and
perceptions about antibiotics prescribing to treat UTIs. All were conducted in European
countries, namely, Germany (Kuehlein et al. 2011), Sweden (Bjorkman et al. 2013) and
Ireland (Duane et al. 2016). All three studies included GPs as participants, although
Duane et al. (2016) also had participants from the community with previous UTI
experience. None of these studies discussed the elderly perspective. They varied in
research design and data collection methods with focus groups (Kuehlein et al. 2011),
phenomenographic and content analysis with semi-structured interviews (Bjorkman et al.
2013) and qualitative in-depth interviews as well as focus groups (Duane et al. 2016).
Qualitative  evidence  of  GPs’  views  and  perceptions  about  UTIs  is  limited  in  the  UK,
especially relating to elderly people. Collectively, three studies provide a wider image
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indicating that GPs’ prescribing practice can be influenced by many factors and can vary
greatly in terms of antibiotics choice, duration, frequency of prescribing, use of
fluoroquinolones, adherence to guidelines and understanding the consequences of
resistance (Bjorkman et  al. 2013). The decision to prescribe antibiotics for UTIs
comprises complex need recognition, information search and evaluation processes,
governed by the relationship and interactions between the GP and the patient (Duane et
al. 2016). GPs’ antibiotics prescribing was mainly driven by former hospital training and
common therapy whereas internal evidence and peer-group opinion were strong
determinants for clinical decisions for UTIs (Kuehlein et al. 2011). Additionally, it was
suggested that more research should be undertaken to understand the decision-making
processes behind the continuing prescription of antibiotics for UTIs within the reality in
which the behaviours exist, as this can lead to successful long-term behavioural change
strategies (Duane et al. 2016).
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Table 16: Summary of studies relevant to GPs’ views and perceptions about antibiotics prescribing for elderly patients with UTIs
Author Country Study Design Data Source N Findings
Kuehlein et al. 2011 Germany Mixed methods Focus groups 18 GPs (6+12)
GPs’ main driver for current GPs prescribing behaviour:
1) Hospital teaching and training.
2) Therapy seen in letters from other specialists.
3) Hospital referral letters.
Previous experience with a successful regimen in treating UTIs:
-GPs’ agreed on lack of difference between the success of trimethoprim or fluoroquinolones.
-GPs’ main influence on treatment decisions: peer-group opinion and personal experience.
-Some GPs admitted that they lack the knowledge about recommendations which resulted in
sustained rise in trimethoprim prescribing.







Three different ways of viewing resistance in UTIs:
1) ‘no problem, I have never seen resistance’;
2) ‘the problem is bigger somewhere else’; and
3) ‘the development of antibiotic resistance is serious and we must be careful’.
Content analysis:
- Recommendations were only applicable for single patient to prevent UTIs recurrence.
- Some GPs stated that each infection should be treated as a new one and the use of previously
prescribed antibiotic agent is something possible.
-The habit of using a specific drug due to its safety, lack of records, patients demand, fear of side
effects and costs was also present in GPs statements.
-Adherence to UTIs alternative recommendations with careful prescribing of fluoroquinolones
was only reported among GPs who considered resistance as serious threat.
-Many GPs were reluctant to follow-up guidelines for shorter durations owing to questionable
efficacy.
-GPs who considered resistance as serious threat expressed view follow guideline including the
use of shorter course of therapy.
-Some GPs were aware of the guidelines and realised their practice must be changed.





15 GPs + 42
community
participants
-GPs were knowledgeable about resistance and the associated negative consequences
-Concern about resistance was more toward long term societal impact.
-GPs admitted that not many GPs’ discuss resistance with patients and it was their responsibility
to do that.
-UTI diagnosis was seen to be simple.
-Antibiotics were seen to be necessary for patients experiencing UTIs and preferred to prescribe
them empirically to reduce reconsultations.
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Factors Influencing GPs’ Antibiotics Prescribing
Several studies have explored factors responsible for GPs’ prescribing antibiotics for
infections such as sore throat (Kumar et al. 2003), RTIs (Brookes-Howell et al. 2012) and
diarrhoea (Paredes et al. 1996) and for hospital doctors doing the same (Tan et al. 2006,
Schouten et al. 2007). However, factors influencing GPs’ prescribing for UTIs in relation
to elderly patients have not been explored qualitatively. Moreover, no previous qualitative
research has explored the differences in the factors influencing GPs’ prescribing between
adult and elderly patients. The literature review identified five studies on factors
influencing GPs’ antibiotics prescribing for UTIs that were critiqued and compared in the
next paragraphs and summarised in Table 17.
In Iceland, Bjornsdottir and Hansen (2002) qualitatively explored physicians’ reasons for
prescribing antibiotics using in-depth semi-structured interviews with 10 GPs and field
observation of three of them throughout 1995. They analysed the interviews and
observational data using an open, axial and selective technique aimed at developing in-
depth understanding rather than theories, to describe factors related to ‘GPs’ attitudes’,
‘uncertainty’, ‘time pressure’, ‘individual patients’ characteristics’ and ‘perceived
influence from colleagues with regards to antibiotics’.  Findings  showed  that  GPs’
attitudes towards prescribing were either restrictive owing to ecological considerations
and spreading concern about resistance or liberal owing to concern about the possible
consequences of withholding a necessary antibiotic. Most GPs mentioned uncertainty
about whether to prescribe, owing to lack of solid diagnostic tests for some conditions,
changes in treatment recommendations and complaints about side effects. Some GPs
described time pressure as an occasional reason for prescribing when there was
insufficient time to explain the inadequacy of antibiotics to patients. They also recognised
that factors such as patients demanding antibiotics, having expectations, being able to
comply  with  instructions  and  their  general  life  situations  play  a  role.  Although  GPs
described colleagues’ prescribing practice as an unimportant source of information, they
were  curious  about  it  and  felt  it  was  crucial  to  discuss  cases  of  doubt  with  colleagues
regardless of any indicated uncertainty about their own superiority. Additionally, young
GPs mentioned that peers can influence their prescribing habits to be more restrictive.
The study identified three different decision-making routes that can lead to antibiotic
prescription. The first – ‘that the infection can/will interfere with the patient’s planned
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activities’ – relies on the belief that antibiotics might help and will not harm. The second
– ‘that the patient will not take no for an answer’ – is compounded by GPs’ lack of
resources to explain why antibiotics are not always appropriate. The third route suggests
that ‘GPs value patient autonomy more than patient welfare’. Although several factors
can influence antibiotics prescribing, helping patients to continue with daily activities was
found to be the most important. One of this study’s limitations was mixing the views of
GPs on contracts and state-hired GPs. No attempt was undertaken to distinguish the views
in either setting, which is unfortunate since the type of practice can influence the factors
that emerge such as consultation fees and workload. Additionally, interviews were
translated into Danish and selected quotations into English, which could have resulted in
misinterpretations or mistranslations. Another limitation was the influence of the
Hawthorne effect on the GPs who were observed in their workplace, which cannot be
ruled out.
Again, in Iceland, Petursson (2005) conducted a qualitative phenomenological study to
explore GPs’ reasons for non-pharmacological antibiotics prescribing from 2000 to 2003.
Data were collected through interviews with 16 GPs from different sites followed by
iterative data analysis. The findings revealed five major factors for antibiotics prescribing:
‘physician’s personal character’, ‘physician’s insecurity, uncertainty or anxiety’, ‘work
pressure and fatigue’, ‘pressure from patients and their families’ and ‘organisational
factors’. Factors related to the physician’s character included earnings incentives,
misinterpretation of patients’ wishes, variable interpretation of symptoms, carelessness,
unprofessionality, cheating to survive, variable attitudes, dislike of protocols, emphasis
on subjective assessment and service mentality. Factors related to the physician’s
uncertainty included lack of continuous care, diagnostic uncertainty, distrust of
colleagues, shrinking from conflict, transfer of patients’ fears, lack of experience, fear of
competition, fear of losing face, complaints and legal action, compromise as a back-up
and reinforcing relationships with patients. Work pressure and fatigue associated factors
included lack of time, means of survival by saving relationships between doctor and
patients, antibiotics as a quick solution to end consultations, physicians in variable form,
surrender to patients’ inability to help themselves and surrender to extreme stimuli.
Factors including misinformation and over-confidence in antibiotics, lower thresholds for
tolerating discomfort, obsession with scheduled plans, craving for security, fear of illness,
consciousness of consumer rights by pushy patients, job market difficulty and easy
solutions without any discomfort were related to patients’ or families’ pressures on GPs
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to prescribe antibiotics. Some GPs perceived that the nature of healthcare’s open access
to physicians can partially justify the widespread use of antibiotics; additionally, lack of
testing facilities and the effect of training processes were also mentioned as part of this
problem. This study had some weaknesses, including the small sample size, which makes
generalisation of the findings impossible, and that interviews were performed over a
three-year  period,  during  which  time  the  researcher’s  and  the  GPs’  views  might  have
changed owing to new guidelines or policies.
Kotwani et al. (2010) conducted focus group discussions in India between May 2008 and
September 2008 to identify antibiotics prescribing factors and appropriate interventions
to promote rational use of antibiotics in a primary care setting. Thirty-six GPs (10 from
public practice and 26 from the private sector) participated in three focus groups (one
comprising 18 private sector GPs, one comprising eight public sector GPs and the third
mixing two GPs from the public sector and eight from the private sector). Discussions
focused on the motivations and behaviours that lead to antibiotics misuse. Data analysis
was done through grounded theory, an inductive and iterative method. Findings were
categorised into three broad themes: ‘characteristic behaviour of doctor and patient’,
‘laxity in regulation for prescribing and dispensing antibiotics’ and ‘intervention
strategies’. Prescribing characteristics responsible for antibiotics misuse and overuse
mainly related to doctors and patients. Doctor-related factors included inadequate
knowledge, perceived patients’ demands and expectations, diagnostic uncertainty, private
practice sustainability and financial considerations, infection susceptibility, lack of time
owing to public sector patient loads, antibiotics oversupply and near-expiry in the public
sector and influences of medical representatives. Patient-related factors included
compliance, improper dosage and self-medication by patients purchasing antibiotics over
the counter and buying only as many tablets as they can afford or feel will provide them
with a quick fix, lack of follow-up owing to expensive consultations in the private sector
and long waiting hours in the public sector, patients seeking rapid cures by visiting several
doctors when their condition does not improve within a day or two. Furthermore, doctors
stated that if prescribing and dispensing of antibiotics by non-legalised persons, for
instance, chemists or alternative medicine practitioners, ceased or was regulated then
three-quarters of the problem would be solved, as their prescribing behaviour worsens the
problem of antibiotics misuse. Interventions such as continuous medical education for
doctors, education for patients’ and families’, advertisements on television and in
newspapers, shared decision-making, guidelines for proper antibiotics use and stricter
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regulations for over-the-counter sales and prescribing by practitioners were suggested.
This study had some weaknesses such as the small sample size of public sector GPs, from
only five different municipalities within the West Delhi region, meaning that perceptions
cannot be generalised. Additionally, the themes that emerged from the data analysis came
mainly from the first focus group then were used in the subsequent two groups.
Furthermore, some GPs within the mixed focus group might not have revealed their true
behaviour, which could have influenced the study outcomes.
Vazquez-Lago et al. (2012) conducted a qualitative study in Spain from April 2009 to
June 2009 to explore GPs’ attitudes, knowledge and habits relating to antibiotics and
resistance. They identified the attitudes and factors that influence antibiotics prescribing
and compared their findings with other studies from countries with low antibiotics
consumption and resistance rates. The study included 33 GPs working for the Spanish
NHS in Galicia, an area with a high percentage of the population aged over 65. Data were
collected through five focus groups, each comprising between four and 10 GPs. The focus
group agenda was drawn up from a theoretical model published previously in a systematic
review to capture GPs’ factors and attitudes. Topics discussed related to the antibiotics
prescribing process, misuse consequences and recommendations for improving
antibiotics use.
The findings were grouped into predefined categories. The GPs considered UTIs to be
one  of  the  most  common  causes  of  antibiotics  prescribing  after  RTIs.  Moreover,
antibiotics such as beta-lactams, particularly amoxicillin, macrolides, topical
aminoglycosides and fluoroquinolones were said to be the most frequently prescribed.
Antibiotics such as cephalosporins, tetracyclines, erythromycin and clarithromycin were
less prescribed. Antibiotic selection was said to be guided by the patient’s clinical profile,
professional experience, clinical guidelines, pharmaceutical industry promotions and
antibiotic price. Factors influencing GPs’ antibiotics prescribing included fears related to
the patient’s characteristics, in particular being elderly, lack of confidence, fear of disease
progression, complacency and patient dissatisfaction, that is, prescribing without real
patient need or indication simply to satisfy patients, insufficient knowledge and external
responsibility, relating to patients not taking antibiotics and pharmacies dispensing
antibiotics without prescription, promotional pressures from pharmaceutical companies,
the healthcare system, laboratories and other HCPs, and concern owing to lack of patient
follow-up. Interestingly, GPs perceived antibiotics resistance as an important
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consequence of antibiotics misuse for UTIs but not lower RTIs. They also believed that
resistance was a problem in hospitals rather than in the community, and attributed the
causes of resistance to patients’ non-compliance, antibiotics dispensing without
prescription and inappropriate antibiotics prescribing by other HCPs, in particular
dentists, community pharmacists and the veterinary industry. To improve antibiotics use,
GPs stressed certain recommendations such as better population education, better access
to diagnostic tests, improved communication between primary and secondary care,
transfer  of  chronic  patients  to  primary  care,  access  to  patients’  electronic  histories,
continuous medical education, appointing professionals in hospitals for discussion and
expert consultation, use of clinical guidelines without literal interpretation, use of delayed
prescribing, development of a map of local resistance, and regular meetings with primary
care pharmacies and local area management to discuss individual prescription profiles
and highlight poor prescribing practice. The study did have some issues such as missing
GP demographics data and qualifications, the small number and source of the participants,
who were selected from a specific area of Spain and therefore reflected the attitudes of
GPs in that particular area, and a lack of clear technique for data analysis.
In Portugal, Teixeira-Rodrigues et al. (2013) systematically reviewed the qualitative
literature published between January 1987 and December 2011 to identify different
factors, attitudes and knowledge that might influence physicians’ perceptions about
antibiotics prescribing. The review covered 35 studies, 18 of which included just
physicians while the rest included hospitals, patients and parents. The physicians
categorised the factors that had an impact on their antibiotics prescribing practice into
two groups: intrinsic and extrinsic. The intrinsic factors described broadly socio-
demographic factors such as previous clinical practice, years of practice, continuous
medical education, university education and physicians’ attitudes, including
complacency, fear, ignorance, indifference, influence by other HCPs and confidence. The
physicians considered diagnostic uncertainty and desire for a quick fix to be the basis of
antibiotics misuse. The extrinsic factors were grouped into three categories. The first was
patient-related factors, including signs, desire for a quick fix expressed by patients/carers,
anxiety, symptoms of other clinical conditions, patient age, economic and social factors,
and educational level. The second category – healthcare system-related factors – included
ownership of practice location, time pressures, implemented policies/guidelines,
influence of group exposure, communication and organisational models, accreditation
level, inexistence of facilities to promote diagnostic tests, workflow, public health
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considerations, use of the same prescription several times and patient health insurance.
The third category related to the influence of and financial incentives offered by
pharmaceutical companies, and to cost savings to the patient or to the healthcare system.
The study concluded that attitudes were the most important factor affecting physicians’
antibiotics prescribing. This review had some limitations, too. For one thing, it included
only published studies, all of which were very heterogeneous, rendering it susceptible to
bias. The heterogeneity was related to different settings (the studies were mainly from
Europe and North America), workplaces (different realities present different factors), data
collection methods and methods of analysis used. Additionally, there was an issue with
the generalisability of the findings, since all of the reviewed studies used a small sample
size. Moreover, as qualitative research is always criticised for its reliability, the
trustworthiness of these studies must be considered within the inclusion criteria.
In summary, five studies described the factors influencing GPs’ antibiotics prescribing
practice in a primary care setting. All were conducted in European countries, namely,
Iceland (Bjornsdottir and Hansen 2002, Petursson 2005), Spain (Vazquez-Lago et al.
2012) and Portugal (Teixeira Rodrigues et  al. 2013) except for one study, which was
conducted in India (Kotwani et al. 2010). All five included GPs as study participants,
although one also looked at hospital doctors, parents and carers (Teixeira Rodrigues et al.
2013). Only one study briefly discussed the elderly as a population and UTIs without
linking them (Vazquez-Lago et  al. 2012). The studies varied in the forms of data
collection, which ranged from focus group discussions (Kotwani et al. 2010, Vazquez-
Lago et  al. 2012), interviews (Bjornsdottir and Hansen 2002, Petursson 2005), field
observation (Bjornsdottir and Hansen 2002) and literature review (Teixeira Rodrigues et
al. 2013).
All five studies agreed that non-clinical factors, in addition to clinical factors, are
important aspects of GPs’ antibiotics prescribing decision-making. They explored several
of these such as GPs’ attitudes and personal characteristics, fears, diagnostic
uncertainties, time pressures, patients’ characteristics, perceived demand and patients’
expectations. These factors were found to affect all prescribing stakeholders including
patients, GPs, healthcare providers, the healthcare system and the general public, making
antibiotics prescribing a complex issue to deal with (Teixeira Rodrigues et al. 2013). Four
studies concluded that identifying factors that may influence GPs’ antibiotics prescribing
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can be very useful in designing specific interventions and strategies to improve antibiotics
use and help reduce resistance (Bjornsdottir and Hansen 2002, Kotwani et al. 2010,
Vazquez-Lago et al. 2012, Teixeira Rodrigues et al. 2013).
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Table 17: Summary of studies relevant to factors influencing GPs’ antibiotics prescribing
Author Country Study Design Data Source N Findings
Bjornsdottir and Hansen 2002 Iceland Qualitative Interview + fieldobservation
10 GPs + 3
GPs
-GPs’ attitudes were either restrictive or liberal.
-Prescribing uncertainty owing to lack of solid diagnostic tests, changes in treatment
recommendations and complaints about side effects.
-Time pressure can be an occasional reason for prescribing.
-Patients’ factors include work and leisure activities, patients’ behaviour in terms of
expectations, pressure and being demanding, patients’ compliance and patients’ job
situations.
-GPs felt curious about colleagues’ prescribing habits.
-GPs felt it was crucial to discuss cases of doubt with colleagues.
-Young GPs prescribing habits can be influenced by peers to be more restrictive.
Petursson 2005 Iceland Phenomenological Interview 16 GPs
-Factors related to the physician’s character: earnings incentive in the payment scale,
misinterpretation of patients’ presumed wishes, variable interpretation of symptoms,
carelessness, unprofessional work, cheating to survive, variable attitudes, dislike of
protocols, emphasis on subjective assessment and service mentality.
-Factors related to the physician’s uncertainty: lack of continuous care, diagnostic
uncertainty, distrust of colleagues, shrinking from conflict, transfer of patients’ fear, lack of
experience, fear of competition, losing face, complaints and legal action, compromise as a
back-up and method of reinforcing relationships with patients.
-Factors related to work pressure and fatigue:
-Lack of time, saving relationships between doctor and patients, prescribing antibiotics to
end consultations, physicians surrender to patients’ inability to help themselves and
surrender to extreme stimuli.
-Factors related to pressure from patients and their families:
-Misinformation and over-confidence in antibiotics, lower thresholds for tolerating any
discomfort, obsession with scheduled plans, craving for security, fear of illness,
consciousness of consumer rights by demanding and pushy patients, difficult job market and
easy solutions without any discomfort.
-Factors related to organisation:
open access healthcare and lack of testing facilities and the effect of training processes.
Kotwani et al. 2010 India Qualitative FGDs 36 GPs
-Doctors related factors: inadequate knowledge, perceived patients’ demands and
expectations, diagnostic uncertainty, practice sustainability and financial considerations of
doctors who work in private practice, consideration of infection susceptibility, lack of time
owing to patient loads in the public sector, antibiotics oversupply and near-expiry in the
public sector and influences of medical representatives.
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Author Country Study Design Data Source N Findings
Kotwani et al. 2010 India Qualitative FGDs 36 GPs
-Patient related behaviour: compliance, improper dosage and self-medication by patients,
lack of follow-up, seeking rapid cures.
-Laxity in regulation: prescribing and dispensing of antibiotics by non-legalised persons.
-Dispensing antibiotics intervention strategies: CME, patients’ and families’ education,
advertisements on television and in newspapers, shared decision-making, publishing and
supplying guidelines, setting up stricter rules and regulations for OTC sales and prescribing
by practitioners.
Vazquez-Lago et al. 2012 Spain Qualitative FGDs 33 GPs
-GPs considered UTIs to be one of the most common causes of antibiotics prescribing after
RTIs.
-Antibiotics such as amoxicillin, macrolides, topical aminoglycosides and fluoroquinolones,
were frequently prescribed.
-Antibiotics such as cephalosporins, tetracyclines, erythromycin and clarithromycin were
less prescribed.
-Antibiotic selection was guided by the patient’s clinical profile, professional experience,
guidelines, pharmaceutical industry promotions and antibiotic price.
-Factors influencing antibiotics prescribing by GPs: fears related to the patient’s
characteristics, in particular being elderly; GPs’ lack of confidence; fear of disease
progression; complacency and the patient’s dissatisfaction; GPs’ insufficient knowledge and
external responsibility, relating to patients not taking the antibiotics and pharmacies
dispensing antibiotics without prescription; promotional pressures applied by pharmaceutical
companies and the industry; the healthcare system; laboratories and other HCPs or
prescribers; and concern owing to lack of patient follow-up.
-GPs perceived that antibiotic resistance was an important consequence of misuse of
antibiotics in UTIs but not in lower RTIs.
-GPs believed that resistance was a problem in hospitals rather than at the community level
-Resistance was attributed to patients’ non-compliance, antibiotic dispensing without
prescription and inappropriate antibiotic prescribing by other HCPs, in particular dentists,
community pharmacists and the veterinary industry.
-GPs stressed on population education, better access to diagnostic tests, improved
communication between primary and secondary care, transfer of chronic patients to primary
care, access to patients’ electronic histories, CME, appointing professionals in hospitals for
discussion and expert consultation, use of guidelines without literal interpretation, use of
delayed prescribing, development of a map of local resistance, and regular meetings with
primary care pharmacies and local area management to discuss individual prescription
Continued Table 17
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Vazquez-Lago et al. 2012 Spain Qualitative FGDs 33 GPs profiles and highlight poor prescribing practice to improve antibiotic use.






Physicians categorised the factors into intrinsic and extrinsic.
-Intrinsic factors:
Socio-demographic: previous clinical practice, years of practice, continuous medical
education, previous clinical practice and university education,
physicians’ attitudes: complacency, fear, ignorance, indifference, prescribing attitudes of
other HCPs and confidence.
-Others: diagnostic uncertainty and desire for a quick fix.
-Extrinsic factors:
Patient-related factors: signs, desire for a quick fix expressed by patients/carers, anxiety,
symptoms of other clinical conditions, patient age, economic and social factors, and
educational level.
-Healthcare system related factors: ownership of practice location, pressure of time,
implemented policies/guidelines, influence of group exposures, communication and
organisational model, implemented policies/guidelines, accreditation level, inexistence of
facilities to promote diagnostic tests, workflow, public health considerations, use of the same
prescription several times and patient health insurance.
-Other factors: pharmaceutical companies, cost savings to the patient or to the healthcare
system and the financial incentives offered by pharmaceutical companies.
CME continuous medical education, OTC over-the-counter FGDs focus group discussions
Continued Table 17
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2.8 Research Rationale
Overall, the findings from the quantitative literature review on the epidemiology of UTIs
suggest that UTIs increase significantly with advancing age, particularly in the over 85
age group (Ruben et al. 1995, Malmsten et al. 1997, Molander et al. 2000, Galatti et al.
2006, Czaja et al. 2007, Eriksson et al. 2010, Marques et al. 2012). Additionally, studies
on antibiotics use revealed that elderly patients were prescribed antibiotics more
frequently than other age groups (Wrigley et al. 2002) and that UTIs were one of the most
common reasons for antibiotics prescription and consumption in the general population
(Petersen and Hayward 2007a) and in the elderly population in particular (Friis et  al.
1989, Leistevuo et al. 1997, Straand et al. 1998). However, various studies suggest the
presence of a gap between recommended practice, namely guidelines, and actual GP
practice, which can be irrational in many situations (Straand et al. 1998, Kahan et al.
2005, Taur and Smith 2007, McIsaac et al. 2008, Llor et al. 2011, Vellinga et al. 2011,
Denes et al. 2012, Haasum et al. 2013). From another perspective, the review of the
qualitative literature on GPs’ antibiotics’ prescribing revealed variations in GPs’
perceptions and views about management and adherence to guidelines (Kuehlein et al.
2011, Bjorkman et  al. 2013, Duane et al. 2016). These variations were found to be
associated with numerous factors that could be related to GPs themselves, to patients, to
the wider healthcare system or to society (Bjornsdottir and Hansen 2002, Petursson 2005,
Kotwani et al. 2010, Vazquez-Lago et al. 2012, Teixeira Rodrigues et al. 2013).
Despite advances in the knowledge and understanding of various aspects of UTIs in
elderly patients such as pathogenesis, diagnosis, resistance and antibiotic therapy (Ronald
et al. 2001), there were number of gaps and issues revealed by the reviewed
bibliographies and literature that deserve to be highlighted and explored. One of these
issues was related to available evidence, which was often either outdated, based on data
form settings other than GP surgeries or synthesised by none GPs (Hummers-Pradier and
Kochen 2002). Additionally, newly published literature contains insufficient or repetitive
information with few new thoughts or significant contributions to the field of knowledge.
It was difficult in some studies to detect incidence, prevalence, antibiotics use and GPs’
adherence to recommendations directly as the presented figures were not stratified
according to patients’ ages, which required manual recalculation of many of the figures.
Furthermore, the literature review identified discrepancies between studies in terms of
research designs and measurement units such as the use of percentages versus 100-person
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years in reporting UTI incidence or prevalence or the use of DDDs versus percentages in
the case of drug utilisation studies. Moreover, assessing the appropriateness of antibiotics
therapy in elderly patients with UTIs was based on adult guidelines, which usually lack
special recommendations for this age group. This was in addition to recommendations
differing greatly between countries in terms of antibiotics choices and estimated treatment
durations. Finally, the generalisability of the findings was limited owing to small sample
size in most of the studies. Differences in global populations meant that results were non-
representative of other countries.
Surprisingly,  the  epidemiology of  UTIs  in  the  elderly  and  GPs’  antibiotics  prescribing
practice relating to UTIs in the elderly appear to have received little or no attention in
general (Hummers-Pradier and Kochen 2002) and in the UK in particular. The same
applies to antibiotics drug utilisation (Willems et al. 2014),  antibiotics prescribing against
published national guidelines (Hummers-Pradier and Kochen 2002, High et  al. 2005,
Griebling 2014), variations in GPs’ views and perceptions about the management of
antibiotics for treating UTIs in elderly patients (Llor et al. 2011) and the factors that might
influence  or  affect  GPs’  antibiotics  prescribing  for  UTIs  in  elderly  and  adult  patients
(Vazquez-Lago et al. 2012, Bjorkman et al. 2013). It was suggested that more qualitative
research needs to be conducted to understand the decision-making processes behind the
continuing prescription and consumption of antibiotics for UTIs (Duane et al. 2016).
Although GPs’ competencies were not in question, without this information, it might be
assumed that elderly patients with UTIs are being well managed with appropriate
evidence-based, cost-effective approaches and a high level of patient satisfaction.
Bridging this knowledge gap might assist in developing strategies that can help to change
GPs’ prescribing behaviour, optimising and rationalising GPs’ antibiotics prescribing and
encouraging the rational use of available healthcare resources as well as enriching the
literature on UTI research. To achieve this, quantitative research on drug utilisation is
needed – one of the actions included in the UK’s five-year antimicrobial resistance
strategy (Davies and Gibben 2013) – in addition to qualitative phenomenographic
research into the variations in GPs’ views as well as the factors influencing their
prescribing.
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2.9 Research Aim and Questions
The previous sections gave an overview of how common UTIs are in elderly patients.
The work described in this thesis was aimed at providing insight on GPs’ antibiotics
prescribing for UTIs in elderly patients in the UK. A mixed method approach was adopted
to meet the thesis research questions, which are:
1. What is the prevalence of UTIs in elderly patients who visit GP surgeries in the UK?
2. What are the patterns and trends of GPs’ antibiotics prescribing for UTIs in elderly
patients?
3. Is GPs’ antibiotics prescribing practice for UTIs in elderly patients in line with the
SAPG decision aid for diagnosis and management of suspected urinary tract infection
(UTI) in older people?
4. Are there variations in GPs’ views and perceptions about antibiotics for UTIs in
elderly patients?
5. What are the factors that might influence or affect GPs’ antibiotics prescribing for
UTIs in the elderly compared with adult patients?
6. What are the impacts of the findings of this thesis on future research?
2.10 Summary
This chapter has reviewed the relevant literature on GPs’ antibiotics prescribing for UTIs
from quantitative and qualitative perspectives, explained the rationale for this research
and listed the study aims and research questions to be answered. The findings from the
literature review have shown that further work is needed to fill the gaps in the current
knowledge of UTIs in elderly patients in terms of recognising GPs’ antibiotics patterns
and trends of prescribing, exploring GPs’ views about antibiotics for UTIs in elderly
patients and identifying the factors influencing GPs’ antibiotics prescribing for UTIs. The
next chapter describes the research framework and methods used in this thesis to fill these
gaps.
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Chapter 3 Research Methodological Approaches and Methods
3.1 Introduction
This chapter outlines the methodological approaches and methods undertaken in this
research. In the next section, each was briefly outlined and the rationale behind its
selection explained. Then the methods implemented were described, along with the
analysis process followed to obtain the results and findings for each part of the research.
The reason for following this structure was to provide the reader with overview on some
important aspects of the method used before describing the research methodology. Owing
to the different nature of employed approaches, structure and content may vary from one
approach to another.
3.2 Research Methodological Approaches
A research methodological approach can be described as a framework that brings together
broad research assumptions into a detailed plan, data collection method(s), analysis of
data and interpretation of research findings (Harwell 2011, Creswell 2014). Different
research questions and hypotheses demand adoption of different research approaches
(Marczyk et al. 2005). Research methodological approaches can be mixed methods,
quantitative or qualitative (Harwell 2011, Creswell 2014).
The mixed methods approach has become more popular over the last two decades
(Harwell 2011, Creswell 2014, Ozawa and Pongpirul 2014) especially in healthcare and
prescribing research (Lapane et al. 2011, Solomon et al. 2012, Reynolds et al. 2016).
Mixed methods research can be defined as:
‘The class of research where the researcher mixes or combines quantitative and
qualitative research techniques, methods, approaches, concepts or language into
a single study. Mixed methods research also is an attempt to legitimate the use of
multiple approaches in answering research questions, rather than restricting or
constraining researchers’ choices (i.e., it rejects dogmatism). It is an expansive
and creative form of research, not a limiting form of research. It is inclusive,
pluralistic, and complementary, and it suggests that researchers take an eclectic
approach to method selection and the thinking about and conduct of research’
(Johnson and Onwuegbuzie 2004, pp. 17-18).
Owing to the differences between qualitative paradigms, which are interpretive and
constructionist, and quantitative paradigms, which is positivist, it has often been argued
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that the two approaches are incompatible and cannot be mixed (Mays and Pope 2000,
Pope and Mays 2006, Harwell 2011). However, running a qualitative study alongside a
quantitative approach can be useful as both share commonality in their goal of
understanding the world in which individuals live, allowing researchers to view problems
from different perspectives, contextualising information and linking it to understanding
and improving the human condition (Creswell 2014). The rigour of this research process
can be especially useful in disciplines where the complexity of phenomena requires data
from a large number of perspectives, as in healthcare research (Sale et al. 2002, Denzin
and Lincoln 2011, Harwell 2011). Additionally, the mixed methods approach has the
ability to quantify hard-to-measure constructs, provide illustrations of context for trends,
examine processes and experiences along with outcomes to capture a wider picture for
phenomenon studies, apply ‘triangulation’, which involves comparing data from the two
approaches in an attempt to validate findings and demonstrate greater credibility when
there is agreement between findings (Johnson and Onwuegbuzie 2004, Denzin and
Lincoln 2011, Harwell 2011).
Using a mixed methods approach can provide the opportunity to outweigh the inherent
weaknesses of both methods, capitalise on inherent method strengths, counteract
unavoidable method biases and provide insights not possible when only a qualitative or a
quantitative approach is used (Harwell 2011, Creswell 2014). For instance, quantitative
methods can provide a robust result about the magnitude of a specific problem. In the
case of antibiotics prescribing, measures determine GPs’ adherence to good practice
points. However, a quantitative method cannot contribute to understanding and capturing
more complex issues that may have influenced GPs’ behaviour in association with
adherence to good practice points. Including a qualitative research element to capture this
phenomenon can enable exploration of a range of issues, such as non-obvious factors that
may come to light through this more in-depth methodology (Pope and Mays 1995).
Qualitative research can provide an understanding of perceptions, views and concepts,
and explore issues that may have influenced GPs’ adherence to good practice points
within  a  naturalistic  setting,  in  this  case  primary  care.  Therefore,  using  a  research
approach that incorporates both qualitative and quantitative methods can yield differing
types of data and perspective (Harwell 2011, Creswell 2014).
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Despite numerous benefits of a mixed methods approach, however, evaluating the
findings can be complicated by the differing epistemological21 assumptions across the
methods. Patton explained:
‘In real-world practice, methods can be separated from the epistemology out of
which they have emerged’ (Patton 2002, p. 136),
to which Flick added that:
‘Mixed methodology approaches are interested in pragmatic links of qualitative
and quantitative research in order to end the paradigm wars of earlier times’
(Flick 2007, p. 9).
Adopting a pragmatic theoretical perspective is therefore a reasonable solution to
overcoming these differences as highlighted and recommended by different researchers
(Johnson and Onwuegbuzie 2004, Teddlie and Tashakkori 2009). Adopting a pragmatist
paradigm allows researchers to adopt whichever method is most suitable for a particular
question or area of research without being restricted to one methodology and viewpoint
(Sale et al. 2002) and to be flexible, often through using both qualitative and quantitative
research methods (Teddlie and Tashakkori 2009). Therefore, in studying GPs’ antibiotics
prescribing for elderly patients with UTIs, a pragmatic approach supports the use of both
qualitative and quantitative approaches.
Use of Mixed Methods Approach
Owing to the nature of the research aim and research questions, a comprehensive mixed
methods approach was adopted with an explanatory sequential approach (Ozawa and
Pongpirul 2014), that is, a quantitative study to set-up the scene followed by a qualitative
study. First, a quantitative drug utilisation study was carried out to explore the prevalence
of UTIs as in (Czaja et al. 2007, Eriksson et al. 2010, Caljouw et al. 2011), antibiotics
prescribing patterns and GPs’ adherence to good practice as in (Llor et al. 2011, Denes et
al. 2012, Haasum et al. 2013). Second, a qualitative study using a phenomenographic
method with two analytical techniques was performed to gain an in-depth understanding
of GPs’ views and perceptions as it was employed by (Kuehlein et al. 2011, Bjorkman et
al. 2013, Duane et al. 2016) in addition to the factors influencing their prescribing practice
21 Refer the manner by which knowledge is constructed and the relationship of the knower to the known’
(Guba and Lincoln 1994, p. 108).
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for treatment of UTIs in adults and the elderly (Bjornsdottir and Hansen 2002, Petursson
2005, Kotwani et al. 2010, Vazquez-Lago et al. 2012, Teixeira Rodrigues et al. 2013).
3.2.1.1 Quantitative Research Approach
3.2.1.1.1 Drug Utilisation Review Background
3.2.1.1.1.1 Definitions and Historical Overview
Drug utilisation research (DUR) has gained in popularity as an essential and special type
of pharmacoepidemiology22 studies. DUR has the ability to describe the nature, extent
and causes of drug exposure (Birkett et al. 2003). It is multidisciplinary research that is
recognised as a valuable and legitimate quality assurance tool for any drug therapy
(Cooke 1991, Blackburn 1993). Interest in DUR began in the 1960s and is still increasing
(Hasle 2002).
The beginnings of drug utilisation research were sparked by initiatives taken in the UK
and Northern Europe in the mid-1960s. The creative leading work of Arthur Engel in
Sweden and Pieter Siderius in the Netherlands in 1968 enlightened the field as to the
importance of comparing drug use and consumption among different regions and
countries (Birkett et al. 2003). The terms ‘drug utilisation review’, ‘drug usage review’,
‘drug use review’ and ‘drug use evaluation’ are more or less synonymous and can be used
interchangeably (Cooke 1991).
WHO defined DUR in 1977 as:
‘Studies or research related to marketing, distribution, prescription and use of
drugs in a society, with special emphasis on the resulting medical, social, and
economic consequences’ (Birkett et al. 2003, p. 8).
This definition covers most, if not all, aspects of drug epidemiology, including
methodological approaches as well as analytical and descriptive evaluations. However,
some researchers recommended the incorporation of drugs development in relation to
health priorities into this definition (Lunde and Baksaas 1987). In North America, a more
22 The study of the use and effects/side-effects of drugs in large numbers of people with the purpose of
supporting the rational and cost-effective use of drugs in the population thereby improving health outcomes
(Birkett et al. 2003, p. 8).
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structured and narrower definition was used in the 1970s to define drug utilisation studies,
namely:
‘Research or studies related to the prescribing, dispensing and ingesting of drugs’
(Brodie 1971, p. 1).
In both definitions, all non-pharmacological factors (behavioural, socio-anthropological
and economic) that influence drug utilisation were recognised and considered either
explicitly or implicitly (Lee and Bergman 2012).
In Europe, countries such as Scandinavia, Northern Ireland and Scotland have been
recognised as pioneers in this field of research, both nationally and internationally
(Sacristan and Soto 1994, Gama 2008, Sachdeva and Patel 2010). Furthermore, DUR
studies in these countries have been designed to describe and compare variations in
patterns of use of specific groups of drugs according to geographical regions and seasons
of the year (Gama 2008); whereas studies from the USA were primarily designed as part
of institutional-level interventions or as part of local health programmes (Blackburn
1993). Historically, the first group in the UK (UK DURG) was founded in 1989 by a
multidisciplinary group of researchers who noticed a lack of awareness of drug utilisation
research among pharmacologists (McGavock 1998).
3.2.1.1.1.2 Classification and Uses of Drug Utilisation Studies
Drug utilisation studies can be broadly categorised as either qualitative or quantitative
(LeLorier et al. 2003). Qualitative studies are often designed to assess the appropriateness
of drug utilisation, usually by linking prescription data to the reasons for prescribing the
drug (Birkett et  al. 2003, Lee and Bergman 2012). Quantitative studies are descriptive
studies of drug use frequency designed with the aims of (Birkett et al. 2003, Lee and
Bergman 2012):
x measuring quantities and comparing variations in drugs prescribed or consumed over
a specific period of time and in a specific geographical region (national, regional,
local) and/or season;
x estimating disease prevalence according to drug consumption rates prescribed to
manage the disease under investigation;
x investigating patterns of drug utilisation over a specific period of time and identifying
regions of possible under- or over-utilisation of drugs; and
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x estimating drug consumption and use according to specific variables such as age, sex
and social class.
DUR studies can be further classified according to the timing of data collection, that is,
methodology, into three types. Each type has its own features that serve a specific study
purpose (Anis et al. 1996). These studies are as follows (Wertheimer 1988, Birkett et al.
2003):
1. prospective studies – in this type of study, the prescribed drug will be compared to
predetermined criteria before the patient receives the drug. This type of study is
recognised for its preventive potential, and for being individual patient-centred in its
interventions;
2. concurrent studies – in this type of study, the prescribed drug will be reviewed during
the course of therapy. This type of study is ideal when drug adjustments may be
necessary based on ongoing diagnostic and/or laboratory tests; and
3. retrospective studies – in this type of study, historical patients or drugs data are used.
These studies involve reviewing drug prescribing and use after the drugs have been
dispensed;  therefore,  they  are  of  some  value.  Although  this  is  the  easiest  and  least
costly approach, there is no opportunity to modify the therapy for the patients on whom
the data were collected.
3.2.1.1.1.3 Drug Utilisation Conceptual Framework
Lipton and Bird (1993) elucidated a conceptual DUR framework model based on
assumptions related to factors that may either hinder or improve the quality of drug
prescribing within the context of other important factors (Lipton and Bird 1993). These
factors include prescriber factors, system factors and patient and family factors as
presented schematically in Figure 13. The model describes how DUR interventions relate
to drug prescribing and dispensing. In the case of prospective DUR, the influence can be
seen on the current process of prescribing and dispensing through considering
prescriber’s and patient’s factors, that is, the micro-level; whereas retrospective DUR can
influence future prescribing and dispensing, which can be a target for healthcare
authorities and agencies when improving drug prescribing policies, that is, the macro-
level (Lipton and Bird 1993). It can result in the development of interventions that can
counteract many of the detrimental influences of patients, prescribers and system factors
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and reinforce positive outcomes on the quality of drug prescribing, improving patients’
clinical outcomes and utilising healthcare institutions’ financial resources more
prudently. It is important to realise that DUR is targeted towards identifying and
correcting avoidable or preventable prescribing problems such as drug dosage and
duration. However, DUR cannot identify or correct unavoidable ADRs that result from
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Figure 13: Factors conceptualised in DUR (Lipton and Bird 1993, p. 1072)
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3.2.1.1.1.4 Drug Classification Systems Used in Drug Utilisation
Since the introduction of DUR, researchers have felt it necessary to have a common drug
classification system to describe drug assortment in a region or country so that drug
utilisation comparisons can be made among drugs at national and international levels
(Truter 2010). Having such a classification system would make it easy for researchers
uniformly to collect and aggregate drug utilisation data to audit different patterns of drug
use, detect drug use issues and problems, and initiate interventions and monitor their
outcomes. In general, drugs can be classified in various ways according to their
indications, therapeutic or pharmacological classes, mode of action, or according to
chemical structure (Birkett et al. 2003, Lee and Bergman 2012).
Currently there are two widely used classification systems based on identical ideologies
(Birkett et  al. 2003, Lee et al. 2013). The first is Anatomical Therapeutic (AT)
classification, developed by the European Pharmaceutical Market Research Association
(EphMRA). In this system, drugs are classified into groups on three or four different
levels. The EphMRA classification system is used worldwide by IMS Health to provide
market research statistics to the pharmaceutical industry. The second system is
Anatomical Therapeutic Chemical (ATC) classification, developed originally by the
Norwegian Medicinal Depot, which became a WHO Collaborating Centre for Drug
Statistics Methodology. This classification system was modified and extended from the
EphMRA system by introducing a therapeutic/pharmacological/chemical subgroup as the
fourth  level  and  chemical  substance  as  the  fifth  level.  The  WHO classification  system
was recommended to be used as a tool to generate statistical reports when international
drug utilisation comparisons are required.
To  demonstrate  how  both  classification  systems  work,  trimethoprim  has  been  used  to
explain the structures of the code in Table 18. Owing to the various technical differences
between the two classification systems, data obtained by the two classification systems
are not directly comparable (Birkett et al. 2003, Shalini et al. 2010).
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Table 18: Trimethoprim code structures showing the difference between AT and ATC classification
systems
Level Description Code WHO Code EphMRA
1st Main anatomical group J Antiinfectives forsystemic use J
General antiinfective
systemic
2nd Main therapeutic group 01 Antibacterial forsystemic use 1 Systemic antibacterial





4th Chemical/therapeutic/pharmacological subgroup A
Trimethoprim and
derivatives - Not applicable
5th Subgroup forchemical substance B
Short-acting
sulphonamides - Not applicable
3.2.1.1.1.5 Drug Utilisation Databases
The sources of drug utilisation databases vary widely from one country to another
according to several factors such as the level of complexity of record-keeping and saving,
methods of data collection, methods of data analysis, healthcare system-related reporting
and operational considerations (Gama 2008). Databases used for drug utilisation studies
can be either diagnosis linked or non-diagnosis linked. The former type provides
information about drugs consumption for particular diseases and outcomes while the
latter type provides information only about drugs consumption in a specific population.
The majority of these databases lack information on patients’ morbidity, so are generally
used to generate drug utilisation statistical reports and descriptive studies of drug
consumption patterns (Birkett et al. 2003).
Currently, available databases can be categorised as administrative, medical,
pharmaceutical or commercial in origin (Truter 2010). In Europe, the automated
databases are primarily medical records databases in origin and they were developed to
assist researchers in performing epidemiological studies. The USA has databases that are
mostly administrative in origin, which were developed for handling claims and payments
for clinical services and therapies (Lee et al. 2013).
Electronic medical records (EMRs) databases were introduced to medical practice nearly
three decades ago (Takahashi et al. 2012). They are population based, that is, longitudinal,
in their nature and they were developed as a result of moving towards more computerised
medical services to capture patients’ related data. EMRs databases normally contain
patients’ related administrative and clinical data, they are maintained primarily for
documenting patients’ conditions, treatments and outcomes, and they can be anonymised
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for the purpose of research (Ogdie et al. 2012). EMRs databases have many unique
advantages, most important among which is that the validity of the diagnosis data is far
better than in other forms of database, as these data are being used mainly for medical
care purposes. However, there are also unique disadvantages, especially the uncertain
completeness of the data from some GPs and practice sites (Ogdie et al. 2012).
EMRs databases can offer unique opportunities to HCPs, researchers and decision-
makers when they are extracted and analysed properly. They can be very useful resources
for planning and monitoring different healthcare services and measuring the quality of
services and care provided. The strengths of data collected from UK GP practices are that
they are population based, population representative and contain information on patients’
conditions, treatment, outcomes and use of healthcare services (Gnani and Majeed 2006).
In  the  UK,  several  EMRs  databases  are  available  in  GP  surgeries.  However,  because
much of these fall beyond the scope of this thesis, only three longitudinal databases will
be discussed in the next section, more specifically the Clinical Practice Research Datalink
(CPRD), The Health Improvement Network (THIN) and the Intercontinental Marketing
Services-Disease Analyzer (IMS-DA). Table 19 compares these three UK-based
databases. Lists details of data supplied by these databases can be found in Appendix 4.
The CPRD is the world’s largest computerised, longitudinal EMRs database for primary
care (Herrett et al. 2015). Established in 1987 in London, it was known at that time as
Value Added Medical Products (VAMP). With time, the data continued to grow and it
became the  GPRD in  1993.  In  2012,  the  GPRD expanded dramatically  to  become the
CPRD. The database contains regularly collected anonymised electronic health record
data from GP practices in England, Wales, Scotland and Northern Ireland. The database
contains the health records from over 674 practices around the UK, which equates to over
13 million patients representing more than 6.9% of the UK’s total population and 5
million active patient records (NIH 2014, Herrett et al. 2015). Access to the latest version
can be purchased at (www.cprd.com) via academic collaboration or by paying a fee.
The second database, THIN, represents a joint collaboration between two companies: In
Practice Systems (INPS), which developed the Vision software used by GPs in the UK to
manage patients’ data, and IMS Health, which provides access to data for use in medical
research. Since it was established in 2002, THIN contains the health records from 587 GP
surgeries around the UK, which equates to more than 12 million patients records and over
3.6 million active patients that represent 5.67% of the UK’s population (up to July 2013)
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(UCL 2013). Extracted data from THIN is organised into seven categories. Recently,
THIN became part of IMS Health. Access to the latest version can be obtained at
(www.csdmruk.imshealth.com) via academic collaboration or by paying a fee.
The third database, IMS-DA, previously known as MediPlus, is maintained by IMS
Health, which is an international healthcare information service and technology company.
IMS Health specialises in collecting and interpreting anonymised health information
within the UK and across the world. Most often, IMS Health is considered the only source
of information on aspects related to drug utilisation globally. The complex and secure
IMS database represents an invaluable source for pharmacoepidemiological studies. IMS-
DA is one of the largest longitudinal clinical databases in the world, derived from the
electronic clinical records maintained by GPs in the course of providing care for their
patients, and anonymised for research purposes (Dietlein and Schroder-Bernhardi 2002).
The database contains the health records from over 130 practices around the UK, which
equates to over 2 million patients that represent almost 3.1% of the UK’s population, and
over 95 million prescriptions prescribed by more than 500 GPs (Pillay et al. 2010, Hsia
et al. 2012). The database has been validated in several published studies and found to be
reliable and accurate with a good correlation between the database population and the UK
population in terms of age distribution and male-to-female ratio (Pillay et al. 2010).
Access to the latest version can be purchased at (www.imshealth.com) via academic
collaboration or by paying a fee.
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Table 19: Summary comparison between the most commonly used databases in the UK (Murray et al. 2013a, UCL 2013, NIH 2014, Herrett et al. 2015)
















-Data are broadly representative of national population
(covers about 6.9% of UK population)
-The quality and completeness of recording are high and
validity have been reported to be high
-Easy to perform denominator counts to allow calculation
of prevalence and incidence rates
-Reliable
-Complete
-Additional services are provided by the CPRD group such
as questionnaires to GPs to obtain further information
-Data linked to HSE
-Data have been widely used by researchers and over 1000
articles published in peer-review journals
-Data are primarily collected for clinical management not for
research purposes
-It requires intensive training to use data and knowledge of
relational databases
-There is no information on hospital data, length of stay and
prescriptions
-There may be misclassification or coding errors
-OTC prescriptions are not recorded
-Prescription records are not directly linked with diagnoses.
-Medication adherence is not recorded
-Only issued prescriptions are recorded












-Data are broadly representative of national population
(covers 5.67% of UK population)
-The database contains useful ‘Acceptable Mortality




-Anonymised comments and Townsend deprivation scores
are available
-Additional service are offered such as questionnaires to
GPs to obtain further information
-Data linked to HSE
-Data have been widely used by researchers and over 540
articles published in peer-review journals
-Data are primarily collected for clinical management not for
research purpose
-There is no information on hospital tests, length of stay and
prescriptions
-There may be misclassification or coding errors
-OTC prescriptions are not recorded
-Ethnicity is not recorded
-No direct link between prescriptions and diagnoses
-Only issued prescriptions are recorded
-The database was newly available so little validation work had
been conducted at the time
-Medication adherence is not recorded
-Expensive
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-Data are broadly representative of national population
(covers about 3.1% of UK population)
-Allow researchers to use population based study designs







-Direct link between diagnosis and prescription
-Test results linked to diagnoses
-Very good age and gender correlation between database
population and UK population
-GPs are broadly representative of those in the UK
population
-Easy to obtain denominator counts to allow calculation of
prevalence and incidence rates
-Free from observer and recall bias
-No specific computerised tool needed to use data
-License is inexpensive
-Data have been widely used by researchers and over 200
articles published in peer-review journals
-Data are primarily collected for clinical management not for
research purpose
-Only issued prescriptions are recorded
-Under-representation of smaller practices
-Over-representation of practices in Scotland and Northern
Ireland
-There may be misclassification or coding errors
-Data on lifestyle factors such as smoking status, and body
mass index may be incomplete
-Only records prescriptions that are issued, therefore primary
compliance and actual drug use are unrecorded
-No additional services offered such as questionnaires to GPs
-Knowledge of relational databases and general practice
essential
-Limited number of studies available on validity of the IMS-
DA database
-Lack of patient socioeconomic status
-Completeness of data
-Occupation and employment status are rarely recorded
-Not all medications are linked to a diagnosis
-Medication adherence is not recorded
-Loss to follow-up over time if patient transfer out of the
practice or if the practice ceases to participate in the database
OTC: over-the-counter; HSE: Hospital Episode Statistics; INPS: In practice systems; VAMP: Value Added Medical Products
Continued Table 19
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3.2.1.2 Qualitative Research Approach
Qualitative research methods have become very popular in the field of healthcare (Britten
2005). As research techniques, they have the ability to answer questions through themes
and ideas generation that are equally valid but quite different from quantitative research
methods (Holloway 2005). Qualitative research has many features and strengths, one of
which is its ability to study people in their natural world or setting rather than in a non-
natural  world  or  setting.  Furthermore,  it  enables  researchers  to  interact  with  people  in
their own language and terminology (Tracy 2013). Another feature is that it tries to
interpret and explain social phenomena, behaviours and interactions in terms of the
meanings people bring to them. In healthcare, qualitative research is very beneficial in
interpreting complex human behaviours such as health decision-making (Shen et al.
2015) and patients’ adherence to drugs (Holt et al. 2014). Additionally, it enables
researchers to mix several different qualitative methods such as observing people closely
in their own field, that is, observation, reading what they have written, that is, surveys,
and interacting with people, that is, focus groups and interviews (Silverman and Marvasti
2008). The term ‘qualitative research’ is a broad term used to describe a wide range of
diverse research approaches with regard to research aims, theoretical assumptions,
understanding of phenomena under investigation, methodological focus and methods
applied (Flick et al. 2004). Examples of these approaches include grounded theory,
ethnography, phenomenography, phenomenology, content analysis and field studies
(Flick et al. 2004). The selection of a research approach should be directed by the research
question or aim and the theoretical assumptions adopted (Lundborg et al. 1999). The
rationale for choosing a qualitative research approach over a quantitative research
approach was that qualitative research mainly concerns the development of concepts that
assist researchers in better understanding phenomena in their natural settings by
emphasising the meanings, views and experiences of the participants (Pope and Mays
2009).
3.2.1.2.1 Phenomenography Background
3.2.1.2.1.1 Definitions and Historical Overview
The word ‘phenomenography’ was derived from two Greek words: ‘phainomenon’,
which refers to appearance, and ‘graphein’, which refers to description (Hasselgren and
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Beach 1997). This approach has been used widely in the field of educational research,
having evolved originally from the work performed by Marton and colleagues at the
University of Gothenberg, Sweden, in the 1970s. However, the term phenomenography
did not appear in the English literature until the early 1980s (Marton 1986).
Phenomenography has also been used in several healthcare services research projects
(Barnard et al. 1999, Sjöström and Dahlgren 2002, Larsson and Holmström 2007).
Phenomenography is an interpretive, descriptive, second-order approach that has the
ability to describe variations in human understanding, meaning, ideas and thoughts
relating to a particular phenomenon within a group of individuals (Marton 1981). It is
most frequently described as:
‘A research method for mapping the qualitatively different ways in which people
experience, conceptualise, perceive, and understand various aspects of, and
various phenomena in, the world around them’ (Marton 1986, p. 31).
A more recent description of phenomenography by Marton and Booth focused on:
‘Variation in ways of experiencing things’ (Marton and Booth 1997, p. 110).
3.2.1.2.1.2 Ontological and Epistemological Stances in Phenomenography
Phenomenography evolved from a strongly empirical origin rather than a theoretical or
philosophical frameworks. Since phenomenography has a characteristic ontological23
position, it differs from other qualitative research approaches. Phenomenography adopts
a non-dualistic ontology, known as constitutionalism. Ontologically, phenomenography
relates to the nature of existence, based on the assumption that an individual and the world
are interrelated through the individual’s lived experience of the world (Marton and Booth
1997, Sandberg 2000). Figure 14 illustrates phenomenography’s focus in relation to
subject, object, researcher and the world.
Phenomenography perceives experience as a relationship between the object, that is, the
world, and the subject, that is, the individual, as this citation by Marton (2000)
demonstrates:
‘From a non-dualistic ontological perspective, there are not two worlds: a real,
objective world, on the one hand, and a subjective world of mental
23 Refer to nature of reality (Guba and Lincoln 1994, p. 108).
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representations, on the other. There is only one world, a really existing world,
which is experienced and understood in different ways by human beings. It is
simultaneously objective and subjective (Marton 2000, p. 105).
Figure 14: Focus of the phenomenographic research approach (Bowden and Green 2005, p. 13)
In phenomenography, ontology and epistemology are interdependent. The concept
underpinning phenomenography is that thinking and experience are inseparable.
Knowledge is neither external nor internal to individuals; rather, it is assumed to be gained
through individuals’ experience of situations in which the phenomenon is present.
Through this experience, individuals have social and intellectual experiences of the
phenomenon, where they gain their own understanding of it, as well as experiencing the
understanding of other individuals (Marton and Booth 1997).
Phenomenographic researchers focus on individuals’ consciousness of reality, that is, on
ontological issues, as well as their expression of reality, that is, on epistemological issues.
Such researchers do not take a first-order perspective and attempt to describe what reality
is like; instead, they take a second-order perspective and focus on how it is experienced
and described by individuals experiencing the phenomenon (Svensson 1997, Yates et al.
2012). Figure 15 describes how phenomenography differs from other research
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by GPs, that is, the subject, for elderly patients with UTIs visiting primary care, that is,









e.g.: Grounded theory, case studies
FOCUS NOT ON VARIATION







Figure 15: Point of departure between phenomenography and other research approaches (Trigwell 2006, p. 369)
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3.2.1.2.1.3 Sample Size
In qualitative research, sample size can be a challenging concept (Patton 2002). The
number of participants needed is different for qualitative research than for quantitative
research since the generalisability of the findings of qualitative research is concept based,
rather than numerically based as in quantitative research. In qualitative research, adequate
sample size is achieved when no new themes emerge from subsequent participants’
interviews, that is, data saturation has been reached, or when the capacity of the researcher
to hold the evolving analysis in their mind has reached its limit (Ayres 2007).
In qualitative research, the sampling techniques used are either non-probability purposive,
that is, the researcher makes the decision about the candidate to be included in the
research based on several criteria including the candidate’s knowledge of the research
subject and their specialisation or capacity and willingness to participate in and answer
the research questions (Jupp 2006), or theory based, that is, participants are chosen for
inclusion to expand, confirm or endeavour to disconfirm a developing theory (Ayres
2007).
3.2.1.2.1.4 Data Collection Methods
Different methods of data collection are used in phenomenography such as asking
participants to complete questionnaires or recording videos. However, interviews
constitute the major method of data collection, since there is a necessity to understand the
participants’ worlds (Marton 1986, Maykut and Morehouse 1994, Marton and Booth
1997). This is evident from the use of interviewing as the primary method for data
collection in several phenomenographic studies (Marton 1986, Dall'Alba and Hasselgren
1996, Ashworth and Lucas 2000). The main reason for this practice is its ability to capture
concepts and beliefs and retrieve rich-content information about participants’ ways of
experiencing particular phenomena (Limberg 2000, Åkerlind 2005, Bowden and Green
2005, Stenfors-Hayes et al. 2013).
In qualitative research, interviewing is not just a casual conversation process, it is an
interaction between the researcher and the participant or a group of participants with a
predetermined subject to serve research objectives (Maykut and Morehouse 1994, Given
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2008). Thus, it differs from other typical versions of interviews, and proposes a
reformulation of the process:
‘At its heart is the proposition that an interview is a form of discourse. Its
particular features reflect the distinctive structure and aims of interviewing,
namely, that it is discourse shaped and organised by asking and answering
questions. An interview is a joint product of what interviewees and interviewers
talk about together and how they talk with each other. The record of an interview
that we researchers make and then use in our work of analysis and interpretation
is a representation of that talk’ (Mishler 1986, p. vii).
In qualitative research, there are three main types of interview: structured, semi-structured
and unstructured (Gill et al. 2008, Ryan et al. 2009). In structured interviews, pre-set
questions are put to the participants with little or no difference and without follow-up
questions  to  responses  that  might  require  additional  explanation.  They  are  efficient  in
terms  of  time,  less  biased  and  easier  to  code  and  analysed;  however,  they  are  of  little
benefit when in-depth information is required (May 1991, Ryan et al. 2009, Doody and
Noonan 2013). At the opposite end of the scale, unstructured interviews do not use any
pre-set designs, thoughts or questions and are usually conducted with little or no
organisation making them flexible and rich in terms of data generation. Since they are
none-directive, they can be time-consuming, difficult to manage and lack preconceived
thoughts, theories or questions which may confuse the participants (May 1991, Ryan et
al. 2009, Doody and Noonan 2013).
Semi-structured interviews, also known as non-standardised interviews, have a certain
level of structure and flexibility since they allow the researcher to change the order of the
questions, reformulate or rephrase questions to gain better understanding and clarification
(Hallberg 2008). Moreover, they have the advantage of collecting detailed and complex
data when in-depth information is needed (Kvale 1996, Patton 2002). Semi-structured
interviews depend on a pre-set interview topic guide containing open-ended questions or
issues to be discussed and explored with the participants. The pre-set interview topic
guide ensures that the same basic lines of enquiry are followed up with each participant
yet provides the interviewer with the chance to ask additional questions, using (Hawkings
et al. 2008):
x probes, that is, open-ended questions that allow the researcher to gain a deeper
exploration of a particular idea, perception or concept. These are used to rephrase
questions whenever the participant is unable to provide an answer or reaction and/or
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to allow further exploration of an answer the participant has given during the interview
process; and
x prompts, which provide participants with several response options following a
question. Their aim is to trigger the participant’s memory and to draw out ideas,
thoughts or concepts that the participant may have been initially reluctant or hesitant
to share. They can be used to enable participants to respond to questions they were
unable to answer previously.
Additionally, both probes and prompts allow the researcher to discover or elaborate on
information that seems important to the participants but that may not have been
considered by the research team members during the topic guide development (Hawkings
et al. 2008). Therefore, the researcher is free to direct the conversation within a particular
topic, to rephrase questions spontaneously and to establish a conversational style, while
keeping within the focus of the particular pre-set subject (Kvale 1996, Patton 2002).
In healthcare qualitative research, semi-structured interviews are the most widely used
type as they provide participants with some guidance on the study or research topic, which
many find helpful (Pope and Mays 2006, Ryan et al. 2009). Thus, for this PhD research,
which requires the gathering of in-depth and complex information, qualitative, semi-
structured, descriptive, single, face-to-face, one-to-one interviews were the best method
of collecting data from recruited participants.
3.2.1.2.1.5 Triangulation
‘Triangulation’ describes the process of combining different study groups, methods,
temporal and local settings, and different theoretical perspectives in dealing with a
phenomenon. As a strategy, triangulation aims to promote and improve the quality of
qualitative research (Flick 2009). In qualitative research, there are five types of




4. theory triangulation; and
5. environmental triangulation.
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Triangulation can have several advantages in qualitative research such as increasing data
confidence, enabling creative and innovative understanding of phenomena, allowing
comparison of research paradigms, challenging theories, revealing and recognising
unique findings and outcomes, and providing clearer understanding of problems. It can
also have many disadvantages, though, such as being resource- and time-consuming, and
resulting in conflicts because of theoretical frameworks, researchers’ biases and lack of
understanding about why triangulation strategies were used (Thurmond 2001).
Phenomenography typically uses one source of data and one round of data collection only,
and even several external members are generally not regarded as an appropriate validity
check for this research approach. As a substitute for data triangulation and to ensure
quality, strict adherence to the data within the interview transcripts is needed (Green
2002).
3.2.1.2.1.6 Qualitative Data Analysis
There is no singularly appropriate method of qualitative data analysis although there is
general agreement that analysis is an ongoing, iterative process that begins in the early
stages of data collection and continues throughout the research (Bradley et al. 2007).
Methods of data analysis must be guided by the research’s philosophical or theoretical
assumptions of qualitative enquiry, epistemological position, research questions and
methods of data collection (Miles and Huberman 1994). Qualitative data can be analysed
either (Pope et al. 2006):
x inductively, which involves analysing data with little or no predetermined theory,
structure or framework and uses the actual data themselves to derive the structure of
analysis. This approach is useful when little or nothing is known about the study
phenomenon; or
x deductively, using a structured or predetermined framework. This approach is useful
when the researcher is aware of probable participant responses.
Two methods of analysis were used for this research: phenomenographic analysis and
thematic analysis. The phenomenographic analysis uses mapping process, which is
differentiated from the type of cataloguing process common in most qualitative analysis
methods (Bowden and Green 2005). Furthermore, the data should be analysed and
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discussed from a second-order perspective that described how the phenomenon was
viewed and understood by the participants rather than how it was understood by the
researcher (Sjöström and Dahlgren 2002). Additionally, it analyses the range of meanings
within a group, as a group, not the range of meanings for each individual within the group.
This is misunderstood by some researchers (Marton and Booth 1997). The
phenomenographic analysis process consists of a seven-step approach. Figure 16
illustrates the process which was proposed by (Dahlgren and Fallsberg 1991) for data
analysis.
Figure 16: Seven-step process to phenomenological data analysis (Dahlgren and Fallsberg 1991, p. 152)
FAMILIARISATION
Reading interview transcripts to get a fresh impression of how the
interview proceeded.
CONDENSATION
Identifying meaning units in the dialogue and marking or saving these
for the purpose of further scrutiny.
CROSS-COMPARISON
Comparing the units with regard to similarities and differences.
GROUPING
Allocating answers expressing similar ways of understanding the
phenomenon to the same category.
ARTICULATING
Capturing the essential meaning of a certain category.
CONTRASTING
Comparing the categories through a contrastive procedure whereby the
categories are described in terms of their individual meanings as well
as in terms of what they do not comprise.
LABELLING
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The  outcomes  of  the  phenomenographic  data  analysis  are  presented  as  categories  of
description and outcome space. Categories of description represent how a group of
participants collectively experienced a specific phenomenon in its context (Åkerlind
2005). Owing to the nature of phenomenography, the categories of description do not fit
into predetermined categories but, rather, emerge from the data themselves (Bruce 1994).
Categories further presented using two components to establish the internal relationship:
the subject–object relationship, which is established through a referential component, and
a structural component (Limberg 2000). The referential component, that is, meaning,
consisting of selected participants’ statements from the interview transcripts to reveal the
richness of the participants’ conceptions. The structural component consisting of internal
and external horizons. The internal horizon referred to the participants’ focus point when
they experienced or addressed the phenomenon, while the external horizon related to how
component parts of the phenomenon are understood and are related to each other (Barnard
et al. 1999, p. 216).
Outcome space is a graphical, hierarchical presentation of findings that consists of a
related set of a finite number of categories of description that collectively express the
variety of ways in which the phenomenon under study is experienced by a group of
individuals in a given context, that is, the real world (Åkerlind 2005). The resulting
outcome space is arranged so that more complex categories are placed above less complex
categories (Marton and Booth 1997). Marton and Booth (1997) addressed three important
criteria for determining the quality of phenomenographic outcome spaces (Marton and
Booth 1997):
1. Each category reveals a unique aspect of how a phenomenon is understood.
2. Categories are connected in a hierarchical structure with relationships.
3. There is a limited number of outcomes, that is, a set few categories.
The second method is thematic analysis, which is independent, qualitative and descriptive
and is mainly used to identify, analyse and report patterns, that is, themes, within data in
nuanced and rich details (Braun and Clarke 2006, p. 79). Thematic analysis is appropriate
for qualitative questions such as ‘What are the concerns?’ or ‘What reasons do people
have?’. The philosophical assumption for thematic analysis is based mainly on what is
known as the ‘factist’ perspective, which assumes that the reality regarding a specific
attitude or behaviour exhibited by participants is indexed somewhere within the data,
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which are more or less accurate and truthful (Vaismoradi et al. 2013). Thematic analysis
consists of a six-step approach. Figure 21 illustrates the process which was proposed by
(Braun and Clarke 2006) for data analysis.
Figure 17: Six-steps processes for thematic data analysis (Braun and Clarke 2006, p. 87)
The outcomes of the thematic data analysis are presented as themes. A theme can be
described as a coherent integration of the disparate pieces of data that constitute the
¿ndings (Vaismoradi et al. 2013). Themes capture important pieces of data that are
relevent to the research question and represent some level of response pattern or meaning
within the data set (Braun and Clarke 2006).
FAMILIARISATION
Reading and re-reading the transcripts, noting down initial ideas.
GENERATING INITIAL CODES
Coding interesting features of the data systematically across the entire
data set, collating data relevant to each code.
SEARCHING FOR THEMES
Collating codes into potential themes, gathering all data relevant to
each potential theme.
REVIEWING THEMES
Checking if the themes work in relation to the coded extracts (Level
1) and the entire data set (Level 2).
DEFINING AND NAMING THEMES
Ongoing analysis to refine each theme.
PRODUCING THE REPORT
Compelling extract examples, doing final analysis of selected extracts,
relating the analysis back to the research questions and literature,
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3.2.1.2.1.7 Trustworthiness (Rigour) in Qualitative Research
Qualitative research is frequently criticised for its lack of scientific rigour. Such
judgements stem from ideals and criteria suitable for a hypothetico-deductive model such
as internal validity, reliability, generalisation and objectivity and as in quantitative
research. Therefore, establishing rigour or trustworthiness is crucial in all qualitative
research (Guba and Lincoln 1992, Hamberg et al. 1994). The concept of trustworthiness
can bring qualities to qualitative research by applying four commonly used criteria
(Figure 18): 1) credibility, that is, a quality assessment of whether the data convincingly
describe the phenomenon under investigation (Lincoln and Guba 1985, Ritchie et al.
2014); 2) transferability, which refers to whether the descriptions and interpretations in
the study are useful in other contexts (Lincoln and Guba 1986, Guba and Lincoln 1992);
3) dependability, which is a concept of consistency of the findings when the research is
replicated and repeated in the same context, using the same method and the same
participants (Lincoln and Guba 1985, Ritchie et al. 2014); and 4) confirmability, which
is  concerned  with  ensuring  objectivity  of  word,  that  is,  neutrality,  and  control  of
researcher bias (Lincoln and Guba 1985, Ritchie et al. 2014).
Figure 18: Indicators of scientific trustworthiness in qualitative research (Hamberg et al. 1994, p. 178)
No qualitative research, regardless of the method used, can provide findings that are
universally applicable (Lincoln and Guba 1985, Mays and Pope 2000). In qualitative
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relevant beyond the setting and context in which they were generated, that is, outside the
sample in which the research was conducted (Lincoln and Guba 1985, Mays and Pope
2000). Qualitative researchers such as Lincoln, Guba, Ritchie and Lewis suggested that
qualitative research’s external validity can be strengthened by providing a thick
description, that is, a comprehensive description and details, of the research design,
method and data interpretation process to allow other researchers to confirm that the
conclusions reached hold validity, assess the trustworthiness of the findings and evaluate
the research limitations (Lincoln and Guba 1985, Ritchie et al. 2014).
3.3 Methods
Quantitative Study: Drug Utilisation Review of Antibiotics Prescribed by GPs
for Elderly Patients with UTIs in a Primary Care Setting
3.3.1.1 Study Design, Duration and Data Source
This study was a quantitative, retrospective, observational, cross-sectional drug utilisation
study. It was designed to identify antibiotics prescribing patterns in addition to auditing
and quantifying any inappropriate prescribing if present based on published good practice
points (SAPG 2013). Patients’ data were retrieved from a database for a 36-month period
from 1 January 2010 to 31 December 2012 as in other research (Wrigley et al. 2002, Ki
et al. 2004, Kahan et al. 2005, Galatti et al. 2006, Czaja et al. 2007, Petersen and Hayward
2007a, Taur and Smith 2007, Haasum et al. 2013). The study used data from the UK IMS-
DA database as a source of patients’ diagnosis and prescriptions data. At the time of this
study in 2013, the database contained anonymised patient records from 135 general
practices distributed all over the UK.
The reason for choosing retrospective drug utilisation was that it was recognised for its
efficiency in addressing and describing drug prescribing patterns and problems, that is,
auditing. Furthermore, it could lead to planning for future interventions intended to
improve prescribing behaviour in addition to being inexpensive, quick and easy to
perform and requiring only the use of routinely accessible data. The main disadvantages
of this design are the limited number of variables available for analysis and there being
more potential for bias and confounding than in other designs. However, the bias and
cofounding in this design can be overcome by adhering to a well-structured design (Folke
and Donald 2003, Shalini et al. 2010).
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The IMS-DA was selected as data source because it is large and population based, that is,
longitudinal, with high quality and validity. Furthermore, IMS-DA is unique, being the
only database available that includes and combines all information on GPs, patients,
diagnoses and courses of therapy relevant to the decision-making process (Becher et al.
2009). Additionally, IMS-DA was used to set the scene and to quantify the magnitude of
inappropriate antibiotic prescribing if present. Moreover, an IMS-DA access licence was
available through academic collaboration.
3.3.1.2 Study Population
The study was designed to include all patients registered in the IMS-DA database aged
65 and older, coded by GPs, having had at least one code of UTI diagnosis, event or
problem and having received antibiotic prescription(s) in the period from 1 January 2010
to 31 December 2012.
3.3.1.3 Data Codes
Study diagnosis codes for UTIs were selected from the Read Codes dictionary (Appendix
5). These codes were listed on a Microsoft (MS) Excel® 2007 spreadsheet (Microsoft®
Corporation. Released in 2007. USA) containing definitions and descriptions for all the
codes found and used in IMS-DA by GPs during the process of data entry into the surgery
computer  system.  All  the  selected  codes  were  sent  to  a  GP  for  validation  before  the
process of data extraction was undertaken. After the codes were validated, a new MS
Excel® spreadsheet was generated with all the approved codes for UTI diagnosis that
would be included in the study.
3.3.1.4 Data Extraction
The validated diagnosis codes list was used to extract patient details from IMS-DA with
the help of a well-trained and experienced specialist in the field of pharmacoepidemiology
and IMS-DA data from University College London (UCL), School of Pharmacy. A
complete list of patient information extracted from the IMS-DA database for this study
can be found in Appendix 6. Retrieved data were separated into several text files: a
prevalence text file, an events text file, a problems text file and an antibiotic therapy text
file (using EphMRA AT classifications J01: Systemic Antibacterial Agents and G04:
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Urinary Anti-Infective Agents and Antiseptics). For details of the AT codes of extracted
antibiotics, see Appendix 7.
3.3.1.5 Data Reviewing and Cleansing
All text files were imported to MS Excel® as spreadsheets. Both events and problems files
were combined in one spreadsheet and labelled as the UTI problems master file. Data
were revised and cleaned by checking for any missing or unusual values and in-complete
or bad entries, if present, before data were processed. No missing values or bad entries
were detected during the review process.
3.3.1.6 Searching for Duplicate Data
The UTI problems master file was exported to IBM® SPSS® (Statistical Package for the
Social Sciences) Version 21.0 software (IBM® Corporation. Released in 2012. IBM®
SPSS® Statistics for Windows, Version 21.0. Armonk, NY: IBM® Corporation) for
comparing practice identifier, patient identifier, diagnosis and date. Searching for
duplicate cases between problems and events in the UTI problems master file was
performed and any duplicate cases were excluded from the data. The search process
successfully identified 25 duplicate cases. A decision was made to delete these cases to
avoid any miscalculation when performing the statistical analysis. A new SPSS® file was
created and saved as the UTIs final problems file.
3.3.1.7 Antibiotic Therapy and Data Linking
The antibiotic therapy file was imported to IBM® SPSS® 21.0 software. Data linking
between antibiotic therapy and the UTIs final problems file was performed. Each patient
was linked to his or her antibiotic therapy through matching several variables including
practice identifier, patient identifier, date, age and gender to increase matching accuracy.
Figure 19 illustrates the process of matching variables between the two files. A new
SPSS® file was created and saved as the patients’ data linked file. The saved file was used
for computing, recoding and analysis.
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3.3.1.8 Computing and Recoding Variables
Old variables from patients’ data were recoded into new variables. The recoded variables
were age, diagnosis, duration and date, as follows:
1. Age was recoded into three major groups: 65–74, 75–84, and 85 and older – to match
some of the age groups published in the literature (Eriksson et al. 2010, Caljouw et al.
2011) and to make comparison between results feasible in terms of prevalence.
2. Diagnosis Read Code descriptions were recoded into four major groups,24 to match the
diagnosis and therapy recommendations:
2.1. upper UTIs including pyelonephritis;
2.2. lower UTIs including all types of cystitis;
2.3. urinary tract infections including all diagnoses entered by GPs as urinary
tract infection or urinary tract infection unspecified site; and
2.4. others, containing any diagnosis other than those previously listed.
More details about the different diagnoses under each of the four categories can be
found in Appendix 8.
3. Duration was recoded into five groups: three days, seven days, 10–14 days, 28 days
and others – to make it easier to compare it with the recommended therapy duration
for different diagnoses.
4. Date as a quantitative variable was recoded into three major years – 2010, 2011 and
2012, according to patients’ date of visit – to make it possible to compare patterns
and trends among the years.





















Figure 19: The process and variables used for data linking between files
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3.3.1.9 Antibiotic Adherence to Good Prescribing Points
The decision aid document for the diagnosis and management of suspected urinary tract
infection (UTI) in older people25 was used to audit and compare the appropriateness of
antibiotic drugs and durations of therapy. The criteria used to label antibiotics as
inappropriate were the use of:
x antibiotic choice other than the recommended one;
x broad-spectrum antibiotics for UTIs other than recommended;
x antibiotics for durations other than recommended for treatment or prophylaxis; and
x doses of antibiotics other than those recommended.
3.3.1.10 Statistical Analysis
Statistics in DUR are mainly descriptive in nature. Provision of certain information –
such as epidemiologic parameters, that is, prevalence; degree of consumption, that is,
number of prescriptions; drug prescription profiles considering different ages and
genders – appears to be essential in DUR studies (Hallas 2005, Sequi et al. 2013).
Descriptive statistics were performed on retrieved data to calculate means, standard
deviation (SD) and distributions of demographics. This analysis was used to summarise,
organise, graph and describe data (Kier 2011). Frequencies, that is, percentages, of
patients’ visits, diagnoses, and choice and duration of antibiotics prescribed were
calculated by dividing each variable numerator by the relevant denominator and
multiplying it by a hundred.
In this research, annual prevalence was defined as the number of patients with at least one
antibiotic prescription for UTI during the year of investigation divided by the total number
of patient-years, which in this particular case is 65 years and older, in the same year.
Patient-years were defined as the sum of the number of years contributed by each patient
at risk of being prescribed an antibiotic for UTI during the study period in the study
population, namely, elderly patients aged 65 or older. In order to calculate patient-years,
25 Although these recommendations were published in 2013, that is, they are newer than the used data, they
were originally summarised from other old guidelines that were published in 2010 or earlier. Further,
although ‘non-adherence’ usually reflects prescribing according to previously established
recommendations, in this research it was used to describe any pattern of prescribing that was not in line
with the 2013 good practice points.
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the censoring date for each individual patient needed to be determined as some patients
may have entered or left the clinic at various points in time owing to a number of reasons
such as death or moving to another surgery in another catchment area that is not included
in the database. Patients were eligible for inclusion in the study between their respective
left-censoring and right-censoring dates in the database, that is, not all elderly patients
were included in the prevalence calculation throughout the whole study period. The left-
censoring date is the study start date, or the patient registration date, or the surgery up-to-
standard date. The right-censoring date is the date data ceased to be contributed to the
database, that is, when patients left, or moved out of the practice to another surgery, or
died, or the study end date was reached. The left-censoring and right-censoring dates were
used to calculate the length of time each patient contributed data to the IMS-DA database
during the study period. Figure 20 illustrates the process of data censoring in the IMS-
DA database for this study. The annual prevalence for elderly patients with UTIs was
calculated per 1,000 person-years for the years 2010, 2011 and 2012 by dividing the
numerator (registered cases of UTI per age) by the relevant denominator (total number of
patients-years of the same age) for the same period of time multiplied by 1,000 as in (Hsia
et al. 2010, Schnabel et al. 2015). The reason for using this unit for prevalence reporting
in this research was its ability to accommodate patients coming into and leaving during
the study period to provide more accurate figure; however, using this unit might result in
a lower prevalence compared with prevalence from other literature.











Elderly patients with UTI not eligible for inclusion
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Overcoming the influence of age and sex that may confound comparison of UTI
prevalence was done using the standardisation method, that is, adjustment in the
calculation. Age and age–sex standardised prevalence rates were calculated using the
direct standardisation method owing to the nature of the study data (Tripepi et al. 2010).
As a standard population for standardisation calculation, the UK 2012-based National
Population Projections by the Office for National Statistics (ONS) were used (ONS
2013). To ensure the reliability of the prevalence estimate, a 95% confidence interval
(CI) was calculated for each prevalence rate. The CI is a range of values calculated by
statistical methods that includes the desired true parameter with a probability defined in
advance. The 95% CI means that the confidence interval covers the true value in 95 of
100 studies performed (du Prel et al. 2009). Student’s t-test was used to compare overall
mean between male and female and per year as well. One way analysis of variance
(ANOVA)  test  was  used  to  assess  the  significant  in  prevalence  over  the  study  period
using year as the dependent factor and prevalence as independent factor.
Patterns of antibiotic use were defined as the extent and profiles of antibiotic use and the
trends in antibiotic use over time (Birkett et al. 2003). Antibiotic patterns and trends were
identified for the most commonly prescribed antibiotics per annum and throughout the
period of the study by dividing the numerator that represents the total amount for each
antibiotic prescribed by the relevant denominator, which in this case was the total number
of whole antibiotics prescribed for a certain period or for the whole period. To examine
if changes in antibiotic prescribing over the study period were significant, Chi-square (Ȥ2)
test was used. GPs’ adherence to good practice points for prescribing antibiotics for UTIs
was assessed through cross-tabulation of diagnosis and gender for the overall study
period then a percentage was calculated for each antibiotic compared with the decision
aid document points using IBM® SPSS®.
Inferential statistics were also calculated to determine the likelihood that a conclusion,
based on the data from a sample, was true and represented the population studied (Kier
2011). The Chi-square test for categorical variables and the Student’s t-test for
continuous variables were used when appropriate to compare group means and to detect
the  statistical  significance  of  results  (du  Prel et al. 2010). A p-value  of  <  0.05  was
considered to be statistically significant.
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In this study, two external statisticians assisted in the performance of statistical analyses,
confirming the suitability of the tests performed and the accuracy of the results obtained.
All results were presented in the form of column charts, cross tables and line charts. All
tables and figures were generated using MS Excel® 2007. Data analysis was carried out
using IBM® SPSS® Version 21.0 software. Figure 21 illustrates the methodology steps







Figure 21: Summary of the methodology steps followed in DUR study
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3.3.1.11 Ethical Considerations
Before starting the study, an email was sent to the Research Ethics office at KCL to verify
whether the study would need ethical approval or not. The response from the Research
Ethics office indicated that the study did not require any ethical approval from KCL since
the study uses only pre-existing, fully anonymised and non-sensitive data. Therefore, no
ethical approval was needed to conduct the study (see Appendix 9). However, IMS Health
requested submission of the research proposal via the Independent Scientific and Ethical
Advisory Committee (ISEAC) form in addition to a payment to review the research
protocol used and provide approval for publication. The form included all details of the
research – study aim, objectives, detailed study protocols – in addition to references to
obtain grants to use the databases and to publish and present the results of the study in the
literature and at conferences. The committee revised the form and requested further
clarification  of  some  minor  points.  Final  ISEAC  approval  was  obtained  from  the
committee in June 2014 (see Appendix 10).
Qualitative Study: Variations in GPs’ Views and Perceptions about
Prescribing Antibiotics for UTIs in Elderly Patients and Factors Influencing GPs’
Antibiotics Prescribing for UTIs
3.3.2.1 Rationale for Phenomenographic Research Design
To achieve the aim of the qualitative arm of research, it was highly important to explore
how people perceive or understand a phenomenon or situation since people plan their
actions according to their perceptions (Svensson 1997). Therefore, a phenomenographic
approach was deemed to be appropriate because of its second order philosophical
approach which is related to exploring variations in peoples’ experiences of a particular
phenomenon by studying their different views, concepts and thoughts about it (Marton
1986), which is one of the objectives of this research. Phenomenography assumes that
experiences can differ not only between people but also within the same subject over
time, because different aspects of a phenomenon are conceived within a framework in
relation to a given context (Barnard et al. 1999). Accepting this fact, in addition to gaining
knowledge about these different ways, allows researchers to understand:
‘How the world appears to others, what the world is like, and what the world
could be like’ (Marton and Booth 1997, p 13).
Chapter Three: Research Methodological Approaches and Methods
164
There is evidence, too, from previously published studies about the appropriateness of
phenomenography for exploring variations in GPs’ views about drug prescribing
(Lundborg et al. 1999, Wahlstrom et al. 2001, Rahmner et al. 2009).
3.3.2.2 Research Setting and Sampling Strategy and Sample Size
The qualitative study was designed to recruit any GP who works in the NHS or for an
NHS  partner  surgery  within  Greater  London,  in  the  UK,  to  maximise  the  variation  in
capturing concepts and understanding. London was chosen for its convenience in terms
of GPs travelling to take part in this research and for the cultural diversity of its GPs and
patients, which might have an impact on the phenomenon of antibiotics prescribing.
The fundamentals that underpinned the recruitment strategy in this research were the
adequacy and appropriateness of the recruited participants. Adequacy referred to
sufficient relevant data being generated through the participants while appropriateness
referred to selecting participants with relevant experience and knowledge to inform the
research (Bassett 2004). Therefore, non-probability purposive sampling, also known as
judgemental, selective or subjective sampling, was adopted as the sampling technique.
As this was PhD research, the anticipated sample size was determined to be between 10
and 20 GPs subject to the concept of data saturation (Fitzpatrick and Boulton 1994, Guest
et al. 2006, Mason 2010). Sample sizes of up to 20 have enabled exploration of all the
diverse  ways  of  conceiving  of  a  phenomenon within  a  group of  participants  in  similar
settings (Lundborg et al. 1999, Wahlstrom et  al. 2001, Rahmner et al. 2009). Studies
relevant to GPs’ views on UTIs have used similar sample sizes, from 15 to 20 (Kuehlein
et al. 2011, Bjorkman et al. 2013, Duane et al. 2016).
3.3.2.3 Inclusion and Exclusion Criteria
In order to capture a variety of perceptions and views regarding GPs’ antibiotics
prescribing, the recruitment criteria were broadened purposefully to include any GP with
a degree in medicine, working in any NHS or NHS partner GP surgery in Greater London
as a part-time or full-time GP, regardless of age, gender, practice location, practice size,
contract scheme, years of practice, level of experience and training qualifications in an
attempt to maximise the variation and diversity within the recruited participants.
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GPs working in private GP surgeries were excluded from the study because of workload
and the socio-economic nature of the patients who visit these surgeries. Additionally, GPs
working in university or college primary care centres or surgeries were excluded since
these centres and surgeries are mostly concerned with treating students rather than elderly
patients.
3.3.2.4 Participants’ Recruitment
Candidate recruitment26 was carried out between 19 November 2014 and 5 February
2015. Three recruitment approaches were used to increase the number of participants and
awareness about the study. The first approach was through email communication,
circulating research details and recruitment invitations through the assistance of the
Primary Care Research Manager at Imperial College London, Department of Primary
Care and Public Health. The circulated email included a brief research description,
research inclusion and exclusion criteria, researcher’s contact details and instructions for
interested GPs to provide the researcher with details including age, gender, certificates,
years of experience, practice site location and whether they worked in a private or NHS
or NHS partner surgery. Instructions to contact the researcher directly for further
enquires, if needed, were also provided. See Appendix 11.
The second approach was through social media (the GPs page on Facebook® includes
more than 3,000 GPs practising within the UK
(www.facebook.com/groups/tikosgpgroup)). A private message containing the research
and recruitment invitation details was sent to all group members through one of the group
administrators. The message included a brief research description, research inclusion and
exclusion criteria, the researcher’s contact details and instructions for interested GPs to
provide the researcher with details including age, gender, certificates, years of experience,
practice site location and whether they worked in a private or NHS or NHS partner
surgery. Instructions to contact the researcher directly for further enquires, if needed, were
also provided.
The final approach involved sending a direct email to medical training supervisors and
medical training programme directors at several primary care surgeries. The email
26 Refers to the process whereby the researcher identifies and invites (recruits) participants to join the study
(Given 2008, p. 743).
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included a brief research description, research inclusion and exclusion criteria, the
researcher’s contact details and instructions for interested GPs to provide the researcher
with details including age, gender, certificates, years of experience, practice site location
and whether they worked in a private or NHS or NHS partner surgery. Instructions to
contact the researcher directly for further enquires, if needed, were also provided.
Any GP interested in participating in the research was screened for appropriateness
against the inclusion and exclusion criteria, with a view to maximising the variation
among interested GPs. All eligible GPs received a detailed invitation email asking them
to select their preferred day, date, time and place. The invitation email included the
research title, a brief explanation of the research, its aim and objectives, the estimated
interview length, suggested dates and times, incentive provided to those who agreed to
take part in the research and never to withdraw from the study and the researcher’s contact
details for further enquires, if needed (Appendix 12).
Once interview dates were confirmed, participating GPs were emailed interview details
and a research information sheet. It provided comprehensive details about the research
including a brief research description, and information about the interview process and
participants’ rights. It included the study title, an invitation paragraph, the purpose of the
research, the reasons for invitation, an explanation of the interview process, the research
withdrawal policy, the incentive, possible disadvantages and risks of taking part in the
research, possible benefits of taking part in the research, participants’ anonymity,
participants’ and data confidentiality, the plan for disseminating research results and the
researcher’s contact details for further enquires (Appendix 13). All selected GPs received
a mobile text message and an email reminder that included the interview day, date, time
and place 48 hours before the interview.
3.3.2.5 Development of the Interview Topic Guide
The interview was directed by an interview topic guide that was prepared in advance to
ensure that the same basic lines of enquiry were followed with all participating GPs
(Appendix 14). The interview topic guide was developed and designed based on
previously published relevant qualitative studies as suggested by (Bowden and Green
2005, Flick 2007). Since there was a lack of similar studies on UTIs in elderly patients in
primary care, studies on children and adults and a variety of infections such as RTIs and
Chapter Three: Research Methodological Approaches and Methods
167
general infectious diseases were used to develop the interview topic guide questions
(Tonkin-Crine et al. 2011a, Brookes-Howell et al. 2012, Bjorkman et al. 2013, Mustafa
et al. 2014). All questions were re-drafted several times by research team members to
best fit the research aim, questions, population, setting and type of infection. The design
of the interview topic guide questions was influenced by the search for qualitative
variations in participants’ conceptions and experience.
The interview topic guide questions were designed to be open-ended to capture in-depth
information and to maximise variations and diversity in the ways in which GPs experience
antibacterial prescribing with special emphasis on elderly patients with UTIs. Questions
were written in neutral and clear language to allow GPs to structure their own
conceptions, beliefs and experiences (Patton 2002). They were prepared in a style to
encourage and motivate participants freely to express their views and perceptions
according to how they experienced the world of antibiotics prescribing in general and in
comparison with their colleagues (Bruce 1994). They were neither too many nor included
too many details that had been determined in advance since the idea was for most of the
questions to follow on from the GPs’ previous answers (Ashworth and Lucas 1998).  The
interview topic guide was divided into two parts as shown in Figure 22.
Figure 22: Summary of the interview guide main parts and the content of each part
The first part had the core questions and was further divided into three sections, each of
which included questions relevant to a specific topic. The first section had introductory
Section 1: General prescribing practice
Section 2: Antibiotics prescribing practice with a focus on
elderly patients with UTIs
Section 3: Antibiotics guidelines, recommendations and decision
support tools, to improve antibiotics prescribing practice
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questions related to GPs’ daily general practice, such as ‘What are the most frequently
prescribed classes of medication?’ and ‘What are the factors affecting GPs’ prescribing
practice and behaviour?’.
The second section related to antibiotics prescribing practice with the emphasis on elderly
patients with UTIs. These were more specific, narrower questions related to antibiotics
such as perceptions, problems, utilisation, prescribing, references, in addition to UTI
drugs decision-making, variations in antibiotics prescribing among different ages of
patients with UTIs, variations in antibacterial prescribing between elderly males and
elderly females and factors affecting GPs’ antibacterial prescribing practice and
behaviour. These questions were developed to provide in-depth insight into how GPs in
the UK approach elderly patients with UTIs in comparison with other age groups.
The third section related to antibacterial guidelines, recommendations and decision
support tools, to improve antibacterial prescribing practice. These questions were
developed to encourage GPs to express their personal experiences and thoughts about
recommendations and guidelines in addition to decision support methods.
The second part of the interview questions focused on GPs’ demographics and
administrative information, including gender, age, practice site, country of study,
qualifications, practice interest, number of years in practice, any experience outside the
UK, working pattern, previous hospital experience, number of working days per week,
average number of patients seen, examined and spoken to over the phone per day and
average consultation length per patient. The reason for including all these details was to
identify whether there was any interrelated pattern or relationship between these factors
that might influence GPs’ antibacterial prescribing perceptions.
3.3.2.6 Piloting the Research
The phenomenographic literature emphasises the benefits of performing a number of
small pilots prior to performing the main interviews (Dall'Alba and Hasselgren 1996).
This practice strengthens the research outcomes, comprehension and clarity of the
questions, and ensures that the data collection best captures the phenomenon under study
(Bowden and Green 2005, Pulcini et al. 2011). Additional benefits include providing the
researcher with a chance to practise and gain the necessary interviewing skills in terms of
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asking questions, prompts, probes and interacting with participants, as well as providing
an average estimated interview length.
After the interview topic guide was revised five times by the research team members,
both independently and together, it was further revised by four different clinical
pharmacists with different qualifications (master’s degree, doctor of pharmacy degree and
doctor of philosophy degree). All necessary amendments and feedback resulting from the
revisions was taken into consideration. A revised version of the interview topic guide was
developed and tested in two pilot interviews. The first interview was with a practising GP
and the second was with a prescribing consultant clinical pharmacist specialising in
infectious diseases. The interview lengths were 50 minutes for the first interview and 67
minutes for the second. The pilot led to splitting one of the interview questions into four
separate questions. No further amendments were suggested and a final version of the
interview topic guide was developed. Neither of the pilot interviews was included in the
qualitative sampling frame or the analysis. Figure 23 illustrates the phenomenographic
research design and data collection approach followed in this research.
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Qualitative study aim Aim of data collection
Qualitative data collection planning Qualitative study questions design
Data collection techniqueSampling (participation inclusion andexclusion criteria/number)
Recruitment of participations Interview topic guide development
Interview topic guide pilotingScheduling of interviews
Introduction session (consent signing
and study introduction)
Interview conducting /recording and



































Data coding and theme generation
Findings presentation
Figure 23: Systematic approach for the phenomenographic research design and data collection
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3.3.2.7 Ethical Approval
The Research Ethics office at KCL advised that no ethical approval was needed for the
study, since this type of research falls under service evaluation and audit. However, since
the study involved GPs from the NHS, the KCL Research Ethics website provided
instructions on how to contact the Health Research Authority (HRA) to check whether
there was any need for ethical approval from the HRA research committee. An enquiry
email was sent to HRA with a brief research description. HRA responded by advising use
of the National Research Ethics Service (NRES) online decision tool.  It  stated that the
outcome generated by the decision tool could be taken as an authoritative decision with
no further confirmation required. It also suggested reading and following the HRA
research guidelines before starting the study. The decision tool showed that the research
did not require ethical approval (Appendix 15).
3.3.2.8 The Interviews Dates and Locations
Interviews were conducted between 7 January 2015 and 10 February 2015. All the 17
interviews were conducted in quiet rooms or similar places according to GPs’ preference
such as GPs’ clinics, departmental meeting rooms, GPs’ houses or study group rooms in
KCL’s Franklin-Wilkins Building library, 150 Stamford Street, London, UK.
3.3.2.9 Pre-interview Process
On interview days, all participant GPs were provided with a brief verbal explanation of
the research and the interview process and invited to ask questions. They then asked to
sign  and  date  a  consent  form  that  provided  all  the  information  required  to  make  an
informed decision. All consent forms were dated and signed by the researcher as well. It
consisted of 11 statements concerning the research, all written in simple, plain language
and included the research title, an introductory paragraph, statements relating to the
information sheet, participants’ willingness to participate voluntarily, participants’
anonymity, participants’ and data confidentiality, the results dissemination plan,
interview recording and use of quotes without using names for research results
dissemination (Appendix 16). Each statement had to be ticked separately. All GPs were
informed about their right to withdraw their data at any time, even after signing the
consent form, without justifying their decision, as long as it was before 28 February 2015.
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If a GP decided to withdraw from the research before that date, all his or her information,
digitally recorded interview and collected data would be deleted and destroyed. Verbal
confirmations from all GPs were obtained to digitally record interviews.
3.3.2.10 The Interview Recording
All interviews were digitally recorded for active listening and verbatim, word-for-word
transcribing. To avoid any bias or confusion, terms used by GPs during interviews were
used as they were. Interviews were digitally recorded using two different digital
recorders. The first digital recorder was an Olympus® VN-712PC digital voice recorder
and the second was the researcher’s iPhone 5® device using the ALON Dictaphone® voice
recording application (ALON Software Limited) Version 1.2. Both recording devices
were tested during the two pilot interviews to check their reliability and quality of
recording. The quality and clarity of the recorded interviews were excellent without
detected noises. The reason for using two different devices was to have a back-up in case
one device ran out of battery or a malfunction occurred. Olympus® digital recorder
batteries were changed before each interview and the electricity charger was plugged into
the iPhone 5® during all the interviews.
3.3.2.11 Interview Process
The interview process was sequential, with responses moving along the topic guide
questions. Each interview began with the general introductory prescribing questions, to
gain GPs’ trust and make them feel at ease, and motivate them to answer the questions
fully. As the interviews progressed, the questions explored antibiotics prescribing for
UTIs in elderly patients in more depth, followed by guidelines and decision support tools
and systems.
To reveal the GPs’ ways of viewing antibiotics prescribing, the following techniques were
used during the interviews to achieve the study objectives (Bruce 1994):
x encouraging reflection on experience (from your own experience) (Bruce 1994);
x asking for information about how the phenomenon appeared to the participants (in
your opinion);
x confronting and pursuing areas of confusion (let me rephrase the question); and
x asking for explanation or more detail (can you elaborate more?).
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Throughout all the interviews, generic probing and prompting questions were asked. A
generic set of probes was used that had been published previously in the
phenomenographic literature (Bowden and Walsh 2000). These included:
x Can you explain that further?
x Can you give me an example?
x What do you mean by that?
x Can you tell me more about that?
x Can you explain that in a different way?
x Is there anything else you would like to say about this?
3.3.2.12 Taking Notes
Notes were taken during the interviews, without distracting the participants. Notes
included details that could not be captured by the digital recorder such as participants’
non-verbal behaviour, tone and context. Notes were also taken of relevant conversations
before and after the recorders were switched on, and of impressions formed about each
interview as soon as possible after completing it. This approach was helpful in reviewing
interview techniques in respect of ways of asking questions, as well as creating rapport
with participants.
3.3.2.13 Research Incentive
As a token gesture, all GPs who took part in the interviews were awarded £100 in the
form of an Amazon gift card. The incentive was given as a reimbursement for GPs’ time
lost to take part in the research. All gift cards were distributed after the end of the research
with an appreciation email.
3.3.2.14 Participants’ Anonymity and Data Storage
All GPs’ information was anonymised by assigning each of the GPs a unique code (GPX)
where (X) referred to the GP number in the research. All of these codes were kept
separately from GPs’ demographics and administrative details and encrypted by
VeraCrypt® Version 66 for Windows® software  (released  by  IDRIX  on  30  December
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2014,  Paris,  France).  Furthermore,  codes  were  kept  strictly  protected  from  any  access
except by research team members.
All digitally recorded interviews and information collected during the interviews was held
on a password-locked encrypted computer. All GPs’ consent forms and interview
transcripts were locked in a filing cabinet in the researcher’s office at the Institute of
Pharmaceutical Science, KCL, Franklin-Wilkins Building, 150 Stamford Street, London,
UK. All digitally recorded interviews and transcripts will be deleted and destroyed when
the research is completed.
3.3.2.15 Interview Transcription
All digitally recorded interviews were transcribed within two days using clean verbatim
technique (Platt 2001, Patton 2002, Denzin and Lincoln 2011). It included the omission
of certain words and utterances such as stutters, repetitions, false starts and most of the
‘ums’ and ‘ahs’ that would not affect the process of analysis. No attempts were made to
correct the researcher’s or the participants’ sentence structure, grammatical mistakes, or
use  of  colloquialisms.  Three  British  English  dictionaries  were  used  to  identify  and
understand the meaning of new or urban words: the Collins English Dictionary (Collins
Dictionaries 2014), the Cambridge Essential English Dictionary (Cambridge University
Press 2011) and the Urban Dictionary (Alexa Internet 2014). For quality assurance
purposes, all transcripts were verified twice by the researcher versus the digitally recorded
interviews and once by another research member (Dr Sue Jones (SJ)). Each revision was
from a different recording device to assure the accuracy of interview transcription and
word capture.
3.3.2.16 Data Coding
In phenomenographic analysis, the processes of data coding and analysis should not be
performed until all the interviews have been conducted (Bowden and Walsh 2000). In
contrast, in thematic analysis, the process of data coding and analysis is ongoing and runs
alongside the data collection process (Braun and Clarke 2006). The reason for keeping
data coding and analysis in phenomenography until the end is that the data must be
analysed as a whole because the aim of phenomenographic analysis is to explore the range
of meanings within a group of individuals, as elaborated on earlier in this chapter.
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In order to be familiar and understand the collected data, all recorded interviews were
listened to twice and transcripts were read three times, all the while keeping the question
in mind: ‘What does this say about how GPs experience antibiotics prescribing when
considering the elderly population?’. This technique ensured intense researcher
engagement with the data at a deeper level, which helped in the ensuing data coding step.
At this stage, the data was treated with an open mind, without any preconceived ideas
about the phenomenon under investigation.
Codes  are  labels  assigned  to  segments  of  transcripts  such  as  words,  sentences  and
paragraphs that facilitate the process of indexing or sorting key concepts while preserving
the context in which these concepts occurred (Denzin and Lincoln 2011). The coding
process used in this research consisted of a three-step approach that included
development, finalisation and application of the code structure. All transcripts were coded
inductively from the ‘bottom up’, because of the limited pre-existing work and theoretical
frameworks. Sections of text, that is, quotes, were assigned to different labelled codes.
To facilitate the data coding and organisation of the interviews, NVivo® for Windows®, a
computer software package developed to assist researchers in organising non-numerical
or unstructured data, Version 10.0 (QSR International. Released in 2012) was used. A
new project was created in NVivo® and saved under the name of GPs UTI Study. Each
interview transcript word file was saved as Interview-X where X referred to the order of
the interview. Each interview was linked to its participant’s demographics and
administrative data to facilitate the detection of interrelation if present. As there was a
large volume of data transcripts, NVivio® was very useful in sorting, selecting, creating
nodes for, comparing and grouping textual data from transcripts in a controlled and
systematic manner (data coded under a topic heading and further coded into sub-topics).
All codes were verified for meaning and consistency by the researcher and supervisors.
See Appendix 17.
3.3.2.17 Data Analysis Methods
Since this research was designed to explore the phenomenon of antibiotics prescribing in
its natural setting, it was crucial to find a method of analysing the data that would allow
exploration of the variations in participants’ views and perceptions without imposing any
pre-existing theory of what they might be. Furthermore, the method needed to allow
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identifying patterns in the data and instances of similarity and dissimilarity both within
and between the participants’ narratives. Additionally, the method had to discover
unexpected findings, explore unique responses, give voice to the participants’
conceptions, thoughts, and, if appropriate, interpret their responses in a way that could
bring life to their narratives by richly describing the data (Sharma 2004, Forster 2013,
Vaismoradi et al. 2013). Therefore, two different methods for data analysis were used:
phenomenographic data analysis and thematic data analysis. Both techniques have many
key advantages such as accessibility to less experienced researchers, flexibility,
convenience of presenting findings, and ability to summarise key features and highlight
similarities and differences across the data (Sharma 2004, Forster 2013, Vaismoradi et al.
2013).
Phenomenographic data analysis was employed in this study to discover and identify
variations in GPs’ experiencing of antibiotics prescribing for UTIs in elderly patients. A
seven-step process proposed by Dahlgren and Fallsberg (1991) was adopted to perform
the analysis. Thematic data analysis was employed to explore the factors influencing GPs’
antibiotics prescribing. The thematic analysis was performed using a six-step process that
was proposed by Braun and Clarke (2006).
Collected data were analysed by two researchers (HA and SJ) manually and
independently. In order to harmonise the categories of descriptions and themes, mutual
discussions between the two researchers were initiated to compare generated conceptions,
categories and themes. The approach taken was not sequential, but was performed in an
iterative manner, until the analysis was completed. The use of this method in analysis has
been shown to be beneficial in generating a reasonable conclusion (Dahlgren and
Fallsberg 1991, McCosker et al. 2004). In this research, all data coding and research
analyses were double-checked by an external expert.
The core findings from the analysis were presented in several formats. The first was tables
summarising participants’ demographics and administrative information as well as
themes and sub-themes generated from the thematic analysis. The second format included
the findings from the phenomenographic analysis of the interview textual data, which
were presented in the form of categories of description and outcome space and figures.
The third format was extracts, that is, quotes, which supported the findings from the
phenomenographic and thematic analyses. The term ‘quote’ in  this  thesis  refers  to  a
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segment of interview textual data of any length that was assigned a specific code. A quote
may  consist  of  a  few  words  only,  a  sentence,  a  paragraph  or  even  multiple  lines  of
interview conversation (Creswell 2007). Each quote was identified by the abbreviation
GP, which stands for general practitioner, followed by a number that described the GP’s
place within the interviews sequence as well as their age, gender and years of practice.
The relevant code was positioned after each quote.
3.4 Summary
This chapter has reviewed the theoretical background to the methodological approaches
employed in this thesis in addition to describing the precise methodologies followed to
achieve the thesis’ aim and research questions. The next chapter describes the research
key results and findings.
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Chapter 4 Drug Utilisation Review of Antibiotics Prescribed by GPs for
Elderly Patients with UTIs
4.1 Introduction
This chapter the key results and discussion about GPs’ prescribing of antibiotics for
elderly patients with UTIs who visited GP surgeries, from quantitative perspectives using
DUR as methodological approach.
4.2 Results
The first section of this chapter presents the key results from the DUR study including
details of patients’ visits, the antibiotics prescribed and the number of GP surgeries that
were included in the analysis during the study period. Patients’ demographic information,
the prevalence of UTIs and the adjusted prevalence for the study period are presented
after that. The results regarding frequencies of patients’ visits including individual
patients’ visits and patients’ diagnoses are presented and categorised per patients’ gender
and age groups. Antibiotics prescribed and treatment durations are presented with regard
to UTI type, years and patients’ age groups. Finally, results of GPs’ antibiotics prescribing
and their adherence to UTIs good practice points were cross tabulated by diagnosis and
gender.
Number of Extracted Records, Elderly Patients, Patients’ Visits, Antibiotics
Prescriptions and General Practices
Table 20: Summary of the number of visits, antibiotics prescriptions and GP surgeries that recorded data
for elderly patients with UTIs during the study period
Year UTI events visits Antibiotics prescriptions GP Surgeries 27
N % N % N %
2010 28,056 36.3 13,551 35.8 134 99.3
2011 25,946 33.6 12,849 34.0 126 93.3
2012 23,288 30.1 11,415 30.2 113 83.7
Total 77,290 100 37,815 100
During the time of commencing of this study, the IMS-DA included more than two
million anonymous patient records and over 95 million prescriptions from about 135 GP
27 Total number of GP surgeries included in IMS-DA for the period from 2010-2012 was 135 surgeries.
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surgeries  from  all  over  the  UK.  Results  shown  in  Table  20  summarise  the  number  of
elderly UTI visits, issued antibiotics prescriptions and GP surgeries from which visits and
prescriptions were retrieved over the study period, (1 January 2010 to 31 December
2012). Results from data analysis identified events and prescriptions recorded by 134
different GP surgeries. These surgeries recorded a total of 77,290 UTI visits by 21,150
elderly patients, of whom (N = 16,375; 77.42%) received at least one antibiotic
prescription per visit over the study period. The total number of issued antibiotics
prescriptions for UTIs during the study period was 37,815. As the table shows, there was
a consistent reduction in UTI events visits and antibiotics prescriptions. The highest
numbers of visits and prescriptions were recorded in 2010 with (N = 28,056; 36.3%) and
(N = 13,551; 35.8%) respectively.
Patients’ Demographics
Table 21: Demographics of elderly patients with UTIs over the study period
Patients’ demographics obtained from the data analysis are shown in Table 21. The mean
age of the elderly patients with UTIs from the data extracted from IMS-DA was 78.81 ±
8.49. As the table shows, most of the recorded UTI events were for female patients (N =
62,913; 81.4%) as compared with male patients (N = 14,377; 18.6%).
Prevalence of UTIs
The figures below illustrate the prevalence of UTIs by gender (expressed per 1,000
person-years) for 2010 (Figure 24), 2011 (Figure 25) and 2012 (Figure 26). Results show
that prevalence was higher in female in all the three years (statistically significant).
Results show that the highest prevalence of UTIs was recorded in 2010 in both genders
followed by 2011 then 2012. Throughout the study period, prevalence of UTIs started to
increase from the age of 60, reaching its peak in elderly patients of both genders aged 84–
93 then starting to decline. The incline in male patients’ prevalence over the study period
was steady with a gradual increase in its trend, whereas the incline in female patients’
prevalence was more progressive. Overall, there was a sharp decline in the prevalence of
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UTIs after the age of 93 in both genders. Interestingly, there was a clear fluctuation trend
in the prevalence when patients reached the age of 98 especially in female patients.
181
*Student’s títest



















































































































































Chapter Four: Results and Discussion for Quantitative Study
184
Table 22: Summary of the mean prevalence of UTIs in both male and female elderly patients over the
study period
The mean prevalence of UTIs for both female and male patients during the study period
can be found in Table 22. As the table shows, the mean age and sex adjusted UTI
prevalence was found to be 23.35 (95% CI 21.84-24.85) per 1,000 person-years for year
2010, 21.44 (95% CI 19.99-22.88) per 1,000 person-years for year 2011 and 17.88 (95%
CI 16.56-19.19) per 1,000 person-years. Additionally, there was almost a threefold
increase in the mean prevalence of UTIs in female elderly patients compared with male
elderly patients. A student’s t–test showed a statistically significant result in terms of
patients’ prevalence with (p < 0.021). Overall, there was a decline in the mean prevalence
of UTIs in both genders over the study period, which was also noticed in the adjusted age
and age–sex mean prevalence.
Number of Individual Patient Visits Per Age Group
The number of UTI visits per patient (single individual patient visit(s)) categorised by
age group can be seen in Figure 27, in which the number of visits is classified into three
main groups. The frequency of visits for each age group was calculated by dividing the
number of patients within that specific visit group over the total number of patients within
that particular age group for that specific year. Over the study period, the highest number
of visits per age group was seen in those aged 85 and older with 6,570 patient visits
followed by those aged 75–84 with 6,569 patient visits then those aged 65–74 with 6,568
patient visits. More patients made a single visit to their GP in all age groups over the study
period than made multiple visits. The only exception to this was elderly patients aged 85




















*Expressed in 1000 Person-Years; C.I. = Confidence Interval
§ Result was obtained from student’s t–test; ¥ Result was obtained from ANOVA test
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and older, in which group the highest number of visits was recorded to be three or more
(N = 3,450; 52.5%). Detailed numbers on patient visits by year and over the study period
can be found in Appendix 18.
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Patients’ Diagnoses by Gender
The frequency of different types of UTI condition by gender during the study period can
be found in Table 23. Unspecified UTI was the most commonly recorded diagnosis by
GPs in elderly patients of both genders prescribed antibiotics over the study period. A
total of 36,468; (47.18%) patients’ visits resulted in at least one antibiotic being
prescribed. Unspecified UTI diagnosis was seen in (N =22,463; 72.5%) of female patients
compared with (N = 5,084; 92.9%) of male patients, making it the most commonly
recorded diagnosis by GPs. Lower UTIs were recorded to be the second most common
condition in (N = 8,236; 26.6%) of female patients compared with (N = 332; 6.1%) of
male patients. The third most common condition was upper UTI with (N = 215; 0.7%)
cases in female patients and (N = 41; 0.7%) in male patients. Other types of UTI were
diagnosed in (N = 82; 0.3%) of female patients and (N = 15; 0.3%) of male patients.
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Table 23: Frequency of different types of UTI in elderly patients by gender with and without antibiotics therapy over the study period
Recorded visits without antibiotics Recorded visits with antibiotics
Diagnosis
Female Male Total Female Male Total
N % N % N % N % N % N %
UUTIs 621 0.9 226 1.57 847 1.1 215 0.7 41 0.7 256 0.7
LUTIs 15,420 24.5 940 6.54 16,360 21.2 8,236 26.6 332 6.1 8,568 23.5
UTI 46,623 74.1 13,122 91.27 59,745 77.3 22,463 72.5 5,084 92.9 27,547 75.5
Others 249 0.4 89 0.62 338 0.4 82 0.3 15 0.3 97 0.3
Total 62,913 100 14,377 100 77,290 100 30,996 100 5,472 100 36,468 100
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Patients’ Diagnoses Categorised by Age Group and Gender
Diagnosis of UTIs according to age group and gender can be found in Table 24, according
to which most of the recorded UTIs were seen in those aged 65–74 followed by those
aged 75–84 then those aged 85 and older. Unspecified UTI was the highest recorded
condition in all patient groups of both genders in all three years with (N = 9,743; 26.7%)
in those aged 65–74, (N = 10,044; 27.5%) in those aged 75–84 and (N = 7,760; 21.3%)
in those aged 85 and older. In both genders, elderly patients aged 75–84 had more UTIs
compared with elderly patients from the other age groups over the three years.
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Table 24: Frequency of different types of UTI categorised by age group per year and over the study period for both genders
Age (years) Diagnosis
2010 2011 2012
2010-2012Female Male Female Male Female Male
N %  N % N %  N  % N %  N  % N %
65-74
UUTIs 37 0.9 4 0.6 48 1.2 4 0.6 27 0.7 8 1.5 128 0.4
LUTIs 1,396 33.4 75 11.1 1,207 29.6 36 5.0 1,195 32.8 33 6.1 3,942 10.8
UTIs 2,747 65.7 598 88.3 2,807 68.9 677 94.3 2,414 66.2 500 92.3 9,743 26.7
Others 3 0.1 0 0.0 14 0.3 1 0.1 9 0.2 1 0.2 28 0.1
Total 4,183 100 677 100 4,076 100 718 100 3,645 100 542 100 13,841 38.0
75-84
UUTIs 23 0.5 7 0.9 30 0.8 2 0.3 36 1.1 12 2.0 110 0.3
LUTIs 1,202 28 51 6.7 1,008 27.0 29 4.1 936 27.7 48 8.0 3,274 9.0
UTIs 3,049 70.9 697 91.6 2,673 71.7 680 95.2 2,406 71.1 539 89.7 10,044 27.5
Others 25 0.6 6 0.8 19 0.5 3 0.4 7 0.2 2 0.3 62 0.2
Total 4,299 100 761 100 3,730 100 714 100 3,385 100 601 100 13,490 37
85
UUTIs 4 0.1 3 0.6 4 0.2 0 0.0 6 0.3 1 0.2 18 0.0
LUTIs 454 17.0 28 5.5 425 16.1 13 2.6 413 17.4 19 4.3 1,352 3.7
UTIs 2,211 82.8 478 93.7 2,207 83.7 490 97.2 1,949 82.3 425 95.5 7,760 21.3
Others 2 0.1 1 0.2 2 0.1 1 0.2 1 0 0 0 7 0
Total 2,671 100 510 100 2,638 100 504 100 2,369 100 445 100 9,137 100
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Antibiotics Prescribing
For elderly patients, the number of antibiotics prescribed for UTIs compared with the
total number of antibiotics prescribed during the study period is presented in Table 25.
Table 25: Frequency of antibiotics prescribing for UTIs compared with the number of total antibiotics prescriptions
for elderly patients
The number of antibiotics prescribed for UTIs was 37,815 resulting from 36,468 visits by
1,083 patients who received at least one antibiotic. The highest number of antibiotics
prescribed for UTIs was in 2010 with (13,551; 25.9%) prescriptions followed by 2011
with (12,849; 23.9%) prescriptions then 2012 with (11,415; 23.2%) prescriptions.
Antibiotic prescriptions for the treatment of UTIs accounted for (N = 37,815; 24.4%) of
the total antibiotics prescriptions for elderly patients within the study period with the
highest prescribing seen in 2012 (11,415; 23.2%). As the table shows, there was a
declining trend in the frequency of prescribing antibiotics for UTIs over the years.
Table 26: Frequency of antibiotics prescriptions for UTIs by age and year over the study period
Age group (years) 2010 2011 2012 2010-2012N % N % N % N %
65-74 5,013 37.0 4,973 38.7 4,348 38.1 14,334 37.9
75-84 5,235 38.6 4,616 35.9 4,137 36.2 13,988 37.0
85 3,303 24.4 3,260 25.4 2,930 25.7 9,493 25.1
Total 13,551 100 12,849 100 11,415 100 37,815 100
Table 26 shows the frequency of antibiotic prescriptions for UTIs according to patient
age group. Over the study period, the general trend of antibiotics prescribing can be seen
to decline with advancing age. Patients aged 65–74 had the highest frequency of
antibiotics prescriptions for UTIs with (N = 14,334; 37.9%) prescriptions, followed by
those aged 75–84 (N = 13,988; 37%) and those aged 85 and older (N = 9,493; 25.1%). In
2010, the number of issued prescriptions was highest in the 75–84 age group (N = 5,235;














N N % %
2010 52,263 13,551 35.8 25.9
2011 53,589 12,849 34.0 23.9
2012 49,266 11,415 30.2 23.2
Total 155,118 37,815 100 24.4
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65–74 age group with (N = 4,973; 38.7%) and (N = 4,348; 38.1) prescriptions
respectively.
Figure 28 shows the antibiotics most frequently prescribed by GPs for UTIs in elderly
patients. Throughout the study period, trimethoprim, nitrofurantoin, cephalexin, co-
amoxiclav, ciprofloxacin and amoxicillin were the most commonly prescribed antibiotics
with (N = 15,772; 41.7%), (N = 9,448; 25%), (N = 5,042; 13.3%), (N = 2350; 6.2%), (N
= 1,920; 5.1%) and (N = 1,866; 4.9%) respectively. What is interesting in this figure is
that nitrofurantoin prescribing was increasing on a yearly basis with the highest
prescribing seen in 2012. However, this increase was not significant as shown by the
result from Chiísquare (p < 0.11), whereas the prescribing of trimethoprim, cephalexin
and  ciprofloxacin  was  declining  over  the  years.  There  was  a  slight  decline  in  co-
amoxiclav prescribing in 2011 followed by a slight incline in its prescribing in 2012.
Amoxicillin was prescribed at a steady rate over the years. Prescribing of other
antibiotics28 decreased over the years to reach its lowest level in 2012. Detailed numbers
of antibiotics prescribed by GPs by year and over the study period can be seen in
Appendix 19.
28 Any antibiotic that was prescribed for UTIs other those listed in the figure.
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Table 27: Frequency of commonly prescribed antibiotics classified according to UTI type
Antibiotic UUTIs LUTIs UTIs OthersN % N % N % N %
Trimethoprim 67 24.9 4,311 49.0 11,361 39.6 33 33.7
Nitrofurantoin 45 16.7 2,238 25.4 7,140 24.9 25 25.5
Cefalexin 31 11.5 987 11.2 4,006 14.0 18 18.4
Co-amoxiclav 48 17.8 374 4.3 1,917 6.7 11 11.2
Ciprofloxacin 47 17.5 285 3.2 1,583 5.5 5 5.1
Amoxicillin 20 7.4 332 3.8 1,513 5.3 1 1.0
UUTIs: Upper UTIs (pyelonephritis); LUTIs: Lower UTIs (Cystitis); UTI: Unspecified UTIs
The most commonly prescribed antibiotics according to UTI diagnosis can be found in
Table 27. Of the patients with an unspecified UTI diagnosis, (N = 11,361; 39.6%)
received trimethoprim, (N = 7,140; 24.9%) received nitrofurantoin and (N = 4,006; 14%)
were prescribed cephalexin. Of those with upper UTIs, (N = 67; 24.9%) received
trimethoprim, (N = 48; 17.8%) were prescribed co-amoxiclav and (N = 47; 17.5%)
received ciprofloxacin. Of the patients with lower UTIs, (N = 4,311; 49%) received
trimethoprim, (N = 2,238; 25.4%) were prescribed nitrofurantoin and (N = 987; 11.2%)
were prescribed cephalexin.
Prescribed Antibiotics Durations
The  duration  of  antibiotics  treatment  prescribed  by  GPs  for  different  types  of  UTI  in
different age groups can be found in Table 28. In patients aged 65–74, frequency table
shows that the most commonly prescribed antibiotics and their durations were
trimethoprim for seven days (N = 2,310; 38.4%) followed by nitrofurantoin for more than
28 days (N = 1,752; 46.3%), cephalexin for seven days (1,204; 66%), co-amoxiclav
mostly for seven days (N = 662; 80.2%), ciprofloxacin for more than 28 days (N = 351;
50.2%) and amoxicillin for seven days (N = 338; 54.1%).
In patients aged 75–84, the most frequently prescribed antibiotics and their durations were
trimethoprim for seven days (N = 2,483; 42.2%) followed by nitrofurantoin for more than
28 days (N = 1,551; 45.5%), cephalexin for seven days (N = 1,206; 63.6%), co-amoxiclav
for seven days (N = 597; 70.4%), ciprofloxacin for more than 28 days (N = 384; 56.2%)
and amoxicillin for seven days (N = 396; 55%).
In  patients  aged  85  and  older,  the  most  commonly  prescribed  antibiotics  and  their
durations were trimethoprim for seven days (N = 1,711; 44.2%), nitrofurantoin for more
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than 28 days (N = 1,063; 47.3%), cephalexin for seven days (N = 797; 60.2%), co-
amoxiclav for seven days (N = 473; 69.9%), ciprofloxacin for more than 28 days (N =
334; 62.1%) and amoxicillin for more than 28 days (N = 250; 48%).
Table 28: Frequency of antibiotics for UTIs categorised by age group and duration of therapy
GPs’ Adherence to UTI Good Practice Points
To evaluate GPs’ adherence to good practice points, tables were generated to compare
the antibiotics prescribed for UTIs in elderly patients against the SAPG good practice
points for female patients (Table 29) and for male patients (Table 30). The results show
that trimethoprim was prescribed in line with the good practice points in (N = 1,617;
38.9%) of female patients and (N = 85; 54.1%) of male patients with LUTIs, and
nitrofurantoin was prescribed appropriately in (N = 190; 8.9%) of female patients and (N
= 49; 50%) of male patients with LUTIs. Use of broad-spectrum antibiotics should be
avoided in elderly patients to avoid Clostridium difficile infection. However, the results
showed that (N = 9,125; 24.1%) broad-spectrum antibiotics prescriptions were issued for
Age
(years) Antibiotic
3 Days 7 Days 10-14Days 28 Days Others
N % N % N % N % N %
65-74
Trimethoprim 2,107 35.0 2,310 38.4 102 1.7 172 2.9 1,325 22.0
Nitrofurantoin 283 7.5 1,577 41.6 98 2.6 77 2.0 1,752 46.3
Cefalexin 60 3.3 1204 66.0 71 3.9 94 5.2 394 21.6
Co-amoxiclav 18 2.2 662 80.2 48 5.8 4 0.5 93 11.3
Ciprofloxacin 7 1.0 171 24.5 153 21.9 17 2.4 351 50.2
Amoxicillin 23 3.7 338 54.1 27 4.3 3 0.5 234 37.4
75-84
Trimethoprim 1,709 29.0 2,483 42.2 102 1.7 212 3.6 1,378 23.4
Nitrofurantoin 245 7.2 1,479 43.3 70 2.1 67 2.0 1,551 45.5
Cefalexin 60 3.2 1,206 63.6 56 3.0 107 5.6 467 24.6
Co-amoxiclav 24 2.8 597 70.4 36 4.2 14 1.7 177 20.9
Ciprofloxacin 26 3.8 167 24.5 99 14.5 7 1.0 384 56.2
Amoxicillin 20 2.8 396 55.0 21 2.9 4 0.6 279 38.8
85
Trimethoprim 930 24.0 1,711 44.2 54 1.4 142 3.7 1,035 26.7
Nitrofurantoin 148 6.6 946 42.1 34 1.5 58 2.6 1,063 47.3
Cefalexin 45 3.4 797 60.2 48 3.6 57 4.3 376 28.4
Co-amoxiclav 28 4.1 473 69.9 35 5.2 8 1.2 133 19.6
Ciprofloxacin 19 3.5 110 20.4 72 13.4 3 0.6 334 62.1
Amoxicillin 12 2.3 250 48.0 14 2.7 8 1.5 237 45.5
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both genders, including for ciprofloxacin (N = 1,733; 4.6%)29, co-amoxiclav (N = 2,350;
6.2%) and cephalexin (N = 5,042; 13.3%). Moreover, (N = 12,159; 32.2%) of antibiotics
prescriptions were prescribed for durations other than the recommended either for
treatment or for prophylaxis; this was seen in (N = 10,605; 33%) of female patients’ total
UTI antibiotics prescriptions and in (N = 1,554; 27.5%) of male patients’ total UTI
antibiotics prescriptions.
29 Prescriptions for male prostatitis were excluded from this number.
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Table 29: Antibiotics prescribing for UTIs in female patients categorised according to condition and duration over the
study period
Antibiotic Duration
UUTIs LUTIs UTIs Others
N  % N % N %  N  %
Trimethoprim
3 days 13 22.4 1,617 38.9 2,923 31.3 6 24
7 days 39 67.2 1,367 32.9 3,710 39.7 8 32
10-14 days 2 3.4 44 1.1 120 1.3 2 8
28 days 1 1.7 74 1.8 359 3.8 0 0
Other30 3 5.2 1,052 25.3 2,227 23.8 9 36
Nitrofurantoin
3 days 3 7.5 190 8.9 463 7.6 0 0
7 days 19 47.5 901 42.1 2,475 40.8 11 45.8
10-14 days 0 0 36 1.7 123 2 3 12.5
28 days 0  0 28 1.3 151 2.5 1 4.2
Other 18 45.0 985 46 2,855 47.1 9 37.5
Cefalexin
3 days 0  0 34 3.5 127 3.7 1 6.3
7 days 21 75.0 614 64 2,091 61.2 11 68.8
10-14 days 0 0 20 2.1 131 3.8 0 0
28 days 3 10.7 57 5.9 177 5.2 0 0
Other 4 14.3 235 24.5 889 26.0 4 25
Co-amoxiclav
3 days 0  0 11 3.1 57 4.1 0 0
7 days 33 89.2 263 73.7 1,015 72.3 4 44.4
10-14 days 3 8.1 14 3.9 65 4.6 1 11.1
28 days 0  0 3 0.8 18 1.3 0 0
Other 1 2.7 66 18.5 248 17.7 4 44.4
Ciprofloxacin
3 days 1 2.7 11 4.1 35 3.2 0 0
7 days 15 40.5 56 20.9 244 22 1 25
10-14 days 10 27.0 25 9.3 161 14.5 0 0
28 days 0  0 5 1.9 7 0.6 0 0
Other 11 29.7 171 63.8 661 59.7 3 75
Amoxicillin
3 days 0  0 12 3.7 41 3.5 0 0
7 days 11 57.9 177 55 576 49.1 0 0
10-14 days 3 15.8 6 1.9 38 3.2 0 0
28 days 0  0 1 0.3 7 0.6 0 0
Other 5 26.3 126 39.1 511 43.6 0 0
UUTIs: Upper UTIs (pyelonephritis); LUTIs: Lower UTIs (Cystitis); UTI: Unspecified UTIs
30 Referred to treatment duration other than the recommended.
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Table 30: Antibiotics prescribing for UTIs in male patients categorised according to condition and duration over the
study period
Antibiotic Duration
UUTIs LUTIs UTIs Others
N  %  N  % N %  N  %
Trimethoprim
3 days 0 0 19 12.1 168 8.3 0 0
7 days 5 55.6 85 54.1 1,285 63.6 5 62.5
10-14 days 0 0 5 3.2 85 4.2 0 0
28 days 0 0 2 1.3 87 4.3 3 37.5
Other 4 44.4 46 29.3 397 19.6 0 0
Nitrofurantoin
3 days 0 0 3 3.1 17 1.6 0 0
7 days 1 20 49 50 546 50.9 0 0
10-14 days 0 0 6 6.1 34 3.2 0 0
28 days 0 0 3 3.1 19 1.8 0 0
Other 4 80 37 37.8 457 42.6 1 100
Cefalexin
3 days 0  0  0  0 3 0.5 0 0
7 days 3 100 22 81.5 443 75 2 100
10-14 days 0 0 1 3.7 23 3.9 0 0
28 days 0 0 1 3.7 20 3.4 0 0
Other 0 0 3 11.1 102 17.3 0 0
Co-amoxiclav
3 days 0  0  0  0 2 0.4 0 0
7 days 10 90.9 12 70.6 393 76.5 2 100
10-14 days 1 9.1 0 0 35 6.8 0 0
28 days 0 0 1 5.9 4 0.8 0 0
Other 0 0 4 23.5 80 15.6 0 0
Ciprofloxacin
3 days 0 0 0 0.0 5 1.1 0 0
7 days 4 40 4 23.5 124 26.1 0 0
10-14 days 3 30 5 29.4 120 25.3 0 0
28 days 0 0 19 12.1 168 8.3 0 0
Other 5 55.6 85 54.1 1285 63.6 5 62.5
Amoxicillin
3 days 0 0 5 3.2 85 4.2 0 0
7 days 0 0 2 1.3 87 4.3 3 37.5
10-14 days 4 44.4 46 29.3 397 19.6 0 0
28 days 0 0 3 3.1 17 1.6 0 0
Other 1 20 49 50 546 50.9 0 0
UUTIs: Upper UTIs (pyelonephritis); LUTIs: Lower UTIs (Cystitis); UTI: Unspecified UTIs
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4.3 Discussion
This section of the chapter discusses and interprets the research results and compares
them  with  the  results  from  the  relevant  reviewed  literature  in  Chapter  Two.  The
application of a quantitative DUR research was successful in describing the prevalence
of UTIs in elderly people in addition to auditing GPs’ antibiotics prescribing for UTIs in
the UK. The study showed that UTIs were significantly (p < 0.021) far more prevalent in
female patients compared with male patients in the study period 2010–2012 as well as
overall within the patient age groups 65–74, 75–84 and 85 and older (Figure 24), (Figure
25) and (Figure 26). Unspecified UTIs were found to be the most commonly recorded
conditions throughout the study period in 75.5% (N = 22,547) of all recorded events
followed by lower UTIs in 23.5% (N = 8,568) of recorded events in elderly patients.
Perhaps a good explanation for this high prevalence in females is the presence of certain
gender-related factors such as the anatomical structure of the female urethra, increased
incidence of urinary incontinence, previous and recurrent history of UTIs, presence of
DM, low oestrogen level as well as longer life expectancy in females compared with
males (Moore and Spence 2014). The findings from the DUR study were consistent with
the findings of several other epidemiological studies (Ruben et al. 1995, Ki et al. 2004,
Czaja et al. 2007, Laupland et al. 2007, Caljouw et al. 2011), all of which agreed that
UTIs were significantly higher in females compared with males, except Omoregie et al.
(2010), who found the prevalence of UTIs to be higher in males aged 60 and over
compared with females. Overall, the prevalence of UTIs in the UK was found to be
declining over the study years. The highest prevalence was seen in 2010 followed by 2011
then 2012. There were several possible explanations for this decline in prevalence, for
example, the increase in the death rate among the elderly patients who were registered
with the surgeries from which the study data were obtained. In this study, the mean age
for elderly patients with UTIs was found to be 78.81 ± 8.49. In the UK, the reported life
expectancy for males aged 85 was 5.8 years (90.8) whereas for females it was 6.8 years
(91.8) for the period 2010–2012 (ONS 2014). Data from the ONS showed that in just one
year there were 5.4% more deaths equating to almost 27,000 extra deaths (ONS 2016).
Figures from the report showed that numbers of deaths have fallen steadily since the
1970s, but that trend began to reverse in 2011 (ONS 2014). This could explain why
females tend to have UTIs at an older age than males. Another possible explanation for
this  reduction  over  the  study  period  is  the  increase  in  the  total  number  of  elderly
population in the UK (ONS 2015a), which in turn reflects the total number of elderly
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patients who visited GP surgeries. A final explanation might be that some elderly patients
moved from one catchment area to another and thus were following up with a different
GP.
From an age perspective, the majority of recorded visits to GP surgeries for UTIs were
found to be highest among elderly patients aged 84–93. Although the number of elderly
patients within this category was lowest compared with the other two age categories (65–
74 and 75–84), frequent GP visits by this age group might explain the high prevalence
and peaks shown in Figures 24, 25 and 26 in Chapter Four. This is in line with both
Laupland et al. (2007) who found elderly people who were 90 or older had the highest
UTI incidence among all age groups with 925.7 for females, 637.8 for males and 850.6
overall per 1,000 per year and Eriksson et al. (2010) who found the prevalence to be 25%
for patients aged 85, 29.6% for patients aged 90 and 34.4% for those aged 95 and over.
Perhaps this increase in the number of visits was a result of age-associated changes in
immunity (Beveridge et al. 2011), cognitive impairment, urinary incontinence and prior
or recent history of UTI (Hu et al. 2004, Foxman 2014) or other risk factors for UTI as
shown  in  Table  10  in  Chapter  One.  The  prevalence  of  UTIs  was  noticed  to  started  to
increase from the age of 60, reaching its peak between 84 and 93 before declining from
the age of 93, in both genders. In this DUR study, the age trend of elderly patients with
UTIs was similar to the findings described by Laupland et al. (2007), who found the
estimated incidence in females to be 40 for those aged 60–69, 46 for those aged 70–79
and 110 for those aged 80–89, all expressed in 1,000 per year, and in males to be 10 for
those aged 60–69, 15 for those aged 70–79 and 60 for those aged 80–89, all expressed in
1,000 per year; and partially to those reported by Ki et al. (2004), who described similar
findings in elderly female patients with incidence of 57.15 per 10,000 population for the
60–79 age group and 28.07 per 10,000 population for the 80 and over age group, but not
in elderly male patients. Additionally, this result was found to be partly in agreement with
the results of other epidemiological studies (Ruben et al. 1995, Malmsten et al. 1997,
Molander et al. 2000, Galatti et al. 2006, Czaja et al. 2007, Eriksson et al. 2010, Marques
et al. 2012), who either linked the increased UTI incidence or prevalence with advancing
age compared with other age groups in general and in elderly patients with this age in
particular or they did not describe the trend in detail beyond the age of 90 (Ruben et al.
1995, Molander et al. 2000, Foxman et al. 2000, Ki et al. 2004, Galatti et al. 2006, Czaja
et al. 2007, Laupland et al. 2007, Caljouw et al. 2011, Marques et al. 2012). On the other
hand, the results of this DUR study did not support Foxman et al. (2000), who found that
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UTIs do not increase with age in the female gender, or Omoregie et al. (2010), who stated
that UTI prevalence decreases with age. Perhaps the discrepancies in the reported
epidemiology among different studies are owing to the heterogeneity in the study sample
sizes caused by including smaller numbers of elderly patients compared with other age
groups, to differences in recruitment settings or to differences in study methodology.
Some of these studies included a small sample size of elderly patients with UTIs while
other studies included other age groups (Malmsten et al. 1997, Foxman et al. 2000, Ki et
al. 2004, Galatti et al. 2006, Czaja et al. 2007, Laupland et al. 2007). Although some
studies focused only on the elderly population (Ruben et al. 1995, Molander et al. 2000,
Eriksson et al. 2010, Omoregie et al. 2010, Caljouw et al. 2011, Marques et al. 2012),
instead of recruiting patients from a non-institutionalised, community setting, they
recruited patients from different settings such as hospitals and nursing homes (Malmsten
et al. 1997, Molander et al. 2000, Laupland et al. 2007, Eriksson et al. 2010, Omoregie
et al. 2010, Marques et al. 2012). One possible explanation for these discrepancies is the
shift in some countries’ population structure towards an ageing population compared with
other countries over the years as reported by Hestbaek et al.(2014), which resulted
primarily from improvements in healthcare services provided to this age group (Hestbaek
et al. 2014). Another possible reason for these discrepancies may be related to the
differentiation between UTIs and ASB, which can be easily distinguished in studies that
based their results on laboratory findings and clinical presentation (Laupland et al. 2007,
Caljouw et  al. 2011, Marques et al. 2012)  but  are  less  easy  to  separate  in  studies  that
depend solely on either survey (Ruben et al. 1995, Malmsten et al. 1997, Foxman et al.
2000, Molander et al. 2000) or computerised database (Ki et al. 2004, Galatti et al. 2006,
Czaja et al. 2007, Laupland et al. 2007) to calculate their incidence or prevalence.
During the study period (2010–2012), around 15–18% of the elderly patients visited their
GP three or more times a year for UTIs (for the exact number see Appendix 18). This
high number of visits might suggest that there was a high rate of UTI recurrence, which
is  very  common  in  elderly  patients  owing  to  several  factors  such  as  existence  of  co-
morbidities, weakened immune system and ageing itself (Nicolle 2005, Caljouw et al.
2011). Another explanation might be that patients might have received ineffective
antibiotics, have been exposed to a multi-drug resistance pathogen, which can be common
in elderly patients as a result of ageing and frequent exposure to antibiotic therapies, as
shown by (De Vecchi et al. 2013), who found that bacterial resistance to antibiotics was
rather widespread in elderly patients and that it may be responsible for antibiotic therapy
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failure in this population, or may not have adhered to antibiotic treatment. Each of these
visits resulted in at least one antibiotic being prescribed for UTI.
In this DUR study, 37,815 (48.9%) of the total recorded UTI events in the IMS-DA ended
with at least one antibiotic being prescribed. The general trend of antibiotics prescribing
decreased with advancing age both annually as well as over the whole study period
(2010–2012). However, this does not support the results of Pan et al. (2011), who reported
the prevalence of antibiotics prescribing for the elderly to be 49% for those aged 65–74,
56% for those aged 75–84 and 69% for those aged 85 and over, or Haeseker et al. (2012),
who reported a high rate of antibiotics prescribing in elderly patients that significantly
increased over time with increase in elderly patients aged in particular 80 or older (p <
0.001). There are several explanations for this. One is that Pan et al. (2011) and Haeseker
et al. (2012) conducted their studies in the  Netherlands  and  Italy  respectively,  two
countries among those in the European Union with high antibiotics consumption and
prescribing rates, particularly in the elderly (Adriaenssens et al. 2011, Haeseker et al.
2012).  Another  explanation  is  that  elderly  patients  have  the  highest  rate  of  antibiotics
consumption in comparison with other age groups (Norris et al. 2011, Pan et al. 2011),
largely because of their frequency of infection owing to weak immunity and worse
general health (Htwe et  al. 2007, Heppner et al. 2013). Yet another explanation is the
inclusion into those studies of other infectious diseases such as RTIs without stratifying
the consumption results per condition (Norris et al. 2011, Pan et al. 2011). A fourth might
be the implantation of certain strategies or interventions to promote prudent use of
antibiotics such as educational programmes, campaigns, audits and awareness
programmes, which have been implemented in the UK since 1999 (Huttner et al. 2010,
Harris 2013). In this study, perhaps, the reducing rate of antibiotics prescribing for UTIs
with advancing age could be owing to the increase in the death rate among the elderly
patients registered with the surgeries from which the data were obtained (ONS 2012).
Another possible reason could be the increase in the total number of elderly population
in the UK (ONS 2015a), which in turn might reflect on the total number of elderly patients
who visit GP surgeries. A final explanation might be that some elderly patients moved
from one catchment area to another and therefore followed up with a different GP whose
records were not included in the IMS-DA.
In this study, trimethoprim was the most commonly prescribed antibiotic, with 15,772
(41.7%) prescriptions. This is consistent with the general result of Petersen and Hayward
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(2007), who reported trimethoprim to be the most commonly prescribed antibiotic for
UTI with a total of 25,147 (56.1%), and the female-specific results of Leistevuo et al.
(1997), who reported either TMP-SMX or trimethoprim in 94 cases (37%), but not with
the results of Friis et al. (1989), who found sulphamethoxazole to be the most commonly
prescribed antibiotic in 1989. Sulphamethoxazole might have been effective in 1989 but
not anymore because of the increased ADRs associated with it (Bendall 1984). Straand et
al. (1998), Kahan et al. (2005), Taur and Smith (2007) and McIsaac et al. (2008) reported
TMP-SMX  to  be  the  most  commonly  prescribed  antibiotic  for  UTIs  while  the  rest
reported other antibiotics as the most common such as quinolones, pivmecillinam,
fosfomycin and co-amoxiclav. A possible explanation for this variation in antibiotics
prescribing for UTIs is variation in bacterial resistance, especially for E. coli., which was
considered to be the main infective pathogen responsible for the majority of UTI cases in
elderly patients with increased resistance to many antibiotics that may also vary between
countries as shown in a multi-country study of 908 E. coli urine cultures from Austria,
Greece, Portugal, Sweden and the UK. The results showed different rates of E. coli
resistance for different antibiotics including trimethoprim, co-amoxiclav, TMP-SMX,
nitrofurantoin and ciprofloxacin (Kahlmeter and Poulsen 2012). Further, WHO global
surveillance reported E. coli resistance of more than 50% of commonly used antibiotics,
particularly Àuoroquinolones and third-generation cephalosporins, which might make
effective treatment of UTIs differ from one country to another based on resistance patterns
(Aarestrup et al. 2014). Other possible explanations for this variation in antibiotics
prescribing could be variations in first-line recommendations, for example, fosfomycin
in Spain (Llor et al. 2011) versus nitrofurantoin or trimethoprim in Ireland (Vellinga et
al. 2011), different geographical areas and cultures such as Ireland (Vellinga et al. 2011)
versus the USA (Taur and Smith 2007), availability of antibiotics such as fosfomycin in
Spain (Llor et  al. 2011) but not in the UK, and antibiotics purchasing without a
prescription from a GP, that is, self-medication as in Spain.
Nitrofurantoin was found to be the second most commonly prescribed antibiotic for
elderly  patients  with  UTIs,  with  9,448  (25%)  prescriptions.  This  result  was  consistent
with the findings from Kahan et al. (2005), who reported nitrofurantoin prescriptions in
11,888 (18.51%) UTI cases in line with the diagnosis and treatment of uncomplicated
UTI guidelines, and also from Denes et al. (2012), who found nitrofurantoin to be the
second most commonly prescribed antibiotic based on urine analysis. Furthermore,
nitrofurantoin was reported to be the third most commonly prescribed antibiotic in studies
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of elderly patients only (Taur and Smith 2007, McIsaac et al. 2008) and of all age groups
and genders except males aged 80 and older (Haasum et  al. 2013). In Petersen and
Hayward (2007) nitrofurantoin was found to be only the fourth most commonly
prescribed antibiotic for UTIs, possibly because the study used UTI patients’ records
without taking into consideration the influence of age, gender or UTI type. Overall, the
prescription of nitrofurantoin for elderly patients may be associated with less compliance
since it needs to be taken four times daily, making it less practical for the elderly.
Additionally, it might not be used for patients with renal impairment, which is common
in elderly patients for many reasons such as ageing-associated changes in the kidneys
ýukuranoviü and Vlajkoviü 2005, Macias Nuñez et al. 2008) or as a result of drug–drug
interactions as shown in Table 7 in Chapter One (Nicolle 2009a).
Only 1,617 (38.9%) antibiotics in females and 85 (54.1%) in males were found to be in
line with the SAPG good practice points for LUTIs; while nitrofurantoin was prescribed
appropriately for 190 (8.9%) female patients and 49 (50%) male patients with LUTIs.
Overall, 9,125 (24.1%) prescriptions in this study were for broad-spectrum antibiotics.
Among these broad-spectrum antibiotics, cephalexin was the most commonly prescribed
in both genders (N = 5,042; 13.3%), followed by co-amoxiclav (N = 2,350; 6.2%) and
ciprofloxacin (N = 1,733; 4.6%). The use of broad-spectrum antibiotics may increase the
susceptibility of elderly patients to infections such as Clostridium difficile, which may
lead to death (Beckett et al. 2015). Additionally, 12,159 (32.2%) of antibiotics
prescriptions were for durations other than those recommended for treatment or
prophylaxis; this was seen in 10,605 (33%) female and 1,554 (27.5%) male cases. Also,
4,416 (28%) trimethoprim prescriptions and 4,771 (50.5%) of nitrofurantoin prescriptions
were  for  longer  durations  than  those  listed  by  the  SAPG  good  practice  points  (SAPG
2013). These exposed elderly patients to inappropriate courses of antibiotic therapy,
which consequently might have deteriorated their condition, caused ADRs and increased
or developed bacterial resistance. Overall, the results from this DUR study in terms of
comparing GPs’ prescribing practices with SAPG good practice points indicated that
there is some lack of adherence to recommendations as well as inappropriate antibiotics
prescribing in terms of antibiotic choice and/or duration of therapy. In this DUR study,
inappropriate prescribing was seen in the form of using broad-spectrum antibiotics and
prescribing for inappropriate durations. These results support Straand et al. (1998), Kahan
et al. (2005), Llor et al. (2011), Vellinga et al. (2011), Denes et al. (2012) and Haasum et
al. (2013), who all reported either a lack of or poor adherence to guidelines on the part of
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GPs and primary care physicians when prescribing for the adult population in general or
for the elderly population in particular. However, these findings might not represent the
true adherence of GPs to guidelines as GPs might deviate from the recommendations for
antibiotics prescribing if urine sample results show resistance bacteria or if the patient has
a reason that makes first-line therapy inappropriate such as co-morbidities, drug–drug
interactions or ADRs in particular studies that based on computerised databases such as
(Wrigley et al. 2002, Kahan et al. 2005, Petersen and Hayward 2007a, Taur and Smith
2007, Haasum et al. 2013).
4.4 Future Research
This quantitative, retrospective, observational, cross-sectional study was designed to
explore GPs’ antibiotics prescribing practice for elderly patients with UTIs over the three-
year period 2010–2012. The results suggest the presence of some variations in GPs’
antibiotics prescribing practice as well as non-adherence to SAPG good practice points
in the forms of using broad-spectrum antibiotics and prescribing for longer durations. In
order to understand whether these prescribing variations and none-adherence were
resulted  from  IMS-DA  data  limitations  such  as  lack  of  patients’  social,  clinical
characteristics and compliance data or owing to presence of prescribing variation by GPs,
future research should focus on exploring the phenomenon of how GPs prescribe
antibiotics for elderly patients with UTIs. This future work needs to investigate whether
there are variations in the way GPs approach, perceive and view antibiotics in this
particular circumstance. Since this work will require in-depth description of GPs’
thoughts, ideas, concepts and views, and because it will focus on describing this
phenomenon in its natural context, qualitative research using a phenomenographic
method might be appropriate.
4.5 Summary
In summary, this chapter presented the key findings for quantitative study related to GPs’
antibiotics prescribing for elderly patients with UTIs. The results from the study were
presented in the form of prevalence, tables and bar charts. The results suggest high
prevalence of UTIs in elderly female patients compared with elderly male patients. With
regard to GPs’ antibiotics prescribing practice, the results suggest that some GPs’
prescribing was not in line with the available good practice points.
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Chapter 5 Phenomenographic Approach for the Variations in GPs’
Views and Perceptions about Prescribing Antibiotics for UTIs in Elderly
Patients and Factors Influencing GPs’ Antibiotics Prescribing for UTIs
This chapter presents the key findings and discussion about GPs’ prescribing of
antibiotics for elderly patients with UTIs who visited GP surgeries, from qualitative
perspectives using phenomenography as methodological approach. The chapter discusses
and interprets the findings and compares them with the findings from the relevant
reviewed literature in Chapter Two. Since the data were allowed to stand on their own,
without interpretation, they were discussed separately and without speculation about their
meaning or trying to ‘get inside the head’ of the GPs and somehow ‘interpret’ what they
meant. Should the findings suggest concepts that were not addressed in Chapters One and
Two, the researcher might need to include a concise description before discussing the
findings (Burnard 2004, Burnard et al. 2008).
5.1 Findings from Phenomenographic Analysis of Variations in GPs’ Views and
Perceptions about Prescribing
Introduction
This section presents the key findings from interviews with GPs about phenomenon of
antibiotics prescribing for elderly patients with UTIs. The first part of this section
discusses in detail the categories of description, including referential and structural
components, that were identified by the researcher in the course of the interpretative
analysis of the data. The second part of this section encompasses the diagrammatical
presentation of findings outcome space.
Number of Interviews and Participants’ Characteristics
Twenty GPs expressed their interest in participating in the research. Two GPs were
located outside the Greater London Area; therefore, they were excluded. One GP out of
the remaining 18 withdrew because of unavailability within the proposed research time
frame. The final number of participants was 17 with no further withdrawals. Out of the
17 GPs, (N = 9; 53%) were female GPs. GPs mean age was 41.12 ± 9.94 and the average
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length for interviews was 68 minutes. Table 31 summarises participants’ demographics
and practice details.

















GP1 F 46 Tanzania 24 5 40 10-15 71
GP2 M 58 NA 29 6 40 10 42
GP3 F 35 Various 5.5 2 25-30 15-20 63
GP4 F 33 NA <1 3 30-35 10-15 72
GP5 M 45 Ireland 9 5 40-50 8-10 43
GP6 F 40 NA 12 2/3 28 10 56
GP7 F 37 NA 6 2.5 24-28 15 57
GP8 M 36 Australia/New Zealand 2 3 36 10 92
GP9 F 30 NA 2 5 40 10 90
GP10 F 33 Zambia 2 3 36 12 72
GP11 M 50 NA 22 5 30 10 55
GP12 F 35 Malawi 5.5 3 45 10 55
GP13 M 45 NA 18 4 30 12 95
GP14 M 34 NA 5 2 45 10-12 81
GP15 F 33 NA 3.5 4 40 10 88
GP16 M 42 NA 4 5 40 10 61
GP17 M 67 NA 14 6 30 15 68
*per week; §per day; ªminutes; ȕin addition to UK; F: Female; M: Male; NA: Not Applicable
Categories of Description of GPs’ Views and Perceptions
Analysis of the 17 GP interviews resulted in identifying five distinctive categories of
description representing the ways in which GPs perceive antibiotic prescribing in elderly






Findings in this section are presented as categories of description that represent the GPs’
conceptions of experiencing the phenomenon of antibiotics prescribing for elderly
patients with UTIs. Here, each of the five distinct categories of description consists of
different dimensions, or subcategories, that represent a view or a perception shared by a
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group of GPs. It is important to stress that whether GPs experienced, viewed or perceived
prescribing antibiotics for elderly patients with UTIs positively or negatively was not
what was of import; it was how GPs perceived antibiotics prescribing in elderly patients
as it was described in each category in the GPs’ practice world. Each of these categories
described below. Figure 29 summarises the five categories of descriptions and the
dimensions from the phenomenographic analysis of the GP interviews.
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5.1.3.1 Category of Description 1: Variations in GPs’ Antibiotics Prescribing
Perceptions
In this category of description, the way in which GPs perceived antibiotics as a group of
drugs was described as perceptions. Data analysis revealed six different subcategories of
admiring and appreciating the therapeutic value of antibiotics, patients’ conceptions,
concerns, conservative prescribing attitudes, guidelines and being cheap drugs. The
following section explores in detail each of these dimensions of perceptions that emerged
from the participants’ answers. Findings are presented with explanations of each
dimension supported by participants’ quotes.
5.1.3.1.1 Admiring and Appreciating
In dimension 1 (admiring and appreciating), the majority of GPs (N = 15) focused on the
therapeutic value of antibiotics, being one of the greatest innovations of this century and
capable of saving patients’ lives if used appropriately to treat bacterial infection.
Moreover,  participants  admired  the  role  of  antibiotics  in  daily  practice  and  the  way
antibiotics have revolutionised current medical practice. Participants used different words
to describe their admiring perceptions of antibiotics, for example, ‘life-saver’, ‘vital’,
‘crucial’ and ‘important’. Below are quotes by some participants to illustrate how they
admired and appreciated antibiotics as a group of drugs:
‘They’re obviously effective. It’s revolutionised patient care and health and life
expectancy. People used to die of bacterial infections and they don’t now. They’re
hugely important and they save lives … They’re hugely important, hugely
effective.’ (GP6: 40, female, 12 years)
‘Wow. My perceptions are that when used appropriately they are wonderful
because we have an unwell situation, a condition that can be treated to what …
in essence is a cure. We don’t have many cures in medicine so treatment of
infection is fantastic.’ (GP7: 37, female, 6 years)
This participant described antibiotics as being the discovery of the millennium owing to
their value in curing and saving millions of patients’ lives. He could not imagine the world
without them as they are the only group of drugs that can be used in any branch of
medicine:
‘I think they're lifesavers. Without antibiotic, millions and millions of people are
dying. I cannot myself imagine the life pre-antibiotics, lots of people are dying for
very, very small little infection … I cannot really believe that any medication in
the whole world has affected human life as much as antibiotics. I think that if
somebody asked what would be the discovery of millennium, I would say antibiotic
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and don’t forget antibiotic is the only medication that is used by any branch of
medicine.’ (GP17: 67, male, 14 years)
Another  participant  described  with  an  example  from  their  own  practice  how  an
appropriate course of antibiotics had saved an elderly patient’s life after the patient was
ill:
‘I think that antibiotics when used appropriately can have a very marked effect
especially on the elderly patient so I can think of numerous examples where I’ve
seen a patient. He’s been really off legs, really struggling and a few days later
with a course of trimethoprim is significantly better’ (GP4: 33, female, less than
a year)
5.1.3.1.2 Patients’ and the Public’s Perceptions
In dimension 2 (patients’ and the public’s perceptions), a group of participants (N = 4)
focused on patients’ perceptions, using utterances such as ‘people’, ‘patient’ and ‘public’.
Their perceptions were discussed from a dimension relating to patients’ and the public’s
expectations, demands, misconceptions and beliefs about antibiotics. The following are
quotes by participants that demonstrate the patients’ and the public’s perspectives on
antibiotics.
This participant considered patients’ expectations of antibiotics as well as their lack of
understanding about the microbial activity of antibiotics as major problems encountered
by GPs, since people do not understand the negative impact of improper use of antibiotics,
which is that it can result in AMR:
‘Patient expecting antibiotics ... Unfortunately, that’s one of our biggest problems
with antibiotics, is that people don’t understand that they only work against
bacterial infections and if you have a viral infection… they’re not going to work
and actually they’re dangerous, because they can mean the bugs start to mutate
and our antibiotics that we have don’t work anymore. I don’t know if people
understand that in general really, I would say not in my population anyway.’
(GP6: 40, female, 12 years)
This  participant  described  how  patients  come  to  see  her  with  the  aim  of  getting  an
antibiotics prescription and explained her own interpretation of this behaviour by the
public and patients:
‘I guess another perception is that people want them, so people often come to see
me with the sole aim of obtaining an antibiotic. And I guess the perception is that
the public want… desire antibiotics and think that they're very helpful drugs.’
(GP9: 30, female, 2 years)
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The quote  given  here  explains  how GPs’  perceptions  about  antibiotics  can  differ  from
patients’ perceptions, focusing on those who consider antibiotics to be a fix for all medical
problems:
‘I think that there is a perception that other people have, that sometimes they can
fix everything… Often patients seem to think that one antibiotic will solve all kind
of what you think need antibiotic themselves and solve this problem which I have,
whatever their problem they have. The patient's perception of how they work, is
not the same as our perception and our impression of how they work and how they
can be used… I think some people over use, potentially, but probably on the basis
that they are being asked for them.’ (GP10: 33, female, 2 years)
5.1.3.1.3 Concerns
Dimension 3 deals with (concerns), focusing on patient safety, microbial resistance, lack
of antibiotic effectiveness and cautious use of antibiotics. The majority of participants
who addressed this perception (N = 14) used terms such as ‘side effects’, ‘problem’,
‘worry’ and ‘cautious’ to describe their concerns in delivering this insight.
This participant revealed the culture of awareness among GPs with regard to AMR, which
can be a consequence of inappropriate antibiotics use:
‘Absolutely have their uses and need to be used appropriately. I think there's an
increasing awareness among general practitioners that these need to be used
appropriately but not abused because of the emerging resistance, as I was saying.’
(GP12: 35, female, 5.5 years)
This quote, on the other hand, suggests that the lack of development of new antibiotics in
the last 20 to 30 years has contributed to the increase in AMR and created a status of
selective pressure. This caused him deep worry should the world ever reach the stage of
a post-antibiotic era:
‘There not being any antibiotics for 20 to 30 years means we've got increasing
resistance and selective pressures because of mutations of bacteria. So that's a
real big worry of mine that, and also the Chief Medical Officer as well in the UK
and internationally in the World Health Organisation talked about a post-
antibiotic world where antibiotics will cease to be effective for many common
conditions. So, that's a worry for me within my lifetime, that could these commonly
used drugs which generally still work for most bacterial infections, maybe they
might not be effective, and that'd be a quite scary thought, to see patients might
start dying again more commonly having bacterial infections that could
potentially harm patients. That's a quite scary thought.’ (GP14: 34, male, 5
years)
Another prime concern by participants was related to the side effects of antibiotics. One
GP associated these with antibiotics administration and the word ‘horrible’, and said it
had a tendency to limit her prescribing to indicated cases only:
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‘A lot of antibiotics have horrible side effects like nausea, and diarrhoea, and all the
common antibiotic side effects’ (GP15: 33, female, 3.5 years)
Strong concerns about side effects were unveiled by the majority of the interviewed GPs:
‘I guess I perceive that they are quite high in terms of side effect risk, so I really
pretty much expect a patient to have side effects when I give them an antibiotic
and I will tell them that. You know gastrointestinal upset or rashes or just not
feeling very well with them.’ (GP9: 30, female, 2 years)
In the following quotes, participants highlighted problem of some GPs over-prescribing
antibiotics, which can result in reduced or lack of efficacy as well as the spread of
bacterial resistance:
‘All know, they’re over-prescribed and this led to lots of problems with resistance,
reduced efficacy, MRSA and things like that…but as I said, the rise of antibiotic
prescribing has led to problems of resistance and unnecessary prescribing.’
(GP6: 40, female, 12 years)
‘I think probably the use of them is ... we over-prescribe them, definitely; and for
lots of the conditions that we prescribe them for, it's probably not going to add a
huge amount of benefit because there's more and more evidence coming out that
antibiotics will only shorten an illness by a few hours, for example, and therefore
overall, they don't offer that much benefit.’ (GP9: 30, female, 2 years)
5.1.3.1.4 Conservative Prescribing Attitudes
In dimension 4 (conservative prescribing attitudes of GPs), few participants (N = 3)
showed a conservative attitude towards antibiotics prescribing. Participants used
utterances such as ‘reluctant’ and ‘failure of them’. Participants tended to be conservative
when there was no definite indication or because they preferred to encourage the use of
over-the-counter (OTC) or non-pharmacological choices as an alternative before
prescribing an antibiotic. The following quotes by participants help to explain the motives
behind their conservative behaviour:
‘If somebody has a UTI, then if it's symptomatic, it should be treated. Sometimes
self-treatment works ... treatment with over-the-counter preparations and by
drinking plenty. Often it doesn't work, and particularly if there's been a failure of
self-treatment, then it's very reasonable to use a course of antibiotics.’ (GP2: 58,
male, 29 years)
‘Personally, I wouldn't want to take antibiotic unless I was on death's door … I
think I'm reluctant to give them unless I think they definitely have got something
that needs treating.’ (GP15: 33, female, 3.5 years)
5.1.3.1.5 Guidelines
Participants (N = 3) in dimension 5 (GPs influenced by guidelines) viewed antibiotics
from guideline perspectives, using utterances such as ‘guideline’ and ‘guidance’ to
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express this perception. Participants used guidelines either to explain to patients how
diagnosis and/or management work or to discuss how adhering to guidelines had a
positive impact on the practice.
This participant described how adherence to guidelines reflected on the prescribing
practice in the surgery where she works:
‘I can comment heavily on the practice in how doctors practice in my practice …,
I'm very pleased because we adhere to the local guidance of what microbiology
have said, ‘Okay, this is first-line for this,’ or if there isn't that guidance, whatever
the local or the national guidance is.’ (GP7: 37, female, 6 years)
One participant provided a scenario about their current practice in the case of a patient
with a UTI and how her awareness of the guideline recommendations was incorporated
into the process of diagnosis and management:
‘If I see a young person and they're well, I'm quite happy to send off. It's not cut
and dry whether they've got a UTI or not, and they're really quite well, then I'll
say, ‘Well, we could just send of a urine sample and then see the results.’ If they've
got classic symptoms, NICE guideline say’s if they've got clear cut symptoms, then
just treat them. Don't even send an MSU.’ (GP12: 35, female, 5.5 years)
5.1.3.1.6 Cheap Drugs
In dimension 6 (GPs perceiving antibiotics as cheap drugs) a group of participants (N =
3) perceived antibiotics from an economic standpoint. Participants used utterances such
as ‘cheap’ and ‘cost’ as  well  as  monetary  terms  to  elaborate  on  this  perception.  This
participant’s quote provides an illustration of how antibiotics are perceived as cheap drugs
compared with others:
‘I guess I perceive that they're fairly cheap in terms of the medications that we
prescribe, so I guess from a cost-effective point of view, they are fairly cost-
effective because often the prescription is only a few pounds rather than more
expensive than that.’ (GP9: 30, female, 2 years)
Another two participants estimated the cost of antibiotics to range from pennies to a few
pounds. The two quotes demonstrate how participants undervalue the economic cost of
antibiotics when prescribing them since the cost of acquiring antibiotics is cheap
compared with other drugs:
‘Because they're so cheap, just a penny.’ (GP17: 67, male, 14 years)
‘They're very cheap. It's like a pound here, a pound there.’ (GP14: 34, male, 5
years)
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5.1.3.2 Category of Description 2: Variations in GPs’ Knowledge and Awareness of
UTI Guidelines
This category described how aware GPs were of available recommendations and
guidelines with regard to the treatment of UTIs with antibiotics in elderly patients, in
particular  the  SAPG  good  practice  points.  In  this  category,  participants  gave  different
responses that indicated the presence of variations in the level of awareness about the
status of specific recommendations or guidelines for elderly patients with UTIs.
Perceptions from participants ranged from uncertainty about the availability of such
recommendations and guidelines, to absolute lack of awareness of specific guidelines in
some cases and confident awareness of recommendations and guidelines specifically for
elderly patients in others.
5.1.3.2.1 Uncertainty
In dimension 1 (uncertainty), some participants (N = 6) expressed their uncertainty about
the availability of recommendations and guidelines using phrases such as ‘I’m not sure’,
‘I don’t think’ and ‘I don’t remember’. In fact, participants who expressed uncertainty
seemed shy or surprised when giving their answers. Moreover, they were curious to know
if there are any guidelines.
This participant was surprised by the question about her awareness of any specific
guidelines or recommendations for UTIs in elderly patients and she expressed her
uncertainty by answering the question in a very confusing way:
‘Oh my gosh. Sorry. That is a good question. No. I don’t think I am actually. I
probably should be. I should know it. Now you’ve mentioned it I think there is. In
this envisaging the guidelines we have which is sort of several pages of very small
text. I think there probably is. Yes, I think there are recommendations. I don’t
think I’ve reviewed them recently and probably should do.’ (GP4: 33, female,
less than a year)
Another participant used the word ‘silly’ to describe her feelings of uncertainty about the
availability of such recommendations:
‘Well, I don't know any names of any. I bet you there are some that exist and I feel
very silly now so I don't know of any.’ (GP7: 37, female, 6 years)
Two more participants expressing their uncertainty about the existence of guidelines and
recommendations related to this topic:
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‘No. I don’t remember seeing any specific... There must be really. I can’t think of
any specific guideline.’ (GP13: 45, male, 18 years)
‘Maybe there is, yeah. I’m not aware of that. Maybe there is. Is there?’ (GP8: 36,
male, 2 years)
5.1.3.2.2 Absolute Lack of Knowledge/Awareness
In dimension 2 (absolute lack of knowledge/awareness of guidelines and
recommendations  relating  to  UTIs),  the  majority  of  participants  (N  =  8)  expressed
complete lack of awareness and knowledge of any specific recommendations or
guidelines by using phrases such as ‘We haven’t’ and ‘I’m not’. Within this dimension,
some participants highlighted the availability of recommendations and guidelines for
UTIs in adults but were not aware that they distinguish between adults and the elderly.
Furthermore, participants tried to justify their position without giving reasons for their
lack of awareness. Again, as in the previous dimension, participants with this perception
were curious to know whether there are any recommendations or guidelines for this
subject.
This quote illustrates the participant’s opinion that it was unnecessary to justify being
aware of asymptomatic UTI recommendations relating to the elderly but not other UTI
guidelines. The participant expressed their curiosity about whether any such guidelines
or recommendations exist for elderly patients with UTIs:
‘I have to confess that no I'm not on any specific ones, no. I am aware of
discussions about symptomatic and asymptomatic UTIs and that you shouldn't be
treating asymptomatic UTIs, but your question is about symptomatic UTIs. In
which case I confess I don't. You can tell me about them afterwards’ (GP3: 35,
female, 5.5 years)
The following quote demonstrates the same ignorance of any specific guidelines or
recommendations and the same conviction that justification of the lack of awareness is
unnecessary, as well as wondering if any new guidelines on the topic are available:
‘Interesting. I cannot… we haven’t any specific ones, because our local hospital
hasn’t actually issued us any specific guidelines. But you're whetting my appetite,
and I'm sort of thinking maybe NICE has come up with some recommendations or
DoH has.’ (GP11: 50, male, 22 years)
These two participants, with more than 20 years’ practice experience each in addition to
their academic background, shared the same lack of awareness of any recommendations
or guidelines:
‘For older people, no…Not specific for older, no.’ (GP1: 46, female, 24 years)
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‘Not specifically for elderly, no.’ (GP2: 58, male, 29 years)
5.1.3.2.3 Affirmative Awareness
Contrary to the previous subcategory, dimension 3 (affirmative awareness) saw a group
of participants (N = 3) answering this question with confidence and revealing an
affirmative awareness of specific guidelines for elderly patients with UTIs. These
participants used ‘there is’ to support their view. The following quotes from three
participants with between four and 14 years of practice experience describe their
confident awareness of specific guidelines for elderly patients with UTIs:
‘There's a NICE guidance on UTIs in general. It mentions elderlies as a part of
that…The NICE guidance on urinary tract infections.’ (GP12: 35, female, 5.5
years)
‘Yes…It’s community guidelines from the local pharmacists and they do it in
collaboration with NICE. Last reviewed in April 2013…It’s not changed. The last
time I looked at it is maybe once or twice a year to see if there’s any differences.’
(GP16: 42, male, 4 years)
‘Yes, there are. There’s NICE guidelines just UTI in elderly people and the
treatment of UTI. They are NICE guideline; you choose the most important one’
(GP17: 67, male, 14 years)
5.1.3.3 Category of Description 3: Variations in GPs’ Decision to Treat
This category focused on important variations in GPs’ often challenging decision to treat
elderly patients with UTIs. Data analysis revealed three distinctive and varied perceptions
with numerous factors that may influence the participants’ decision to treat elderly
patients with UTIs, including the patient’s socio-medical status, diagnostic tests and
safety and compliance.
5.1.3.3.1 Patients’ Socio-medical Status
In dimension 1 (patients’ socio-medical status), all participants (N = 17) perceived
patients’ living status or presence of a person to take care of them, current symptoms and
clinical presentation, previous UTI episodes, UTI recurrence and co-morbidities as main
factors on which to base the decision to treat elderly patients with UTIs. Utterances such
as ‘co-morbidities’, ‘history’, ‘examination’, ‘living’ and ‘alone’ were used to highlight
this view.
The following four quotes illustrate how important it is for GPs to consider elderly
patients’ living status when deciding to treat them:
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‘I would also be looking at, if they lived alone at home, all of those things would
have an impact on my decision to prescribe or not.’ (GP1: 46, female, 24 years)
‘Are they unwell, what are the social circumstances?’ (GP6: 40, female, 12
years)
‘Are they alone or they’ve got people caring for them who will be able to call
someone quicker?... Are they housebound?.’ (GP12: 35, female, 5.5 years)
‘Whether the patient living alone, can somebody give the medication on time…
It's a social situation with the patient.’ (GP17: 67, male, 14 years)
These participants discussed patient medical history and examination as an influential
factor in their decision to treat:
‘The history, examination, whether the patient has got a fever, got significant
abdominal pain and severity of the symptoms, have they had a fall, confusion,
delirium, so all of those things would mean that I would treat the patient.’ (GP8:
36, male, 2 years)
‘Basically history and story that they've told me and examination. Although we
might not expect to find much on clinical examination if it's UTI. Making sure that
it isn't something else.’ (GP10: 33, female, 2 years)
These participants perceived the decision to treat elderly patients with UTIs from a
symptoms-focused perspective:
‘I guess whether they present with urinary symptoms, or you want to check
whether they've got dysuria, frequency, urgency, poor flow, seen blood, then
whether they've actually got pain suprapubic pain. Whether they've got any sense
of renal involvement, they've got groin pain, checked their observations, blood
pressure, pulse, temperature, examine them. All those I guess will inform the
decision.’ (GP3: 35, female, 5.5 years)
‘Mostly their symptoms. if someone’s got very specific urinary symptoms, you
know burning, go more often, then I'd be much more likely to prescribe rather
than if they were just a bit non-specifically unwell and had a bit of a fall or
something.’ (GP15: 33, female, 3.5 years)
5.1.3.3.2 Diagnostic Tests
Several participants in dimension 2 (diagnostic tests) (N = 9) viewed the decision to treat
elderly  patients  with  UTIs  from  a  diagnostic  perspective.  Words  such  as ‘diagnosis’,
‘MSU’, ‘urine analysis’ and ‘dipstick’ were used extensively during the interviews.
Participants based the decision to treat on diagnostic tests, by requesting a urine sample
for MSU or a urine dipstick test, as is shown in the following two quotes:
‘It might be reasonable to do an MSU ... the urine test .... and then only treat on
the basis of that MSU.’ (GP2: 58, male, 29 years)
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‘Obviously then you do a urine analysis and dipstick it. If there's nitrites,
definitely, but a lot of the time it's not nitrites. A lot of the time you just see
leukocytes or some blood, but I think if there's blood and leukocytes then I
normally do still treat and then I send of the MSU as well… I think I always send
an MSU off’ (GP3: 35, female, 5.5 years)
A third participant stressed heavily that they requested a urine sample from the patient
where possible, upon which to base the decision to treat:
‘I would want a sample. I'd want a dip, a sample. And it would be based on that,
that I would decide what to do… Where possible, I would always want a sample.’
(GP10: 33, female, 2 years)
This  participant  explained  how  their  decision  to  treat  elderly  patients  with  UTIs  was
mainly based on the result of urine dipstick tests that he often requested:
‘If the urine dips are showing nitrates and they’re not catheterised, I’m likely to
start them on the antibiotics. If it’s showing leukocytes… essentially, I do the urine
dip. I do that on most of my patients.’ (GP16: 42, male, 4 years)
5.1.3.3.3 Patients’ Drug Safety and Compliance Concerns
Dimension 3 (patients’ drug safety and compliance concerns) focused on participants’
perceptions relating to drug safety and compliance in elderly patients (N = 4). Utterances
such as ‘take’, ‘interaction’ and ‘compliance’ describe  this  view,  as  illustrated  by  the
following quotes:
‘Are they likely to take the medicine? Are they able to take the medicine? Cause
of course with elderly patients often you have to consider doing it to get district
nurses in to supervise the medication and then the dosing of that… Particularly
for instance I now prescribe nitrofurantoin often in a BD basis rather than QDS
basis because of that particularly because actually if the district nurse would
come in twice a day and monitor that person taking that medicine, then that can
be much more easily. Of course four times a day for district nurses is pretty much
impossible.’ (GP4: 33, female, less than a year)
‘Look at their allergies, look at what other medications they're on, look at
interactions, then you make a decision about which antibiotic to give them.’
(GP14: 34, male, 5 years)
‘Does she going to get the antibiotic on time, is she able to be compliant with the
antibiotic’ (GP17: 67, male, 14 years)
5.1.3.4 Category of Description 4: Variations in GPs’ Prescribing Practice
This category mapped the variations in participants’ perceptions following the decision
to prescribe antibiotics for elderly patients with UTIs. Interview analysis identified six
qualitative characteristic dimensions. Elderly patients should not be distinguished from
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adult patients, treating the elderly differently, elderly patients’ socio-medical status,
safety and compliance concerns, local guidelines and recommendations and diagnostic
tests.
5.1.3.4.1 Elderly Patients Should not be Distinguished from Adult Patients
In dimension 1 (elderly patients should not be distinguished from adult patients), a group
of participants (N = 6) centred their discussions on treating elderly patients with UTIs in
a similar way to adult patients. They used phrases such as ‘the same’ and ‘I don’t think’
in describing their practice in this vulnerable group. The following quotes by several
participants illustrate this view:
‘I don’t think there would be huge variation between young and old people.’
(GP8: 36, male, 2 years)
‘I guess whether it's young or old, if it's a suspected UTI, it's automatically
something that is going to get an antibiotic.’ (GP9: 30, female, 2 years)
This participant revealed his perception of treating elderly patients with UTIs using the
same antibiotic and the same dose as for adult patients. Also, he perceived elderly patients
as a subgroup of adults:
‘We'll be using the same antibiotics by and large, which I've already mentioned
the names of, anyway. The dosages of the medication ... you'd probably stick to a
fairly standard dose of those as well…. I don't tend to think of the very elderly as
a separate subgroup of patients for the UTIs … It's more I tend to think of adults
and the elderly as one group and children as the other group.’ (GP11: 50, male,
22 years)
5.1.3.4.2 Treating the Elderly Differently
In dimension 2 (treating the elderly differently), several participants (N = 7) admitted to
treating elderly patients with UTIs in a different way than they would treat adult patients.
These participants tended to prescribe more antibiotics, to initiate antibiotic treatment
earlier if possible or to use antibiotics with altered duration compared with adult durations
owing to multiple factors such as frailty and fear of further complications.  Participants
used phrases such as ‘treat early’, ‘more likely to treat’ and ‘duration’. Several quotes
were used here to support this perception by different participants.
The following quotes describe how they initiate antibiotic therapy in elderly patients as
early as possible because of frailty, risk of falling as well as confusion:
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‘If they're quite frail, in order to prevent to come up falling, come up confused. I
think there's a window of trying to start them on antibiotics and quite early.’
(GP10: 33, female, 2 years)
‘I think because elderly people can become more unwell with UTIs then we would
probably, I think, we would probably treat them … be more likely to treat them
rather than wait and see.’ (GP13: 45, male, 18 years)
Several participants expressed their tendency to prescribe antibiotics for elderly patients
in terms of a low-threshold compared with adults:
‘I’m more likely to give them antibiotics in some ways, because this is someone
who doesn't come in. So there is something a little bit of that, that which you're
taught that people who rarely come in, and they're old, and they come in with
something which might seem minor, you've just got to be a little more mindful and
cautious about what that might mean.’ (GP1: 46, female, 24 years)
‘I think it’s generally with elderly patients you might have a lower threshold for
prescribing just to ensure safety because with elderly patients that’s why you’ve
got to be more mindful of things like Clostridium difficile and that sort of thing.’
(GP4: 33, female, less than a year)
Other participants tended to prescribe differently by prescribing antibiotics with different
durations:
‘You want to give them a short course as possible.’ (GP3: 35, female, 5.5 years)
‘I think you’re probably more likely to prescribe in the elderly and you more
prescribe the longer courses as well, cause the standard course is three days for
UTI. In the elderly, I know some people think you should give them a week’s
course of the antibiotics, so it might affect, there would be a number of
medications you gave as well.’ (GP6: 40, female, 12 years)
‘It tends to be the duration of treatment which is different. I think ... I'm trying to
remember the local guidelines from my head…. Okay. No, I think the only
difference really would be the duration.’ (GP15: 33, female, 3.5 years)
5.1.3.4.3 Elderly Patients’ Socio-medical Status
In dimension 3 (elderly patients’ socio-medical status), participants (N = 4) stated that the
treatment decisions were influenced by patients’ socio-medical status when prescribing
antibiotics for elderly patients with UTIs. The concept was reported in the form of
determinants such as patients’ living status, frailty and patients’ co-morbidities.
These quotes from participants demonstrate the influence of elderly patients’ socio-
medical status as an explanation for the variations in antibiotics prescribing for elderly
patients with UTIs:
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‘What the social situation is. Whether somebody's at home to care for them, look
after them. Making fall back plans, so it's less about prescribing but more about
the surrounding care and the safety netting of the patient.’ (GP3: 35, female, 5.5
years)
‘Taking into account the … again, it's more co-morbidities…it's usually if there's
diabetes or of the illnesses present’ (GP7: 37, female, 6 years)
In this quote, the participant explains comprehensively the differences in her perception
with regard to treatment when she examines an elderly patient versus a young patient:
‘I admit I've been more incline to give an elderly patient an antibiotic, particularly
if they have co-morbidities like lung disease, ischemic heart disease, diabetes,
because I want to give them the best possible chance of getting better. And If there
is even a twenty percent chance this is bacterial, then it's worth giving them an
antibiotic to be safe, I guess … there is also a perception that young people will
always come back if they're not better. Elderly patients may be less likely to
because they're house-bound or they have problems with contacting us because
they have hearing problems or eyesight problems or don't want to bother the
doctor.’ (GP9: 30, female, 2 years)
5.1.3.4.4 Safety and Compliance Concerns
In dimension 4 (safety and compliance concerns), safety was the main concept mapped
from participants’ interviews regarding variations in prescribing for elderly patients (N =
4). This was seen in various elements including interactions, side effects, appropriate
dosing as well as patient compliance.
The following quote illustrates the participant’s perception of safety and compliance in
general and in elderly patients in particular:
‘You have a much higher awareness of the safety and implications of prescribing
things both in terms of drug interactions, allergies, side effects, all those kind of
things. Obviously you're aware of all age groups, but particularly drug
interactions because they're more likely to be taking other medications.’ (GP12:
35, female, 5.5 years)
Another two quotes are centred on safety from the perspective of drug–drug interaction
in elderly patients:
‘I guess I'm just more conscious about interactions with the drugs with the elderly,
particularly with things like anticoagulants.’ (GP3: 35, female, 5.5 years)
‘I’m just a bit more cautious about dosages and drug interactions than I might be
with a younger person.’ (GP15: 33, female, 3.5 years)
The same participant expressed further concerns regarding safety by focusing on
appropriate dosing in elderly patients with renal problems:
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‘I'm just a bit more cautious in terms of any dose changes that might be needed
because of their renal function … I'd probably just check they didn't have any kind
of renal impairment and things…. I just always be bit cautious with the dosing.’
(GP15: 33, female, 3.5 years)
Another participant perceived concerns about safety by considering appropriate antibiotic
doses in elderly patients:
‘I think one is the considerations of just making sure the doses are super correct
because some have to be reduced. Renal function is checked.’ (GP7: 37, female,
6 years)
Compliance was another perception mapped by a few participants when deciding to
prescribe antibiotics for elderly patients, as exemplified by these two quotes:
‘You might want to issue a blister pack. You might want to check about issues
around compliance.’ (GP3: 35, female, 5.5 years)
‘Then again you're thinking more about compliance. Is he taking tablets,
remembering to take them? Does it need to be added to a dosette or is this
something that they're going to be able to take themselves? Those kind of things.’
(GP12: 35, female, 5.5 years)
5.1.3.4.5 Local Guidelines and Recommendations
In dimension 5 (local guidelines and recommendations), a few female participants spoke
of adhering to and implementing recommendations. They used phrases such as ‘local
guidance’ during the interview. The following two quotes were extracted from
interviewees who elaborated on their practice, which centred on adherence to local
recommendations:
‘Local guidance that we do have in terms of, okay, if you got a patient over 65,
you can give this the first-line and it's for seven days and not three if it's a UTI, if
it's a female.’ (GP7: 37, female, 6 years)
‘I'd still go with the local guidelines or if they had a urine result that came back
and the sensitivities didn't match with what they had already been given, I would
still go with whatever drug was recommended but I would… unless it was
absolutely contraindicated.’ (GP15: 33, female, 3.5 years)
5.1.3.4.6 Diagnostic Tests
Dimension 6 (diagnostic tests) included perceptions relevant to the use of diagnostic tests
in the form of MSU, mainly, to confirm UTI infections for the purpose of prescribing (N
= 3). Participants used ‘MSU’ extensively  to  express  these  perceptions.  The  following
quotes are illustrations of how participants perceived the role of diagnostic tests in elderly
patients with UTIs:
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‘If somebody if the symptoms appeared mild ... if somebody was otherwise fit and
well, if there was no clinical features of any complications, so no blood, no fever,
no sign of kidney infection ... I suppose bladder infection ... then it might be
reasonable to do an MSU ... the urine test .... and then only treat on the basis of
that MSU.’ (GP2: 58, male, 29 years)
‘I suppose the only thing with that UTI is that you have the benefit of an MSU that
you can get more of an answer I suppose. You can also look back to see if
somebody has had a problem with recurrent UTIs especially in elderly patient.
You might have the benefits of looking back and seeing lots of positive MSUs in
the past or a history of mixed bacterial growth with improvement in physical
symptoms…. With UTI if you’ve got lots and lots of negative MSUs, you might be
looking for another reason for symptoms rather than just carrying on prescribing
antibiotics that’s I suppose that’s the only thing.’ (GP4: 33, female, less than a
year)
This participant described in detail their own prescribing practice for elderly and adult
patients and when they might request an MSU sample:
‘A younger female with two-day history of dysuria and frequency and slight mild
abdominal pain, I’ll prescribe three days of trimethoprim. I probably wouldn’t
send off the MSU and so on in an uncomplicated UTI. Elderly patients I’ll
probably be more likely to send off an MSU.’ (GP8: 36, male, 2 years)
5.1.3.5 Category of Description 5: Variations in Antibiotics Prescribing Approach
for Elderly Patients with UTIs According to Gender
In this category, participants showed two different perceptions when they were asked
whether they differentiated between males and females when prescribing antibiotic
therapy for UTIs in elderly patients. The first group did not consider that gender was a
factor and confirmed that both genders should be treated the same, whereas the second
group of participants centred their approach on treating male and female elderly patients
differently.
5.1.3.5.1 No Variation in Treatment to be Considered
In dimension 1 (no variation in treatment to be considered), participants (N = 7) expressed
that elderly male patients did not necessarily differ from elderly female patients in terms
of antibiotics treatment approach. Neither the antibiotic choice nor the duration needed to
be changed in elderly male patients with UTIs when compared with elderly female
patients. Utterances such as ‘no difference’ were used to address this view.
This participant indicated no difference in relation to treatment although the process
might be slightly different:
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‘Probably no difference at all. I'm aware that the process is slightly different, and
it's more prostate related in older men and common in older men and women, but
both are vulnerable to septicaemia; both are vulnerable to kidney infection. (GP2:
58, male, 29 years)
The quotes from these two participants demonstrate how their antibiotics prescribing for
elderly males does not differ from their prescribing for elderly females:
‘When I am prescribing for old men versus old women for UTI there would be no
major differences in my prescribing.’ (GP4: 33, female, less than a year)
‘It doesn't really. I don't think there's a huge amount of difference. I'm more likely
to think about prostate problems in old men who get recurrent UTIs. Have they
got some sort of obstruction? Are they emptying their bladder, that sort of thing.
In terms of would I give them antibiotics or not, it's probably similar.’ (GP12: 35,
female, 5.5 years)
5.1.3.5.2 Approach Elderly Male Patients Differently
In dimension 2 (approach elderly male patients differently), just over half of the group (N
= 10) expressed that they used different approaches when dealing with elderly males and
females. Some reported a difference related to antibiotic choice, which may have been
broader in its spectrum; others reported the use of the same antibiotic choice but with an
extended duration of therapy.
This participant described her approach with the word ‘aggressive’ in terms of the use of
broader-spectrum antibiotics with longer duration for elderly male patients as compared
with elderly female patients:
‘I'm a bit more aggressive with the men and I think the local guidelines I really
should have checked them. I don't see it that often in a man, but usually a bit more
aggressive in terms of antibiotics, so I give them a broader spectrum antibiotic I
think for a longer period of time’ (GP3: 35, female, 5.5 years)
Several participants (N = 8) used the same antibiotic choice with a longer duration of
therapy, as can be seen in the following quotes:
‘Well, obviously, it would be the duration, you know, you'd spend longer for men
than women. But yeah, not the choice of the antibiotic per se, but the length of
time.’ (GP1: 46, female, 24 years)
‘Well a man obviously quite different than females. So if a man is symptomatic he
needs longer antibiotics.’ (GP5: 45, male, 9 years)
‘Well, in men, I tend to give a longer course of antibiotics. Say women, a three or
five-day course. In men, we treat it for a bit longer. This is based on what? I knew
you were going to ask about that. I mean, a lot of the implications’ based on UTIs
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in women but there probably isn’t any rationale to it but I would say in men, I’d
probably give a seven-day course of antibiotics.’ (GP13: 45, male, 18 years)
The following two participants approached treatment of elderly male patients with UTIs
differently, focusing on the choice of antibiotic drug:
‘Old men versus old women? So in old men, the guidelines tell us, I think, to use
cipro? Is that right? No. trimethoprim. Oh my God. Prescribing in men is different
to women, in anyway. I think in men ... God, what do we do? trimethoprim, first
line. And then we more likely to use things like ciprofloxacin in elderly men. But
always seven days. Yeah. I think your choice of antibiotic might be slightly
different in a man, but the duration will be the same’. (GP9: 30, female, 2 years)
‘I have worked in some places where they recommend Augmentin first line rather
than trimethoprim or nitrofurantoin for men.’ (GP8: 36, male, 2 years).
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Internal and External Horizons of GPs’ Antibiotics Prescribing
The internal horizon of GPs’ perceptions about antibiotics were discussed through GPs
exposing and interacting with different factors and stakeholders including healthcare
bodies, diagnostic and investigative processes, diseases, drugs, economics, GPs, patients
and society. While knowledge of guidelines and recommendations for elderly patients
with  UTIs  was  mainly  felt  by  participants  to  be  related  to  GPs  guidelines  and  the
healthcare system, the treatment decision was experienced through considerations of
multiple factors related to patients, diagnostics and investigation, GPs, diseases,
guidelines and drugs. A variation in both the practice and the approach of antibiotics
prescribing for elderly patients with UTIs was identified through participants’
considerations including GPs, diseases, patients, gender, guidelines, diagnostics and
investigation, and drugs. Figure 30 summarises the internal aspects of participants for
each category of description.
Participants were aware of their perceptions, knowledge, decision, practice and approach
in relation to what they were experiencing. The analysis revealed the presence of seven
aspects that shaped and impacted participants’ current understanding and practice in
relation to this phenomenon under study, namely, undergraduate education, postgraduate
training, interaction with peers, influence of patients, the healthcare system, GPs’
personal experience, and the availability of guidelines and evidence. Figure 30
summarises the aspects of the external horizon as recognised from the participants’
interviews. Participants described the aspects that shaped their intellectual understanding
and impacted their practice by using different expressions, as shown by the following
quotes:
‘Because of the evidence, because of the evidence in the literature and talking to
other people, talking to colleagues, but you’re talking about the same evidence
though. You’re exchanging facts that come from literature.’
(GP3: 35, female, 5.5 years)
‘Also feedback to the practice about prescribing patterns.’ (GP3: 35, female, 5.5
years)
‘I think because of the nature of our practice and the type of patient that you might
do that prescription for is often the kind of person you don’t see regularly’ (GP4:
33, female, less than a year)
‘I guess with increased experience; I've gained more knowledge of which
antibiotic ... Which are appropriate for specific conditions.’ (GP9: 30, female, 2
years)
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‘In medical school, we were taught a lot about side effects and risks and side effect
profiles.’ (GP9: 30, female, 2 years)
‘I think really just working in a hospital. Seeing more patients. Seeing patients
with infections and the practicalities of how they are managed.’ (GP10: 33,
female, 2 years)
‘I believe in the rule of thirds. I believe a third of the patients will just get the
drugs and start them anyway; a third of the patients will get the drugs and put
them in a cupboard and think about starting them; and I think a third of them
actually won't take them at all.’ (GP13: 45, male, 18 years)
‘I think just the experience of having worked for longer as a GP, just having that
under your belt, I'd say.’ (GP15: 33, female, 3.5 years)
‘I know more about the infection and antibiotics, but that’s my personal view
because this is my subject of study.’ (GP17: 67, male, 14 years)
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Outcome Space
The outcome space presented here describes antibiotic prescribing practice for elderly
patients with UTIs as it is experienced by GPs in GP surgeries. The categories have been
arranged on a four level hierarchical block ranging from simple to more sophisticated
category as illustrated in Figure 31. Knowledge was placed on level one because it is the
least  complex  way  of  viewing  antibiotics  in  elderly  patients  with  UTIs  as  a  result  of
interaction within the healthcare system itself, GPs and guidelines. In level two, the
decision category was placed above knowledge owing to the more complex interaction
with the internal horizon. Level three was shared between the approach and practice
categories because the experience of antibiotics in both was more complex than in the
previous two categories. The perceptions category was placed at the top of the hierarchy
on level four owing to the complexity of the interaction between the category components
and incorporating the wider context of all previously highlighted internal horizons such
as national healthcare system and society.
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5.2 Discussion about Phenomenographic Analysis of the Variations in GPs’
Views on and Perceptions of Prescribing Antibiotics for Elderly Patients with
UTIs
The application of phenomenographic, semi-structured interviews with
phenomenographic analysis was successful in identifying the diversity and complexity of
GPs’ perceptions of and views on antibiotics prescribing for elderly patients with UTIs.
This variation could make antibiotics prescribing deviate in key principals from rational
GP decision-making as a result of GPs themselves, clinical, economic, regulatory and
social factors. This may explain why interventions do not tend to be effective, as shown
by a quantitative systematic review of 46 cases aimed at identifying the factors, attitudes
and knowledge linked to misprescription of antibiotics (Lopez-Vazquez et al. 2012).
Capturing all of the GPs’ shared and conflicting perceptions and views in their natural
context was difficult as these perceptions and views were usually ‘visible’ only within
each elderly patient consultation. The attempt to capture the GPs’ perceptions and views
was further limited by the fact that no individual can ever be certain of what is going on
in someone else’s mind. This section discusses these perceptions and views in relation to
the literature reviewed earlier in Chapter Two.
Categories of Description GPs’ Views and Perceptions
Phenomenographic analysis of the data suggested that GPs’ views on antibiotics for
elderly patients with UTIs fitted into five qualitatively distinct categories: perceptions,
knowledge, decision, practice and approach. The first category of description showed
variations in the way the GPs perceived antibiotics as a group of drugs. The inductive
nature of phenomenographic data analysis identified six dimensions of variation within
this category. The majority of GPs interviewed (N = 15) admired and appreciated
antibiotics as a group of drugs. Within this dimension, GPs elaborated extensively on the
therapeutic values of antibiotics, considering them one of the greatest innovations of the
last  century  as  well  as  being  capable  of  saving  thousands  of  patients’  lives  if  used
appropriately to treat bacterial infections (Powers 2004). However, having appreciation
for  and  trust  in  antibiotics’  efficacy  and  value  does  not  give  GPs  the  right  to  over-
prescribe them without clear evidence or to prescribe them inappropriately. This was the
view of another group of GPs (N = 3) who pointed out the essential role of antibiotics in
practising medicine and treating infectious diseases, in line with the findings of Duane et
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al. (2016) who acknowledged GPs’ knowledge about AMR and highlighted the value of
antibiotics as part of modern healthcare while stating that they should not be over-
prescibed, to avoid the long-term negative consequences for society (Duane et al. 2016).
This perception was highlighted mainly by GPs whose main intention was to treat patients
for bacterial infections and save their lives. A similar perception was reported in several
qualitative studies such as Bjornsdottir and Hansen (2002) and Bjorkman et al. (2011),
who indicated that GPs valued the efficacy of antibiotics and indicated that they should
be protected for future use through restrictive antibiotics prescribing. Although this might
be inconvenient, it is something GPs and patients need to get used to. Patients must be
instructed about their symptoms and advised to get back to GPs only if the symptoms
worsen as reported by GPs from (Bjorkman et al. 2011) study.
A second dimension stated by some GPs (N = 4) related to the influence of patients and
public perceptions. This dimension was discussed by GPs from different viewpoints,
including patients having expectations, making demands, believing misconceptions about
antibiotics’ microbial activity, seeing antibiotics as a cure for any type of infection and
anticipating an antibiotics prescription by the end of the consultation. Having the
perception that patients demand antibiotics might lead GPs to falsely assume that their
patients  expect  an  antibiotics  prescription  by  the  end  of  the  consultation  as  it  was
indicated by a number of qualitative studies by (Petursson 2005, Kotwani et al. 2010,
Vazquez-Lago et al. 2012, Bjorkman et al. 2013, Teixeira Rodrigues et al. 2013) who all
highlighted GPs’ misinterpretation of presumed patients’ expectations without asking
them about their wishes. GPs might feel that not prescribing antibiotics will damage their
relationship with their patients or dissatisfy their patients. Also, they might prescribe to
avoid conflict or confrontation with patients when patients just need reassurance.
Therefore, GPs should first explore their patients’ expectations about antibiotics in order
to enhance shared decision-making, respect autonomy and to rationalise antibiotics
prescribing, particularly when the patients’ presentation does not warrant prescribing of
antibiotics (Bjornsdottir and Hansen 2002, Petursson 2005). That said, these steps may
not always be warranted owing to factors such as workload and time pressures (Petursson
2005, BMA 2014). Several studies have supported the influence of GPs’ perception of
patients’ demands and expectations on prescribing practice (Bjornsdottir and Hansen
2002, Petursson 2005) or described it as complacency (Lopez-Vazquez et al. 2012,
Vazquez-Lago et al. 2012, Teixeira Rodrigues et al. 2013).
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A third dimension concerned perception, which GPs (N = 14) discussed in worried tones
from different perspectives including patient safety, microbial resistance, loss of
effectiveness and cautious use of antibiotics, mainly as a result of inappropriate
prescribing, which suggests a high level of awareness about the negative consequences
of antibiotics use. GPs felt that they prescribed antibiotics more wisely when they were
aware of the negative consequences of inappropriate prescribing, such as side effects,
future consultations and bacterial resistance. Bjorkman et al. (2013) and Duane et al.
(2016) highlighted the positive influence of having a perception focused on side effects,
AMR and loss of effectiveness. Furthermore, Bjorkman et  al. (2013) considered side
effects to be a factor that can cause GPs to repeat prescribe antibiotics they know are safe.
However, similar concerns were considered to be influential factors in discouraging GPs
from prescribing antibiotics (Petursson 2005, Kotwani et al. 2010, Vazquez-Lago et al.
2012, Bjorkman et al. 2013, Teixeira Rodrigues et al. 2013).
The fourth dimension within this category dealt with conservative prescribing practice,
with a few GPs (N = 3) stating that they preferred to encourage the use of OTC drugs or
non-pharmacological choices as alternatives to antibiotics before deciding to prescribe
one; or that they refused to issue antibiotics prescriptions without clear evidence or
indications, mainly because of their personal experience and awareness of the negative
consequences of antibiotics prescribing. This perception was highlighted by Bjorkman et
al. (2013), who linked this behaviour with GPs’ level of understanding of resistance.
However, GPs with this perception might not be the best GPs to consult for patients
seeking antibiotics, which in turn may influence the GP–patient relationship and create a
sense of patient dissatisfaction, making GPs less popular, as reported in this study and by
Ashworth et al. (2016), who conducted a retrospective cross-sectional study in England
to determine the relationship between antibiotics prescribing in general practice and
reported patient satisfaction. From data from 7,800 practices, the study found that patients
were less satisfied in practices that promoted prudent antibiotics prescribing. Therefore,
a cautious approach to antibiotics prescribing may require a trade-off in terms of patient
satisfaction (Ashworth et al. 2016).
A fifth dimension (N = 3) centred on the influence of guidelines that are generally meant
to help GPs in terms of things like peer discussions, providing patients with explanations
and making prescribing, choice and duration decisions. The GPs in this study described
the positive side of using guidelines that may enhance the level of practice, as did a
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number of GPs in Bjorkman et al. (2013), who found that GPs admired the value of
guidelines when it comes to prescribing. This was a common perception among GPs who
considered resistance a serious threat. Additionally, another group of GPs within the same
study were aware of the value of guidelines and their positive impact on prescribing and
they believed that their practice must be changed towards more guideline-style
prescribing. However, the influence of guidelines on GPs is still doubtful as found by one
systematic review that identified seven studies out of 12 supporting the influence of
guidelines on GPs’ antibiotics prescribing (Teixeira Rodrigues et al. 2013). This
inconclusive result was owing to incorporating two studies from settings other than
general practice.
The last dimension to emerge from this category focused on the economic view of GPs
(N = 3) who approached antibiotics as inexpensive drugs. Having such a perception might
trigger GPs to prescribe antibiotics as a matter of course as seen in Bjorkman et al. (2013),
who found that  cost  can  influence  GPs’  decision  to  prescribe  and  choice  of  antibiotic,
which might consequently increase patient demand for antibiotics in the future.
Moreover, the cost of antibiotics can influence the habit of using a specific antibiotic as
it becomes part of GPs’ perception with time. However, economic values must not be
prioritised over the cost resulting from the negative consequences of over-prescribing
antibiotics, such as resistance (Petursson 2005). The influence of this perception on GPs
in the UK seems to be minimal since GPs in the UK use the local prescribing formulary
issued by the local CCG to assist and control GPs’ prescribing decisions and cost
(Knowles and Bliss 2014).
In the second category, marked variations were recognised in GPs’ views in relation to
their knowledge and awareness of available guidelines for UTIs in elderly patients. Three
unique dimensions emerged from the data analysis. The first concerned uncertainty about
the availability of any recommendations for this particular condition in that particular
population. GPs (N = 6) with this view demonstrated shy or surprised reflexes during the
interviews. The second dimension involved GPs (N = 8) who demonstrated a complete
lack of knowledge about any recommendations. Although those GPs tried to justify and
defend their position, though without really explaining the reasons for their ignorance,
they were curious to know whether any guidelines existed. The final dimension within
this category was affirmative awareness of specific guidelines, expressed by GPs (N = 3)
who referred either to NICE guidelines or to community guidelines prepared in
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collaboration with NICE when they answered the question. Although the GPs in the third
dimension seemed to be confident and comfortable in their answers, there were
discrepancies and variations in providing details about the source and nature of these
recommendations, ranging from their being part of the NICE guidelines to their being
more specific and tailored to elderly patients with UTIs. Although the intention of this
question was not to embarrass the GPs or evaluate their competencies, the responses
reflected widespread variations across the three dimensions with regard to awareness of
guidelines that might affect the quality and equity of antibiotics prescribing in terms of
patient safety, trust in evidence-based guidelines and cost control (Ingemansson et al.
2014).
In the first two dimensions, some GPs in this study did not take responsibility for their
lack of knowledge about the recommendations, preferring instead to blame guidelines
publishers such as healthcare authorities and secondary care organisations for not issuing
tailored recommendations for elderly patients or for not distinguishing clearly which
recommendations apply to all adults and which specifically to elderly patients. This is
probably true to some extent, as addressed by a number of GPs in one meta-synthesis by
Carlsen et al. (2007) aimed at exploring and synthesising qualitative research on GPs’
attitudes to and experiences with guidelines. Based on 12 studies it found that GPs claim
some reasons for not following guidelines more often than others (Carlsen et al. 2007).
This finding supports Cabana et al. (1999) who reviewed 76 studies to identify barriers
that might prevent physicians from adhering to guidelines. This review revealed that lack
of awareness and lack of familiarity were among the factors responsible for non-
adherence behaviour among physicians (Cabana et al. 1999). Additionally, some GPs
have reported lack of awareness about recommendations with regard to UTI treatment
(Kuehlein et al. 2011). Although Bjorkman et al. (2013) reported on perceptions related
to guidelines, the GPs in that study did not agree with the guidelines owing to the
questionable efficacy of short courses of antibiotics for UTI treatment, as also highlighted
by Cabana et al. (1999). The findings from all these studies suggest that strategies to
improve GPs’ familiarity with and awareness of guidelines must be incorporated into any
intervention to promote prudent antibiotics prescribing.
Moreover, the GPs interviewed were interested in knowing whether any specific
recommendations for UTIs existed, which might suggest a problem with guidelines
dissemination and promotion. This was in line with the results from a UK questionnaire-
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based study of 391 GPs who considered dissemination of guidelines as one of the barriers
that can influence their uptake and implementation of guidelines (Watkins et al. 1999).
This finding was also supported by Cabana et al. (1999) who addressed the dissemination
issue as one of the barriers that can prevent physicians from adherence to guidelines.
Moreover, the findings of this category might explain and support the results from the
DUR study with regard to some GPs’ non-adherence to good practice points.
The third category of description successfully captured three distinct variations in GPs’
perceptions associated with the process of making the decision to treat elderly patients
with UTIs, which starts from the moment the GP begins to interact with the patient in the
surgery. The first dimension related to elderly patients’ social and medical status and was
considered by all the GPs (N = 17), which might suggest the importance of this
perception. Aspects discussed included patients’ living status, the presence of a carer, the
current clinical presentation, previous UTI episodes, UTI recurrence and co-morbidities.
GPs focused heavily on patients’ signs and symptoms compared with other aspects within
this dimension. This combination of clinical and non-clinical factors suggests the
complexity of the decision-making process,  which was found to be consistent with the
findings of Duane et al. (2016) in relation to a group of GPs who decided to treat UTI
patients with antibiotics. The GPs in this group considered factors such as symptoms
severity, personal circumstances, GP’s and patient’s previous experiences, and GP’s
general attitude, which can require good background knowledge and systematic
evaluation, especially with elderly patients with atypical disease presentations (Beveridge
et al. 2011). Studies of factors influencing GPs’ antibiotics prescribing for infections
demonstrated the importance of patients’ signs and symptoms, which were described as
a  major  and  direct  determinant  of  the  decision  to  treat  patients  with  antibiotics  as
highlighted by Petursson (2005) and Teixeira Rodrigues et al. (2013). Surprisingly, none
of  the  qualitative  studies  on  GPs’  perceptions  discussed  these  views  in  the  elderly
population and no previously published literature highlights living status as a factor in
GPs’ perceptions, so this can be considered a novel finding.
Diagnostic tests were the subject of the second dimension, discussed by several GPs (N
= 9) as influencing the decision to treat. GPs indicated that they requested MSU most of
the time owing to the fact that elderly patients with infections usually presented with
atypical symptoms (Beveridge et  al. 2011). GPs were less likely to depend on dipstick
testing owing to its weak reliability when diagnosing UTIs, particularly in elderly
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patients, as highlighted by UTI guidelines for adults in the UK (SIGN 2012). This
perception explains how GPs overcome diagnostic uncertainty about clinical
presentations in elderly patients and also suggests good adherence to diagnostic
recommendations. The finding from this study was in agreement with Duane et al. (2016)
who highlighted the use of diagnostic tests by Irish GPs, specifically, dipstick testing to
guide antibiotics prescribing to overcome diagnostic uncertainty. They also described a
group of GPs in Ireland as ‘questioning prescribers’ who believe that there is a grey zone
in the diagnosis of UTIs and are more willing to question the need for an antibiotic
depending on the symptoms presented to them by the patient and the dipstick results.
Moreover, this group of GPs were found to be willing to change this hesitant behaviour
once their antibiotics prescribing linked to AMR. In fact, the literature confirms that the
use of diagnostic tests for UTIs can make antibiotics treatment more effective, reduce
unnecessary antibiotics use and differentiate UTIs from ASB, which usually requires no
treatment, as was supported by a systematic review of 9 cases aimed at determining the
value of diagnostic testing (Schmiemann et al. 2010).
The third dimension related to drug safety and compliance concerns. Some GPs (N = 4)
felt comfortable prescribing certain antibiotics according to their knowledge and practice
experience as reported by Teixeira Rodrigues et al. (2013). GPs should be aware of their
limitations as well as their skills to ensure that they are not prescribing beyond their
knowledge and that patients are safe, as highlighted by the general practice prescribing
guidelines issued by the BMA clinical practitioners committee (BMA 2013). The decision
to treat can be challenging in some circumstances, especially with elderly patients who
usually present with polypharmacy and co-morbidities (Bellmann-Weiler and Weiss
2009). GPs’ perceptions about patient compliance with proposed antibiotic regimens can
play a role in reducing inappropriate use of antibiotics. However, this might be seen as
non-adherence to guidelines by some. It seems that GPs who have drug safety perceptions
have greater knowledge of antibiotics prescribing issues about side effect and therefore
have an attitude of explaining antibiotic side effects to their patients. However, the
findings in this study about antibiotics prescribing issues and the quality of prescribing
were  contrary  to  the  finding  from  Bjorkman et al. (2013) who linked the side effects
perception with GPs’ fear. This study was consistent with Bjornsdottir and Hansen (2002)
and Kotwani et al. (2010) with regard to patient compliance as a determinant for
antibiotics prescribing whereas in Vazquez-Lago et al. (2012) patient compliance was
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linked with AMR. Additionally, side effects were highlighted only by Bjornsdottir and
Hansen (2002) as a factor that can influence antibiotics prescribing.
The fourth category of description highlighted variations in GPs’ antibiotics prescribing
as an essential part of UTI management. Mapping this view resulted in identifying six
different dimensions. In the first dimension, several GPs (N = 6) perceived antibiotics
prescribing in elderly patients in a similar way to adults. They did not make any
distinction between older patients with possible co-morbidities, polypharmacy and
limited reserve capacity and younger or middle-aged patients when prescribing
antibiotics, whether they focused on decision, choice, dose or duration. The finding from
this category was inconsistent with the findings from one qualitative grounded theory
interview study of 40 GPs from the UK, aimed at exploring GPs’ reasons for prescribing
antibiotics for general infections, and found that being elderly is one of the reasons for
prescribing antibiotics in a different way from other age groups (Wood et al. 2007). This
dimension emerged from GPs with long years of clinical practice experience who stated
that they practise mainly based on their clinical experience, although no experience can
be a substitute for evidence-based guidelines as reported in a qualitative focus group study
aimed at identifying the barriers to the implementation of UTI guidelines as perceived by
13 GPs from the Netherlands and exploring interventions to overcome them (Lugtenberg
et al. 2010).
On the contrary, the second dimension clearly distinguished between elderly patients and
the  rest  of  the  population.  GPs  with  this  view  (N  =  7)  described  a  low-threshold  of
prescribing, that is, more antibiotics prescribing, initiating antibiotics treatment as early
as possible, and using antibiotics with altered durations compared with adult patients.
However, this practice might be seen as non-adherence to guidelines if there were no
specific recommendations concerning elderly patients or no clear distinguishing between
elderly and other age groups. Moreover, GPs within this dimension expressed their worry
and the need to be mindful, careful and cautious whenever prescribing antibiotics for
elderly patients owing to multiple factors such as frailty and fear of developing further
complications. This perception might favour prescribing antibiotics for elderly patients,
although the GPs stated that this should not be without clear evidence of infection. GPs
showing concern is a good sign as it makes them consider whether the benefits outweigh
the risks before making the decision to treat. This finding was consistent with Wood et
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al. (2007) who tended to consider being elderly as a reason to start antibiotics very early
to prevent deterioration of patient condition.
The  third  dimension  related  to  elderly  patients’  social  and  medical  status.  In  this
dimension,  GPs  (N  =  4)  intended  to  provide  elderly  patients  with  UTIs  with  a  better
quality of care by considering their surrounding social lives, future accessibility to GP re-
consultation and co-morbidities. This finding was in line with the findings from Teixeira
Rodrigues et al. (2013) who considered the presence of a direct relationship between
patients’ social factors and GPs’ antibiotics prescribing for the general population.
Safety and compliance concerns were the fourth dimension, seen in the form of cautious
and careful prescribing practice with emphasis on drug interactions, side effects,
appropriate dosing and patient compliance. GPs (N = 4) with this view reported awareness
and understanding of elderly patients’ special considerations as part of their practice. It
seems that GPs who have drug safety and compliance perceptions have greater knowledge
of antibiotics prescribing issues and therefore have an attitude of explaining antibiotic
side effects to their patients.
The fifth dimension, centred on adhering to and implementing local guidelines, was
reported by a few GPs (N = 3) who took a firm position on adhering to guidelines, whether
local, national, diagnostic or treatment, to avoid any mistakes in prescribing for this
vulnerable population. No previous work has been done to determine the perception of
GPs with regards to antibiotics local recommendations. However, the finding from this
study was in line with Teixeira Rodrigues et al. (2013), who considered implementing
policies and guidelines as a factor that might contribute to GPs’ antibiotics prescribing
for the general population.
The last dimension involved the use of diagnostic tests, mainly in the form of MSU to
confirm UTIs, to justify antibiotics prescribing. A few GPs (N = 3) who reported this
perception admired the value of diagnostic tests in elderly patients especially if the patient
examination showed atypical presentation for UTIs, which is the main case with elderly
patients (Beveridge et al. 2011). GPs expressed feeling comfortable whenever they based
their antibiotics prescribing on MSU results as this practice is associated with prudent
antibiotics prescribing and provides GPs with confidence, especially when there is a
chance for diagnostic uncertainty. This was in agreement with the findings from Duane
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et al. (2016), who explored Irish GPs’ use of diagnostic tests, specifically, dipstick testing,
but not MSU to guide antibiotics prescribing especially when there was a grey zone in
the diagnosis of UTI.
Overall, this category showed different perceptions and views that either oppose other
views, as is evident in dimensions one and two, or have different perspectives on existing
views. This might explain the widespread variations in antibiotics prescribing that were
quantified and identified in the DUR study. The findings also suggest that some GPs can
have a high level of awareness of the value of diagnostic tests in elderly patients with
UTIs, especially if patients present with atypical symptoms, and of distinguishing UTIs
from ASB. They also suggest that some GPs are aware of aspects of prescribing practice
for elderly patients, especially safety and compliance.
No previous work has been carried out to explore GPs’ perception in terms of antibiotics
prescribing approach for UTIs in the elderly population. Searching the literature resulted
in identifying two qualitative works that contain a little information on antibiotics
prescribing for elderly patients in general. One was excluded as it discussed antibiotics
for elderly institutionalised patients with ASB. The included study was carried out in 1995
and focused on 10 Icelandic GPs using qualitative, in-depth interviews to understand the
use of evidence by GPs in the diagnostic process preceding antibiotics prescribing in the
general population (Bjornsdottir et al. 2010). The only finding relevant to this research
and in agreement with the research findings was that physicians tend to prescribe
antibiotics for elderly patients on the ‘slightest suspicion’ of all infections except for
sinusitis. The GPs in this study also used the term ‘low-threshold’.
The fifth and final category of description in this study deals with variations in antibiotics
prescribing for elderly patients with UTIs based on gender. GPs in this category showed
two different dimensions. The first dimension supports the concept of approaching elderly
male patients in a different way, whereas the second dimension supports treating elderly
male and female patients the same as other adults. GPs (N = 10) within the first dimension
highlighted taking a more aggressive approach to treating male patients, either by
choosing broader-spectrum antibiotics or by prescribing for extended durations without
indicating the reason for such practice, whereas the rest of the GPs explained that males
tend to have prostatitis and get more complicated infections than females. Using broader-
spectrum antibiotics, alternative antibiotic choices or longer therapy durations without
Chapter Five: Findings and Discussion for Qualitative Study
241
clear justification might be a strong indicator of inappropriate antibiotics prescribing and
non-adherence to recommendations when treating this vulnerable group of patients. GPs
(N = 7)  with  the  second view did  not  consider  gender  to  be  a  factor  in  the  process  of
prescribing antibiotics for elderly patients with UTIs. Although those GPs acknowledged
the presence of certain differences between genders with regard to process and aetiology,
they did not consider these to be determinants for treating differently. As in the previous
category, no previous qualitative work has been carried out to explore variations in GPs’
antibiotics approach for different sexes. From a quantitative perspective, studies on
adherence to antibiotics guidelines demonstrated this variation in GPs’ prescribing
according to patient sex. For instance, Haasum et al. (2013) found that 1,457 (32.1%)
elderly females received pivmecillinam whereas 1,584 (68.2%) males from the same age
group received quinolones. Another study by Leistevuo et al. (1997) revealed variations
in prescribing between male and female elderly patients as 36% (N = 50) of elderly male
patients received first-generation cephalosporins whereas 37% (N = 94) of elderly female
patients received TMP-SMX or trimethoprim. In both studies, the link to guidelines,
diagnoses and culture and sensitivity results needs to be explored before stating whether
this variation is because of gender differences or other factors such as UTI type and
susceptibility of infecting pathogen.
Although there were several variations noticed during this study, several dimensions were
found to be similar across the different categories, including patients’ socio-medical
status, antibiotics concerns, diagnostic tests, patients’ safety and compliance, and the no
variation dimension between elderly and adult patients or between elderly male and
elderly female patients. While these dimensions seem to be similar at first glance,
however, the perspectives of participants likely differed according to the nature of the
specific question, their experience and perspective. For instance, diagnostic tests were
discussed in category three as a tool for guiding diagnosis whereas in category four they
were discussed as a tool for guiding antibiotic therapy. This finding can be helpful in
terms of designing a comprehensive intervention that incorporates all GPs’ perspectives.
Outcome Space and Internal Horizon
From the outcome space perspective (Figure 31), knowledge and awareness of available
guidelines have the least complex relationship with GPs’ antibiotics prescribing for
elderly patients with UTIs. The healthcare system and guidelines were the central focus
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of GPs’ knowledge and awareness. On the second level, the decision to treat was seen to
be more complex than knowledge as it focused on patients, diagnostic testing and
investigation, GPs, diseases, drugs and guidelines. Practice was placed on the third level
of the hierarchically ascending outcome space diagram, alongside approach. In these two
categories, the relationship between approach and practice compared with other
categories was found to have commonalities with the components of both decision and
knowledge. The process of prescribing an antibiotic requires GPs to be knowledgeable
about and familiar with diseases, patients, gender variations, guidelines, diagnostic testing
and investigation, and drugs. Perceptions were located at the top of the hierarchical
structure as they represent the most complicated GP views on antibiotics prescribing for
elderly patients with UTIs. In addition to including the components from the other
categories, perceptions concern how antibiotics prescribing affects society as a whole as
well  as  the  economic  aspects  of  antibiotics.  Only  one  phenomenographic  study  was
identified from the reviewed literature with regard to UTIs. However, this study did not
present, interpret or discuss the outcome space and internal horizon (Bjorkman et al.
2013).
External Horizons
The analysis revealed seven external horizons that helped to shape GPs’ understanding
and practice of antibiotics prescribing. These horizons were undergraduate education,
postgraduate training, personal experience, interaction with peers, interaction and
influence of patients’ expectations, the healthcare system, and availability of guidelines
and evidence.
GPs’ undergraduate education and postgraduate training can be considered part of their
core experience and knowledge of antibiotics prescribing as shown by a Canadian
historical cohort study of 852 primary care physicians to assess whether physician
knowledge, time in practice, place of training and practice volume explain the differences
in antibiotics prescribing among physicians and linking inappropriate antibiotics
prescribing with physicians who received their training and education abroad, which
might be related to cultural expectations (Cadieux et al. 2007). University education was
also identified as one of the factors that can influence GPs antibiotics prescribing as
reported by (Teixeira Rodrigues et al. 2013). During undergraduate study, GPs usually
come across antibiotics and elderly patients for the first time, through pharmacology and
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pharmacotherapy courses that provide them with basic knowledge of these drugs and this
population. However, it was found that little curricular time was devoted to elderly
patients’ pharmacology and that educational programmes have not been thoroughly
evaluated, as reported by one systematic review aimed at exploring the quantity and
nature of geriatric pharmacology education in undergraduate (12 hours) and postgraduate
curricula for GPs (11 hours) including the UK (Keijsers et al. 2012). In their postgraduate
training, GPs are exposed to a variety of antibiotics for treating different infectious
diseases, and involved in the process of medical decision-making, including prescribing
and managing real cases under the supervision of specialised consultants (Kuehlein et al.
2011). During the interviews, some GPs did mention the influence of postgraduate
training on their antibiotics prescribing practice and perceptions, although, as time went
on, they became more confident in addition to being influenced by their practice
environment. Kuehlein et al. (2011) described the influence of postgraduate hospital
training as a key factor in the development of GPs’ prescribing behaviour supported this
horizon from the research. GPs’ postgraduate education and training also play a vital role
as these two factors were linked with the quality of prescribing in different studies (Akici
et al. 2004, Kamarudin et  al. 2013)  as  a  result  of  their  abilities  to  maximise  GPs’
knowledge, keep GPs updated, reduce prescribing errors and impact the quality of care
delivered to patients. Targeting clinicians early, at the point of education and training, can
have a great impact on their antibiotics prescribing behaviour, as suggested by one
qualitative study of 80 GPs from nine European countries about antibiotics prescribing
decisions for LRTIs (Brookes-Howell et al. 2012).
Another horizon identified by the analysis was GPs’ personal experience, which evolves
through GPs’ continual prescribing and exposure to different cases. In practice, GPs
prescribe  antibiotics  from a  range  they  are  familiar  with.  This  habitual  experience  and
skill is usually gained over years of practice as a GP, sharpening the knowledge they
gained during undergraduate education and postgraduate training. In this study, the GPs
had different years of practising experience, during which they came into contact with
countless elderly patients with UTIs whom they managed with different antibiotics. GPs
reported experience as being one of the factors that shape their antibiotics prescribing in
two qualitative studies of UTIs (Kuehlein et al. 2011, Duane et al. 2016), both of which
reported that previous experience can reinforce the norms and expectations of their
practice particularity for antibiotics therapy, which also supports the findings from this
study.
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Interaction with peers was found to be another external horizon that affects GPs’
antibiotics prescribing. Whether the interaction is formal or informal, GPs share,
communicate and discuss many things such as knowledge, experience and advice. GPs
might consult their peers, who might be working with them within the same surgery, or
in  the  local  hospital,  microbiology  laboratory  or  academia,  to  seek  advice  about  a
diagnosis or an antibiotic for a specific patient’s condition. This interaction might result
in the iterative development of prescribing habits, which in turn might develop into a
perception. This factor was highlighted by GPs in one qualitative research (Kuehlein et
al. 2011) in relation to antibiotics prescribing for UTIs. The findings from that research
named  peers  and  interaction  with  peers  as  one  of  the  strongest  inÀuences  on  GPs’
treatment decisions perception.
Patients were also seen as major determinants of GPs’ antibiotics perception
development. Patients may interact and influence GPs’ perceptions in different ways such
as through their expectations and by exerting pressure. For instance, patients might visit
their GP expecting an antibiotic, or GPs might assume that is the case when the patients
are only looking for reassurance (Duane et al. 2016). In some cases, patients might start
demanding antibiotics without a clear indication or push GPs towards particular
antibiotics even if they are inappropriate for their condition. Consequently, GPs might
prescribe antibiotics unnecessarily or inappropriately in both situations. This practice has
been described in much qualitative literature using different terms including complacency
(Vazquez-Lago et  al. 2012, Teixeira Rodrigues et al. 2013). In line with this research
finding, both Bjorkman et al. 2013 and Duane et al. (2016) identified the same perception
with  GPs  who  were  aware  of  both  patients  expecting  antibiotics  and  patients  seeking
reassurance. Additionally, GPs from Duane et al. (2016) study stated that it is much more
dif¿cult not to prescribe for patients visiting private clinics because they are paying for
what they are getting.
The healthcare system was identified as a major contributor to GPs’ views and
perceptions. GPs referred to topics relevant to the healthcare system to describe its
influence over antibiotics perceptions, including resource constraints, scheme incentives,
guidelines and policies, and patient access to antibiotics through out-of-hours services.
The healthcare system context can shape GPs’ perceptions through their immediate
environment – the GP surgery – on a CCG level or through a national context as discussed
by research focused on the quality of GP prescribing in England under the influence of
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current challenges (Duerden et al. 2011). Limited surgery budgets, low salaries, increased
working hours and very strict policies can all restrict GPs’ decisions and options (Taylor
et al. 2012, BMA 2014). For instance, the influence of time pressure can be seen clearly
in situations where demanding patients insist on getting antibiotics. The standard
consultation length according to policy is 10 minutes while the actual average length spent
with patients ranges from 10 to 15 minutes (Lakhani et al. 2007) and there is usually a
queue of patients waiting. All this can force GPs to prescribe unnecessary antibiotics just
to put an end to consultations with demanding patients. This influence of the healthcare
system on GPs’ external horizon has been reported by several other qualitative studies
(Petursson 2005, Vazquez-Lago et al. 2012, Teixeira Rodrigues et al. 2013) as one of the
non-pharmacological behavioural determinants of GPs’ antibiotics prescribing for
general infections.
Guidelines and evidence were highlighted by the interviewed GPs as another external
horizon responsible for shaping their antibiotics prescribing practice. Although guidelines
and evidence might be considered a cornerstone of medical practice, some GPs do not
always adhere to them either because they depend on their practice experience or because
they believe they are not in the best interests of their patients. This is similar to the
findings from one meta-synthesis that explored GPs’ attitudes to and experiences with
guidelines (Carlsen et al. 2007). However, guidelines could be one of the best ways of
rationalising practice and replacing the idiosyncrasies of individualised decisions, that is,
standardising practice (Watine et al. 2014). There were discrepancies in GPs’ awareness
of recommendations in this study. However, several GPs valued the guidelines when
diagnosing and prescribing antibiotics, especially in cases where uncertainties are present
or when dealing with elderly patients, who are particularly vulnerable. The influence of
guidelines has been discussed inconclusively in many qualitative studies as a result of
including studies from non-primary care settings such as surgical wards and emergency
departments (Teixeira Rodrigues et al. 2013). However, the finding about guidelines and
evidence as an external horizon for GPs’ antibiotics prescribing in this study is in line
with Kuehlein et al. (2011), who noticed an improvement in GPs’ prescribing practice
and acceptance of guidelines after a focus group discussion about guidelines and current
GPs’ prescribing attitudes. Bjorkman et al. (2013) found that GPs who prescribe
antibiotics rationally are those influenced by and compliant with UTI guidelines.
Additionally, Duane et al. (2016) reported that GPs were aware and influenced by UTI
guidelines but rarely cited them as the primary reason for antibiotic treatment decisions.
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Given the fact that this was one of the first studies to capture and map GPs’ perceptions
of antibiotics prescribing for elderly patients with UTIs in the UK, several findings were
considered to be novel, adding to what is already known, while others were comparable
with the previously reviewed literature in Chapter Two. The findings relating to training,
education and interaction with peers were in line with Kuehlein et al. (2011), who
identified peer group interaction, personal experience and previous medical training as
the main drivers behind German GPs’ prescribing behaviour, leading to reflex-like
treatment decisions. Additionally, the influence of guidelines and evidence in shaping
GPs’ prescribing attitudes and rationalising prescribing was in agreement with the
findings from (Kuehlein et al. 2011, Bjorkman et al. 2013, Duane et al. 2016). Looking
at the study by Duane et al. (2016),  GPs in the UK shared perceptions with GPs from
Ireland  in  relation  to  antibiotics  prescribing,  society,  diagnosis  and  treatment  of  UTIs,
which were considered to be easy to diagnose and treat. Social and medical factors were
shown in this study to influence GPs’ decision to prescribe. Although the interpretation
may be different owing to differences in the method of analysis, the perceptions are there.
From a treatment perspective, in both studies GPs reported that treatment usually started
empirically as a result of the delay between sending the sample off for testing and
obtaining the microbiological results to confirm UTI. Moreover,  the influence of GPs’
attitudes, socio-demographic status, knowledge, patient-related factors, CCG and
healthcare system for driving antibiotics prescribing by GPs was clearly documented in
this study, which is consistent with the findings from (Bjornsdottir and Hansen 2002,
Petursson 2005, Kotwani et al. 2010, Vazquez-Lago et al. 2012, Teixeira Rodrigues et
al. 2013).
Side effects, concerns and compliance were discussed in this study in terms of
understanding, elderly patients and the quality of prescribing, whereas Bjorkman et al.
(2013) discussed them from a fear perspective. GPs discussed the influence of guidelines
from a positive standpoint, unlike the GPs from Bjorkman et al. (2013) study who were
both positive and negative. Moreover, GPs in this study showed a lack of familiarity and
awareness with regards to UTI guidelines, which is not the case for the GPs in Bjorkman
et al. (2013), who referred to lack of agreement as a reason for not following UTI
guidelines. Another key difference from other studies is that in this study GPs valued the
use of diagnostic tests in guiding antibiotics prescribing, particularly MSU but not
dipstick resting as highlighted by Duane et al. (2016), which could be owing to
differences in diagnostic guidelines between the two countries. Additionally, uncertainty
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was present in Duane et al. (2016) study in relation to diagnosis and prescribing whereas
in this study uncertainty was seen as a perception related to knowledge and awareness of
UTI guidelines.
Future Research
The findings from this study suggest the presence of variations in GPs’ views and
perceptions, often within the same category. Additionally, variations in knowledge of
guidelines might be responsible for GPs’ non-adherence. Some GPs reported contrasting
views about how elderly patients should be managed compared with adult patients, as
well as how elderly male patients should be treated compared with elderly female
patients. Therefore, it would be interesting to know the factors that may influence GPs’
prescribing decisions for adults and elderly patients with UTIs. Future thematic analysis
should be carried out to identify these factors in the two age groups.
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5.3 Findings from Thematic Analysis of Various Factors Influencing GPs’
Prescribing of Antibiotics for UTIs
The following section presents the findings that emerged from the thematic analysis of
the interviews with regard to factors influencing GPs’ prescribing of antibiotics for UTIs
in elderly patients in comparison with adults. Three main categories, comprise the themes
and sub-themes that emerged from the interviews analysis 31.  The  analysis  resulted  in
identifying a total of 29 factors to influence GPs antibiotics prescribing for UTIs. These
can be found in Table 32. Both themes and sub-themes were consolidated into one of the
three categories based on (Watt et al. 2007) definitions and prescribing models discussed
earlier in Chapter One . During the interview, GPs were asked to highlight and discuss
the different factors that might influence antibiotics prescribing for UTIs and whether
there is/are differences in these factors between adult and elderly. If there were no
differences between adult and elderly, the factor will be described in general however
when GPs indicated presence of a difference in the factors between adult and elderly
patients a comparison was made, supported by GPs’ quotes.
31 The words ‘themes’ and ‘sub-themes’ are used interchangeably with the word ‘factor(s)’ in this thesis.
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Table 32: Themes (factors) that emerged from the thematic analysis categorised into three main categories











 GPs’ personal experience and
familiarity with specific antibiotics





 Responsibility of other HCPs
Others
 Antibiotic resistance threat,
microbial resistance results and
information about local resistance
pattern
 GPs’ antibiotic prescribing concerns
 Diagnosis and clinical decision
making
 GPs’ ethos and ethical values
Extrinsic factors:
Patient’s related factors
 Patient’s age and gender
 Patient’s medical history and clinical
characteristics
 Patient’s social situation and living
conditions
 Patient’s level of understanding and
knowledge








Factors related to practice or CCG
context
 Visits and education by prescribing
advisors,
 Audit, monitoring and feedback of
prescribing
 Influence by secondary care doctor
prescribing practice








Factors related to society, national
or international context
 Time





 Healthcare resources and constraints
 Pharmaceutical companies
 Over-prescribing
 Society experience and expectation
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Factors Influencing GPs’ Antibiotics Prescribing for UTIs
5.3.1.1 Category 1: Micro-Level Factors
In this category, factors related to GP characteristics as well as GP–patient interactions
were discussed. The category can be further divided into two main themes – intrinsic
factors and extrinsic factors – which between them include 15 factors.
5.3.1.1.1 Theme 1: Intrinsic Factors (GP-related Factors)
Numerous factors within this theme were highlighted and discussed by participants as
influencing the way they experience antibiotics prescribing. Collectively, they were found
to be part of a broader three categories that mainly related to GPs’ characteristics as
important factors in influencing antibiotics prescribing. These include GPs’ socio-
demographic profiles, GPs’ attitudes and others. The following section discusses these
factors in detail with the use of appropriate quotes from participants’ interviews.
5.3.1.1.1.1 GPs Socio-demographic
5.3.1.1.1.1.1 Personal Experience and Familiarity with Specific Antibiotics
Looking  at  the  socio-demographic  aspects  of  GPs,  first,  in  terms  of  GPs’  personal
experience and familiarity with specific antibiotics, several participants (N= 6) stated
their personal experience of infectious diseases and familiarity with specific antibiotics
to be one of the strongest factors that might influence and shape their antibiotics
prescribing. Participants who considered this factor used the words ‘personal’,
‘familiarity’, ‘knowledge’, ‘previous’ and ‘experience’ to describe it.
This quote supports participants’ familiarity with antibiotics through experience as one
of the factors that can influence antibiotics prescribing:
‘I think your own familiarity with medications, that there may be that there's a
couple of medications appropriate. You know the dosage. You know the side
effects of one well, so I think you tend to go back to that. Just your own experience
of using it.’ (GP2: 58, male, 29 years)
Another quote describes how the participant’s judgement and habits of prescribing could
be based to an extent on his personal experience with antibiotic relating to a previous
patient:
Chapter Five: Findings and Discussion for Qualitative Study
251
‘My judgments and habits may also be based on some of my personal experience
so what will I’ve seen worked and not worked for certain patients.’ (GP8: 36,
male, 2 years)
Another quote describes experience and knowledge of certain antibiotics as influential
factors on prescribing:
‘Your experience of using antibiotics. Your knowledge of certain antibiotics.’
(GP12: 35, female, 5.5 years)
A fourth participant explains how previous subjective experience with antibiotics can
raise the level of confidence in prescribing until it becomes a habit:
‘It's also your experience in these different medications, whether you're confident
prescribing them, if you felt confident about patients who got better on them in
your subjective experience, and that often will flavour which drug you use. It's
kind of how you've experienced these drugs before. The psychology of it, really.’
(GP14: 34, male, 5 years)
5.3.1.1.1.1.2 Education, Knowledge and Training
GPs’ undergraduate education, postgraduate training as well as Continuing Medical
Education (CME) were said to be a key influencing factor in antibiotic prescribing since
education is likely to be the core of GPs’ experience and knowledge. Participants (N = 6)
who considered this factor used utterances such as ‘knowledge’ and ‘training’ in the
discussion.
In the following quote, the participant explained how her previous medical training and
practice in an infectious diseases unit in a hospital during her internship shaped and
influenced her current antibiotic prescribing owing to her exposure to different cases and
her having to work in line with the standard procedures and protocols within that hospital:
‘I think really just working in a hospital. Seeing more patients. Seeing patients
with infections. And the practicalities of how they are managed. I worked in the
infectious diseases unit, which I think has influenced me quite a lot, because
during that time, my knowledge of using antibiotics was hugely increased
knowledge of the test they do. The lab part. Getting the importance of getting
samples at the beginning of an illness, rather than only if it doesn't work. Because
we were seeing the patients who weren't responding to antibiotics. I think that's
definitely influenced my practice in general practice. (GP10: 33, female, 2 years)
Another participant said that he considers training and education to be core for his
prescribing antibiotic attitude:
‘Well, I guess your own training in medicine and what you’ve learned as a
trainee.’ (GP13: 45, male, 18 years)




This factor was considered a major driver for antibiotics prescribing and was stated by all
the participants (N = 17) using different words to describe it such as ‘demand’, ‘pressure’,
‘expectation’, ‘desire’, ‘previous experience’ and ‘need’.
In this quote, a GP addressed complacency as a factor affecting antibiotics prescribing.
He explained why this attitude is common among GPs, for reasons that include avoiding
to confront angry patients, concern about losing the GP–patient relationship and pleasing
patients, although he was aware that this attitude could result in increased bacterial
resistance:
‘Every GP dreads the angry patient ... the angry patient who comes in demanding
treatment. It's much easier to give it and say, ‘Okay, you want antibiotics? I don't
think they're going to work, but you might as well take them anyway. I can see
how strongly you feel. I want you to leave happy rather than upset, so here's your
antibiotics.’ That, if you like, is the path of least resistance. It's too easy,
sometimes, for a GP to do that; it's too easy for the GP to be a people pleaser….
Of course it will increase resistance; of course it will also increase their likelihood
of coming back again and again and again. Each time they get those symptoms,
they expect each time to have antibiotics… In general practice, the patient ... the
individual ... is more important than the population, and an individual
relationship. And yes, there may be resistance in the community, but that's a more
theoretical concern. What's a more immediate concern is the individual patient in
front of you. My argument would always be it's so important to see the bigger
picture, that you're creating a longer-term crisis of resistance; but when you've
just got one patient in front of you, that patient says, ‘‘That crisis of resistance is
nothing to do with me. I need some treatment now. I'm sick. Can't you see I'm
sick?.’’ (GP2: 58, male, 29 years)
A participant illustrated how patients can be very forceful about getting antibiotic
prescriptions because they expect them:
‘A patient's desire to have an antibiotic. Their expectation of what you are going
to do for them, and if they you know how forceful they are in demanding an
antibiotic will certainly influence prescribing practices, I think… Yeah. Your
perception of how much they're going to kick-off if you don't prescribe.’ (GP9:
30, female, 2 years)
Another participant discussed how patients’ expectations can be a driving factor affecting
antibiotics prescribing:
‘Patient expectation is a big one… if patients have a clear expectation that an
antibiotic is what they’re going to come away with from the consultation then that
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is quite a powerful drive… I think with patients that have prior expectation is one
of the main factors.’ (GP13: 45, male, 18 years)
This quote describes how patients’ expectations can go beyond having an antibiotic; they
sometimes ask for a much stronger one because they have been given it in the past
regardless of its appropriateness:
‘Expectation from patients that you're going to prescribe them antibiotic. When
they don't actually need it because they haven’t got a bacterial infection. But then
also some patients often ask for a strong antibiotic because they've been given
something before, either appropriately or inappropriately.’ (GP15: 33, female,
3.5 years)
A few participants, mainly females, elaborated on complacency as a key factor of
antibiotics prescribing when they discussed elderly patients with UTIs. A young female
participant illustrated how elderly patients can be very demanding when it comes to
receiving antibiotic prescriptions for UTIs:
‘They’ll come and they’ll be demanding antibiotics but that might well be the
appropriate thing for them at that point.’ (GP4: 33, female, less than a year)
Yet a second participant referred to elderly patients’ expectations as a factor in the kind
of complacency that affects the prescribing of antibiotics:
‘I suspect with UTIs and elderly patients, there's just more of an expectation that
they will get antibiotics and that they need them. If they don't have antibiotics, it's
not going to go away on its own.’ (GP12: 35, female, 5.5 years)
One participant referred to both patients’ perceptions and patients’ demands to describe
the complacency factor that influences prescribing antibiotics for elderly patients with
UTIs:
‘Sometimes they keep on asking for antibiotics but that can also be too good to
though, other reasons why they’re thinking about antibiotics why they need
antibiotic. So, patient perception.’ (GP16: 42, male, 4 years)
Additionally,  elderly  patients’  carers,  whether  family  members  or  nursing  home  staff,
were seen as part of this factor. Carers usually expect their patients to receive antibiotics
during consultations for several reasons such as fear of patients’ conditions getting worse,
belief that antibiotics are the drug of choice, and desire to relieve patients’ symptoms and
shorten the duration of the disease. This influence exerted by carers was described by a
few participants as a part of complacency, as can be seen in the following quotes:
‘I think also if the patient is elderly themselves and they're vulnerable, they can't
vocalise their concern, it makes the treatment they receive can very much be
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subject to the will of the individual doctor or the pressure by those around them
whether that's the family or carer.’ (GP3: 35, female, 5.5 years)
‘I think there is again pressure from carers of nursing homes to prescribe and
because they often don’t see the patient and they do it over phone and they ring,
they might say ‘oh well I’ll fax a prescription and you can get it.’ (GP5: 45, male,
9 years)
5.3.1.1.1.2.2 Fear
This was described by two participants (N = 2) as one of the factors that could influence
her prescribing antibiotics. She gave an example about treating an autistic child who was
sick for almost four weeks. The participant linked her antibiotic prescribing for this child
with the mother’s previous experience and her concern about the possible deterioration
of this child’s condition:
‘I had this case today. It was with a child actually so the mom … The child had a
cough for four, three and a half to four weeks now and the child is 10 or 11 and
has autistic spectrum disorder so the communication is not excellent there and so
mom was very worried that he'd end up in hospital with a chest infection. It did
happen in the past about two years ago and she was worried and this is the same
pattern. It started and the cough persisted and then it's getting worse. When I
examined him, I did not find any evidence of lower respiratory tract infection but
ultimately I had this mom to deal with that I had to then instil confidence in her
and also actually make her feel validated that she's got some quite genuine
concerns. I've got a child who doesn’t communicate very well particularly in him.
If he's going to get sick, we'll find out a bit later than in other kids so there I gave
her a prescription with the agreement that actually she would hold off at least
until the weekend and see how he is after a few days.’ (GP7: 37, female, 6 years)
This  factor  was  also  described  by  one  participant  when  she  discussed  the  case  of  an
elderly patient with a UTI. The female participant indicated that she might prescribe more
antibiotics for elderly patients with UTIs owing to their weak immune systems and
prolonged disease length:
‘I guess as a doctor, like I've already talked about, you may worry more than an
elderly patient may recover less easily or be able to fight an infection as easily
and therefore you're more likely to prescribe in an elderly patient.’ (GP9: 30,
female, 2 years)
5.3.1.1.1.2.3 Responsibility of other HCP
In terms of the responsibility of other HCPs, this factor was highlighted by one of the
participants (N = 1). The participant spoke about other HCP who work in walk-in centres
and provide antibiotic prescriptions outside GP surgery hours. This participant expressed
his frustration with this conflict in prescribing, especially when patients become
demanding:
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‘These people then find another way of getting it so they don’t get … It doesn’t
mean to say I'm going to give it. Many times I've not and I'm quite pleased that I
haven’t done that but they will go to say to a walk-in centre or they'll go to any. I
get the discharge summary two days later, they managed to get antibiotics and
that is a real source of frustration.’ (GP7: 37, female, 6 years)
5.3.1.1.1.3 Others
5.3.1.1.1.3.1 Resistance
Resistance was a seen by the majority of participants (N = 13) as one of the strongest
factors that can influence and impact antibiotics prescribing. Participants used words such
as ‘resistance’ and ‘sensitivity’ to address the influence of this factor. Being one of the
widespread problems involving antibiotics, resistance was discussed by the participants
from three different views: understanding resistance as a threat that mandates judicious
prescribing, undertaking microbiological resistance tests, and seeking information about
local resistance patterns.
The following quote emphasise the first view, which focused on GPs’ understanding of
and belief in resistance as a threat that should be considered during antibiotics prescribing:
‘I think there is a physician perspective. It influences your decision; particularly
how much you buy into current theories about antibiotic resistance, and some
GPs are very worried about antibiotic resistance; some GPs think it doesn't apply
to them and are very unworried about antibiotic resistance.’ (GP2: 58, male, 29
years)
This participant discussed the resistance from the second viewpoint, which related to
microbiology resistance results:
‘Essentially my current practice tends to be give the first-line antibiotic. If it’s not
responding, the second-line antibiotic. I tend to get an MSU, a urine sample for
cultures and sensitivities and I give them the second-line. If it’s not responding to
the second-line then I have the answer by five days in terms of what the urine
cultures say.’ (GP16: 42, male, 4 years)
The third view, which related to information about local resistance patterns, was reported
by these two participants in answer to the question about factors influencing their
prescribing practice:
‘I think information is going to affect my prescribing. Antibiotic resistance and
sensitivities…. information like it's going to be what has a high of degree of
sensitivity; in other words, what antibiotics work locally. If something is becoming
so useless to prescribe, then we don't want to be giving something that's not going
to work in the vast majority of patients.’ (GP11: 50, male, 22 years)
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‘What are the pattern of resistance of the antibiotic locally and nationally?’
(GP17: 67, male, 14 years)
5.3.1.1.1.3.2 Concerns
Several participants (N = 10) demonstrated a high level of responsibility towards patients’
drug safety, drug practicability and patient compliance by considering these concerns as
major contributors to the factors influencing their antibiotic prescribing in adult and
elderly. Participants used words such as ‘side effects’, ‘tolerability’, ‘interactions’ and
‘compliance’. The following quotes from different participants’ interviews were used to
support the influence of side effects such as allergy on GPs antibiotics prescribing:
‘If they say, ‘oh, I had an allergy or vomited with that or I had a bad rash,’ that
might influence it. I'm trying to remember what medicines they’re on, if they’re
on things like statins and just advising them. Sometimes I forget which ones to tell
them to stop so I tell them, "Once you're started on the antibiotics, stop your statin
for a week," because actually it's much easier to do that and they understand to
that as well, these sorts of things.’ (GP7: 37, female, 6 years)
‘What’s the side effect profile likely to be? What’s the tolerability of the
medicine?’ (GP4: 33, female, less than a year)
‘Side effects. Thinking about metronidazole. Drugs that can give you side effects’
(GP10: 33, female, 2 years)
The following quotes from different participants’ interviews were used to support the
influence  of  drug-drug  interactions,  practicability  and  compliance  as  a  part  of  GPs
concerns on antibiotics prescribing for elderly patients:
‘I think with elderly patients; I suppose we just are more conscious of prescribing
for elderly patients because of the possibility of it more medication interactions.’
(GP4: 33, female, less than a year)
‘I always thinking about how the practicalities of taking the pills, whether it's BD,
it will be easier than QDS, things like that. Which I might think more about in an
elderly person. I wouldn't be worried about that too much in a younger person,
because I think they can just deal with it. That's one of the main differences.’
(GP10: 33, female, 2 years)
‘Certainly I'm more likely to prescribe something that's BD rather than QDS
because it's just easier taking it.’ (GP12: 35, female, 5.5 years)
‘They're generally more complicated. So they'd probably consult more often, I
think. And that's from a patient safety point of view. You'd be less likely to do an
antibiotic prescription on the phone for an elderly person versus a younger
person.’ (GP14: 34, male, 5 years)
‘Compliance with antibiotics… is she or he going to take the medication on time.
You have to be very careful with the antibiotic, make sure that you have advised
them how much of the antibiotic, how many times a day and how to take it, with
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empty stomach or full stomach with food or something.’ (GP17: 67, male, 14
years)
5.3.1.1.1.3.3 Diagnosis and Clinical Decision-making
A few female participants (N = 3) considered diagnosis and clinical decision-making to
be influencing factors in the practice of antibiotics prescribing. Participants used the
words ‘diagnosis’ and ‘decision’ to elaborate on this. In the quotes below, three
participants addressed diagnosis and clinical decision-making as important factors in
antibiotics prescribing decisions:
‘What clinical decision am I making about the patient?’ (GP4: 33, female, less
than a year)
‘The diagnosis that he or she has reached about which infection it may be whether
antibiotics are absolutely necessary.’ (GP7: 37, female, 6 years)
‘You've made a diagnosis.’ (GP9: 30, female, 2 years)
5.3.1.1.1.3.4 GPs’ Ethos and Ethical Values
GPs’ ethos and ethical values in relation to antibiotics emerged in the interview as one of
the factors that might influence antibiotics prescribing in primary care. Only one
participant (N = 1) addressed these factors when she was asked the question:
‘Well I think, it’s your own motive, your own ethical values, your own motivation
for doing your job…. your own values and ethos about antibiotic prescribing and
the time you have with your patient to explain that’ (GP6: 40, female, 12 years)
5.3.1.1.2 Theme 2: Extrinsic Factors (Patient-related Factors)
Factors within this theme were discussed by the majority of participants as being key
driving factors in their antibiotics prescribing. The following section discusses these
factors in detail with the use of appropriate quotes from participants’ interviews.
5.3.1.1.2.1 Patients’ Age and Gender
Age and gender were stated by a few participants (N = 2) to be elderly patient-related
factors that might influence antibiotic prescribing as seen in the following quotes:
‘Obviously there’s the patient's individual factors…. their age and their gender’
(GP15: 33, female, 3.5 years)
‘The factors, the age of the patient’ (GP17: 67, male, 14 years)
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5.3.1.1.2.2 Patients’ Medical History and Clinical Characteristics
Several  participants  (N  =  8)  considered  this  factor  to  be  a  key  aspect  of  antibiotics
prescribing. This aspect was often described by participants as being based on multiple
factors including previous medical history, clinical presentation such as signs and
symptoms,  co-morbidities,  frailty  and  severity  of  the  infection.  Utterances  such  as
‘symptom’, ‘presentations’ and ‘co-morbidity’ were used frequently by participants to
express this factor.
This quote highlights the factor of patient presentation, which was mentioned many times
during the interview owing to its importance:
‘I suppose really again it’s about how is the patient presenting.’ (GP4: 33,
female, less than a year)
In the following two quotes, co-morbidities were the centre of the discussion by these two
participants as a major factor in antibiotics prescribing using different utterances to refer
to them:
‘Well it’s the clinical pictures the main thing and then secondly is what co-
morbidities you’re dealing with’ (GP5: 45, male, 9 years)
‘Obviously there’s the patient's… other medical problems’ (GP15: 33, female,
3.5 years)
This participant focused on patients’ medical history by considering infection recurrence
and the presence of underlying conditions that could predispose patients to more serious
infection as part of this factor:
‘I suppose… prior medical history, have they had recurrent infections that have
been proven to be bacterial? Have they got underlying illness that might
predispose them to developing a more serious infection and those sorts of things.’
(GP6: 40, female, 12 years)
Another participant used the word ‘symptoms’ many times when discussing the factors
influencing antibiotics prescribing:
‘Based on what are the symptoms they've got’ (GP15: 33, female, 3.5 years)
Two participants considered elderly patients’ characteristics and medical history as a key
aspect of antibiotics prescribing.
This  quote  by  one  male  participant  emphasises  GPs’  level  of  awareness  of  elderly
patients’ co-morbidities and its influence on antibiotics prescribing to avoid further
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aggravating patients’ condition. The participant used diabetes and dementia as examples
to highlight this factor:
‘Some doctors are more aware of the implications of co-morbidity than others,
and particularly poorly-controlled diabetes and it often doesn't take much to tip
an elderly patient with co-morbidity over the edge into much more serious illness,
particularly if you've got a mild dementia. It just takes a simple infection, and the
mild dementia will become acute confusion … most elderly patients, as I said
before, are going to need an antibiotic… and the more you can treat problems
early, the less you end up with them having to see specialists for treatment of their
multi-morbidity.’ (GP2: 58, male, 29 years)
Another quote by a female participant focused on elderly patients’ co-morbidities and
frailty as factors that can encourage her antibiotic prescribing:
‘The fact that they might have renal impairment, be on other medications and
other medical problems I might ... that's a difficult one because like I said before
if it's a younger woman it's often a lot more obvious from their symptoms that
they've got a UTI, but in an elderly patient because they're more frail I might be
more tempted to prescribe. It's difficult, it's really case by, case by case I would
say.’ (GP15: 33, female, 3.5 years)
5.3.1.1.2.3 Patients’ Social Situations and Living Conditions
Patients’ social situations and living conditions were seen by a few participants (N = 2)
as influential factors in that they might encourage or discourage a prescription as well as
the choice of antibiotic. Words such as ‘social’ and ‘living’ were used by participants to
elaborate on these factors.
One participant mentioned social situation and social factors in her answer to the question:
‘Their social situation as well. They need some support. Yeah, I think the physical,
mental and social factors of the patient need to be taken into consideration when
you're prescribing.’ (GP3: 35, female, 5.5 years)
This participant explained his genuine concerns about knowing his patients’ social
situation and living conditions as he linked them to the process of antibiotic
administration:
‘Social situation of the patient, living alone…  For the social side of it, if patient
is living alone, has there somebody to care her, is she aware that she should take
antibiotic this time of this or that. The patient’s point of view, as I said that if they
are capable of taking the antibiotic and are aware of the duration or doses of the
antibiotics, so each factor has to be ... just carefully.’ (GP17: 67, male, 14 years)
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One of the participants who addressed social situation and living conditions in his
previous answer repeated the same factor when he highlighted the factors related to
elderly patients with UTIs, since these patients might need support by other individuals:
‘The elderly patient sometimes depends on the carer, it depends if they’re living
alone, they forget, they have got co-morbidity, there’s a huge difference from them
or somebody has got UTI and works in office and every six hours remembers to
take medication, no problem… again, it's because of the social situation…again
social situation with the patient that I've mentioned several times that may affect
the choice of antibiotics.’ (GP17: 67, male, 14 years)
5.3.1.1.2.4 Patients’ Level of Understanding and Knowledge
Only a few participants (N = 3) addressed patients’ level of understanding and knowledge
as a factor that influences their antibiotics prescribing. Words such as ‘understand’ and
‘informed’ were used by participants to discuss it.
The following two quotes by participants who used the word ‘people’ to refer to patients
explain how lack of knowledge and understanding about antibiotics activity is a driving
factor in antibiotics prescribing:
‘I think a lot of people don't know really that antibiotics only work on bacteria …
People's knowledge as well and understanding.’ (GP10: 33, female, 2 years)
‘Also, what they understand about virus versus bacteria. That would kind of
influence it as well.’ (GP14: 34, male, 5 years)
The following quote explains how informed and educated patients can be less likely to
demand an antibiotic when it is deemed to be unnecessary:
‘I think the uneducated will come in and just go, ‘I need medicine. I need
medicine.’ There's an element of often the uneducated will just come and want
medicine, and medicines, they'll mean antibiotics… I think if you're informed and
educated, no matter where you're from, you'll probably go, ‘Do I really need
treatment? Is there anything I can do that will get me better without taking a
drug?’ I think often the well-informed and the educated will try and avoid taking
unnecessary drugs, whereas the uneducated love to take drugs.’ (GP11: 50, male,
22 years)
A few participants (N = 3) addressed the level of patients’ understanding and knowledge
as a factor that influences their antibiotics prescribing in elderly patients with UTIs. This
quote by one female participant explains how elderly patients being able to understand
the signs and symptoms of UTIs can be very useful with regard to early management:
‘I think the only thing is just again if somebody had a UTI before and they’ve had
lot of UTIs, they’ll know that they’ll come early probably to talk to us about it… I
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think it can be a very useful thing. It can also be a challenge as well.’ (GP4: 33,
female, less than a year)
Another participant explained how a lack of knowledge about UTIs in elderly patients
can influence their awareness of the necessity of antibiotics:
‘Well, I think that's a bit more difficult because then they might have less concept
of when they should be on antibiotics or not. Obviously, if somebody doesn't have
the internet, they can't look up guidance, so they can't look up information on
that.’ (GP14: 34, male, 5 years)
5.3.1.1.2.5 Patients’ Desire for a Quick Fix
One participant (N = 1) focused on patients’ desire for a quick fix as a factor affecting
antibiotics prescribing. GPs might find themselves under pressure from the patient to
prescribe  antibiotics  for  a  quick  fix  to  meet  a  prescheduled  activity,  occasion  or  event
such as travelling or a holiday. This can happen quite often, according to the participant:
‘Are they going on holiday in two days and they want to get better quickly? That’s
often the reason for the patients wanting them as well.’ (GP6: 40, female, 12
years)
5.3.1.1.2.6 Patient’s Autonomy
This factor was highlighted by a few participants (N = 3) only when they discussed the
case of elderly patients with UTIs compared with the general population. Terms such as
‘less willing’ and ‘you are the doctor’ were used by participants to describe this factor.
In this quote, the participant explained how elderly patients are usually less willing to be
involved in the processes of prescribing and decision-making, preferring GPs to make the
decision on their behalf:
‘I think elderly patient generally speaking are, this is very general It is a
generalisation but of course there are exceptions to this rule. I think elderly
patients are generally more and willing to accept your decision as their decision.
Perhaps you find them sometimes less willing to be part of the decision-making
process themselves. They want you to make the decision for them. There’s only a
certain some type of elderly patients.’ (GP4: 33, female, less than a year)
A second participant elaborated on this attitude of elderly patients, suggesting that it
might be because elderly patients grew up in a culture and time when patients’ autonomy
was not discussed extensively:
‘The patients who tend to have very clear expectations and agendas don’t tend to
be the elderly patients not to say, I think elderly patients tend to be … I don’t know
whether it’s just because that’s how, I mean, I think, elderly people have a culture
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with doctors where they’re perhaps more likely to challenge doctors but they
certainly tend to be more directed by what the doctor says rather than what
they’ve come in with, with the expectations they come in with. I think elderly
patients are much more likely to be happy with whatever prescribing decision is
made by the doctor. I think there’s been a cultural shift, I mean I think some of
the elderly patients are 70, 80, 90, will have grown up in a culture where patient
autonomy wasn’t even really discussed. When the doctor would make decisions
on the patient’s behalf without really very much consultation with the patient and
that was the norm probably until about 30 or 40 years ago. They’ve grown up in
that culture. It may also be that older people are generally less bolshie than
younger people. Also, those younger are used to getting a lot more information
and has a lot more access to information which maybe some o people don’t make
so much use of. Younger people will have often looked online and they come to
their own decisions but they will certainly be expecting the doctor to sit up and
listen to what they’ve got to say. Whereas older people will sometimes find it a bit
strange if you ask them what they think, they will sometimes say, ‘Well, you’re the
doctor.’ I think it’s about cultural shift really.’ (GP13: 45, male, 18 years)
5.3.1.2 Category 2: Meso-Level Factors
In this category, themes related to the practice/surgery or CCG context were the key
components discussed. The category comprises four factors, namely, visits and education
by advisors; auditing, monitoring and feedback on prescribing; influence of secondary
care doctors’ practice; and implementation of local policies, guidance and formulary.
5.3.1.2.1 Theme 1: Visits and Education by Prescribing Advisors
A few participants (N = 2) discussed the influence of prescribing advisor visits to discuss
and educate GPs who tend to prescribe loads of antibiotics frequently. The participants
used  the  word ‘advisor’ to describe this factor. This participant explained how over-
prescribing antibiotics can result in a visit by a prescribing advisor to discuss with the
prescribing GP the reason behind the behaviour, which can end up flagging the GP owing
to inappropriate prescribing:
‘We all know it’s not good to over-prescribe, so I think if you are prescribing
loads of antibiotics, your prescribing advisor might come and talk to you about
that or saying why you’re prescribing all these medications and it would be
flagged up and you’d have to look at that.’ (GP6: 40, female, 12 years)
The second participant acknowledged the educational role of the prescribing advisor in
influencing GPs’ prescribing behaviour:
‘To educate us when we are using antibiotic and keeping reminding us what
antibiotics available, what is the benefits of the antibiotics, why should change
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from this medication to that medication, why, what are the pattern of resistance
of the antibiotic locally and nationally?.’ (GP17: 67, male, 14 years)
5.3.1.2.2 Theme 2: Audit, Monitoring and Feedback on Prescribing
Several participants (N = 5) stated that audit and feedback are strong factors that might
influence their antibiotics prescribing. Participants used different utterances to highlight
this factor such as ‘audit’, ‘monitoring’ and ‘feedback’.
This participant explained the use of the electronic prescribing system and its role in the
auditing of antibiotics prescribing, which can raise questions about any detected high
prescribing rate and pattern:
‘I think certainly with, in primary care with the use of ePACT, look at your own
prescribing and patterns and seeing how you compare with another, those can be
useful. I think that it's much more useful to, so I think those, I think when you
audit, that definitely does make you think, oh, yes, I might do more than my
partners.’ (GP1: 46, female, 24 years)
This participant explained the influence of CCG on prescribing through medicine
management teams, which mainly work to control budgets:
‘There's that influence from the CCG, back to the medicine management advisors.
They have a strong influence on our prescribing, but it's largely a budgetary
influence.’ (GP2: 58, male, 29 years)
Another participant acknowledged auditing and feedback as being helpful in identifying
her personal prescribing practice for confirmed UTIs:
‘Peer review… and feedback from outside sources… having personal feedback
about actually how many of those I treated had a confirmed UTI, because you
can't really do that with a respiratory tract infection, but you could do it with
urinary tract infections. That would be helpful feedback for me.’ (GP3: 35,
female, 5.5 years)
One participant considered audit and feedback very helpful especially in comparing
prescribing between local practices, which could raise questions about specific
prescribing behaviours and even suggest reasons for them:
‘We’re often given charts of our prescribing compared to local practices which
are helpful, see if where prescribing more or less than for the same population.
It’s good to look at those things, we look at them question why you’re doing that
and what are the reasons looking into that, doing audit.’ (GP6: 40, female, 12
years)
Another participant explained the influence of pharmacy advisors and their duties, which
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include giving feedback on antibiotics prescribing patterns:
‘Feedback from pharmacy advisers and looking through prescribing patterns.’
(GP13: 45, male, 18 years)
5.3.1.2.3 Theme 3: Influence of Secondary Care Doctors’ Prescribing Practice
Secondary care prescribing appeared as one of the factors that can have an influence over
GPs’ prescribing of antibiotics. A participant who acknowledged this factor used
‘secondary care doctor’ to refer to it. The following participant expressed her annoyance
with secondary care doctors’ prescribing attitudes, which have an influence on GPs’
antibiotics prescribing:
‘Obviously secondary care requesting something to be prescribed which might
not be things you exactly prescribe. Then there's somethings, some tension there
and some challenges between what secondary care doctor wants to prescribe and
what primary care can prescribe and evidence-based surround it… This might be
inappropriate to say, but as it's confidential I feel there's more maverick
behaviour… I feel the problem with secondary care doctors are more willing to
step outside the guidelines or feel that they can because that's their area of special
interest. They might have learned about the newest drug or whatever more than
primary care doctors do normally, because of what they're guided on. Also with
regard to their knowledge, you might not be up to scratch with the latest, the
newest antibiotic for ‘x’ condition compared to the specialist doctor in hospital…
Yeah, I think it happens quite often, yeah. Yeah, often enough to cause a bit of a
headache to have that conversation with the patient or try to contact the doctor in
the hospital and see who he is, because sometimes it's a younger doctor who
doesn't know or sometimes it's a locum doctor who's come from elsewhere. Yeah,
it's reasonable, yeah. Yeah, it does happen. I'm sure there's GPs that do it as well,
but from the GP side of things I feel it often comes from off secondary care… Also
it can set a bad example because frankly, regular doctors are regularly doing and
primary care doctors might start to think that it's okay for them to do it, because
they've read the latest advice. The newest journal, the newest drug or some advert
for medication.’ (GP3: 35, female, 5.5 years)
5.3.1.2.4 Theme 4: Implementation of Local Policies, Guidance and Formulary
Several participants (N = 9) addressed implementation of local policies, guidance and
formulary as a factor that can influence their prescribing. Participants used the words
‘policy’, ‘local guidance’ and ‘formulary’ to explore this factor.
The following quotes describe the influence of local guidance, policy and formulary on
participants’ antibiotics prescribing:
‘I'd say I think the factors that influence it are probably changes in guidelines, or
formulary within an area that you're practicing in… I think that again goes back
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to those kind of wide policy that says you need to prescribe this, or availability of
particular drugs changes, and you can't prescribe certain drugs. I think those
would all influence it, if there was any, yeah, I think those would be the key ones,
I would say.’ (GP1: 46, female, 24 years)
‘Local antibiotic prescribing guidance, which should be available via your CCG
or iPhone, Apple, whatever they have for that, which might be the same as the
national guidance or it might be slightly different in some ways. So you always
have to look at both, really.’ (GP14: 34, male, 5 years)
‘The choice of antibiotic is down to for me anyway local antibiotic prescribing
guidelines which are based on local sensitivities... When it comes to guidelines
and stuff and when it comes to antibiotics I do tend to stick to them in particularly
if they're local guidelines for antibiotics because they're supposed to be based on
local sensitivities.’ (GP15: 33, female, 3.5 years)
5.3.1.3 Category 3: Macro-Level Factors
In this category, themes related to society or to the national healthcare system were the
key components discussed. The category consists of 10 factors, namely, time, guidelines
and evidence, drug availability, incentives, media, cost, healthcare resources and
constraints, pharmaceutical companies, over-prescribing, society influence and
expectations, and lack of differences between adults and the elderly.
5.3.1.3.1 Theme 1: Time
Lack of time during consultations was stated by a few participants (N = 2) as one of the
factors that can influence antibiotics prescribing. The participants used the word ‘time’ to
discuss their viewpoint. The average reported consultation time ranged between 10 and
20 minutes.
The following quotes by two participants discuss how time as an aspect can be an
important factor in making an informed decision about antibiotics:
‘I guess to having enough time to make the informed decisions so technical history
and examination, having urine analysis, to be able to do the dipstick, having he
patient's history in front of you so you can know they frequently have UTIs or if
you don't they can help inform you. You need to have the time for that’ (GP3: 35,
female, 5.5 years)
‘Time you have with your patient to explain that.’ (GP6: 40, female, 12 years)
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5.3.1.3.2 Theme 2: Guidelines and Evidence
Many participants (N = 11) said that guidelines and evidence can have a strong impact on
their antibiotics prescribing. Participants used the words ‘guidelines’ and ‘evidence’ to
discuss these factors.
A quote by a female participant highlighted the impact of frequently updated antibiotics
guidelines on prescribing decisions:
‘I think especially for antibacterial prescribing there’s a lot of guidance available
and that’s which is constantly updated I think and all have a big impact.’ (GP4:
33, female, less than a year)
These  two  participants  mentioned  that  guidelines  are  a  factor  that  can  influence  their
antibiotics prescribing:
‘I think it's going to be guidelines coming from above. It's going to be things like
Department of Health guidelines, NICE guidelines.’ (GP11: 50, male, 22 years)
‘Then what you’ve read in terms of evidence-based guidelines or literature.’
(GP13: 45, male, 18 years)
This participant explained how his antibiotics prescribing is influenced by the evidence
and national guidelines published by the national healthcare organisations:
‘It comes back to your… the overall kind of national guidelines. I'm talking about
obviously you've got national guidance, which tells you what the evidence basis
for ... based on research evidence papers on what antibiotics to use in UTI, but
then also that's national evidence… It's much more about what's the research
evidence, national guideline evidence for decision-making, and also key
stakeholders or local GPs, NICE, Public Health England, that sort of people.’
(GP14: 34, male, 5 years)
5.3.1.3.3 Theme 3: Antibiotics Shortage
Drug shortage was addressed as one of the factors influencing antibiotics prescribing by
several  participants  (N =  7).  Words  such  as ‘availability’ and ‘shortage’ were used to
highlight this factor. The following quotes by participants highlight the availability of
antibiotics as one of the factors that influences their antibiotics prescribing:
‘What's available? What antibiotics … You know something might be in short
supply and suddenly we can't use it. Yeah.’ (GP7: 37, female, 6 years)
‘Availability. Sometimes, not so much of antibiotics, but every now and then you
get things that are not available … There's a supply problem.’ (GP12: 35, female,
5.5 years)
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‘If there’s a natural shortage of the antibiotic, that will also change what I’m
doing as well which happens. Yes, the pharmacists run out of antibiotics running
out of the antibiotic. Then I’ll give whatever else they have in stock… It depends.
It’s just periodic in terms of certain types of medications, it can happen. I think
there was recently a shortage of chloramphenicol. I think there was a point where
something odd happened like that … and there was just a lack in supply. It
happened for a couple of weeks and then it sorts itself out. It’s got to do with the
manufacturing of the pharmaceutical companies rather than my side. I get to
know about it when the patient comes back from the carrier saying they don’t have
this available.’ (GP16: 42, male, 4 years)
5.3.1.3.4 Theme 4: Incentives
Only a few participants (N = 2) focused on incentives as one of the factors that affects
antibiotics prescribing. Participants used the word ‘incentive’ to describe their interest in
this factor. In this quote a participant discusses how a prescribing incentive can have a
role in reducing and influencing antibiotics prescribing in general practice:
‘I guess there's sometimes financial incentives that are more targeted at practice
partners, but obviously trickled down to the salary doctors about reducing
prescribing… incentives to reduce prescribing I think all affect prescribing’
(GP3: 35, female, 5.5 years)
A second participant talked a lot about the incentive scheme during the interview and
explained his own point of view by discussing the positive impact of taking part in this
system:
‘Well, as a GP, you’ve got to consider your budget and also incentive scheme… I
think it helps particularly with antibiotic prescribing because whenever you
prescribe antibiotics, you have to think is it one of the top ten that we are asked
to prescribed from… Maybe these prescribing incentive schemes I think play an
important role... There’s incentives or disincentives for poor prescribing or
incentives for good prescribing and that’s a driver.?’ (GP13: 45, male, 18 years)
5.3.1.3.5 Theme 5: Media
Media was urged by a few participants (N = 5) as being one of the factors that could affect
antibiotics prescribing through influencing patients and the public. Participants used the
words ‘TV’, ‘radio’, ‘Internet’ and ‘newspapers’ as the main channels for this factor.
One participant commented on the role played by the media and how it shaped society’s
perspective with regard to antibiotics demand and resistance patterns:
‘Working up from sort of a patient level so patients experience their own
personal... the things that they read in the newspapers, see on television and those
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thing I think that society’s perspectives are very much shaped these days by the
media as I said before… I think that in terms of antibacterial prescribing, I think
people are more conscious now of patterns of resistance. Some sets of patients
who are very responsible about that and are aware of it and will come and say, ‘I
don’t want to add to that problem.’... I think the media has a lot of role to play in
terms of that.’ (GP4: 33, female, less than a year)
Another participant described the effect of TV and radio on patients’ own views:
‘Also, things that happen… in TV that can also make a big difference as well when
the patients come in. Or things they’ve heard on the radio. All these sort of things
can have big impact.’ (GP16: 42, male, 4 years)
5.3.1.3.6 Theme 6: Cost
Many participants  (N =  8)  stated  cost  to  be  one  of  the  strongest  factors  affecting  their
prescribing practice. Participants tended to use words such as ‘cost’ and ‘cost-
effectiveness’ to describe this factor. Antibiotics costs were viewed from two different
perspectives, namely, acquisition (purchase) cost and cost-effectiveness.
The following quotes by several participants look at antibiotics cost from an acquisition
cost point of view. Within this perspective, two different views were identified based on
participants’ interpretation. On one hand, a group of participants respected the economic
value of antibiotics in general; on the other hand, a second group of participants
underestimated the cost of antibiotics and therefore considered it a minor factor:
‘The cost of the drug’ (GP3: 35, female, 5.5 years)
‘What’s the cost as well… Is it a hugely expensive drug you know to prescribe in
the first place?’ (GP4: 33, female, less than a year)
‘Also, cost comes into it as well… Well I guess… there is always some cost
considerations that have been taking into consideration’ (GP15: 33, female, 3.5
years)
These two participants addressed the perspective of the cost-effectiveness of antibiotics
with contradictory opinions:
‘I guess my decision is based on… what is cost-effective’ (GP8: 36, male, 2 years)
‘For these drugs, I don't think cost-effectiveness really comes into it, unless,
obviously, we've got a new drug and it's really expensive.’ (GP14: 34, male, 5
years)
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5.3.1.3.7 Theme 7: Healthcare Resources and Constraints
Two participants (N= 2) described healthcare resources as influencing factors on
antibiotics prescribing. Words such as ‘health economy’ and ‘constraints’ were
mentioned when describing this factor. The following quotes by two participants discuss
the downside of healthcare resource constraints on patient treatment under the factors
influencing their antibiotics prescribing practice:
‘It's that awareness of the overall health economy ... that all of us in general
practice are trying to reduce A and E attendances, so you want to treat the
problem in primary care and not have the embarrassment of the person failing to
have adequate treatment in primary care and turning up in Casualty.’ (GP2: 58,
male, 29 years)
‘Who's funding things? What budge re-constraints there are?’ (GP7: 37, female,
6 years)
5.3.1.3.8 Theme 8: Pharmaceutical Companies
Pharmaceutical companies can play an important role in influencing the prescribing
process in general. Only one participant acknowledged the influence of this factor during
interviews. However, in the case of antibiotics the influence is minimal, as highlighted
by this participant who mentioned the role of pharmaceutical companies as one of the
influencing factors:
‘We prescribe as influenced sometimes by drug companies but in antibiotics, not
very much.’ (GP13: 45, male, 18 years)
5.3.1.3.9 Theme 9: Over-prescribing
Only a couple of participants (N = 2) elaborated on over-prescribing as one of the factors
that influences their antibiotics prescribing. The word ‘over-prescribing’ was stated by
both of them. The following two quotes illustrate the effect of over-prescribing on GPs’
antibiotics prescribing:
‘Well the main thing that influences me is the concern about over-prescribing.’
(GP5: 45, male, 9 years)
‘We all know it’s not good to over-prescribe, so I think if you are prescribing
loads of antibiotics, your prescribing advisor might come and talk to you about
that or saying why you’re prescribing all these medications and it would be
flagged up and you’d have to look at that.’ (GP6: 40, female, 12 years)
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5.3.1.3.10 Theme 10: Society’s Experience and Expectations
The influence of society and public experience of antibiotics prescribing were mentioned
by a few participants (N = 5) who used utterances such as ‘society’ and ‘people’. The
following three examples of participants support the influence of this factor on GPs’
antibiotics prescribing practice:
‘I think within what people’s previous experience, people’s experience of
prescribing in their immediate family or friends that will normally determine …
Because there’ll be a conversation, someone is ill and they think, ‘Do I need
antibiotics?’ Normally we come to the discussion which happens at home or with
someone they trust or a partner or parent or whoever, there’ll be some
conversation about should I go and get antibiotics? That’s very much based on
people’s own experience. If people are very used to the fact that if you’ve got a
sore throat and you go and get the antibiotic, they will only advice either a friend
or relative to do the same.’ (GP13: 45, male, 18 years)
‘I think society wants to get better and I can understand that and so if there's a
treatment that is out there that potentially will work, they will want to ask for that.
Again, if they're aware of things, if they feel that they're able to ask for such in
treatments, then that will affect their … That potentially could affect the
prescription.’ (GP7: 37, female, 6 years)
‘General societal beliefs about antibiotics’ (GP14: 34, male, 5 years)
However,  only  two  participants  considered  this  factor  when  they  discussed  elderly
patients with UTIs. The following two quotes explain the influence of society’s
expectations and attitudes on antibiotics prescribing in the case of elderly patients with
UTIs:
‘I think there is common knowledge in society that antibiotics will help a urine
infection in somebody who's elderly. It's not just the Internet generation. Elderly
people generally are aware of that.’ (GP2: 58, male, 29 years)
‘I suppose it sometimes is relative that you worry or society worries more about
a younger child or a young woman versus an elderly patient. I think that those
ageist attitudes exist, so they might influence behaviour.’ (GP3: 35, female, 5.5
years)
Two participants (N = 2) considered that all the factors that influence antibiotics
prescribing for elderly patients are the same as those that relate to adult patients and, if
present, they do not differ much, as suggested by these two participants:
‘I don't think there’s much in terms of differences. You go through still the same
process of what the diagnosis is, has there been a change in the policy locally,
what was their previous history been, have they had antibiotics recently. So that
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might influence it, if they've already had one set of antibiotics, then you might be
much more mindful of waiting’ (GP1: 46, female, 24 years)
‘I don’t think so because other than being mindful that elderly patients have a
different sort of physiology perhaps, a different blood test but you use what is in
front of you. It could be the same. I might have a 30-year-old who's got a renal
transplant and it has low renal function or that they have ... I still need to look at
the blood test, the co-morbidities, so no... I think it's the same criteria… On the
whole I think society still wants the same things. They want the treatment that will
make them better and it doesn’t necessarily matter if they're older or younger’
(GP7: 37, female, 6 years)
5.4 Discussion about Thematic Analysis of Factors Influencing GPs’
Prescribing of Antibiotics for UTIs
The application of phenomenographic, semi-structured interviews with thematic analysis
identified numerous factors that might influence GPs’ antibiotics prescribing for UTIs,
which  is  complex  and  involves  GPs,  patients,  local  practices  and  CCGs as  well  as  the
healthcare system. This section discusses these factors in relation to the literature
reviewed earlier in Chapter Two.
Micro-Level Factors
In this analysis, the micro context was found to include several factors related to
individual  GP–patient  interactions.  Within  this  context,  GPs  addressed  a  number  of
factors that were sub-categorised into intrinsic factors, related to GPs, and extrinsic
factors, related to patients.
5.4.1.1 Intrinsic Factors
One of the intrinsic factors found to influence GPs’ antibiotics prescribing was their
personal experience and familiarity with specific antibiotics. This was stated by several
GPs (N= 6) to be one of the strongest factors that might impact antibiotics prescribing.
GPs’ personal experiences might direct their actions spontaneously towards or against
prescribing, as addressed by some of them. GPs who tended to prescribe under the
influence of this factor often prescribed from a range of antibiotics they knew well.
Familiarity with certain antibiotics can make GPs feel comfortable and confident about
the antibiotic they are prescribing. Personal experience and familiarity as factors could
result from the knowledge the GPs developed during their undergraduate study and the
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previous experiences they gained during their postgraduate training and years of practice.
These findings were in line with other qualitative literature reviewed (Kuehlein et  al.
2011, Vazquez-Lago et al. 2012). Being a common factor, this might explain why GPs
tend sometimes to prescribe specific antibiotic(s) or altered durations against
recommendations. This finding can explain why there are variations in antibiotics
prescribing practice among GPs, which was consistent with the findings from the DUR
study in this research with regard to GPs’ non-adherence as well as the variations in GPs’
perceptions and views as found in the phenomenographic analysis.
GPs’ undergraduate education, knowledge and postgraduate training were said to be a
key influencing factor in antibiotics prescribing (N = 6). However, antibiotic
pharmacology was not given enough weight in the undergraduate curriculum, as one of
the academic GPs in this study commented. Furthermore, another GP stated that an
elderly rotation was only elective training for GPs. It was found that little curricular time
was devoted to elderly patients’ pharmacology and that educational programmes have not
been thoroughly evaluated. This was reported by one systematic review aimed at
exploring the quantity and nature of geriatric pharmacology education in undergraduate
(12 hours) and postgraduate curricula for GPs (11 hours) including the UK (Keijsers et
al. 2012). The study finding with regard to the influence of education on prescribing was
similar to that reported by Kuehlein et al. (2011), who described this factor as a key driver
for GPs’ prescribing behaviour and by Teixeira Rodrigues et al. (2013), who reviewed
the influence of this factor in five studies and identified a direct link. Moreover, this factor
was also described as one of the external horizon findings in the phenomenographic
analysis, which could explain why changing GPs’ prescribing behaviour can be
challenging. Although these findings might suggest the need for incorporating more
educational interventions aimed at increasing the level of knowledge about elderly
patients and antibiotics in terms of prescribing, no course would entirely change GPs’
prescribing practice.
Another strong factor that might influence GPs’ attitudes to prescribing antibiotics was
complacency, which was discussed by all of the interviewed GPs (N = 17), suggesting
the dominant influence of this factor on GPs’ antibiotics prescribing practice. This factor
was found to originate from patients, family members, carers and even GPs themselves
as reported by GPs in this study and found by two systematic reviews (Lopez-Vazquez et
al. 2012, Teixeira Rodrigues et al. 2013). Complacency was described by GPs as being a
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very uncomfortable attitude that can make some of them feel they have to prescribe
antibiotics to avoid any kind of confrontation or tension, to maintain the GP–patient
relationship, or to end consultations with demanding patients. Greater patient expectation
can be driven by prior experience of receiving an antibiotic during a consultation or
falsely assumption by GPs that patient expect an antibiotic and to satisfy patients who
expect antibiotics as expressed by GPs in this study. Therefore, improving GP–patient
communication can play a major role in reducing the influence of complacency, as
communication may reduce inappropriate or unnecessary antibiotics prescribing. This is
evident from the findings of qualitative, semi-structured interviews with 20 GPs from the
UK aimed at exploring GPs’ views and experiences about communicating with their
patients, with a focus on the problem of expectations of antibiotics as a possible treatment
(Mustafa et al. 2014). The finding about complacency in this study was found to be in
agreement with the reviewed literature (Bjornsdottir and Hansen 2002, Petursson 2005,
Kotwani et al. 2010, Vazquez-Lago et al. 2012, Bjorkman et al. 2013, Teixeira Rodrigues
et al. 2013) and also with the phenomenographic analysis of GPs’ views in this research.
Although these studies support the influence of complacency on GPs’ prescribing,
conflicting opinions have been reported in other qualitative research that comments on
this factor having little or no influence on GPs prescribing (Paredes et al. 1996,
Bjornsdottir et al. 2010). However, these findings were based on old data, including
Bjornsdottir et al. (2010), who used data from 1995. The recent shift in practice towards
more patient-shared decision-making might have augmented the influence of
complacency on GPs’ prescribing. Additionally, differences in countries’ regulations for
purchasing antibiotics without prescription could explain this conflicting opinion.
Interestingly, GPs discussed this as a disturbing factor in adult patients. However, they
considered it to be a very useful, acceptable and appropriate approach when dealing with
elderly  patients  and  their  carers  or  family  members  since  elderly  patients  often  have
trouble vocalising their problems, hardly visit their GPs and are more susceptible to UTI
complications. This finding was found to be novel since no previous work has studied the
influence of complacency on GPs’ antibiotics prescribing for elderly patients. Further
research is indicated to explore the influence of antibiotic complacency for elderly
patients, elderly carers and family members.
Fear was another factor within the micro context, related to a restrictive prescribing
attitude and possible future complications arising from withholding antibiotics (N = 2).
Fear  was  discussed  as  a  factor  in  adult  patients  by  one  GP,  although when it  came to
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giving an illustration she chose a same-day case involving a mother and child. Another
GP discussed this factor from the perspective of elderly patients. Fear can be seen in this
study in two different scenarios: where the GP has fearful patients, carers or family
members who transfer this feeling to the GP, and where the GP feels that prescribing
antibiotics,  although  not  indicated,  might  be  in  the  best  interests  of  patients,  carers  or
family members. Both scenarios were highlighted and described by Petursson (2005) as
a non-pharmacological reason for antibiotics prescribing by GPs. In both scenarios GPs
are more likely to prescribe antibiotics. In this study fear as a factor was described in adult
patients consistently with the first scenario, while the second scenario was described by
GPs focusing on fear in elderly patients. The findings with regard to both scenarios were
in  line  with  those  of  Petursson  (2005)  in  adult  patients  as  a  result  of  having  a  fearful
patient or family member, conflict and discomfort, and fear about self-reputation and
losing patients, of Vazquez-Lago et al. (2012) in elderly patients as a result of patient
condition and characteristics and of Teixeira Rodrigues et al. (2013) in as a result of fear
of developing more serious complications and fear of losing patients, which has been
shown to be directly related to antibiotics prescribing. All these studies linked fears
directly to antibiotics misuse. In this research, findings from GPs’ perceptions in the
phenomenographic analysis identified some GPs who described their antibiotics
prescribing practice to be associated with low-threshold in elderly patients, which could
be a consequence for their fears about elderly patients’ conditions deteriorating. This
could make fear one of the important factors that should be targeted in GPs’ perceptions
change.
In practice, the responsibility for antibiotics prescribing is assigned to GPs, but
interestingly the role of other HCPs in this process was highlighted by one GP (N = 1)
(non-medical prescribing). Prescribing by other HCPs such as nurses who work in walk-
in centres (WIC) or out-of-hours (OOH) services was considered to be influential as some
patients misuse the introduction of these services to obtain drugs such as antibiotics, as
was reported in one qualitative study by (Carey et al. 2014), who conducted semi-
structured interviews with 40 nurses who stated that some patients use immediate access
services for medicines that should have been obtained through a GP. At present, it is not
possible nationally to estimate antibiotics prescribing rates/volume via OOH. However,
given the volume of activity, it is likely to contribute substantially to overall prescribing
rates, as highlighted by a governmental report that estimated antibiotic courses prescribed
by OOH general practice to be 2.2% of all medical antibiotics (and 1.9% by cost) based
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on antibiotics utilisation data from 2012–2013 (Pinder et al. 2015). This factor was
perceived to create a status of conflict in prescribing as stated by the GP, as it can result
in feeding patients’ demanding attitudes, further increasing demand for antibiotics
prescribing. Furthermore, antibiotics prescribing practices vary among these
professionals  in  terms  of  threshold,  volume  and  antibiotic  choice,  which  can  in  some
circumstances be second-line antibiotics when patients’ conditions have deteriorated
(Pinder et al. 2015). This prescribing practice and variations in prescribing by other
professionals could be owing to worsening of patients’ condition, avoidance of re-
consultation or simply because of the workload. Additionally, WIC professionals tend to
prescribe antibiotics without knowing patients’ characteristics or medical history, which
might affect patients negatively. This finding was found to be similar to those in the
reviewed literature (Kotwani et al. 2010, Vazquez-Lago et al. 2012, Teixeira Rodrigues
et al. 2013), which identified the presence of a direct relationship between the
responsibility of other HCPs and antibiotics prescribing. However, GPs who stated this
factor might want to share the responsibility or the blame of inappropriate antibiotics
prescribing with other HCPs. To understand the impact of these services on antibiotics
prescribing, further research aiming to estimate, audit and explore HCPs’ antibiotics
prescribing in WIC and during OOH services is indicated.
Resistance was seen by the majority of interviewed GPs (N = 13) to be a key factor
affecting GPs’ antibiotics prescribing practice. Being one of the most widespread
problems with antibiotics, resistance was discussed in relation to understanding its
meaning as a threat that requires judicious prescribing, results from microbiology
laboratories and information about local resistance patterns. Overall, GPs who recognised
resistance as a factor understood the risks and responsibilities associated with the impact
of resistance on antibiotics efficacy, antibiotics treatment outcomes and society.
Moreover, GPs who discussed resistance as a threat showed concern about those GPs who
tended to believe that their antibiotics prescribing practice was unlikely to contribute to
the development of resistance. GPs who considered resistance from a microbial
perspective as well as local or national resistance patterns felt very comfortable when
their prescribing was guided by laboratory cultures and sensitivity results, and when they
could use knowledge of resistance patterns to minimise the risks and impact of resistance.
The  findings  about  resistance  were  consistent  with  those  in  much  of  the  reviewed
qualitative research (Bjornsdottir and Hansen 2002, Vazquez-Lago et al. 2012, Bjorkman
et al. 2013, Duane et al. 2016), which found that the vast majority of GPs considered
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resistance an important factor in guiding prescribing in various degrees, in addition to
showing a good level of understanding, awareness and knowledge about the negative
consequences of resistance for those who prescribed rationally. Although the literature
reported the presence of variations in understanding resistance, interventions aiming to
narrow these variations should be promoted among GPs including personal audit and
feedback for those with inappropriate prescribing.
In practice, GPs prescribe antibiotics to treat infections and reduce patients’ recovery time
from UTI symptoms by one to two days, as concluded in different studies (Little et al.
2009, Booth et al. 2013) and a systematic review (Milo et al. 2005). However, this must
be balanced against the negative consequences of antibiotics. As with any drug,
antibiotics are associated with risks relating to side effects, drug–drug interactions and
patient  compliance.  In  this  study,  several  GPs  (N  =  10)  demonstrated  a  high  level  of
responsibility towards patients’ drug safety, the practicability of any antibiotics regimen
and patient compliance. GPs expressed uncomfortable or anxious feelings when they had
limited choices of antibiotics with minimal risk, especially if patients expected or
demanded different antibiotics. Interestingly, concerns as a factor was highlighted more
in adult patients compared with elderly patients. Elderly people tend to have issues with
memory, vocalising problems and using polypharmacy, thus extra caution should be
applied when prescribing antibiotics for elderly patients (Corsonello et al. 2015).
Additionally, education should take place more than once with consideration of proper
methods of increasing patient compliance. This might be linked with GPs’ backgrounds
in elderly pharmacology and pharmacotherapy, in particular in relation to antibiotics.
Findings about concerns were mainly discussed in the literature from a general safety and
side-effects perspective. In this study the findings regarding safety and side effects were
in line with Bjornsdottir and Hansen (2002), Petursson (2005) and Bjorkman et al. (2013)
as a theme but not as a perspective, as GPs in this study discussed these issues from the
point of quality of prescribing and awareness of antibiotics prescribing issues. However,
in Bjornsdottir and Hansen (2002), Petursson (2005) and Bjorkman et al. (2013), GPs
discussed side effects and patient safety in terms of fear of ADR consequences, as one of
the main principles of medicine practice is ‘do not harm’ (Kohn et al. 2000). This factor
was also part of GPs’ perceptions in the phenomenographic analysis, which could make
it one of the strongest influences on prescribing.
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Only a few GPs (N = 3) considered patient diagnosis and clinical decision to be influential
factors on antibiotics prescribing. GPs who highlighted these factors listed the diagnostic
challenges they encountered when diagnosing patients with infection such as limited
availability of rapid diagnostic testing, the time gap between performing the test and
obtaining the results and the lack of laboratory facilities within GP surgeries. In situations
where there is a degree of uncertainty owing to a lack of a reliable test as in the case of
the urine dipstick, delay in receiving laboratory results and having demanding patients or
family members, the GP can develop a low-threshold and over-prescribe antibiotics either
unnecessarily or inappropriately. Rapid and effective diagnostic techniques are required
for diagnosis of infectious diseases to reduce uncertainty and promote more prudent
antibiotics prescribing, as is evident by a cluster RCT aimed at assessing the effect of
rapid and point-of-care testing for LRTIs on GPs’ antibiotics prescribing, which showed
prescribing of antibiotics to 31% of patients in a test group compared with 53% in the no
test group (p = 0.02) (Cals et al. 2009). The finding in this study is consistent with several
studies considering diagnosis from different angles as a factor that can influence GPs’
antibiotics prescribing (Bjornsdottir and Hansen 2002, Petursson 2005, Kotwani et al.
2010, Vazquez-Lago et  al. 2012, Teixeira Rodrigues et  al. 2013), all of which linked
diagnosis and clinical decision with misuse of antibiotics, especially when there is room
for uncertainty or when there is a lack of diagnostic facilities and rapid diagnostic tests
with high reliability. This factor was also described in the phenomenographic analysis
study by GPs as one of the dimensions in different categories that can influence their
prescribing views and perceptions.
One GP (N = 1) highlighted the role of ethos and ethical values in influencing GPs’
antibiotics  prescribing.  The  GP  felt  that  she  had  a  moral  and  ethical  obligation  when
prescribing antibiotics to provide proper patient education and justification to avoid any
negative consequences of unjustified prescribing. The finding was in line with the
findings from a multi-country European qualitative study that investigated the factors
influencing primary care doctors prescribing for LRTIs, which were that ethos is part of
doctors’ characters and can influence their antibiotics prescribing practice (Brookes-
Howell et al. 2012). Furthermore, Brookes et al. (2012) found that clinicians who did not
adopt a receptive ethos behaviour will continue to prescribe antibiotics as they have
always done through routine and everyday experience even if it is inappropriate or against
guidelines. Therefore, interventions are needed to change GPs’ perceptions, to make them
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more receptive so that they can keep an open mind and embrace new developments to
improve antibiotics prescribing and reduce resistance.
5.4.1.2 Extrinsic Factors
Antibiotics prescribing was also found to be influenced by extrinsic factors related to
GPs’ interaction with patients. Patient-related factors can have a huge impact on
antibiotics prescribing, whether they encourage GPs to prescribe, discourage them, or
influence the choice of drug. Patients’ characteristics were addressed by two GPs (N = 2)
who  indicated  that  both  age  and  gender  can  be  seen  as  important  components  that
contribute to this factor. With some infections such as UTIs, age and gender are very
important determinants of infection incidence (Foxman 2010). The finding in this study
about age as a factor was in agreement with the finding of Teixeira Rodrigues et al.
(2013), which indicated that patient’s age can be a major determinant in antibiotics
prescribing. In this research, linking the findings from the thematic and
phenomenographic analyses suggested that patient’s age can be a predictor for low-
threshold prescribing in elderly patients whereas gender can be a predictor for the use of
broad-spectrum antibiotics in male elderly patients.
Another extrinsic factor that dictated several of the GPs’ antibiotics prescribing was
patients’ medical history and clinical characteristics (N = 8). This encompasses a variety
of factors such as previous medical history, clinical presentation, that is, signs and
symptoms, co-morbidities, frailty and severity of infection. GPs who acknowledged this
factor highlighted the importance of considering patients’ clinical situation before issuing
prescriptions as these factors may interfere, modify or influence the decision to treat with
antibiotics in terms of the choice of antibiotic, the dose, the frequency or the formulation
(Leekha et al. 2011). In some situations, this factor might result in prescribing antibiotics
that are not recommended as first-line therapy. For instance, it would be unsafe to
prescribe for a patient with a known antibiotic allergy. Similarly, a previous history of
recent antibiotic administration might mean an alternate antibiotic choice is required. In
this study, only two GPs addressed patients’ characteristics and medical history as factors
that should be highlighted when a patient is elderly. Further, they recognised that factors
such as severe clinical presentations, co-morbidities and frailty make them tend to
prescribe an antibiotic very early for elderly patients (Herring and Williamson 2007).
Overall, the findings in this study with regard to adults were in agreement with the
findings of Teixeira Rodrigues et al. (2013). They showed a direct relationship between
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antibiotics prescribing and signs and symptoms, as described in 12 cases as well as co-
morbidities, which were reported in four cases. However, patients’ signs and symptoms
were suggested to have the higher impact compared with co-morbidities on GPs’
antibiotics prescribing. Findings from this study are also supported by the
phenomenographic analysis, which included patients’ clinical characteristics in different
dimensions.
Two GPs saw patients’ social situations and living conditions as an influential factor in
both adult and elderly patients. they reported that knowing a patient’s living status might
encourage prescribing, discourage prescribing or influence the choice of antibiotic,
particularly for elderly patients. Living alone can influence antibiotic administration
especially  if  the  antibiotic  needs  to  be  administered  four  times  daily  as  in  the  case  of
nitrofurantoin, as one GP stated. This may place a burden on healthcare resources and
family members. Additionally, elderly patients might have issues with memory and
confusion, so a family member or carer might need to provide support to ensure that the
antibiotic is taken at the right time for the right duration. In some situations, this factor
might result in prescribing an antibiotic that is not recommended as first-line therapy. The
finding regarding this social factor was consistent with the finding from the systematic
review by Teixeira Rodrigues et al. (2013), who identified this factor as having a direct
influence on GPs’ antibiotics prescribing. The influence of this factor on GPs’ prescribing
was  also  clear  in  the  phenomenographic  analysis  as  being  one  of  the  dimensions  that
influence GPs’ prescribing views.
Few GPs (N = 3) reported that patients’ education level and lack of knowledge and
understanding of the difference between viral and bacterial infections and the role
antibiotics play in combating infection can influence GPs’ prescribing patterns. The factor
is important, though, because it is a significant determinant of antibiotics misuse and
inappropriate use, as was evident from a cross-sectional study of 375 adult patients
conducted using a pre-tested and structured questionnaire aimed at understanding
patients’ knowledge of antibiotics usage. It found that patients with good knowledge of
the difference between viral and bacterial infections and a higher education level
(university) had a better attitude towards rational antibiotics use than those with a lower
education level (p < 0.001) (Abu Taha et al. 2016). When patients understand how
antibiotics work it can cut down the demand and pressure exerted on GPs to prescribe
antibiotics unnecessarily or inappropriately. Patients with poor knowledge, understanding
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or misconceptions about antibiotics often engage GPs in lengthy conversations, are
confrontational and overwhelm healthcare resources by scheduling unnecessary
appointments just to demand antibiotics, as stated by some GPs. The GPs interviewed
valued elderly patients’ previous experience with UTIs as it enabled them to recognise
the symptoms and understand the consequences of untreated conditions, which in turn
can encourage them to seek medical care early. The GPs understood that getting
information can be more difficult for elderly patients as often they do not have easy access
to the Internet, for instance, as most adults do. This factor was reported in a qualitative
study by Hawkings et al. (2007), who carried out qualitative grounded-theory interviews
with 46 adults to examine their attitudes towards and knowledge of AMR. The impact of
patients’ knowledge and understanding of infection, resistance and antibiotic activity was
reported to be minimal in this study, possibly because the public perceive the problem of
AMR to be beyond their influence. A pilot survey investigated 38 elderly participants’
knowledge of antibiotic use, expectations regarding the prescription of antibiotics and
awareness of AMR and showed that 66% (N = 25) were familiar with AMR and that 90%
(N = 34) felt that it was an important healthcare issue. Further, 56% (N = 21) got their
information from the media and 17% (N = 6) through their primary care physician.
Moreover, 26% (N = 10) believed that antibiotics would help them recover from a
common cold and 50% (N = 19) expected to receive antibiotics if they visited their
primary care physician. These results illustrate the lack of knowledge held by elders
regarding appropriate use of antibiotics owing to lack of primary care physicians’
educational role (Mahmood et al. 2009).
Only one GP considered the desire for a quick fix to be a factor that influences antibiotics
prescribing.  Pressure  to  treat  the  UTI  quickly  was  said  to  come  from  patients,  family
members or carers, often to be clear of infection in time for an exam, a special occasion
or some other event such as a holiday. Thus, GPs who are aware of the quick fix issue
might just issue an antibiotic prescription to end the consultation. This practice by GPs
might not be possible to modify owing to time pressures and long waiting lists. The
finding from this study was in line with the findings from Bjornsdottir and Hansen (2002),
Kotwani et al. (2010) and Teixeira Rodrigues et al. (2013), who acknowledged the direct
impact of patients’ desire for a quick fix on GPs’ antibiotics prescribing. Although this
factor might be seen as a socially important influence for prescribing, GPs must base their
decision on patients’ ability to access healthcare facilities when needed if the GP decides
not to prescribe.
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Patient autonomy was found to be influential in antibiotics prescribing. This factor was
highlighted by just a few GPs (N = 3) who addressed it only when they compared elderly
patients with UTIs with adults. Although GPs have a moral obligation to respect patient
autonomy (Stiggelbout et al. 2004, Littmann and Viens 2015), this was not the case when
GPs were asked about the factors that might influence their prescribing for elderly patients
with UTIs. They considered that elderly patients are usually less willing to be involved
in the decision-making process, preferring GPs to decide for them. They suggested that
this was because of the culture and time in which elderly people grew up, when patient
autonomy was not discussed or explored extensively. This factor possibly drives some
GPs to adopt low-threshold prescribing behaviour for elderly patients because they will
take them seriously when they visit the surgery as a result of being less complaining as a
group of patients, less likely to interfere in the GP’s decision and less likely to demand
an antibiotic. Bjornsdottir and Hansen (2002) linked GPs’ prescribing tendencies with
patients’ complaint levels. This finding was not discussed in any previous qualitative
research, which makes it a novel finding. Further research is indicated to explore the
influence of elderly patients’ autonomy on GPs’ perceptions and decision to prescribe
antibiotics.
Meso-Level Factors
GPs discussed four factors relevant to prescribing practice within surgery and local CCG
contexts, that is, meso-related factors. The first was visits and education by advisors,
which was seen by two GPs (N = 2) only. GPs who identified this factor acknowledged
and valued the role of these advisors in influencing and reducing irrational antibiotics
prescribing by GPs. According to GPs, they achieve this through executing external
pressures, flagging GPs who prescribe irrationally and conducting regular visits and
educational sessions to avoid antibiotics over-prescribing. The findings from this study
support those of Kumar et al. (2003), who conducted grounded-theory interviews with 40
GPs  to  understand  why they  prescribe  antibiotics  for  some cases  of  sore  throat  and  to
explore the factors that influence their prescribing. The results also support Wood et al.
(2007), who interviewed 40 GPs to explore the reasons for their choice of prescribed
antibiotics and both found and categorised the role of prescribing advisors among the
strongest factors that can influence GPs’ antibiotics prescribing behaviour. However, GPs
must not depend heavily on prescribing advisors to guide and change their antibiotic
prescribing behaviour as there is a shortage in the number of antimicrobial pharmacists
Chapter Five: Findings and Discussion for Qualitative Study
282
advisors, as reported by one survey aimed at assessing the implementation of
antimicrobial stewardship interventions in primary and secondary care. That survey, of
82 CCGs, found that only 5% (N = 4) of CCGs had antimicrobial pharmacists specialists
working as advisors. This role was otherwise undertaken by quality or nursing clinical
leads (N = 5; 6%) or by general practice clinical leads (N = 2; 2%) (Ashiru-Oredope et
al. 2016). Therefore, increasing the number of prescribing advisors should be part of any
antimicrobial stewardship interventions owing to their value and impact.
Auditing, monitoring and feedback seemed to be one of the strongest influences on GPs’
antibiotics prescribing, as discussed by several GPs (N = 5). In the current study, the GPs
identified the influence of auditing and feedback through activities by prescribing
advisors and medicine management teams relating to both prescribing practice and cost
control. The findings from this study were found to be consistent with those from a
qualitative grounded-theory interview study by Wood et al. (2007) in the UK. Their study
explored the reasons for 40 GPs’ prescribing choices of antibiotics and found that auditing
was one of the strongest factors that influence GPs’ prescribing and choice, although it
was not universally valued by all GPs interviewed. That said, audit and feedback should
be part of any antimicrobial stewardship intervention owing to their value and impact in
encouraging behaviour change (Eccles et al. 2007). This is supported by a recently
published national RCT in the UK aimed at reducing unnecessary antibiotics
prescriptions by GPs through feedback letter. Antibiotics prescribing was reduced by an
average of 3.3% over a six-month period, saving over £92,000 in prescription costs
(Hallsworth et al. 2016).
Secondary care prescribing behaviour appears to be another factor in this category that
might influence GPs’ antibiotics prescribing (N = 1). In practice, GPs respect hospital
doctors professionally owing to their expert knowledge and experience, as was
highlighted by UK-based qualitative in-depth interviews of 12 GPs, 12 hospital doctors
and four focus groups, each with four GPs and four hospital doctors, aimed at describing
the relationship, identifying strengths and possible problems and considering ways of
improving professional interaction between GPs and hospital doctors (Marshall and
Phillips 1999). However, the prescribing practice of some hospital doctors can have
unexpected impacts and influences on GPs’ prescribing practice, which is not only
annoying to GPs but can have negative consequences in the long term. The GP who
highlighted this factor extensively indicated that there are two pathways of influence. The
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first relates to GPs who prescribe antibiotics but find the outcome poor, ineffective or
associated with side effects or interactions. They then seek advice from local hospital
consultants  who  might  not  adhere  to  local  or  national  recommendations,  preferring  to
prescribe based on their experience. This can lead GPs to adopt the same prescribing
practice. The second pathway concerns patients who are discharged from hospital, attend
an  outpatient  clinic  or  have  been  treated  by  a  consultant  who works  in  a  hospital  and
whose practice is based totally on hospital experience. The consultants prescribe
according to common hospital practice, which leads patients to demand the same
antibiotic next time they visit their GP, regardless of whether it is suitable for their
particular infection in a community setting. This finding supports Kuehlein et al. (2011),
who studied the influence of secondary care doctors on GPs’ antibiotics prescribing and
perceptions. Another GPs’ prescription analysis study in the UK by Taylor and Bond
(1991) identified that 1,092 (17.6%) GPs out of 6,195 mentioned hospital doctors as being
major influences on prescribing habits and perceptions of some drugs including
antibiotics (Taylor and Bond 1991). Thus, hospital doctors should be careful when
advising their colleagues from primary care or treating patients in GP surgeries to avoid
the spread of hospital practice that could indirectly promote inappropriate antibiotics
prescribing.
Implementation of local policies, guidance and formulary was discussed as another factor
that can influence GPs’ (N = 9) prescribing on the meso-level. GPs in this study described
how antibiotics prescribing is strongly influenced by adopting surgery and local practice
policies and guidance, although some of these local policies and guidance might be
restrictive in nature or irrelevant to primary care settings because they were based on data
obtained from local hospitals, which might not always translate well to GP surgeries, as
highlighted  by  some  GPs.  Although  this  was  seen  as  one  of  the  factors  impacting  on
prescribing, the GPs admitted to sometimes finding themselves forced to step outside
these policies and guidance to better serve an individual patient. Moreover, some GPs
were cynical about the possible cost-saving incentives behind such guidance. Overall,
GPs valued the role of local guidance and local policies on their antibiotics prescribing.
This was in line with Kumar et al. (2003), who referred to local policy as one of the
factors that influences all GPs’ prescribing with regard to decision-making, and partly in
line with Teixeira Rodrigues et al. (2013), whose results were inconclusive. However,
this inconclusive finding can be explained by including studies from other non-primary
care settings such as surgical wards and emergency departments.
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Macro-Level Factors
GPs discussed a number of factors that went beyond the previous level to include society
and national healthcare system contexts at the macro-level. This category consisted of 10
factors that the interviewed GPs considered were major determinants of antibiotics
prescribing practice.
Limited consultation time was stated by two GPs (N = 2) as a factor that influences GPs’
antibiotics prescribing. In average, GPs have a 10–15 minute time slot for each patient
(Lakhani et al. 2007). This restrictive time allocation in addition to other pressures such
as long waiting lists might result in GPs issuing prescriptions against their better
judgement. GPs reported a consultation time of 10–20 minutes per patient. Elderly
patients with co-morbidities complaining of infection might need to extend this time. The
GPs who addressed this factor considered the benefits of having more time to be able to
make informed decisions by taking proper histories and carrying out more investigations
as well as having the opportunity to explain more about antibiotics to patients, especially
when the decision has been made not to prescribe despite the patient’s expectations. The
findings corroborate those of previous studies (Bjornsdottir and Hansen 2002, Petursson
2005, Kotwani et al. 2010, Teixeira Rodrigues et al. 2013), all of which addressed the
influence of time pressure, which can lead GPs to exhibit low-threshold tolerance,
especially when it is linked with heavy workloads and a shortage in the GP workforce.
Issuing a prescription becomes the quickest option and a way of coping.
Many of the interviewed GPs (N = 11) stated that national guidelines and evidence can
have a strong impact on antibiotics prescribing practice. GPs are responsible for ensuring
that what is prescribed is supported by evidence and literature. In the phenomenographic
analysis of this research, the GPs showed varied levels of knowledge and awareness
regarding UTI guidelines while in the thematic analysis they described the strong impact
of  guidelines  on  the  decision  to  prescribe  antibiotics,  especially  if  the  guidelines  and
evidence were issued by national bodies and organisations such as NICE, DoH and PHE
and are up to date. However, being aware of and familiar with guidelines and evidence
does not guarantee their uptake, as reported by Cabana et al. (1999), Carlsen et al. (2007)
and Casey (2013), who referred to several factors such as lack of confidence in
developers, disagreement between the theoretical content of guidelines and daily practice,
and organisational constraints. Stepping outside recommendations might not always be
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wrong  as  guidelines  have  been  known  to  be  rigid  and  not  suitable  to  adopt  for  many
patients for reasons such as existence of co-morbidities and poor compliance (Woolf et
al. 1999). Additionally, some GPs might feel that guidelines can interfere with their
prescribing autonomy, therefore they prefer not to conform with them (Woolf et al. 1999).
Since this factor has a strong influence on prescribing practice, as highlighted by the
majority of GPs, healthcare bodies and organisations must synthesise their guidelines and
evidence to be more user friendly, concise, flexible and representative, and to encourage
uptake and assimilation into practice. Tonkin-Crine et al. (2013) qualitative interview
study of 50 participants from five countries including the UK supports this. Moreover,
guidelines and evidence can be useful tools in disseminating key messages to encourage
macro-level changes in antibiotics prescribing attitudes. Much of the literature debates
the influence of guidelines and evidence on antibiotics prescribing in settings other than
primary care. However, the findings in the current study support those of Kotwani et al.
(2010), Vazquez-Lago et al. (2012), Teixeira Rodrigues et al. (2013) and Duane et al.
(2016), who agreed on the direct impact of guidelines on GPs’ antibiotics prescribing.
Interestingly, some GPs from Petursson (2005) study saw guidelines as a threat in
practising medicine and were unwilling to conform with antibiotics guidelines. GPs who
do not comply with antibiotics guidelines might tend to prescribe antibiotics more
frequently, unnecessarily or inappropriately.
Shortage of antibiotics was addressed as a factor influencing antibiotics prescribing
practice by several GPs (N = 7). In this study GPs reported antibiotics shortages lasting
for several weeks for some antibiotics. From a marketing perspective, antibiotics were
reported to be removed from the market six times faster than new ones were being
produced (Reinberg 2015). Occasional antibiotics shortages might be a consequence of
things such as manufacturer mergers, quality issues, supply and procurement problems of
pharmaceutical companies, facility consolidation, narrow pro¿t margins and internal
purchasing issues within the healthcare system, as stated by the GPs. Shortages might
have significant implications in the context of other factors that limit availability of
effective antibiotics, including a shrinking pipeline of new antibiotics and increasing drug
resistance (Simpson et  al. 2009). By itself, a shortage can influence GPs’ antibiotics
prescribing by limiting their choice of drugs and exposing patients to risks, especially in
the case of drug-resistance infection or lack of alternative antibiotics. If GPs continue to
prescribe antibiotics inappropriately under the influence of some of the previously
discussed factors, antibiotics shortages might continue to rise in the coming years, which
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might impact patients’ clinical outcomes. No previous studies have discussed antibiotics
shortages as one of the influencing factors on GPs’ antibiotics prescribing practice.
Further research is indicated to explore the influence of antibiotics shortage on GPs’
inappropriate antibiotics prescribing.
Incentives were seen by a couple of GPs (N = 2) as a factor that might affect antibiotics
prescribing practice. In the current study, the two GPs who referred to this factor in adults
both discussed the economic side of it and one linked incentives to prescribing quality.
Taking part in antibiotics incentive schemes was found to influence GPs’ prescribing
behaviour, in this case relating to the choice of antibiotic, improved antibiotics
prescribing and reduced prescribing cost by keeping it within the annual indicative
prescribing budget (McNulty and Francis 2010). This influence was clear in a cross-
sectional survey in the UK that examined the prescribing incentive schemes used by 121
primary care groups and found that the most frequently used clinical areas for prescribing
indicators were antibiotics in 76% (N = 92) of cases with the majority resulting in desired
changes in antibiotics cost savings and improved prescribing quality perception with, to
a lesser extent, improvement in prescribing short courses and according to guidelines
(Ashworth et al. 2002). Only two previous qualitative studies have highlighted the direct
influence of healthcare system incentive schemes on antibiotics prescribing (Petursson
2005, Wood et al. 2007). The concept of incentive in Petursson’s (2005) study was found
to encourage prescribing behaviour, which in turn can lead to promotion of inappropriate
prescribing and increase AMR. In Wood et al (2007), incentive was described to be a
strong influence on the choice of antibiotic but not on prescribing. Therefore, antibiotic
incentive schemes must be linked with judicious prescribing in complying with
recommendations.
The influence of the media, whether in the form of TV, radio, the Internet or newspapers,
was considered one of the macro-level factors by five GPs interviewed. GPs who
supported this factor considered the media to be a very powerful communication tool that
can shape patients’ and the public’s views by evoking reactions to podcasts, published
stories, news and medical insight, whether negatively through causing downward
prescribing trends or positively. The role and impact of the media on the public and
infection was described in qualitative research to explore the attitudes of the public
towards bacterial resistance (Hawkings et al. 2007). They interviewed 46 members of the
public and found the media to be the main information source on bacterial resistance.
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However,  media  content  might  be  misleading  or  written  in  a  way  to  attract  attention,
which  may  counteract  and  complicate  the  work  of  many  GPs.  The  GPs  in  this  study
revealed that the media might be responsible for influencing patients’ and society’s
demands  for  and  expectations  of  antibiotics,  either  towards  prescribing  or  in  terms  of
reassuring patients about their conditions. Patients who are influenced negatively by the
media can be seen as a challenge for GPs as their expectations and demands might evoke
stress and frustration for GPs during consultations. Perhaps healthcare bodies should
work closely with media sources to ensure that proper content is handled more evenly
and accurately, as highlighted by a report published by (WHO 2012b). In addition, key
messages need to be delivered to the public on behalf of GPs including educational
programmes for different ages aimed at explaining the differences between viral and
bacterial infections, activity of antibiotics in bacterial infections, when to seek medical
attention for antibiotics, threat of resistance and the public role and responsibilities in this
regard, the importance of reducing demand for antibiotics if not indicated and when to
discuss expectations with GPs. Surprisingly, no previous qualitative works have
identified the influence of the media on antibiotics prescribing behaviour by GPs. Further
research is indicated to explore the impact of the media on antibiotics prescribing in the
community.
In the current study, two findings were associated with the financial impact on prescribing
and services provided by healthcare bodies. The majority of GPs acknowledged the
impact  of  antibiotics  cost  (N  =  8)  and  healthcare  resources  and  constraints  (N=  2)  on
prescribing practice. GPs who addressed cost as an influencing factor said that it should
not be a major determinant for prescribing. In this study, antibiotics cost was viewed from
two different perspectives: acquisition cost, that is, purchase cost, and cost-effectiveness.
In the UK, the NHS equates good prescribing with the lowest-cost prescribing that meets
public health needs (Duerden et al. 2011). Moreover, the NHS strongly recommends that
GPs keep their prescribing costs to a minimum as well as prescribing generically where
appropriate (Duerden et al. 2011). Most antibiotics are now off patent, which has made
them cheaper owing to the availability of several generic preparations. However, the
existence of these might encourage some GPs to prescribe antibiotics more frequently.
GPs  who  focused  their  discussion  on  acquisition  cost  fell  into  two  camps:  one  group
respected the economic value of antibiotics in general whereas the second group
underestimated the economic value of antibiotics, considering it to be only a minor factor.
Most GPs who were consciously aware of cost-effectiveness as a factor believed that the
Chapter Five: Findings and Discussion for Qualitative Study
288
NHS  pressurises  GPs  to  adopt  a  cost-saving  approach  rather  than  a  cost-effective  one
when prescribing. Adopting cost-effective prescribing might promote more rational
prescribing but at the same time increase expenditure, which might be against healthcare
policies. Some GPs highlighted the impact of limited healthcare resources and funds on
antibiotics prescribing behaviour. GPs are disciplined to make efficient use of healthcare
resources, yet the NHS resources available are under pressure because of increasing costs,
limited scope for productivity gains and constrained public resources (Dawda et al. 2010).
With all these constraints such as limited healthcare budget, GPs might find themselves
in a challenging position with regard to antibiotics prescribing. Constraints as a factor can
put pressure on GPs, which can be reflected negatively in the quality of prescribing
decisions or positively by directing and encouraging rational and cost-effective
prescribing. Thanks to financial constraints, GPs have the dilemma of trying to prescribe
both rationally and cost-effectively, putting them under increasing pressure from the
demands of more consumerist patients. The finding regarding cost supports those of
Bjorkman et al. (2013) and Teixeira Rodrigues et al. (2013), who linked the concept of
antibiotics’ low cost with the tendency of antibiotics prescribing. Owing to the low cost
of antibiotics compared to the cost resulting from non-treatment hospitalisation, GPs
might  prefer  to  prescribe  antibiotics  on  the  basis  of  ‘just  in  case’  more  frequently  and
unnecessarily to prevent disease progression. Therefore, healthcare organisation should
promote cost-effective prescribing rather than cost-saving. Limited healthcare resources
and constraints were not previously discussed by any qualitative research related to
antibiotics, making this finding novel. Further research is indicated to explore the impact
of healthcare resources constraints on GPs’ antibiotics prescribing practice.
Pharmaceutical companies can play an important role in encouraging prescribing through
several methods such as arranging sponsored events, visiting surgeries to give GPs
marketing speeches and distributing personal gifts, gifts for the surgeries and free samples
to promote and sell their products (McNulty 2001). In this study one GP (N = 1) valued
these presentations and activities as they give him convenient, up-to-date information in
addition to time to socialise with peers. However, the GP understood that pharmaceutical
companies might provide biased or selected information about products including
antibiotics, as one mixed methods study of 107 UK GPs concluded (Prosser et al. 2003).
In this study, the influence was seen to be minimal, as highlighted by one GP who felt it
might be because of the lack of new antibiotics or classes of antibiotics being produced.
The influence of pharmaceutical companies on antibiotics prescribing was reported in
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Kotwani et al. (2010), Vazquez-Lago et al. (2012) and Teixeira Rodrigues et al. (2013),
who found pharmaceutical companies to be more influential in terms of antibiotics
prescribing because of their direct relationship. Although this influence might be
minimal, it should not be ignored in any strategy aiming for prudent antibiotics
prescribing.
Unsafe and unnecessary over-prescribing of antibiotics was also identified by two GPs
(N = 2) as a factor that can impact antibiotics prescribing practice. Although antibiotic
use can be beneficial to individuals, excessive use can be detrimental (Laxminarayan et
al. 2013). Prescribing more antibiotics than are clinically needed was linked with negative
consequences such as increased antibiotic resistance, unnecessary costs, side effects,
rendering antibiotics ineffective (Llor and Bjerrum 2014) and encouraging patients to
believe  they  need  antibiotics  even  for  trivial  conditions  –  ‘a  pill  for  every  ill’,  as  was
highlighted in one governmental report (SMAC 1998) aimed at examining the issue of
AMR  in  relation  to  clinical  prescribing  practice  in  the  UK.  In  this  study,  one  GP’s
perspective was concerned with the negative consequences of over-prescribing in relation
to microbial resistance and side effects whereas the second GP had linked over-
prescribing behaviour with visits from prescribing advisors, suggesting that their
monitoring and feedback can have a positive impact on GPs’ future prescribing to cut
down this behaviour. This diversity of the perspectives within the same factor could
explain the variations among GPs’ antibiotics prescribing. Surprisingly, no previous
qualitative works have identified over-prescribing as a factor that can influence GPs’
antibiotics prescribing practice. Further research is indicated to explore GPs
characteristics and the reasons for their antibiotics over-prescribing behaviour.
Antibiotics prescribing is not limited to GP surgeries and hospitals; it is also a societal
matter because it involves public attitudes and beliefs. The impact of society and public
expectations on antibiotics prescribing was mentioned by some GPs (N = 5). Society’s
desires and expectations can be very complex since they concern the behaviours that
people who live within society are expected to sustain. Because these behaviours are a
result of interactions between people, GPs and the healthcare system, society’s influence
on antibiotics prescribing can be seen in the form of societal demand to reduce the disease
burden and infection transmission (McDonnell Norms Group 2008). Society’s views
must be shifted towards a sustainable rise in antibiotics awareness and limiting
unnecessary use to preserve the value of antibiotics for future generations. Cutting down
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GPs’ non-pharmacological prescribing in addition to balancing individual and societal
interests may be required. However, this view related to elderly patients with UTIs is not
the same as for adult patients with UTIs. GPs, society and even elderly people are greatly
aware that elderly patients need antibiotics for UTIs more than other age groups. This
might explain why GPs have a lower threshold for prescribing antibiotics for elderly
patients with UTIs. This view can be related to an ageist attitude within society.
Interestingly, the finding has not been explored by any previous qualitative study, which
makes it a novel finding.
In this study, only two GPs considered the factors influencing antibiotics prescribing in
elderly  patients  with  UTIs  to  be  the  same  as  for  adult  patients  with  UTIs  on  all  three
levels.  The  GPs  who  were  aware  of  variations  between  elderly  and  adult  patients’
physiology, co-morbidities and other related factors still considered the factors the same.
Moreover, those GPs considered the influence of local policy and the needs of society to
be the driving forces that made them consider adult and elderly patients the same.
Therefore, to enforce changes in GPs’ antibiotics prescribing for elderly patients,
interventions must consider the influence of society and local policies in their design for
effective behaviour change.
The findings from the thematic analysis with regard to demographics revealed that
females were associated with the following factors when discussing adult patients: fear
(N = 1), diagnosis and clinical decision-making (N = 3), ethos and values (N = 1), desire
for a quick fix (N = 1), influence of secondary care doctor practice (N = 1), time pressure
(N  =  2),  responsibilities  of  other  HCPs  (N  =  1);  and  fear  (N  =  1)  and  no  differences
between adults and the elderly (N = 2) when discussing elderly patients. The influence of
pharmaceutical companies and industry was the only factor associated with males (N =
1). Moving to GPs’ age, factors including: diagnosis and clinical decision-making, ethos
and values and time pressure in adults and fear and patient’s level of understanding and
knowledge in the elderly were highlighted by GPs who were 40 years and younger (N =
10). Pharmaceutical companies as a factor was highlighted by a GP aged 45 (N = 1). With
regard to GPs’ years of practice, no direct relationship to the factors was observed. Owing
to the small number of GPs participating in this research, it was difficult to establish a
concrete relationship between the factors influencing GPs’ prescribing and GPs’
demographics. Although there might be an association between age and certain factors,
as highlighted above, this could be justified by the relatively high number of young GPs
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included in the research compared with other ages. This finding with regard to age, gender
and years of practice is supported by a qualitative systematic review and another
quantitative systematic review about the factors influencing GPs’ antibiotic prescribing
Lopez-Vazquez et al. (2012) and Teixeira Rodrigues et al. (2013), which could not
establish a solid relationship between these factors and GPs’ demographics. A recently
published three-year cohort study in Portugal that included 1,094 primary care physicians
and aimed to assess the influence of the determinants of physicians’ prescribing on the
quality of antibiotic use showed no statistical difference with regard to age (OR [95% CI]
= 0.99 [0.95–1.03]; p = 0.105) or gender and contradictory results for previous clinical
practice, years of practice and CME (Teixeira Rodrigues et al. 2016). An ethnographic
qualitative study might be indicated to explore the influence of GPs’ demographics and
years of practice on their prescribing practice.
5.5 Summary
In summary, this chapter presented the key findings for qualitative studies related to GPs’
antibiotics prescribing for elderly patients with UTIs. The outcomes of the
phenomenographic analysis were presented in the form of categories of description and
outcome space. In this study, five qualitatively distinctive categories of description were
identified; namely, perceptions, knowledge, decision, practice and approach. The internal
horizon of GPs’ perceptions on antibiotics prescribing comprises multiple foci that
include healthcare, diagnostics and investigation, diseases, drugs, economics, GPs,
patients, gender and society; whereas the external horizon consists of training, education,
peers, patients, the healthcare system, personal experience and guidelines. Categories of
description  were  displayed  in  an  outcome  space  to  show  the  complex  structure  of  the
phenomenon of antibiotics prescribing as experienced by GPs.
The  findings  of  the  thematic  analysis  were  presented  in  the  form of  themes  as  well  as
quotes from participants’ interviews. Themes were grouped into one of three main
categories: micro, meso- and macro-level related factors. Micro-level related to factors
that target GP–patient interaction; meso-level related to factors were mainly relevant to
practice and the CCG context; and macro-level related factors provided the wider picture
of factors that take into account society and healthcare resources. Additionally, factors
that influenced GPs’ prescribing for elderly patients with UTIs were seen from two
different standpoints. The first standpoint was addressed by participants who recognised
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elderly  patients  as  a  distinctive  group of  the  population  in  some aspects  of  antibiotics
prescribing,  if  not  all.  As  a  result,  specific  factors  were  seen  to  be  important  and
influential in terms of antibiotics prescribing. The second standpoint was highlighted by
a group of participants who looked at elderly patients with UTIs as a subgroup of adults
and therefore saw no differences in terms of factors that influence antibiotics prescribing
for UTIs.
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Chapter 6 Overall Discussion and Conclusion
6.1 Introduction
In this final chapter, summary of research key findings, overall discussion and
conclusions drawn from this research are offered, followed by a section addressing the
original contribution of this research to the body of knowledge, research methodology
and theoretical contribution. The chapter concludes by offering suggestions for further
research.
6.2 Summary of Research Key Results and Findings
x The research suggests high prevalence of UTIs in elderly female patients compared
with elderly male patients.
x Adherence  results  showed  that  some  GPs’  prescribing  was  not  in  line  with  the
available good practice points as they prescribed broad-spectrum antibiotics and issued
prescriptions with durations other than those recommended either for treatment or for
prophylaxis.
x The research identified five distinct categories of description representing the ways in
which GPs perceive antibiotics prescribing in elderly patients with UTIs; namely,
perceptions, knowledge, decision, practice and approach.
x GPs’ knowledge and perceptions about antibiotics were found to be shaped through
seven external horizons: undergraduate education, postgraduate training, personal
experience, interaction with peers, interaction and influence of patients’ expectations,
the healthcare system, and availability of guidelines and evidence.
x The research identified 29 factors that may influence GPs’ antibiotics prescribing for
UTIs. These factors comprise GP-related factors, patient-related factors and healthcare
system-related factors and were found to influence GPs’ antibiotics prescribing in
patients with UTIs across prescribing practice at the micro-, meso- and macro-level.
6.3 Overall Discussion
Prior to the commencement of this research, a number of gaps were identified from the
reviewed literature and bibliographies in the existing knowledge of GPs’ antibiotics
prescribing for elderly patients with UTIs in the UK, gaps this thesis has sought to
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address. Overall, the aims and research questions in Chapter Two have been achieved
through a mixed methods research approach. One part of this thesis investigated the
prevalence of UTIs in elderly patients, antibiotics prescribing by GPs for elderly patients
with UTIs and audited GPs prescribing against available recommendations through a
special  type  of  pharmacoepidemiological  study,  namely,  a  DUR  using  the  IMS-DA
database.  Another  part  in  the  form of  phenomenographic  qualitative  research  explored
GPs’ views and perceptions about antibiotics for elderly patients with UTIs as well as
factors that can influence GPs’ antibiotics prescribing practice for adult and elderly
patients with UTIs. The following section discusses the key findings from this research.
Overall, UTIs were found to be a more common health condition in female elderly
patients than in male elderly patients, which might be owing to gender-related factors
such as the anatomical structure of the female urethra, increased incidence of urinary
incontinence,  previous  and  recurrent  history  of  UTIs,  presence  of  DM,  low  oestrogen
levels as well as longer life expectancy in females compared with males (Moore and
Spence 2014). The prevalence of UTIs increased with advancing age in the elderly
patients studied until the age of 93, when it started to decrease. Almost 49% (N = 37,815)
of the elderly patients who visited GP surgeries for UTIs have received at least one
antibiotic. From a drugs perspective, trimethoprim was among the most commonly
prescribed antibiotics for elderly patients with 15,772 (41.7%) prescriptions followed by
nitrofurantoin (N = 9448, 25%). GPs’ non-adherence to SAPG good practice points took
place in practice in two different forms. The first form related to prescribing broad-
spectrum antibiotics, namely, cephalexin, co-amoxiclav and ciprofloxacin in 9,125
(24.1%) of all UTI antibiotics prescriptions. The use of broad-spectrum antibiotics in
elderly patients should be avoided since these drugs can increase the susceptibility of
elderly people to Clostridium difficile infection (SIGN 2012, SAPG 2013). The second
form of non-adherence was seen through prescribing antibiotics for durations other than
those stated by the recommendations in 4,416 (28%) trimethoprim prescriptions as well
as 4,771 (50.5%) of nitrofurantoin prescriptions, or in prescribing alternative antibiotics
choices in particular for LUTIs. This practice could result in deterioration of elderly
patients’ conditions, expose them to ADRs and increase or develop bacterial resistance.
Overall, the results from the comparison between GPs’ prescribing practices and UTI
recommendations suggested that there was a lack of adherence to recommendations,
variations in antibiotics prescribing as well as inappropriate antibiotics prescribing in
terms of antibiotic choice and duration of antibiotic therapy.
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During the interviews, the GPs showed a high level of awareness of both diagnostic
aspects of UTIs in elderly patients with regard to distinguishing between UTIs and ASB
as well as prescribing aspects of antibiotics, namely, safety, practicability, compliance
and quality of prescribing, relative to elderly patients. From a qualitative and
phenomenographic perspective, the findings from all five categories – perceptions,
knowledge, decision, practice and approach – clearly suggest the presence of substantial
variations among GPs’ views, which explain the way GPs prescribe and act. Furthermore,
they demonstrate how the phenomenon of antibiotics prescribing by GPs for elderly
patients with UTIs is complex and diverse, as was evident from the presence of several
dimensions  representing  different  views  and  conceptions  among  GPs.  Overall,  it  is
acceptable to see variations in perceptions within the same category. Individuals all have
different life experiences, as highlighted in Chapter Three. However, the presence of
contrasting perceptions within the same category in different dimensions might explain
why there are variations in antibiotics prescribing practice among GPs, as was detected
in the study. The presence of variations in antibiotics perceptions, knowledge, awareness
of and familiarity with guidelines, decision to treat UTIs and approaching elderly patients
collectively can explain why there was a lack of adherence to recommendations,
variations in antibiotics prescribing as well as inappropriate antibiotics prescribing in
terms of using broad-spectrum antibiotics and non-recommended antibiotic choices and
therapy  durations,  as  shown  by  the  DUR  study.  Moreover,  lack  of  awareness  of  and
familiarity with any guidelines might suggest that there is a problem within the evidence
dissemination process. The findings showed several shared dimensions across some
categories, including patients’ socio-medical status, antibiotic concerns, diagnostic tests,
patients’ safety and compliance, and the no variation dimension in approach or practice.
However, the GPs’ perspectives likely differed according to the nature of the specific
question and the GPs’ experience.
Additionally, the findings demonstrate how some GPs were more flexible when deciding
to prescribe antibiotics for elderly patients with UTIs by showing low-threshold
behaviour, considering age, severe illness or presentations, co-morbidities and frailty as
predictors for. The camp of GPs who reported a modified treatment approach according
to gender differences considered being male a predictor for using broader-spectrum
antibiotics and prescribing longer or extended durations and/or alternative choices
compared with elderly female patients. These two irrational prescribing behaviours could
be  a  result  of  the  influences  of  the  external  horizons  that  shaped  GPs’  antibiotics
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prescribing practice perceptions rather than the guidelines for this particular context
including peers and GPs’ personal experience.
The findings suggest that GPs’ antibiotics prescribing for UTIs is influenced by numerous
and diverse factors that make the prescribing process very complex. Factors highlighted
by the GPs fell into three major contexts: micro, meso and macro and factors may operate
at each level alone, or across all three, as in the cases of over-prescribing, guidelines,
policies and resistance. Moreover, the findings revealed a lack of agreement among GPs
on any factor in addition to variations in reporting factors that can influence prescribing
practice in either adult or elderly patients. The findings suggest that a host of clinical as
well as non-clinical factors can influence antibiotics prescribing. According to the number
of factors, it seems that GPs are mainly influenced by micro-level factors followed by
macro-level factors and then meso-level factors. In micro-level factors, both intrinsic and
extrinsic factors received the same weight of importance among the interviewed GPs.
Overall, 29 factors were cited as influencing GPs’ antibiotics prescribing for adult
patients with UTIs whereas 10 factors were named as determinants for antibiotics
prescribing in elderly patients with UTIs. Of these, nine were shared between both age
groups: complacency, fear, concerns about antibiotics, medical history and clinical
characteristics, patients’ social situation and living conditions, patients’ level of
understanding and knowledge, incentives, patients’ autonomy and society. Gender and
age were the only factors discussed in elderly but not adult patients. This might suggest
that  GPs  have  a  better  understanding  of  adults  as  patients  compared  with  the  elderly.
Responses from GPs to questions related to the elderly were noticeably very short and
hesitant compared with responses related to adult patients.
Certain factors in the thematic analysis also emerged from the phenomenographic
analysis, including but not limited to social and medical status, concerns, guidelines, local
guidance, resistance, diagnosis and clinical decision, training, education, society,
healthcare systems, economics and gender. This finding from two different methods of
analysis supports ‘triangulation’. Moreover, that the GPs’ views placed them in two
camps with regard to factors within elderly patients could also support the findings from
the phenomenographic analysis with regard to variations in practice and approaches as
well as explain the variations in prescribing from the DUR study. Furthermore,
discussions with GPs revealed contradictory opinions with regard to certain factors seen
from  different  perspectives  or  angles  when  comparing  adults  with  the  elderly.  For
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instance, complacency, patient knowledge and previous experience with UTIs in elderly
patients were seen as factors that can encourage GPs to prescribe antibiotics for elderly
patients but not necessarily for adult patients. These can result in lack of adherence to
recommendations, variations in antibiotics prescribing as well as inappropriate antibiotics
prescribing in terms of antibiotic choice and duration of antibiotic therapy, which
supports the findings from the DUR study with regard to prescribing.
The findings from the research explain what GPs do and do not see happening in relation
to antibiotics prescribing for elderly patients. Therefore, a theoretical framework was
proposed to model the GPs’ knowledge, attitude, perceptions and practice to enable the
development of multifaceted practical interventions. The one proposed was modified
from the literature-based framework proposed by Teixeira Rodrigues et al. (2013) by
incorporating perceptions emerged from the phenomenographic analysis and considering
perceptions about antibiotics in terms of the intrinsic factors that were the most complex
influence on GPs’ antibiotics prescribing. The proposed theoretical framework integrates
GPs’ perceptions with other core components of the original KAP model and
demonstrates how they work together in shaping GPs’ practice (Figure 32).
SDF: Sociodemographic factors
PI: Pharmaceutical industry
PRF: Patient related factors
HCSRF: Healthcare system related factors
KAP Model
Intrinsic Factors Extrinsic Factors











Figure 32: Modified theoretical framework from Teixeira Rodrigues framework of interrelationships
among factors influencing antibiotics prescribing (Teixeira Rodrigues et al. 2013)
Overall Discussion and ConclusionChapter Six:
298
As there is little evidence about the factors that influence antibiotics prescribing in
general, and for UTIs in elderly patients in particular, a finding that perhaps explains why
the different interventions implemented to promote rational antibiotics prescribing have
not been successful in meeting expectations was highlighted by (Lopez-Vazquez et al.
2012). To make this work, all identified factors from the three thematic analysis levels
(macro, meso and micro) were considered in addition to GPs’ views and perceptions
identified from the phenomenographic analysis to design a successful multifaceted
intervention approach (Figure 33). The effectiveness of this proposed multifaceted
intervention can be enhanced and informed by utilising implementation science in form
of  theoretical  domains  framework  (TDF)  which  was  shown  to  be  very  useful  in
understanding the barriers to, and facilitators of, uptake of even the most “evidence
based” intervention strategies. The TDF consists of 14 conceptual determinants and
associated constructs from organisational and psychological theory that putatively
influence behaviour and stimulate behaviour change (Lipworth et al. 2013).
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6.4 Research Appraisal, Strengths and Limitations
Owing to the nature of the gaps identified by the literature review, which include UTI
prevalence in the elderly, GPs’ antibiotics prescribing adherence to good practice points
for UTIs in elderly patients, GPs’ antibiotics prescribing perceptions and views on UTIs
in the elderly and factors influencing GPs’ antibiotic prescribing for UTIs, the study used
mixed methods research in the form of a DUR and a phenomenographic approach to
explore GPs’ antibiotics prescribing for UTIs in elderly patients in the UK. This research
was one of the first of its kind in the UK. The use of mixed methods seemed well suited
to the thesis aim and objectives. As was argued in Chapter Three, quantitative methods
can provide invaluable information about the epidemiology of UTIs and the size of the
problem of inappropriate antibiotics prescribing for elderly patients, but do not provide
an in-depth view of GPs’ behaviour in the same way that the qualitative approach taken
here does. This research was unique in approach and intensity. Quality time was spent
harvesting IMS-DA data and talking with GPs to investigate their prescribing practice.
This allowed a better understanding of the UK’s medical records databases, the general
practice system, GPs’ prescribing practice and the regulatory aspects of prescribing. The
methods, sampling strategy, data analysis and in-depth presentation of the findings of this
research have all been described in detail to allow others to adopt the research method or
to assess the transferability of the findings.
Quantitative Study
The quantitative study took the form of a retrospective, observational, cross-sectional
DUR.  The  reason  for  choosing  this  method  and  design  was  its  known  efficiency  in
addressing and describing prevalence, patterns, trends as well as exploring the adherence
of GPs to the good practice points, that is, auditing (Wertheimer 1988, Dukes 1993).
Furthermore, this study design could lead to planning for future interventions intended to
improve prescribing behaviour in addition to being inexpensive, quick and easy to
perform compared with other types of drug utilisation research, requiring only the use of
routinely accessible data (Wertheimer 1988, Dukes 1993). The main disadvantages of this
design were the limited number of variables available for analysis and there being more
potential for bias and confounding than in other drug utilisation study designs. However,
the bias and cofounding can be overcome by adhering to a well-structured study design
(Cooke 1991, Shalini et al. 2010).
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To serve the purpose of this study, data were obtained from the IMS-DA database. It was
selected because it contains robust prescriptions data that were collected from a good
number of GP surgeries and issued by GPs from different geographical distributions,
which makes this database largely representative of the UK population and thus allows
its results to be generalised (Becher et al. 2009). Moreover, the IMS-DA database is
known for being valid, inexpensive and of high quality. It has robust quality control
standards carried out by an IMS Health panel (Becher et al. 2009). Additionally, an IMS-
DA access licence was available, which was a further advantage. These characteristics of
the  IMS-DA  database  allowed  the  retrieval  and  analysis  of  a  massive  amount  of
population-based data, which provided descriptive insight into UK GPs’ antibiotics
prescribing volume and the status of GPs’ adherence to recommendations on a national
level. In this study, more than 77,000 UTI events in elderly patients were obtained from
135 GP surgeries from England Scotland, Wales and Northern Ireland. The huge number
of events is one of this study’s strengths as it resulted in increasing the external validity
of the results and ensuring that the results were representative of the elderly population
in the UK. Moreover, the use of a computerised database to study routinely collected
patient records made by trained GPs also minimised issues associated with the Hawthorne
effect and recall bias, which can frequently be seen in any auditing research.
However, there were inherent limitations associated with this method that need to be
addressed. First, it is important to mention that the data held within the IMS-DA database
were collected primarily for clinical rather than for research purposes (Ogdie et al. 2012).
Second, as with any computerised database, misclassification or imprecise use of the
disease classification system might have occurred during GPs’ data entry as in Ki et al.
(2004), Galatti et al. (2006), Czaja et al. (2007), Laupland et al. (2007), Caljouw et al.
(2011) and Marques et al. (2012), which in turn might have resulted in incomplete capture
of  all  cases  or  measuring  of  GPs’  adherence.  For  instance,  the  study  found  that  most
recorded UTI events were site unspecified, which made comparison between GPs’
prescribing and the recommendations problematic. Although IMS-DA has quality control
measures in place that help to improve the records, some inaccuracies may have remained.
Third, lack of laboratory results including urine analysis, urine cultures and renal function
tests in addition to availability of limited variables might have influenced the results of
the study in several ways such as distinguishing between UTIs that require antibiotic
therapy versus ASB that does not, and influencing GPs’ antibiotic choice, dose or duration
as in Kahan et al. (2005), Eriksson et al. (2010) and Haasum et al. (2013). However, the
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study assumed that elderly patients who were coded as having UTIs and given antibiotics
had a high likelihood of actually having a UTI. Fourth, lack of patients’ co-morbidities
information  to  guide  treatment  options  can  cause  some  GPs  not  to  adhere  to
recommendations with regard to antibiotic choice, dose, frequency or duration as in
Straand et al. (1998), Kahan et al. (2005), Taur and Smith (2007), McIsaac et al. (2008),
Llor et al. (2011), Vellinga et al. (2011), Denes et al. (2012) and Haasum et al. (2013).
The presence of such details might justify some broad-spectrum antibiotic prescriptions,
use  of  second-line  antibiotics  or  altered  durations.  Fifth,  the  IMS-DA  includes  only
antibiotics prescribed by GPs; it lacks the link with pharmacy dispensing data, therefore
it cannot distinguish between antibiotics prescribed and antibiotics actually dispensed
(Friis et al. 1989, Straand et al. 1998, Wrigley et al. 2002, Kahan et al. 2005, Petersen
and Hayward 2007a, Taur and Smith 2007, McIsaac et al. 2008, Llor et al. 2011, Vellinga
et al. 2011, Denes et al. 2012, Haasum et al. 2013). All five limitations might result in
over- or underestimation of UTI prevalence, the patterns and trends of antibiotics and the
magnitude of GPs’ adherence to good practice points. One last limitation was related to
the difficulty in comparing the results from the quantitative study with other published
literature, either on a national or an international level, owing to there being limited
published work on elderly patients in primary care, variations in the data sources, namely,
laboratory data (McIsaac et  al. 2008, Vellinga et al. 2011, Denes et al. 2012) versus
computerised database (Wrigley et al. 2002, Kahan et al. 2005, Petersen and Hayward
2007a, Taur and Smith 2007, Haasum et al. 2013) versus survey (Ruben et al. 1995,
Malmsten et al. 1997, Foxman et al. 2000, Molander et al. 2000), variations in the
reporting units for prevalence such as percentage in (Molander et al. 2000, Galatti et al.
2006, Eriksson et al. 2010, Omoregie et al. 2010) or 100 person-years, per 1,000 per year
or 10,000 person-years for incidence (Czaja et al. 2007, Laupland et al. 2007, Caljouw et
al. 2011) and antibiotics prescribing between published work such as the use of DDD
(Norris et al. 2011, Pan et al. 2011) or percentage (Wrigley et al. 2002, Kahan et al. 2005,
Petersen and Hayward 2007a, Taur and Smith 2007, Haasum et al. 2013) and finally the
recommendations in different countries, for instance, trimethoprim (Vellinga et al. 2011)
versus fosfomycin (Llor et al. 2011).
Qualitative Study
Use of a phenomenographic approach, considered one of the strengths of this thesis, along
with two different analytical techniques, made it possible to attain in-depth understanding
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of the phenomenon without adopting a predetermined hypothesis and allowing the
findings to be derived inductively from the data obtained from the interviewed GPs’
perspectives (Bruce 1994). The use of semi-structured interviews as the method of data
collection for the qualitative research allowed understanding of the GPs’ different
standpoints through motivating them to speak for themselves using their own words and
language to express their thoughts, views, concepts and perceptions about the
phenomenon of antibiotics prescribing besides the factors that might affect their
antibiotics prescribing from within their general practice context (Kvale 1996, Patton
2002). The research included over 1,160 minutes of digital recording (more than 600
pages of A4 transcript papers) representing the total length of semi-structured interviews
with 17 GPs who were selected through non-probability purposive sampling that resulted
in generating rich information and an in-depth representation of GPs’ prescribing practice
in the UK (Jupp 2006). The research was validated in relation to the quality of the
collected data, the theoretical data saturation and the qualitative data analysis through
review by external field experts other than the research team members.
6.4.2.1 Trustworthiness of Qualitative Study
Trustworthiness was ensured by applying rigorous qualitative research criteria that were
described in Chapter Three of this thesis. Transferability was achieved by providing clear
and  detailed  description  of  how  GPs  were  selected  with  different  genders,  years  of
experience and from different practice site locations, presenting GPs’ demographics in
the findings, with clear description of the research culture and context, data collection and
the  process  of  analysis  as  well  as  appropriate  presentation  of  the  findings  and  use  of
appropriate quotations. Although this research used a purposive sample to recruit GPs, its
main aim was to explore and identify GPs’ views and perceptions and to generate themes
but not statements that are generalisable to other practitioners. In this research, credibility
was ensured through the researcher’s background and familiarity with the subject matter
under investigation, adherence to the interview topic guide, proper presentation and
rephrasing of open-ended interview questions, use of prompts and probes to encourage
GPs to deepen and develop their thoughts and ideas, selection of GPs with different
practice experience to increase the possibility of approaching the research aim from
different perspectives, thick description of the phenomenon under investigation as well
as interviewing GPs with different genders and ages, which maximised the variations and
enriched the research. Since prescribing practice can be a sensitive topic to discuss with
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GPs who might be aware of their deviation from what exists within the guidelines, their
responses may have been biased to attempt to describe a more responsible and correct
prescribing practice than actually exists. To attempt to minimise this effect, all GPs were
reassured at the start of the interview that there were no right or wrong answers, that they
were not going to be judged on their prescribing practice and that no consequences would
result from anything revealed during the interviews. The GPs were relaxed and honest
whenever they described issues related to their prescribing practice. Dependability was
achieved through using the same introductory questions and additional questions with all
interviewed GPs within a short period of time to ensure consistency, conducting a code–
recode procedure on the data during the analysis phase of the study, that is, comparing
the  initial  coding  of  the  data  with  the  recoding  of  the  data  after  two weeks,  and  using
external field experts, that is, educational experts, to check the data saturation point and
research analysis in addition to supervisor as peer examination, to check the research plan
and implementation. Confirmability was achieved by ensuring that what was said during
the interviews was inextricably connected to how the GPs said it, by having two research
team members work independently to check the quality and consistency of the data
transcripts, data coding and interpretations then meeting regularly to discuss and resolve
coding discrepancies and agree upon interpretation of the findings. In line with the
recommendations from Lincoln and Guba (1985) and Ritchie et al. (2014), research
external validity was strengthened by providing a thick description of all aspects of the
research in this thesis, involving a detailed account of the methods and data analysis
procedures and an in-depth presentation of the findings.
One of the strengths of the approach followed is that it was descriptive and interpretative,
which enabled detection of new factors and views, as seen in Chapter Five. Owing to the
fact that thematic analysis can result in de-contextualisation of the GPs’ words, careful
consideration was undertaken during analysis of the GPs’ words in the broader context of
the surrounding utterances to avoid any misinterpretation or presentation. This research
represented the views about antibiotics prescribing for elderly patients of the 17 GPs from
the UK, which may not be the same as the views of other GPs either in the UK or from
other countries. Although data saturation was achieved, as evidenced by the emergence
of the same views and themes throughout the interviews, caution was needed when
generalising the findings. The GPs who agreed to take part in the qualitative research may
have had a special interest in antibiotics, elderly patients or UTIs, making their responses
skewed. To minimise this influence, the GPs were asked to provide a brief description of
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their qualifications, research interests and backgrounds. Only one GP showed an interest
in UTIs and antibiotics as a result of previous work carried out during the GP’s PhD study.
The risk of bias may have been increased if the GPs had known the interviewer
professionally or if the interviewer had a clinical background. To eliminate the risk of
bias, the researcher recruited GPs who were totally unknown to him in addition to
introducing himself as a clinical pharmacist and a PhD student.
6.5 Conclusions
The purpose of this thesis was to give a quantitative and qualitative account of how GPs
prescribe  antibiotics  for  elderly  patients  with  UTIs  in  the  UK.  According  to  both  the
researcher’s knowledge and the identified gaps in the previous research work, as
highlighted in Chapter Two, this is one of the first studies in this field.
In conclusion, the research suggests that there is no available national guideline in the UK
for the management of UTIs in elderly patients that provides specific recommendations
on the best choice of antibiotic therapy according to the type of UTI based on evidence
retrieved from studies performed particularly for elderly people. The newly introduced
SAPG decision aid tool was built on summaries from previously published
recommendations for adult patients with UTIs. The results from the research showed that
UTIs were found to be more common in female elderly patients compared with males and
the prevalence of UTIs seems to increase with advancing age in the elderly. Using DUR
to audit antibiotics prescriptions showed that some UK GPs did not adhere to SAPG good
practice points by prescribing broad-spectrum antibiotics, namely, cephalexin, co-
amoxiclav and ciprofloxacin in 24.1% of all UTI antibiotics prescriptions. This should be
avoided since these antibiotics can increase the susceptibility of elderly people to
Clostridium difficile infection. Additionally, GPs prescribed antibiotics for durations
other than those stated by the recommendations in 28% of trimethoprim prescriptions as
well as 50.5% of nitrofurantoin prescriptions, or prescribed alternative drugs in particular
for LUTIs. This practice could result in deterioration of elderly patients’ conditions,
exposing them to side effects and increase or development of bacterial resistance.
Qualitatively, five categories were identified from the phenomenographic analysis:
perceptions, knowledge, decision, practice and approach. Of these, perception was found
to be the most sophisticated view since it involves a wider context of this phenomenon.
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Within these, there was substantial variation among the GPs’ views. That said, it is
normally accepted to see variations in perceptions within the same category, as each
individual has a different life experience, as highlighted in Chapter Three. However, the
presence of contrasting perceptions within the same category might explain why there is
variation in antibiotics prescribing practice among GPs, which can be inappropriate too.
The research has shown that some GPs tend to prescribe antibiotics for elderly patients
more flexibly, more frequently and more quickly than for adult patients. Considering
gender variation, some GPs were found to prescribe broad-spectrum antibiotics as well
as altered choices and durations. Also, variation in GPs’ knowledge and awareness of
guidelines might indicate the presence of a problem in the dissemination process and may
explain why GPs prescribe antibiotics inappropriately.
Until conducting this research, there was little evidence about the factors influencing
antibiotics prescribing for UTIs in elderly patients (Lopez-Vazquez et al. 2012). This
research identified a number of factors that belong to different contexts, mainly micro-
level, that were identified as contributing to and influencing GPs’ antibiotics prescribing
practice. The research has shown that the factors cited by GPs were more related to adults
compared with elderly patients, which could suggest a poor understanding of the elderly
in terms of prescribing. Interestingly, some of these factors were novel and discussed for
the first time from an antibiotics perspective.
This research has advanced the knowledge about GPs’ antibiotics prescribing for UTIs in
elderly patients. The findings highlighted the need for urgent, practical and efficient
interventions to optimise and rationalise GPs’ antibiotics prescribing for elderly patients.
These should take the form of robust guidelines that should be easy, concise,
representative to general practice contexts and developed by a panel. The guidelines
should engage GPs through multifaceted intensive interventions aimed at improving
prescribing practice for elderly patients and incorporate perceptions modification as part
of their design, to reduce, or eliminate, if possible, any discrepancies in prescribing
practice and to impact positively on GPs’ inappropriate prescribing, non-adherence and,
most importantly, reduce the threat of resistance in this context. Moreover, interventions
should be targeted towards the seven external horizons that shape GPs’ antibiotics
prescribing practice perceptions. Healthcare bodies responsible for issuing guidelines,
such as PHE and NICE, must issue specific guidelines or incorporate a separate section
for the management of UTIs in elderly patients in primary care settings. Further research
Chapter Six: Overall Discussion and Conclusion
307
should investigate the influence of unexplored factors influencing GPs’ antibiotics
prescribing for elderly patients such as elderly autonomy, complacency, healthcare
resources constraints and societal experience and expectations as well as the relationships
between these factors and GPs’ demographics, as these points have never been explored.
Original Contribution of this Research
The original contribution made by this research is threefold. First, it adds to the body of
knowledge; second, it contributes to the research methodology; and third, it contributes
to the strategies for improving antibiotics prescribing.
6.5.1.1 Contribution to the Body of Knowledge
This research has advanced understanding and contributed to the body of knowledge
about the prevalence of UTIs, GPs’ patterns and trends of antibiotics prescribing, the
quality  of  GPs’  antibiotics  prescribing  for  elderly  patients  with  UTIs,  and  the
understanding of GPs’ perceptions and views, and has identified clinical and non-clinical
factors that may influence GPs’ antibiotics prescribing for elderly patients who visited
GP surgeries in the UK.
6.5.1.2 Contribution to the Research Methodology
This research has made an original contribution to the research methodology because it
is the first to use phenomenographic approach with two methods of data analysis as a part
of a mixed methods approach to discuss a sensitive topic with GPs. The interpretive and
descriptive research paradigm made it possible to understand GPs’ experiences of
antibiotics prescribing practice in its original context from their own perspective by
encouraging GPs to speak openly, to reflect and to share their experiences of prescribing.
6.5.1.3 Theoretical Contribution
The original theoretical contribution is that this research has proposed a theoretical
framework for developing antibiotics strategies incorporating findings from the mixed
methods research. This approach was designed bearing in mind that changing GPs’
behaviour is a lengthy, complex and difficult task. Therefore, the framework involves a
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combination of interventions that may provide tangible outcomes in the short term as well
as in the long term (Figure 33).
6.6 Implications for Practice and Research
This research has contributed to the growing body of evidence suggesting that antibiotics
are being widely prescribed by GPs in the UK, often with limited adherence to guidelines,
recommendations or good practice points, which in turn raises concerns about the
negative consequences of such practice such as financial, AMR, budgetary constraints,
clinical outcomes, inefficiencies and distortion and behaviour of healthcare systems
practice (Maragakis et al. 2008, Llor and Bjerrum 2014). The various results and findings
from this research might have implications for future policy, practice and research. A
number of suggested thoughts are given below.
Findings from this research highlighted the presence of variations in GPs’ antibiotic
prescribing practice including inappropriate prescribing by some GPs. Efforts to
encourage GPs’ rational prescribing of antibiotics for elderly patients in primary care
should consider factors associated with patients, GPs, the healthcare system as well as
society. Taking into consideration all these factors might help in designing practical
interventions aimed at promoting appropriate antibiotics prescribing by GPs that may add
to the current interventions implemented by the NHS such as antimicrobial stewardships.
However, no single intervention was found to be influential by itself in curbing
inappropriate prescribing; therefore a multifaceted approach targeting all these
stakeholders would be more feasible for improving antibiotics prescribing for elderly
patients taking into consideration the local contexts as shown in different qualitative
research (Tonkin-Crine et al. 2011b, Duane et al. 2013) and a Cochrane systematic review
(Arnold and Straus 2005).
As a part of this multifaceted intervention, there should be perceptions modification
interventions to improve prescribing practice for elderly patients as they may influence
GPs’ attitudes and determine whether they will change their practice. Although changing
human behaviour, habits and perceptions is recognised as being challenging, facilitating
the process to modify behaviour is possible (Stålsby Lundborg and Tamhankar 2014).
Such interventions might reduce, or eliminate, if possible, the contrasting views, thus
overcoming any discrepancies in prescribing practice and impacting positively on GPs’
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inappropriate prescribing, non-adherence and making them responsible prescribers
(Mustafa et al. 2014). Furthermore, narrowing the variation in GPs’ concepts with regards
to dimensions as was noted in GPs’ views about AMR might improve prescribing
practice. Furthermore, modification of GPs’ perceptions may improve many aspects that
may be associated with misperceptions such as patients’ anticipation of antibiotics,
patients’ satisfaction, antibiotics cost, prescribing broad-spectrum antibiotics to improve
patient condition or drugs being safe (McDonnell Norms Group 2008, Ashworth et al.
2016).
The interventions should also be targeted towards the seven external horizons that shape
GPs’ antibiotics prescribing practice through multifaceted educational and training
programmes that start in the early stages of GPs’ medical school education and future
career. For example, increasing the number of credited hours for antibiotic pharmacology
and elderly patients during undergraduate courses, exposing trainee GPs to more cases of
elderly patients with infections during hospital training, providing CME-related material
promoting rational antibiotics prescribing for elderly patients with confirmed infections,
increasing antibiotics educational activities for GPs such as conferences, seminars and
skills training programmes and motivating GPs to become more receptive in their
practice. The influence of such interventions is supported by the findings from a RCT
aimed at evaluating the effectiveness and costs of a multifaceted flexible educational
programme consisting of various learning methods and topics for UK GPs to reduce
antibiotics prescribing. The results from this study showed a successful reduction in
antibiotics prescribing by 4.2% after implementing the educational programme (95% CI
0.6% to 7.7%) (Butler et al. 2012).
Another part of these multifaceted interventions should be introducing antibiotics
prescribing guidelines specifically synthesised for the elderly population based on clinical
trials, studies and evidence with representative samples of elderly patients (Singh and
Bajorek 2014, Beckett et al. 2015). Increasing GPs’ awareness, uptake and
implementation of SAPG good practice points for UTIs should also be incorporated with
perceptions change. GPs must be convinced with strong arguments why they should
change their practice to become more evidence-based. GPs must be involved in the
process of evidence synthesis because of their knowledge of the context of general
practice, especially relating to guidelines targeting primary care practice. Moreover,
guidelines must be more flexible and tailored to meet individual patient conditions and
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local practice settings, as in the case of elderly patients. Owing to GPs workload and time
limits, guidelines must be accessible, useable, clear and concise with clear statements
about evidence quality. Both the NHS and local CCGs should assure GPs that the
developed guidelines are not synthesised for budgetary cuts over the quality of clinical
services provided. Rewarding GPs who adhere to guidelines in the form of financial
incentives or holidays might assist in increasing guideline uptake and facilitate GPs’
behaviour change. Several qualitative and quantitative studies have discussed different
strategies to change GPs’ behaviour with regard to UTI guidelines and shared in many
interventions (Lugtenberg et al. 2010, Willems et al. 2012, Demonchy et al. 2014)
including those related to other infections, as highlighted by (Tonkin-Crine et al. 2013).
The NHS and CCGs should continue their successful role in promoting rational
antibiotics prescribing through integrating their winning initiatives and tools in this
framework. This can include updating and improving antimicrobial stewardship
programmes, increasing the number of activities of local and national auditing and
feedback and recruiting more prescribing advisors and medicine management teams,
promoting cost-effectiveness philosophies over cost-saving practices and encouraging
practices to become part of recently launched incentive schemes. Additionally, they
should work on improving the logistics of care, for instance, reducing the time between
requesting laboratory diagnostics and prescribing antibiotics or introducing rapid
diagnostic tests. Although these interventions seem to be simple, the factors that influence
antibiotics prescribing are engrained in all stakeholders including national governmental
policy, which might make the process of transformation and change impossible in the
short term.
This research has thrown up many thoughts and ideas in need of further investigation
among elderly patients with UTIs. It is recommended that further quantitative research be
undertaken in the following areas:
x Further research should be conducted to identify the factors responsible for the peak
prevalence and frequent visits to GP surgeries in elderly patients aged 84–93.
x Another worthwhile idea would be to carry out a prospective, cohort population-based
study to estimate the prevalence of UTIs, audit GPs’ antibiotics prescribing and
calculate  the  direct  drug  cost  for  elderly  patients  with  UTIs  using  patients’  clinical
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presentation, laboratory information for MSU and culture and actual antibiotics
dispensing data.
x It would be interesting to explore the national burden and long-term consequences of
UTIs in the UK for this particular age group by linking existing medical records
databases to the Hospital Episode Statistics (HSE) database. Medical records databases
contain countless valuable pieces of information that can be utilised for further studies
on elderly patients with UTIs within the context of GP surgeries.
x It is recommended that further research be undertaken to explore the impact of elderly
patients’ co-morbidities on GPs’ antibiotics prescribing for UTIs including antibiotic
choice, dose and duration of therapy. Drug utilisation studies might be a valuable
research method for providing insight into GPs’ antibiotics prescribing as they can be
used to improve the quality of prescribing.
x Considerably more work needs to be done to evaluate the impact of introducing a
national drug utilisation programme or a computerised system for improving the
quality of GPs’ antibiotics prescribing against predetermined audit criteria. This could
be very useful in providing GPs with feedback about their prescribing practice and
minimising variations in prescribing, both locally and nationally.
x It would be very interesting to carry out future research to design, implement and
evaluate the effectiveness of various multifaceted interventions for improving
antibiotics prescribing for elderly patients in primary care. However, as in all
implementation research, the context is of great importance, whereas local validations
of interventions will always be required.
Qualitative research is becoming routine in healthcare studies, assuming the main role of
exploring complex topics and defining new approaches to the targeted field (Jack 2006).
Qualitative research should address antibiotics prescribing for elderly patients with UTIs
in the following areas:
x As this qualitative research included only 17 GPs perhaps the findings should be tested
and refined over a larger number of GPs from different countries, perhaps with other
types of interview question and using different qualitative methods and different
analytical approaches to gain a deeper understanding of GPs’ prescribing habits and
behaviour.
x Although this thesis explored the perceptions of GPs regarding antibiotics prescribing
for elderly patients, more complex research needs to involve GPs, patients, families,
Chapter Six: Overall Discussion and Conclusion
312
carers and healthcare decision-makers to fully understand the perceptions of
antibiotics prescribing, in interaction within a complex, social context. Socio-cultural
theories may offer a useful framework for future research by providing a lens that can
accommodate the wide range of interacting factors influencing GPs’ prescribing habits
and behaviour.
x Another area worth exploring is the impact of specific factors on antibiotics
prescribing by GPs by dedicating a complete research study to each factor. The factors
may include the impact of elderly patients’ autonomy and expectations on GPs’
antibiotics prescribing; the impact of scheme incentives on GPs’ antibiotics
prescribing; the influence of secondary care doctors on GPs’ antibiotics prescribing;
and habits of adoption and the influence of ageing on GPs’ antibiotics prescribing.
x Exploring GPs’ views and perceptions of having specifically developed guidelines for
elderly patients is another good research theme.
x It would be interesting to explore the impact of different multifaceted interventions on
GPs’ antibiotics prescribing for elderly patients.
x Considerably more work needs to be done by using other methodological approaches
for future research such as a multilevel analysis of patients’ and GPs’ factors,
recognising the lack of some findings from GPs such as the importance of finishing a
course of antibiotic and some of the limitations for using a London based sample for
the qualitative research.
x Finally, research could explore the impact of GPs’ demographics and personal
characteristics on their perceptions and prescribing practice for elderly patients in the
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Appendix 1. Oral and parenteral antibiotic regimens for the treatment




Nitrofurantoin 50–100 mg four times a day
TMP-SMX 160/800 mg, twice daily
TMP 100 mg twice daily
Amoxicillin 500 mg three times daily
Others
Co-amoxiclav 500 mg three times daily or 875 mg twice daily
Norfloxacin 400 mg twice daily
Ciprofloxacin 250–500 mg twice daily
Ofloxacin 200–400 mg twice daily
Levofloxacin 500 mg once a day
Cephalexin 500 mg four times a day
Cefaclor 500 mg
Cefadroxil 1 g once a day or twice daily
Cefixime 400 mg once a day
Cefuroxime axetil 250 mg twice daily
Cefpodoxime proxetil 100–400 mg twice daily
Parenteral
Preferred
Gentamicin 1–1.5 mg/kg q8h or 4–5 mg/kg q24h
Tobramycin 1–1.5 mg/kg q8h or 4–5 mg/kg q24h
Ampicillin 1g q4–6h
Cefazolin 1–2 g q8h
Others
TMP-SMX 16- /800 mg q12h
Amikacin 5mg/kg q8h or 15 mg/kg q24h
Piperacillin 3g q4h
Piperacillin-tazobactam 4g-500 mg q8h
Cefotaxime 1–2 g q8h
Ceftriaxone 1–2 g q24h
Cefepime 2g q12h
Ceftazidime 0.5–2 g q8h
Aztreonam 1–2 g q6h
Imipenem/cilastatin 500mg q6h
Vancomycin 500mg q6h or l g q12h
Ciprofloxacin 200–400 mg q12h
Levofloxacin 500 mg daily
* Assuming normal renal function; Q: every
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Appendix 2 Decision aid for diagnosis and management of suspected





Appendix 3. Key terms and search strategy used for literature search
Appendix 3.1: Search terms and strategy for UTI epidemiology in elderly patients
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Appendix 3.3: Search terms and strategy for GPs adherence to antibiotics
prescribing guidelines for treating UTIs in elderly patients
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Appendix 3.4: Search terms and strategy for variations in GPs’ antibiotics
prescribing perceptions and views for UTIs in elderly patients
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Appendix 3.5: Search terms and strategy for Factors influencing GPs antibiotics
prescribing for UTIs in elderly patients
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Patient Patient identifier, month and year of birth, registration status, death date, transfer out date
Practice Practice identifier, geographical region, date practice became 'Up to standard', last data collection date
Staff Staff identifier, gender, role
Consultation Date of clinical event, date of data entry, type of consultation, staff identifier and duration of consultation
Clinical Date of clinical event, date of data entry, the CPRD medical code for the chosen Read code, additional details identifier, entity type
ACD Type of information held, called an 'entity', specific clinical details relating to that entity
Referral The CPRD medical code for the chosen Read code, method of referral, referral specialty, urgency of referral
Immunisation Reason for immunisation, type, stage, status and the compound used
Test Type of test, result, normal range of result, unit of measure
Links to external data CPRD data linked with HES




Date patient registered at practice, date patient left practice, patient registration status, year of birth, gender, patients residing at the same address
or members of the same family linked if at the same practice using a household identifier number. Data not included (name, exact address or
postcode, exact date of birth (year can be given), NHS number
Diagnoses
Medical diagnoses for all conditions and symptoms, date of diagnosis, and location (e.g., GP’s office, hospital, consultant) of the event and
adding free text (optional); referrals to hospitals and specialists.
Secondary care information and other related information received by the practice, including (details on hospital, admissions, discharge
medication and diagnosis, outpatient consultation diagnosis, investigation and treatment outcomes)
THIN data linked with HES.
Prescribing All prescriptions along with the date issued, formulation, strength, quantity, and dosing instructions, indication for treatment for all newprescriptions (inferred from cross reference to medical events on the same date), and events leading to withdrawal of a drug or treatment.
AHD Vaccinations and prescription contraceptives; smoking, height, weight, immunizations, pregnancy, birth, death, and laboratory results.
Free Text Comments Free text fields that can contain confidential or identifying information that is pseudonymised by THIN.
Socioeconomic/PVI Postcode linked area based socio-economic, ethnicity and environmental indices





Practice Regional health authority, town size, patients per practice in the current quarter, patients per practice in the last quarter, drug-dispensing flag,number of GPs
Doctor Active status, age, sex, date of birth, doctor registration year, trainer status
Patient Age, sex, height, weight and BMI, marital status, registration status, regional health authority
Consultation day Date of visit
Clinical records Read codes and text, ICD-10 codes and text, referral records, sick notes, tests, further diagnosis and symptoms, history of or family history
Therapy records Medication, manufacturer, ATC, product (brand and generic name), pack form, therapy text (Read code), price, pack size, form and strength,recommended dosages, therapy stop
ACD: Additional Clinical Details; AHD: Additional Health Data; PVI: Postcode variable indicators; BNF: British National Formulary; HSE: Hospital Episode Statistics; BMI: Body Mass



























Appendix 5. IMS-DA Read codes dictionary for UTIs Study
Code Description Code Description
Kyu6. [X]Disease/male genital organs 14D4. H/O: recurrent cystitis
Kyu50 [X]Other chronic cystitis 14D7. H/O: recurrent UTI
Kyu51 [X]Other cystitis 8D74. Indwelling urethral catheter
K150. Acute cystitis K10z. Infection of kidney NOS
14D2. H/O: kidney infection K10.. Infections of kidney
68D2. Asympt. bacteriuria screen K1021 Perinephric abscess
K1900 Bacteriuria,site not specified K1902 Post-operative UTI
4JJ4. Catheter urine -> culture. K10y4 Pyelitis + disease EC
K1001 Chr.pyelonephr.+medullary necr K10y1 Pyelitis unspecified
K1000 Chr.pyelonephr.-no medull.necr K10y3 Pyelonephritis + disease EC
K1005 Chron obstructv pyelonephritis K10yz Pyelonephritis unspecif.NOS
K152y Chronic cystitis unspecified K10y0 Pyelonephritis unspecified
A9831 Chronic gonococcal cystitis K10y. Pyelonephritis/pyonephr.unspec
K151z Chronic interstit.cystitis NOS K103. Pyeloureteritis cystica
K151. Chronic interstitial cystitis K10y2 Pyonephrosis unspecified
K1002 Chronic pyelitis K1901 Pyuria, site not specified
K100. Chronic pyelonephritis 1AG Recur urinary tract infections
K100z Chronic pyelonephritis NOS K155. Recurrent cystitis
K1003 Chronic pyonephrosis K1903 Recurrent urinary tract infecn
K1904 Chronic urinary tract infectn K1020 Renal abscess
K15.. Cystitis K102. Renal and perinephric abscess
K1540 Cystitis + actinomycosis K102z Renal/perinephric abscess NOS
K1541 Cystitis + amoebiasis 1J4.. Suspected UTI
K1542 Cystitis + bilharziasis K190z Urinary tract infect.unsp.NOS
K1544 Cystitis + diphtheria K190. Urinary tract infect.unsp.site
K1543 Cystitis + echinococcus infest K1905 Urinary tract infection
K1545 Cystitis + gonorrhoea K1012 Acute pyelitis
K1546 Cystitis + moniliasis K1011 Acute pyelitis
K1547 Cystitis + trichomoniasis K1010 Acute pyelitis
K1548 Cystitis + tuberculosis K101. Acute pyelonephritis
K15y0 Cystitis cystica K101z Acute pyelonephritis NOS
K154. Cystitis in diseases EC K1530 Acute trigonitis
K154z Cystitis in diseases EC NOS K1004 Nonobstr rflx/ass chrn pyelnph
K15z. Cystitis NOS K152. Other chronic cystitis
A32y3 Diphtheritic cystitis K152z Other chronic cystitis NOS
Q001. Fetus+mat.renal/urinary diseas K15yz Other cystitis NOS
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3. Date of prescription
4. Read code level 4 or 5
5. ICD-10 code level 4
6. ATC code level 4
7. Product name
8. Name of product form
9. Strength
10. Unit of strength
11. Volume




16. Unit of prescribed quantity
17. Measurement unit of prescribed quantity
18. Daily dosage
19. Unit of daily dosage
20. Measurement unit of daily dosage
21. Duration (days)
22. Read code description
23. Sex
24. Date of birth (year)
25. Birth year
26. Start of follow up period
27. End of follow up period
28. Year of prescription
29. Age at event
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Appendix 7. EphMRA AT main therapeutics group for antibacterial
agents used in IMS-DA
ATC Code Drug Substance Name
G4A URINARY ANTI-INFECTIVES AND ANTISEPTICS
G4A1 Urinary antibacterials
 G4A2 Urinary non-halogenated quinolones
 G4A3 Out of use; can be reused from 2010
G4A9 Other urinary antiseptics
 G4B Out of use; can be reused from 201
J GENERAL ANTI-INFECTIVES SYSTEMIC
J1 SYSTEMIC ANTIBACTERIALS
J1A TETRACYCLINES AND COMBINATIONS
J1B CHLORAMPHENICOL AND COMBINATIONS
J1C BROAD SPECTRUM PENICILLINS
J1C1 Oral broad spectrum penicillins




J1E TRIMETHOPRIM AND SIMILAR FORMULATIONS




J1H MEDIUM AND NARROW SPECTRUM PENICILLINS
J1H1 Plain medium and narrow spectrum penicillins
J1H2 Penicillin/streptomycin combinations
J1J Out of use; can be reused.
J1K AMINOGLYCOSIDES
J1L CARBENICILLIN AND SIMILAR TYPES
J1M RIFAMPICIN/RIFAMYCIN
J1N Out of use; can be re-used from 1997
J1P OTHER BETA-LACTAM ANTIBACTERIALS, EXCLUDINGPENICILLINS, CEPHALOSPORINS
J1P1 Monobactams
J1P2 Penems and carbapenems
J1P3 Carbacephems




J1X9 All other antibacterials
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Renal and perinephric abscess
Pyelitis unspecified
Infection of kidney NOS
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Appendix 9. Email response from the Research Ethics office at King’s
College London regarding DUR study ethical approval
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Appendix 10. Email from IMS Health ISEAC committee with regard to
DUR study research protocol and results publication approval
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Appendix 11. Recruitment email circulated research through the
assistance of the Primary Care Research Manager at Imperial College
London, Department of Primary Care and Public Health
From: El-Osta, Austen
Sent: 28 November 2014 18:11
To: Newth, Aisha; Gnani, Shamini; Stewart, Tara E; Browning, Neil R; Block, Martin L
Cc: Alomar, Hussain (hussain.al-omar@kcl.ac.uk)
Subject: Expression of Interest: Variations in ABX prescribing for UTI
Dear colleagues,
Hussain Al-Omar is conducting a PhD study on ‘Variations in GPs’ views and perceptions
and factors influencing GPs’ antibiotics prescribing for UTIs in elderly patients in a
primary care setting’, and is keen to meet with up to 20 GPs to inform his research via 30-
45min discussion. Please see trailing email below about Hussain’s doctoral research interest.
Hussain would be delighted to meet with you should you have the time to fit him in your busy
diary. He would of course be happy to work around your schedule and to meet you at your
practice/or wherever is convenient for you.
Hussain is happy to extend £100 in Amazon vouchers as a token gesture for your time.
Please do not hesitate to contact Hussain should you have an interest in supporting his research,
and should you be able to fit him in over the next couple of weeks.
N.B. for those interested to participate, please email Hussain with your age, gender, certificates,
years of experience, practice site location and whether you work in a private or NHS or NHS
partner surgery.




Clinical Practice and Medication Use Group














My name is Hussain Alomar, a PhD student, and I am doing qualitative research with a focus on
antibacterials prescribing by GPs. My research title is ‘Variations in GPs’ views and perceptions
and factors influencing GPs’ antibiotics prescribing for UTIs in elderly patients in a primary
care setting’ and I am trying to interview GPs for this research. GPs who meet the following
inclusion criteria are welcomed to take part in this research:
x GP with a degree in medicine,
x working in any NHS or NHS partner general practice surgery in Greater London
x working as a part-time or full-time GP
x any age,
x any gender,
x any practice locations,
x any practice size,
x any contract scheme,
x any number of years or practice,
x any level of experience and training qualifications.
Exclusion criteria:
x GP working in a private general practice surgery,
x GP working in any university or college primary care centre or surgery,
x GP with a poor command of English,
x GP with poor communication skills.
I am aiming to start the interviews by 7 January 2015. The interview will take approximately
one hour and will be digitally recorded. If you agree to participate, I will be happy to schedule a
meeting with you according to your preference for date, time and place.
As a token gesture for GPs who support this research, I will be happy to extend £100 in the
form of an Amazon gift card.




Clinical Practice and Medication Use Group










Appendix 13. Information Sheet sent through email to selected GPs
INFORMATION SHEET FOR PARTICIPANTS
YOU WILL BE GIVEN A COPY OF THIS INFORMATION SHEET
Title  of  Study: Variations in GPs’ views and perceptions and factors influencing GPs’
antibiotics prescribing for UTIs in elderly patients in a primary care setting
Invitation
I invite you to participate in this study, which will form part of my PhD research at the Institute
of Pharmaceutical Science, King’s College London. You should participate only if you want to;
choosing not to participate will not disadvantage you in any way. Before you decide whether you
want to participate, it is important for you to understand why the study is being done and what
your participation will involve. Please take the time to read the following Information Sheet
carefully and discuss it with others if you wish. Ask me if there is anything that is not clear or if
you would like more information.
What is the purpose of the study?
The purpose of this study is to explore the variations in the ways GPs experience, conceptualise,
perceive and understand antibiotics prescribing practice for elderly patients with UTIs.
Why have I been invited to take part?
You have been invited to participate in this study because you are a GP working in a primary care
setting and I believe that your experience and qualifications as a GP can contribute much to the
understanding and knowledge of this phenomenon regarding elderly patients with UTIs.
Do I have to take part?
Your participation in this study is entirely voluntary. You may refuse to participate without
providing any reasons and this will not disadvantage you in any way. You may choose to ask for
independent information or advice about your rights as a participant or about being involved in
this particular study by discussing it with others if you wish.
If you decide to participate, you will be given this Information Sheet to keep and asked to sign a
Consent Form. You may also withdraw your data from the study at any time before 28 February
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2015. You may also refuse to answer some or all of the questions if you do not feel comfortable
with them. You should not agree to take part in this research until you have had all your questions
answered satisfactorily.
What will happen to me if I take part?
If you decide to participate in this study, you will be given this Information Sheet to keep and
asked to sign a Consent Form. The researcher will then contact you to discuss the details of the
study and the interview process, schedule the interview at a time that is convenient for you and
answer your questions. The interview will take place at your practice site, at any comfortable
place of your choice or at King’s College London, Franklin-Wilkins Building, 150 Stamford
Street, London, UK, whichever is most convenient for you.
The  interview  will  last  approximately  1  hour  and  will  be  based  on  the  interview  topic  guide,
although it is designed to be flexible. If you do not wish to answer any of the questions during the
interview, you may say so and the researcher will move on to the next question. The questions
will revolve around general prescribing practice, antibacterial prescribing practice with a focus
on elderly patients with UTIs and antibacterial guidelines, recommendations and decision support
tools, to improve antibacterial prescribing practice. The questions will be straightforward and
simple, asking what, how and why? You will then be asked to answer questions about your
demographics information, educational background, qualifications and practice. The researchers
will talk with you about such phenomenon in a sensitive, non-judgemental and empathic way.
The entire interviews will be digitally recorded, but participants will not be identified by name.
The recorded interviews will be kept on password-locked and encrypted computer files and locked
filing cabinets in the researcher’s office at the Institute of Pharmaceutical Science, King’s College
London, Franklin-Wilkins Building, 150 Stamford Street, London, UK, until the study is finished.
The information recorded is confidential, and no one else except the researcher and his research
supervisors will have access to the digitally recorded interviews or transcripts. All of the digitally
recorded interviews and transcripts will be deleted after completing the PhD research. If you
change your mind and decide that you no longer want to take part, you may withdraw your data
from the study at any time before 28 February 2015. You will not have to give a reason for your
withdrawal.
What will happen if I participate in the study but then I want to withdraw from the study?
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Participants can withdraw from the study/withdraw their data at any time without having to justify
their decision. If you decide to withdraw from the study it must be before 28 February 2015. All
of your information, recorded interview and data will be deleted.
Incentives
There will be an incentive of £100 payable as an Amazon gift card. This gift card will be given
only to those who complete the interview successfully and do not withdraw from the study. This
incentive is given as reimbursement for participants’ time lost to take part in this study. The gift
card will be distributed by the end of the study.
What are the possible disadvantages or risks of taking part?
There are no expected risks of participating in the study. However, the main disadvantage in
participating in this study is that you will be spending approximately an hour of your time being
interviewed. Some of the interview questions might cause psychological distress, anxiety or might
be challenging. However, if you feel the questions are challenging and/or distressing or you feel
uncomfortable, you can refuse to answer them and the researcher will move to the next question.
What are the possible benefits of taking part?
There are no direct benefits of your participation in this study. However, the information I get
from the research will help to improve the quality of antibacterial prescribing for older people.
This improvement will be noticed in the form of improving patients’ outcomes, decreasing
antibacterial resistance and reducing economic expenditure on all levels. Furthermore, if you like,
a copy of the study findings can be sent to you by the end of the study.
Will my taking part be kept confidential?
All the data and information collected about you during the study will be kept strictly confidential.
All information gathered within the interviews will be held on password-locked and encrypted
computer files and locked filing cabinets in the researcher’s office at the Institute of
Pharmaceutical Science, King’s College London, Franklin-Wilkins Building, 150 Stamford
Street. Your information and interview will not be shared with or given to anyone except the
research supervisors. At all times there will be no possibility of you as individuals being linked
with the data. All recordings of data on the digital recorder and transcripts will be deleted after
the PhD research is completed.
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The data will be collected and stored in accordance with the UK Data Protection Act (1998),
secured and encrypted against unauthorised access.
What will happen to the results of the study?
The  results  and  findings  from  this  research  will  be  part  of  the  researcher’s  PhD  thesis,
disseminated through scientific publications, conferences and seminars. If you like, a copy of the
study results can be sent to you once the study is completed.
Who should I contact for further information?
If you have any questions or require more information about this research, please contact me or
my research supervisors using the following contact details:
Mr Hussain Alomar
PhD Research Student
Clinical Practice and Medication Use Group


















Dr Sue C Jones











What if I have further questions, or if something goes wrong?
If  this study has harmed you in any way or if  you wish to make a complaint about the
conduct of the study you can contact my supervisors at King’s College London using the











Dr Sue C Jones


























Appendix 15. The result from NRES online decision tool regarding
ethical requirement for qualitative research
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2010 2011 2012 Over studyperiod
N  % N  % N  % N  %
65-74
1 visit 1,991 67 1,853 64.6 1,588 63.8 3,928 59.8
2 visits 524 17.6 576 20.1 482 19.4 1,211 18.4
3 Visits 456 15.3 440 15.3 418 16.8 1,429 21.8
75-84
1 visit 1,886 63.6 1,696 64.9 1,481 64 3,532 53.8
2 visits 550 18.6 480 18.4 432 18.7 1,106 16.8
3 Visits 528 17.8 438 16.8 401 17.3 1,938 29.5
85
1 visit 1,220 64.7 1,159 64 992 61.9 2,406 36.6
2 visits 345 18.3 315 17.4 325 20.3 714 10.9


















2010 2011 2012 p - value Over study periodAntimicrobial N % N % N % N %
Trimethoprim 5,826 43 5,245 40.8 4,701 41.2 0.68 15,772 41.7
Nitrofurantoin 2,892 21.3 3,324 25.9 3,232 28.3 0.11 9,448 25
Cefalexin 2,047 15.1 1,725 13.4 1,270 11.1 0.06 5,042 13.3
Co-amoxiclav 822 6.1 767 6 761 6.7 0.42 2,350 6.2
Ciprofloxacin 717 5.3 647 5 556 4.9 0.18 1,920 5.1
Amoxicillin 660 4.9 645 5 561 4.9 0.99 1,866 4.9
Others 587 4.33 496 3.86 334 2.93 0.04 1,417 3.7
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